CREDIT AGREEMENT dated as of September 25, 2013, among BLACKLINE SYSTEMS, INC., SLS BREEZE INTERMEDIATE HOLDINGS, INC. THE LENDERS PARTY HERETO and OBSIDIAN AGENCY SERVICES, INC., as Administrative Agent and Collateral Agent
Exhibit 10.2
EXECUTION VERSION
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Β
dated as of
SeptemberΒ 25, 2013,
among
BLACKLINE SYSTEMS, INC.,
SLS BREEZE INTERMEDIATE HOLDINGS, INC.
THE LENDERS PARTY HERETO
and
OBSIDIAN AGENCY SERVICES, INC.,
as Administrative Agent and Collateral Agent
Β
Β
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Table of Contents
Β
Β | Β | Β | Β Β | Page | Β | |
ARTICLE I DEFINITIONS |
Β Β | Β | 1 | Β Β | ||
SECTION 1.01. | Β | Defined Terms | Β Β | Β | 1 | Β Β |
SECTION 1.02. | Β | Terms Generally | Β Β | Β | 24 | Β Β |
SECTION 1.03. | Β | Independence of Covenants | Β Β | Β | 25 | Β Β |
SECTION 1.04. | Β | Deliveries | Β Β | Β | 25 | Β Β |
SECTION 1.05. | Β | Construction | Β Β | Β | 25 | Β Β |
SECTION 1.06. | Β | Certain Pro Forma Calculations | Β Β | Β | 25 | Β Β |
SECTION 1.07. | Β | Certain Increased Amounts | Β Β | Β | 25 | Β Β |
ARTICLE II THE CREDITS |
Β Β | Β | 26 | Β Β | ||
SECTION 2.01. | Β | Commitments | Β Β | Β | 26 | Β Β |
SECTION 2.02. | Β | Loans; Notice of Borrowing | Β Β | Β | 26 | Β Β |
SECTION 2.03. | Β | Disbursement of Funds | Β Β | Β | 26 | Β Β |
SECTION 2.04. | Β | Evidence of Debt; Repayment of Loans | Β Β | Β | 27 | Β Β |
SECTION 2.05. | Β | Fees | Β Β | Β | 28 | Β Β |
SECTION 2.06. | Β | Interest on Loans | Β Β | Β | 28 | Β Β |
SECTION 2.07. | Β | Default Interest | Β Β | Β | 29 | Β Β |
SECTION 2.08. | Β | Termination of Commitments | Β Β | Β | 29 | Β Β |
SECTION 2.09. | Β | Repayment of Loans | Β Β | Β | 29 | Β Β |
SECTION 2.10. | Β | Optional Prepayment | Β Β | Β | 30 | Β Β |
SECTION 2.11. | Β | Mandatory Prepayments | Β Β | Β | 31 | Β Β |
SECTION 2.12. | Β | Reserve Requirements; Change in Circumstances | Β Β | Β | 33 | Β Β |
SECTION 2.13. | Β | Indemnity | Β Β | Β | 34 | Β Β |
SECTION 2.14. | Β | Pro Rata Treatment | Β Β | Β | 34 | Β Β |
SECTION 2.15. | Β | Ratable Sharing | Β Β | Β | 34 | Β Β |
SECTION 2.16. | Β | Payments | Β Β | Β | 35 | Β Β |
SECTION 2.17. | Β | Taxes | Β Β | Β | 35 | Β Β |
SECTION 2.18. | Β | Assignment of Loans Under Certain Circumstances; Duty to Mitigate | Β Β | Β | 39 | Β Β |
SECTION 2.19. | Β | Obsidian Agency Services as Administrative Agent | Β Β | Β | 40 | Β Β |
SECTION 2.20. | Β | Tax Treatment | Β Β | Β | 40 | Β Β |
SECTION 2.21. | Β | AHYDO | Β Β | Β | 40 | Β Β |
SECTION 2.22. | Β | Incremental Facility | Β Β | Β | 40 | Β Β |
ARTICLE III REPRESENTATIONS AND WARRANTIES |
Β Β | Β | 43 | Β Β | ||
SECTION 3.01. | Β | Organization; Powers | Β Β | Β | 43 | Β Β |
SECTION 3.02. | Β | Authorization | Β Β | Β | 43 | Β Β |
SECTION 3.03. | Β | Enforceability | Β Β | Β | 43 | Β Β |
SECTION 3.04. | Β | Governmental Approvals; Third Party Approvals | Β Β | Β | 43 | Β Β |
SECTION 3.05. | Β | Financial Statements | Β Β | Β | 44 | Β Β |
SECTION 3.06. | Β | Title to Properties; Possession Under Leases | Β Β | Β | 44 | Β Β |
SECTION 3.07. | Β | Subsidiaries; Ownership Interests | Β Β | Β | 45 | Β Β |
SECTION 3.08. | Β | Litigation; Compliance with Laws | Β Β | Β | 45 | Β Β |
SECTION 3.09. | Β | Agreements | Β Β | Β | 45 | Β Β |
SECTION 3.10. | Β | Federal Reserve Regulations | Β Β | Β | 46 | Β Β |
Β
i
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Table of Contents
(continued)
Β
Β | Β | Β | Β Β | Page | Β | |
SECTION 3.11. | Β | Government Regulation | Β Β | Β | 46 | Β Β |
SECTION 3.12. | Β | Use of Proceeds | Β Β | Β | 46 | Β Β |
SECTION 3.13. | Β | Tax Returns | Β Β | Β | 46 | Β Β |
SECTION 3.14. | Β | No Material Misstatements | Β Β | Β | 46 | Β Β |
SECTION 3.15. | Β | Employee Benefit Plans | Β Β | Β | 47 | Β Β |
SECTION 3.16. | Β | Environmental Matters | Β Β | Β | 47 | Β Β |
SECTION 3.17. | Β | Insurance | Β Β | Β | 47 | Β Β |
SECTION 3.18. | Β | Security Documents | Β Β | Β | 47 | Β Β |
SECTION 3.19. | Β | Location of Real Property and Leased Premises | Β Β | Β | 48 | Β Β |
SECTION 3.20. | Β | Labor Matters | Β Β | Β | 48 | Β Β |
SECTION 3.21. | Β | Solvency | Β Β | Β | 48 | Β Β |
SECTION 3.22. | Β | No Material Adverse Effect | Β Β | Β | 49 | Β Β |
SECTION 3.23. | Β | Sanctioned Persons | Β Β | Β | 49 | Β Β |
SECTION 3.24. | Β | Financial Advisors | Β Β | Β | 49 | Β Β |
SECTION 3.25. | Β | Foreign Assets Control Regulations, Etc. | Β Β | Β | 49 | Β Β |
SECTION 3.26. | Β | Deposit Accounts; Securities Accounts | Β Β | Β | 50 | Β Β |
SECTION 3.27. | Β | Indebtedness | Β Β | Β | 50 | Β Β |
SECTION 3.28. | Β | Intellectual Property; Copyright Matters | Β Β | Β | 50 | Β Β |
SECTION 3.29. | Β | Activities of Holdings | Β Β | Β | 51 | Β Β |
ARTICLE IV CONDITIONS OF LENDING |
Β Β | Β | 51 | Β Β | ||
SECTION 4.01. | Β | Conditions Precedent to Closing | Β Β | Β | 51 | Β Β |
SECTION 4.02. | Β | Post Closing Obligations | Β Β | Β | 55 | Β Β |
ARTICLE V AFFIRMATIVE COVENANTS |
Β Β | Β | 56 | Β Β | ||
SECTION 5.01. | Β | Existence; Compliance with Laws; Businesses and Properties | Β Β | Β | 56 | Β Β |
SECTION 5.02. | Β | Insurance | Β Β | Β | 56 | Β Β |
SECTION 5.03. | Β | Obligations and Taxes | Β Β | Β | 57 | Β Β |
SECTION 5.04. | Β | Financial Statements, Reports, etc | Β Β | Β | 57 | Β Β |
SECTION 5.05. | Β | Litigation and Other Notices | Β Β | Β | 58 | Β Β |
SECTION 5.06. | Β | Information Regarding Collateral | Β Β | Β | 59 | Β Β |
SECTION 5.07. | Β | Maintaining Records; Access to Properties and Inspections | Β Β | Β | 59 | Β Β |
SECTION 5.08. | Β | Use of Proceeds | Β Β | Β | 60 | Β Β |
SECTION 5.09. | Β | Employee Benefits | Β Β | Β | 60 | Β Β |
SECTION 5.10. | Β | Compliance with Environmental Laws | Β Β | Β | 60 | Β Β |
SECTION 5.11. | Β | Preparation of Environmental Reports | Β Β | Β | 60 | Β Β |
SECTION 5.12. | Β | Further Assurances | Β Β | Β | 60 | Β Β |
ARTICLE VI NEGATIVE COVENANTS |
Β Β | Β | 62 | Β Β | ||
SECTION 6.01. | Β | Indebtedness | Β Β | Β | 62 | Β Β |
SECTION 6.02. | Β | Liens | Β Β | Β | 65 | Β Β |
SECTION 6.03. | Β | Sale and Lease-Back Transactions | Β Β | Β | 68 | Β Β |
SECTION 6.04. | Β | Investments | Β Β | Β | 68 | Β Β |
SECTION 6.05. | Β | Consolidations, Dispositions of Assets and Acquisitions | Β Β | Β | 71 | Β Β |
SECTION 6.06. | Β | Restricted Payments; Restrictive Agreements | Β Β | Β | 73 | Β Β |
SECTION 6.07. | Β | Transactions with Affiliates | Β Β | Β | 74 | Β Β |
SECTION 6.08. | Β | Business of Holdings, Borrower and Subsidiaries | Β Β | Β | 75 | Β Β |
SECTION 6.09. | Β | Other Indebtedness and Agreements, etc. | Β Β | Β | 75 | Β Β |
SECTION 6.10. | Β | Maximum Consolidated Leverage Ratio | Β Β | Β | 76 | Β Β |
Β
ii
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Table of Contents
(continued)
Β
Β | Β | Β | Β Β | Page | Β | |
SECTION 6.11. | Β | Fiscal Year | Β Β | Β | 76 | Β Β |
SECTION 6.12. | Β | Amendments or Waivers of Documents Relating to Subordinated Indebtedness, Certain Documents and Equity Interests | Β Β | Β | 77 | Β Β |
SECTION 6.13. | Β | Conduct of Business by Holdings | Β Β | Β | 77 | Β Β |
ARTICLE VII EVENTS OF DEFAULT |
Β Β | Β | 77 | Β Β | ||
SECTION 7.01. | Β | Events of Default | Β Β | Β | 77 | Β Β |
SECTION 7.02. | Β | Right to Cure | Β Β | Β | 80 | Β Β |
ARTICLE VIII THE ADMINISTRATIVE AGENT AND THE COLLATERAL AGENT |
Β Β | Β | 82 | Β Β | ||
ARTICLE IX MISCELLANEOUS |
Β Β | Β | 85 | Β Β | ||
SECTION 9.01. | Β | Notices | Β Β | Β | 85 | Β Β |
SECTION 9.02. | Β | Survival of Agreement | Β Β | Β | 85 | Β Β |
SECTION 9.03. | Β | Binding Effect | Β Β | Β | 86 | Β Β |
SECTION 9.04. | Β | Successors and Assigns | Β Β | Β | 86 | Β Β |
SECTION 9.05. | Β | Expenses; Indemnity | Β Β | Β | 89 | Β Β |
SECTION 9.06. | Β | Right of Setoff | Β Β | Β | 91 | Β Β |
SECTION 9.07. | Β | Applicable Law | Β Β | Β | 91 | Β Β |
SECTION 9.08. | Β | Waivers; Amendment | Β Β | Β | 91 | Β Β |
SECTION 9.09. | Β | Interest Rate Limitation | Β Β | Β | 92 | Β Β |
SECTION 9.10. | Β | Entire Agreement | Β Β | Β | 92 | Β Β |
SECTION 9.11. | Β | WAIVER OF JURY TRIAL | Β Β | Β | 92 | Β Β |
SECTION 9.12. | Β | Severability | Β Β | Β | 93 | Β Β |
SECTION 9.13. | Β | Counterparts | Β Β | Β | 93 | Β Β |
SECTION 9.14. | Β | Headings | Β Β | Β | 93 | Β Β |
SECTION 9.15. | Β | Jurisdiction; Consent to Service of Process | Β Β | Β | 93 | Β Β |
SECTION 9.16. | Β | Confidentiality | Β Β | Β | 93 | Β Β |
SECTION 9.17. | Β | USA PATRIOT Act Notice | Β Β | Β | 94 | Β Β |
Β
iii
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SCHEDULES
Β
Schedule 1.01(a) |
Β Β | βΒ Β | Β Β | Subsidiary Guarantors |
Schedule 1.01(c) |
Β Β | βΒ Β | Β Β | Existing Debt to Be Repaid |
Schedule 2.01 |
Β Β | βΒ Β | Β Β | Lenders and Commitments |
Schedule 3.07(a) |
Β Β | βΒ Β | Β Β | Subsidiaries |
Schedule 3.07(c) |
Β Β | βΒ Β | Β Β | Stock Appreciation Rights, Phantom Stock Plans or Similar Plans |
Schedule 3.08 |
Β Β | βΒ Β | Β Β | Litigation |
Schedule 3.17 |
Β Β | βΒ Β | Β Β | Insurance |
Schedule 3.18(a) |
Β Β | βΒ Β | Β Β | UCC Filing Offices |
Schedule 3.19(a) |
Β Β | βΒ Β | Β Β | Owned Real Property |
Schedule 3.19(b) |
Β Β | βΒ Β | Β Β | Leased Real Property |
Schedule 3.24 |
Β Β | βΒ Β | Β Β | Financial Advisors |
Schedule 3.26 |
Β Β | βΒ Β | Β Β | Deposit Accounts and Securities Accounts |
Schedule 3.28(a) |
Β Β | βΒ Β | Β Β | Intellectual Property |
Schedule 6.01 |
Β Β | βΒ Β | Β Β | Existing Indebtedness |
Schedule 6.02 |
Β Β | βΒ Β | Β Β | Existing Liens |
Schedule 6.04 |
Β Β | βΒ Β | Β Β | Existing Investments |
Schedule 6.07 |
Β Β | βΒ Β | Β Β | Transactions with Affiliates |
EXHIBITS
Β
Exhibit A |
Β Β | βΒ Β | Β Β | Form of Notice of Borrowing |
Exhibit B |
Β Β | βΒ Β | Β Β | Form of Note |
Exhibit C |
Β Β | βΒ Β | Β Β | Form of Administrative Questionnaire |
Exhibit D |
Β Β | βΒ Β | Β Β | Form of Assignment and Acceptance |
Exhibit E |
Β Β | βΒ Β | Β Β | Form of Guarantee and Collateral Agreement |
Exhibit F |
Β Β | βΒ Β | Β Β | Capitalization Table |
Exhibit G |
Β Β | βΒ Β | Β Β | Form of Solvency Certificate |
Exhibit H |
Β Β | Β Β | Form of Warrant Agreement | |
Exhibit I |
Β Β | Β Β | Form of Warrant |
Β
iv
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
This CREDIT AGREEMENT (this βAgreementβ) is dated as of SeptemberΒ 25, 2013 and entered into by and among BLACKLINE SYSTEMS, INC., a California corporation (the βBorrowerβ), SLS BREEZE INTERMEDIATE HOLDINGS, INC., a Delaware corporation (βHoldingsβ), the Lenders (as defined in Article I), and OBSIDIAN AGENCY SERVICES, INC., as administrative agent (in such capacity, the βAdministrative Agentβ) and as collateral agent (in such capacity, the βCollateral Agentβ) for the Lenders.
PRELIMINARY STATEMENT
Holdings and the Borrower desire that the Lenders extend a term loan to the Borrower to refinance certain existing indebtedness, to pay certain transaction expenses and for working capital and other general corporate purposes of the Borrower and its Subsidiaries, including, to the extent permitted hereby, to make capital expenditures, acquisitions, investments and distributions from time to time.
The Lenders have agreed to extend such term loan to the Borrower.
The Borrower desires to secure all of the Obligations hereunder and under the other Loan Documents by granting to the Collateral Agent, for the benefit of the Secured Parties, a first priority Lien (subject to Liens permitted by SectionΒ 6.02) on substantially all of its assets, as and to the extent provided herein and in the other Loan Documents.
Holdings and all of the Domestic Subsidiaries of the Borrower (subject to exceptions set forth herein and the other Loan Documents) have agreed to guarantee the Obligations hereunder and under the other Loan Documents and to secure their guaranties by granting to the Collateral Agent, for the benefit of the Secured Parties, a first priority Lien (subject to Liens permitted by SectionΒ 6.02) on substantially all of their respective assets, as and to the extent provided herein and in the other Loan Documents.
The Lenders are willing to extend such term loan to the Borrower on the terms and subject to the conditions set forth herein. Accordingly, the parties hereto agree as follows:
ARTICLE I
Definitions
SECTIONΒ 1.01. Defined Terms.
As used in this Agreement, the following terms shall have the meanings specified below:
βAcceptance Noticeβ shall have the meaning assigned to such term in Section 2.22.
βAcquired Entityβ shall have the meaning assigned to such term in SectionΒ 6.04(vii).
βAcquisitionβ shall mean the acquisition of the Borrower by Holdings pursuant to the Acquisition Agreement.
βAcquisition Agreementβ shall mean that certain Agreement and Plan of Merger, dated as of AugustΒ 9, 2013, by and among SLS Breeze Holdings, Inc., SLS Breeze Intermediate Holdings, Inc., SLS Breeze Merger Sub, Inc. and Blackline Systems, Inc.
Β
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βAdministrative Agentβ shall have the meaning assigned to such term in the Preamble.
βAdministrative Questionnaireβ shall mean an Administrative Questionnaire in the form of Exhibit C, or such other form as may be supplied from time to time by the Administrative Agent.
βAffiliateβ shall mean, when used with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified; provided, however, that, for purposes of SectionΒ 6.07, the term βAffiliateβ shall also include any Person that directly or indirectly owns 10% or more of any class of Equity Interests of the Person specified or that is an officer or director of the Person specified.
βAgentsβ shall have the meaning assigned to such term in Article VIII.
βAgreementβ shall mean this Credit Agreement.
βAlternate Base Rateβ means, for any day, a fluctuating rate of interest per annum equal to the highest of:
(i) the Prime Rate in effect on such day; and
(ii) the Federal Funds Effective Rate in effect on such day plus Β 1β2 of 1.0%Β per annum.
Any change in the Alternate Base Rate due to a change in the Prime Rate or the Federal Funds Effective Rate shall be effective from and including the effective day of such change in the Prime Rate or the Federal Funds Effective Rate, respectively. Interest calculated pursuant to clause (i)Β above will be determined based on a year of 365 days or 366 days, as applicable and actual days elapsed. Interest calculated pursuant to clause (ii)Β above will be determined based on a year of 360 days and actual days elapsed.
βApplicable Prepayment Premiumβ shall have the meaning assigned to such term in Section 2.10(a).
βAsset Saleβ shall mean the sale, transfer, license or other Disposition by Holdings, the Borrower or any Subsidiary to any Person (other than the Borrower or any Subsidiary Guarantor) of (i)Β any of the Equity Interests of the Borrower or any of its Subsidiaries, (ii)Β substantially all of the assets of any division or line of business of the Borrower or any of its Subsidiaries, or (iii)Β any other assets (whether tangible or intangible) of the Borrower or any of its Subsidiaries (other than (a)Β inventory sold in the ordinary course of business, (b)Β sales, assignments, transfers or Dispositions of accounts in the ordinary course of business for purposes of collection, (c)Β non-exclusive licenses and sublicenses of Intellectual Property, in the ordinary course of business, (d)Β leasing and sub-leasing of property and (e)Β any such other assets to the extent that the aggregate value of such assets sold or otherwise Disposed of in any fiscal year of the Borrower does not exceed $500,000); provided that (y)Β a Casualty Event, the issuance of Equity Interests of Holdings, the issuance of Equity Interests of Borrower or any Subsidiary to Holdings or any other Loan Party or the issuance by Holdings or any of its Subsidiaries of Indebtedness shall not constitute an Asset Sale and (z)Β the events set forth in clausesΒ (iv), (vi), (vii), (x), (xii), (xvi), (xvii)Β and (xix)Β of SectionΒ 6.05 shall not constitute an Asset Sale for purposes of SectionΒ 2.11(a) or the definition of βNet Asset Sale Proceeds.β
Β
2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βAssignment and Acceptanceβ shall mean an assignment and acceptance entered into by a Lender and an Eligible Assignee and with the consent of any Person whose consent is required by SectionΒ 9.04(b), in the form of Exhibit D or such other form as shall be approved by the Administrative Agent.
βBankruptcy Codeβ shall mean Title 11 of the United States Code entitled βBankruptcyβ, as now and hereafter in effect, or any successor statute.
βBoardβ shall mean the Board of Governors of the Federal Reserve System of the United States of America.
βBorrowerβ shall have the meaning assigned to such term in the Preamble.
βBusiness Dayβ shall mean any day other than a Saturday, Sunday or day on which banks in New York, New York or Los Angeles, California are authorized or required by law to close.
βCapital Lease Obligationsβ of any Person shall mean the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP; provided that the adoption or issuance of any accounting standards after the Closing Date will not cause any lease that was not or would not have been Capital Lease Obligations prior to such adoption or issuance to be deemed Capital Lease Obligations.
βCasualty Eventβ shall mean any event or occurrence described in clauses (i)Β and/or (ii)Β of the definition of βNet Insurance/Condemnation Proceedsβ.
βCFCβ shall mean a βcontrolled foreign corporationβ within the meaning of SectionΒ 957(a) of the Code.
βChange in Lawβ shall mean (a)Β the adoption of any law, rule or regulation after the date of this Agreement, (b)Β any change in any law, rule or regulation or in the interpretation or application thereof by any Governmental Authority after the date of this Agreement or (c)Β compliance by any Lender (or, for purposes of SectionΒ 2.12, by any lending office of such Lender or by such Lenderβs holding company, if any) with any request, guideline or directive (whether or not having the force of law) of any Governmental Authority made or issued after the date of this Agreement; provided that notwithstanding anything herein to the contrary, (x)Β the XxxxβXxxxx Xxxx Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives issued thereunder or in connection therewith and (y)Β all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a βChange in Law,β regardless of the day enacted, adopted, issued or implemented.
βChange of Controlβ shall mean the occurrence of any of the following:
(i) the Permitted Holders collectively shall cease to beneficially own and Control at least 25% on a fully diluted basis of (x)Β the issued and outstanding Equity Interests of Holdings entitled (without regard to the occurrence of any contingency) to vote for the election of members of the Governing Body of Holdings or (y)Β the total economic interests (for the avoidance of doubt, which shall exclude any Indebtedness (other than Disqualified Stock)) of the Equity Interests of Holdings, in each case with such 25% being free and clear of any Liens, rights, options, warrants or similar agreements or understandings;
Β
3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(ii) the direct or indirect sale, lease, transfer, conveyance or other disposition, in one or a series of related transactions, of all or substantially all of the assets of the Borrower and the Subsidiaries, taken as a whole, to any Person;
(iii) the occurrence of a change in the composition of the Governing Body of Holdings or the Borrower such that a majority of the members of any such Governing Body are not Continuing Directors;
(iv) (a) the failure at any time of Holdings, directly, to legally and beneficially own and Control 100% on a fully-diluted basis of the issued and outstanding Equity Interests of the Borrower free and clear of any Liens, rights, options, warrants or similar agreements or understandings other than Liens in favor of the Collateral Agent created pursuant to the Security Documents and other Liens permitted under SectionΒ 6.02 or (b)Β the failure at any time of Holdings to have the ability to elect all of the Governing Body of the Borrower;
(v) the occurrence of any βchange of controlβ (or similar event, howsoever denominated) under the Revolving Loan Agreement or the definitive documentation governing or evidencing any Material Indebtedness of any Loan Party;
(vi) a βpersonβ or βgroupβ (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act), other than any such βpersonβ or βgroupβ comprised solely of Permitted Holders, becomes the βbeneficial ownerβ (as defined in Rules 13d-3 and 13d-5 under the Exchange Act) of or Controls, directly or indirectly, a greater percentage of (a)Β the issued and outstanding Equity Interests of Holdings entitled (without regard to the occurrence of any contingency) to vote for the election of members of the Governing Body of Holdings or (b)Β the total economic interests of the Equity Interests of Holdings than that collectively beneficially owned or Controlled (whichever is applicable above) by the Permitted Holders.
As used herein, the term βbeneficially ownβ or βbeneficial ownershipβ shall have the meaning set forth in the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this definition, a Person shall not be deemed to have beneficial ownership of the voting Equity Interests subject to a stock purchase agreement, merger agreement or similar agreement, so long as such agreement contains a condition to the closing of the transactions contemplated thereunder that the Obligations under this Agreement and the other Loan Documents shall be paid in full and terminated prior to (or contemporaneous with) the consummation of such transactions.
βChange of Control Prepayment Premiumβ shall have the meaning assigned to such term in Section 2.11(d).
βChargesβ shall have the meaning assigned to such term in SectionΒ 9.09.
βClosing Dateβ shall mean the date on which the initial Loans are made.
βCodeβ shall mean the Internal Revenue Code of 1986.
βCollateralβ shall mean all the real, personal, and mixed (real and personal) property of the Loan Parties in which Liens are granted pursuant to the Security Documents, including all βCollateralβ (as defined therein), and all Mortgaged Properties (for the avoidance of doubt, excluding any Excluded Assets (as defined in the Guarantee and Collateral Agreement)).
βCollateral Agentβ shall have the meaning assigned to such term in the Preamble.
Β
4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βCommitmentβ shall mean, with respect to each Lender, the commitment of such Lender to make Loans hereunder as set forth on ScheduleΒ 2.01, or in the Assignment and Acceptance pursuant to which such Lender assumed its Commitment, as applicable. The aggregate amount of the Lendersβ Commitments as of the Closing Date is $25,000,000.
βCompetitorβ shall mean any of those Persons or entities that are competitors of the Borrower and its Subsidiaries and affiliates of any such competitors, in each case, identified by the Borrower to the Administrative Agent in writing, and as updated from time to time with prior written consent of the Administrative Agent (such consent not to be unreasonably withheld, delayed or conditioned).
βConnection Income Taxesβ shall mean Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.
βConsolidated Leverage Ratioβ shall mean, on any date, the ratio of the principal amount of all Loans (including, for the avoidance of doubt, any PIK Interest that has been previously added to the principal amount of the Loans) outstanding on such date to Consolidated Revenue for the period of four consecutive fiscal quarters most recently ended on or prior to such date.
βConsolidated Revenueβ shall mean, for any period, the subscription and maintenance revenue of Holdings and its Subsidiaries on a consolidated basis determined in a manner consistent with GAAP, for such period.
βConsolidated Total Assetsβ shall mean, as of any date, the total property and assets of Holdings and its Subsidiaries, determined in accordance with GAAP, as set forth on the consolidated balance sheet of Holdings delivered in connection with the most recent audited annual financial statements of Holdings (on a pro forma basis after giving effect to any Permitted Acquisitions or any Investments or Dispositions permitted under the Loan Documents).
βContingent Obligationβ, as applied to any Person, shall mean any direct or indirect liability, contingent or otherwise, of that Person (i)Β with respect to any Indebtedness, lease, dividend or other obligation (the βprimary obligationβ) of another if the purpose or intent thereof by the Person incurring the Contingent Obligation is to provide assurance to the obligee of such primary obligation of another that such primary obligation of another will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such primary obligation will be protected (in whole or in part) against loss in respect thereof, (ii)Β with respect to any bankerβs acceptance, letter of credit or surety bond or similar instrument issued for the account of that Person or as to which that Person is otherwise liable for reimbursement of drawings, or (iii)Β under Hedging Agreements. Contingent Obligations shall include (a)Β the direct or indirect guarantee, endorsement (otherwise than for collection or deposit in the ordinary course of business), co-making, discounting with recourse or sale with recourse by such Person of the primary obligation of another, (b)Β the obligation to make or pay similar payments if required regardless of non-performance by any other party or parties to an agreement, and (c)Β any liability of such Person for the primary obligation of another through any agreement (contingent or otherwise) (1)Β to purchase, repurchase or otherwise acquire such primary obligation or any security therefor, or to provide funds for the payment or discharge of such primary obligation (whether in the form of loans, advances, stock purchases, capital contributions or otherwise) or (2)Β to maintain the solvency or any balance sheet item, level of income or financial condition of another if, in the case of any agreement described under subclauses (1)Β or (2)Β of this sentence, the purpose or intent thereof is as described in the preceding sentence; provided, however, that βContingent Obligationβ shall not include (A)Β endorsements for collection or deposit in the ordinary course of business, (B)Β customary indemnity obligations in effect on the Closing Date or entered into in connection with any acquisition or disposition of assets or Equity Interests permitted under this Agreement or the other Loan Documents, (C)Β product warranties or other
Β
5
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
similar contingent obligations given or incurred in the ordinary course of business and (D)Β ordinary course performance guarantees by Holdings or any of its Subsidiaries of the obligations (other than for the payment of Indebtedness) of any other of Holdings or any of its Subsidiaries. The amount of any liability in respect of a Hedging Agreement shall be the amount determined in respect thereof as of the determination date, based on the assumption that such Hedging Agreement had terminated as of such date. In making such determination, if any agreement relating to such Hedging Agreement provides for the netting of amounts payable by and to such Person thereunder or if any such agreement provides for the simultaneous payment of amounts by and to such Person, then in each such case, the amount of such obligation shall be the net amount so determined. The amount of any other Contingent Obligation shall be equal to the lesser of (y)Β the outstanding amount of the primary obligation so guaranteed or otherwise supported and (z)Β the stated maximum amount for which such Person may be liable under such Contingent Obligation, unless such primary obligation and the maximum amount for which such guaranteeing Person may be liable are not stated or determinable, in which case, the amount of such Contingent Obligations shall be determined by the Borrower reasonably and in good faith.
βContinuing Directorsβ shall mean the directors of Holdings on the Closing Date, and each other director, if, in each case, such other directorβs nomination for election to the board of directors of Holdings is recommended by at least a majority of the then Continuing Directors or such other director receives the vote of the Permitted Holders in his or her election by the shareholders of Holdings or such director is appointed pursuant to any shareholder agreement or governing document by any Permitted Holder.
βContractual Obligationβ shall mean, with respect to any Person, any agreement, instrument or other undertaking (other than a Loan Document) to which such Person is a party or by which it or any of its property is bound.
βControlβ shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise, and the terms βControllingβ and βControlledβ shall have meanings correlative thereto.
βControl Agreementβ shall mean an agreement, reasonably satisfactory in form and substance to the Collateral Agent and executed by the financial institution or securities intermediary at which a Deposit Account or a Securities Account, as the case may be, is maintained, pursuant to which such financial institution or securities intermediary confirms and acknowledges the Collateral Agentβs security interest in such account, and agrees that the financial institution or securities intermediary, as the case may be, will comply with instructions or entitlement orders, as applicable, originated by the Collateral Agent as to disposition of funds in such account, without further consent by the Borrower or any Subsidiary; provided that the Collateral Agent shall only deliver instructions or entitlement orders when an Event of Default has occurred and is continuing.
βControlled Investment Affiliateβ shall mean, with respect to any Person, any other Person that (a)Β directly or indirectly, is in Control of, is Controlled by, or is under common Control with, such Person and (b)Β is organized primarily for the purpose of making equity or debt investments in one or more companies.
βCopyright Actβ shall mean Title 17 of the United States Code, including the Copyright Act of 1976, and all rules and regulations issued or promulgated thereunder, all as amended and in effect from time to time.
βCredit Facilityβ shall mean the term loan facility provided for by this Agreement.
Β
6
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βCure Amountβ shall have the meaning assigned to such term in SectionΒ 7.02(a).
βCure Contributionβ shall have the meaning assigned to such term in Section 7.02(a).
βCure Dateβ shall have the meaning assigned to such term in SectionΒ 7.02(a).
βCure Rightβ shall have the meaning assigned to such term in SectionΒ 7.02(a).
βCure Securitiesβ shall have the meaning assigned to such term in Section 7.02(a).
βDeclined Proceedsβ shall have the meaning assigned to such term in Section 2.11(f).
βDefaultβ shall mean any event or condition which upon notice, lapse of time or both would constitute an Event of Default.
βDeposit Accountβ shall have the meaning assigned to such term in the UCC.
βDesignated Event of Defaultβ shall mean any Event of Default of the type described in any of clauses (a), (b), (g)Β or (h)Β of SectionΒ 7.01.
βDispositionβ shall mean with respect to any property (other than cash), any sale, lease, sublease, sale and leaseback, assignment, conveyance, transfer, license or other disposition thereof. The terms βDisposeβ and βDisposed ofβ shall have correlative meanings. For the avoidance of doubt, the terms Disposition, Dispose and Disposed of do not refer to the issuance, sale or transfer of Equity Interests by Holdings.
βDisqualified Stockβ shall mean any Equity Interest that, by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable), or upon the happening of any event, (a)Β matures (excluding any maturity as the result of an optional redemption by the issuer thereof) or is mandatorily redeemable (other than solely for Qualified Capital Stock), pursuant to a sinking fund obligation or otherwise, or is redeemable at the option of the holder thereof, in whole or in part, or requires the payment of any cash dividend or any other scheduled payment (other than payments solely in the form of issuances of Qualified Capital Stock) constituting a return of capital, in each case at any time on or prior to the date that is 91 days following the Maturity Date; or (b)Β is convertible into or exchangeable (unless at the sole option of the issuer thereof) for (i)Β Indebtedness securities or (ii)Β any Equity Interest referred to in clauseΒ (a) above, in each case at any time on or prior to the date that is 91 days following the Maturity Date, except, in the case of clause (a), if as a result of a change of control event or asset sale or other Disposition or casualty event, so long as any rights of the holders thereof to require the redemption thereof upon the occurrence of such a change of control event or asset sale or other Disposition or casualty event are subject to the prior payment in full of the Obligations (other than unasserted contingent indemnification or reimbursement obligations not yet due).
βDollarsβ or β$β shall mean lawful money of the United States of America.
βDomestic Subsidiaryβ shall mean any Subsidiary organized under the laws of the United States of America, any State thereof or the District of Columbia in each case, other than a Foreign Subsidiary Holdco.
βEligible Assigneeβ shall mean (i)Β any Lender, any Affiliate of any Lender and any Related Fund of any Lender; and (ii)Β (a)Β a commercial bank organized under the laws of the United States or any state thereof; (b)Β a savings and loan association or savings bank organized under the laws of the United States
Β
7
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
or any state thereof; (c)Β a commercial bank organized under the laws of any other country or a political subdivision thereof; provided that (1)Β such bank or association is acting through a branch or agency located in the United States or (2)Β such bank is organized under the laws of a country that is a member of the Organization for Economic Cooperation and Development or a political subdivision of such country; and (d)Β any other entity that is an βaccredited investorβ (as defined in Regulation D under the Securities Act) that makes or purchases loans or investments in the ordinary course of business; provided that, notwithstanding anything to the contrary in this Agreement, each of the Borrower, any Affiliate of the Borrower and any Excluded Lender shall not be an Eligible Assignee and any attempted assignment to such Persons shall be absolutely void ab initio.
βEligible Incremental Lenderβ shall mean all Eligible Assignees reasonably acceptable to the Administrative Agent and the Borrower.
βEmployee Benefit Planβ shall mean, at any time, an employee benefit plan, as defined in SectionΒ 3(3) of ERISA, which the Borrower or any ERISA Affiliate maintains, contributes to or has an obligation to contribute or with respect to which Borrower could reasonably be expected to incur liability (including under SectionΒ 4409 of ERISA or on account of an ERISA Affiliate).
βEnvironmental Lawsβ shall mean all former, current and future Federal, state, local and foreign laws (including common law), treaties, regulations, rules, ordinances, codes, decrees, judgments, directives, orders (including consent orders), and agreements in each case, relating to protection of the environment, natural resources or the presence, Release of, or exposure to, Hazardous Materials, or the generation, manufacture, processing, distribution, use, treatment, storage, transport, recycling or handling of, or the arrangement for such activities with respect to, Hazardous Materials.
βEnvironmental Liabilityβ shall mean all liabilities, obligations, damages, losses, claims, actions, suits, judgments, orders, fines, penalties, fees, expenses and costs (including administrative oversight costs, natural resource damages and remediation costs), whether contingent or otherwise, arising out of or relating to (a)Β compliance or non compliance with any Environmental Law, (b)Β the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c)Β exposure to any Hazardous Materials, (d)Β the Release of any Hazardous Materials or (e)Β any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.
βEquity Interestsβ shall mean shares of capital stock, partnership interests, membership interests in a limited liability company, beneficial interests in a trust or other equity interests in any Person, and any option, warrant or other right entitling the holder thereof to purchase or otherwise acquire any such equity interest.
βERISAβ shall mean the Employee Retirement Income Security Act of 1974, as the same may be amended from time to time.
βERISA Affiliateβ shall mean any trade or business (whether or not incorporated) that, together with the Borrower, is, or was within the last six preceding plan years, treated as a single employer under SectionΒ 414(b) or (c)Β of the Code, or solely for purposes of SectionΒ 302 of ERISA and SectionΒ 412 of the Code, is, or was within the last six preceding plan years, treated as a single employer under SectionΒ 414 of the Code. Any trade or business that was an ERISA Affiliate under the preceding sentence during the six preceding plan years shall continue to be deemed an ERISA Affiliate hereunder solely with respect to liabilities asserted against Borrower under the Code or ERISA attributable to the period such trade or business was in fact an ERISA Affiliate under the preceding sentence.
Β
8
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βERISA Eventβ shall mean (a)Β any βreportable eventβ, as defined in SectionΒ 4043 of ERISA or the regulations issued thereunder, with respect to a Plan (other than an event for which the 30-day notice period is waived), (b)Β the failure of any Plan to meet the minimum funding standard under SectionΒ 412 of the Code or SectionΒ 302 of ERISA, whether or not waived, (c)Β the filing pursuant to SectionΒ 412(d) of the Code or SectionΒ 303(d) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan, (d)Β the incurrence by the Borrower or any ERISA Affiliate of any liability under Title IV of ERISA with respect to the termination of any Plan or the withdrawal or partial withdrawal of the Borrower or any ERISA Affiliate from any Plan or Multiemployer Plan, (e)Β the receipt by the Borrower or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan or the occurrence of any event or condition which would reasonably be expected to constitute grounds under ERISA for the termination of or the appointment of a trustee to administer, any Plan, (f)Β the receipt by the Borrower or any ERISA Affiliate of any notice, or the receipt by any Multiemployer Plan from the Borrower or any ERISA Affiliate of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent or in reorganization, within the meaning of Title IV of ERISA, (g)Β the occurrence of a non-exempt βprohibited transactionβ with respect to which the Borrower or any of the Subsidiaries is a βdisqualified personβ (within the meaning of SectionΒ 4975 of the Code) or with respect to which the Borrower or any such Subsidiary could reasonably be expected to incur a material liability, (h)Β the incurrence by the Borrower or any ERISA Affiliate of any liability pursuant to SectionΒ 4063 or 4064 of ERISA, (i)Β the imposition of liability on the Borrower or any ERISA Affiliate pursuant to SectionΒ 4062(e) or 4069 of ERISA or by reason of the application of SectionΒ 4212(c) of ERISA or (j)Β the imposition of a Lien on the Borrower pursuant to SectionΒ 430(k) of the Code or ERISA.
βEvents of Defaultβ shall have the meaning assigned to such term in Article VII.
βExcess Rateβ shall have the meaning assigned to such term in SectionΒ 2.22.
βExchange Actβ shall mean the Securities Exchange Act of 1934, as amended.
βExcluded Equityβ shall mean (a)Β in the case of Equity Interests of all existing first-tier Foreign Subsidiaries that are CFCs of any Loan Party, 35% of the voting Equity Interests of such Foreign Subsidiary, (b)Β in the case of Equity Interests of any Foreign Subsidiary Holdco, 35% of the voting Equity Interests of such Foreign Subsidiary HoldCo or, in the case under the foregoing clause (b)Β only such lesser amount to the extent the pledge of or a granting of a Lien on a greater amount of such Foreign Subsidiary Holdcoβs Equity Interests could not reasonably be expected to (i)Β result in adverse tax consequences, (ii)Β result in costs to Holdings and its Subsidiaries that are disproportionately large in relation to the benefit to the Lenders, as mutually determined by the Collateral Agent and the Borrower in their reasonable discretion or (iii)Β be prevented or impaired by applicable law, order or regulation, (c)Β any Equity Interests in a joint venture or non-Wholly Owned Subsidiary (other than a non-Wholly Owned Subsidiary acquired pursuant to a Permitted Acquisition) to the extent (i)Β the granting, creating or perfecting a pledge, security interest or Lien on such Equity Interests is prohibited or restricted by a Contractual Obligation or (ii)Β the consent or approval of a Person other than an Affiliate of the Borrower is required, or (d)Β any Equity Interests of any Person that is not a first-tier Subsidiary of any Loan Party (except (but only) to the extent such Person is a first-tier Subsidiary of another Loan Party).
βExcluded Lenderβ shall mean (a)Β natural Persons, (b)Β Competitors and (c)Β those banks, financial institutions, institutional lenders and other Persons that have been specified to the Administrative Agent by the Borrower or the Sponsor in writing prior to the Closing Date (it being agreed and understood by the Agents and each Lender on the Closing Date that the list specifying the Persons in clauseΒ (c) of this definition shall not be delivered to (or any of its contents shared with) any Person other
Β
9
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
than the Persons that are Lenders on the Closing Date; provided that the Administrative Agent may verbally state whether a Person is an Eligible Assignee based on such list so long as the question is posed by a Lender for the sole purpose of considering assigning the Loans or selling participations hereunder to a non-Affiliated third-Person that is not otherwise excluded from being an Eligible Assignee by the other provisions in the definition of βEligible Assigneeβ).
βExcluded Taxesβ shall mean any of the following Taxes imposed on or with respect to a Recipient or required to be withheld or deducted from a payment to a Recipient, (a)Β Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i)Β imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii)Β that are Other Connection Taxes, (b)Β in the case of a Lender, U.S. federal withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date of which (i)Β such Lender acquires such interest in the Loan or Commitment (other than pursuant to an assignment request by the Borrower under SectionΒ 2.l8(b)) or (ii)Β such Lender changes its lending office, except in each case to the extent that, pursuant to SectionΒ 2.17, amounts with respect to such Taxes were payable either to such Lenderβs assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed its lending office, (c)Β Taxes attributable to such Recipientβs failure to comply with SectionΒ 2.17(f) and (d)Β any U.S. federal withholding Taxes imposed under FATCA.
βExisting Debt Refinancingβ shall mean the repayment in full of the Indebtedness set forth on ScheduleΒ 1.01(c) and the termination of commitments thereunder and the release of all guarantees and security in respect thereof.
βFair Labor Standards Actβ shall mean the Fair Labor Standards Act of 1938, as amended from time to time.
βFATCAβ shall mean Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof and any agreements entered into pursuant to SectionΒ 1471(b)(1) of the Code.
βFederal Funds Effective Rateβ shall mean, for any day, the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System of the United States arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day for such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by it.
βFederal Power Actβ shall mean the Federal Power Act of 1935, as amended from time to time.
βFeesβ shall mean the Yield Enhancement Fees.
βFinancial Officerβ of any Person shall mean the chief financial officer, chief executive officer, vice president of finance, principal accounting officer, treasurer, assistant treasurer or controller, or, in each case, anyone acting in such capacity or any similar capacity, of such Person.
βForeign Lenderβ shall mean any Lender that is not a U.S. Person.
Β
10
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βForeign Planβ shall mean any defined benefit pension plan maintained or contributed to by any Loan Party solely with respect to employees employed outside the United States.
βForeign Subsidiaryβ shall mean any Subsidiary that is not a Domestic Subsidiary.
βForeign Subsidiary Holdcoβ shall mean a direct or indirect Subsidiary organized under the laws of the United States of America, any State thereof or the District of Columbia of the Borrower formed or acquired before, on or after the Closing Date, that has no material assets other than capital stock or other Equity Interests of CFCs.
βGAAPβ shall mean United States generally accepted accounting principles applied on a consistent basis.
βGoverning Bodyβ shall mean the board of directors or other body having the power to direct or cause the direction of the management and policies of a Person that is a corporation, partnership, trust or limited liability company.
βGovernmental Authorityβ shall mean any Federal, state, local or foreign court or governmental agency, authority, instrumentality, regulatory body, board or commission.
βGranting Lenderβ shall have the meaning assigned to such term in Section 9.04(j).
βGuarantee and Collateral Agreementβ shall mean the Guarantee and Collateral Agreement, in the form of Exhibit E, among the Borrower, Holdings, the Subsidiary Guarantors party thereto, and the Collateral Agent for the benefit of the Secured Parties.
βGuarantorsβ shall mean Holdings and the Subsidiary Guarantors.
βHazardous Materialsβ shall mean (a)Β any petroleum products or byproducts and all other hydrocarbons, coal ash, radon gas, asbestos, urea formaldehyde foam insulation, polychlorinated biphenyls, chlorofluorocarbons and all other ozone-depleting substances and (b)Β any chemical, material, substance or waste that is prohibited, limited or regulated by or pursuant to any Environmental Law.
βHedging Agreementβ shall mean any interest rate protection agreement, foreign currency exchange agreement, commodity price protection agreement or other interest or currency exchange rate or commodity price hedging arrangement.
βHoldingsβ shall have the meaning assigned to such term in the Preamble.
βICC Termination Actβ shall mean the ICC Termination Act of 1995, as amended from time to time.
βImmaterial Subsidiaryβ means Subsidiaries of the Borrower that (i)Β are not Loan Parties, (ii)Β own assets in an amount no greater than 2.5% individually and 5% in the aggregate of the Consolidated Total Assets of Holdings and its Subsidiaries (on a consolidated basis), (iii)Β generate revenue in an amount no greater than 2.5% individually and 5% in the aggregate of the total revenues of Holdings and its Subsidiaries (on a consolidated basis) and (iv)Β have previously been designated in writing by the Borrower to the Administrative Agent as βImmaterial Subsidiaries.β
Β
11
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βIncrease Conditionsβ means the following conditions: (i)Β Consolidated Revenue for the most recently ended four fiscal quarter period for which financial statements under SectionΒ 5.04(a) or (b)Β have been delivered equaling or exceeding $50,000,000 and (ii)Β receipt by the Administrative Agent of a certificate of a Financial Officer of the Borrower setting forth in reasonable detail the calculations showing satisfaction of the foregoing condition.
βIncreased Amount Dateβ shall have the meaning assigned to such term in Section 2.22.
βIncremental Commitmentsβ shall have the meaning assigned to such term in Section 2.22.
βIncremental Lenderβ shall have the meaning assigned to such term in Section 2.22.
βIncremental Loanβ shall have the meaning assigned to such term in Section 2.22.
βIncremental Loan Amendmentβ shall have the meaning assigned to such term in Section 2.22.
βIndebtednessβ of any Person shall mean, without duplication, (a)Β all obligations of such Person for borrowed money, (b)Β all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c)Β all obligations of such Person under conditional sale or other title retention agreements relating to property or assets purchased by such Person, (d)Β all obligations of such Person issued or assumed as the deferred purchase price of property or services, including any-earn out obligations (excluding (i)Β trade accounts payable and accrued obligations incurred in the ordinary course of business and not more than 180 days past due, (ii)Β purchase price adjustments and earn-out obligations (unless such amounts are not paid after becoming due and payable or appear (or would be required to appear pursuant to GAAP) as liabilities on the balance sheet of such Person), (iii)Β royalty payments made in the ordinary course of business in respect of licenses, any accruals for payroll and (iv)Β other non-interest bearing liabilities accrued in the ordinary course of business and deferred rent obligations), (e)Β all Indebtedness of others (excluding prepaid interest thereon) secured by any Lien on property owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, but limited to the lower of (x)Β fair market value of such property as determined by such Person reasonably and in good faith and (y)Β the amount of Indebtedness secured by such Lien, (f)Β all Contingent Obligations of such Person in respect of Indebtedness of others, (g)Β all Capital Lease Obligations and Synthetic Lease Obligations of such Person to the extent classified as indebtedness under GAAP (for the avoidance of doubt, lease payments under any operating leases (other than Capitalized Lease Obligations recorded as capitalized leases in accordance with GAAP as in effect on the Closing Date) shall not constitute Indebtedness), (h)Β all obligations of such Person as an account party in respect of letters of credit, (i)Β all obligations of such Person in respect of bankersβ acceptances, (j)Β Disqualified Stock and (k)Β all obligations of such Person in respect of any Hedging Agreement, in each case, whether entered into for hedging or speculative purposes or otherwise; provided that (1)Β Indebtedness shall not include (A)Β accrued expenses, deferred rent, deferred revenue, deferred taxes and deferred compensation and customary obligations under employment arrangements, (B)Β customary payables with respect to money orders or wire transfers, and (C)Β obligations under operating leases and (2)Β the items in clausesΒ (a) through (k)Β above shall constitute Indebtedness of such person solely to the extent (x)Β such Person is liable for such item, (y)Β any such item is secured by a Lien on such Personβs property but only to the extent of the lesser of the fair market value of the property subject to such Lien and the principal amount of, and interest and other amount owing in respect of, such Indebtedness or (z)Β any other Person has a right, contingent or otherwise, to cause such Person to become liable for any part of any such item or to grant such a Lien. The amount of any Indebtedness of any Person in respect of a Hedging Agreement shall be the amount determined in respect thereof as of the determination date, based on the assumption that such Hedging Agreement had terminated as of such date. In making such determination, if any agreement relating to such Hedging Agreement provides for the netting of amounts payable by and to such Person thereunder or if any such agreement provides for the simultaneous payment of amounts by and to such Person, then in each such case, the amount of such obligation shall be the net amount so
Β
12
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
determined. The Indebtedness of any Person shall include the Indebtedness of any partnership or joint venture (other than a joint venture that is itself a corporation or limited liability company) in which such Person is a general partner or joint venturer, but only to the extent such Person is obligated therefor by contract or operation of applicable law.
βIndemnified Taxesβ shall mean (a)Β Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of any Loan Party under any Loan Document and (b)Β to the extent not otherwise described in (a), Other Taxes.
βIndemniteeβ shall have the meaning assigned to such term in SectionΒ 9.05(b).
βInformationβ shall have the meaning assigned to such term in SectionΒ 9.16.
βInsolvency Proceedingβ shall mean (i)Β any case, action or proceeding before any court or other Governmental Authority relating to bankruptcy, reorganization, insolvency, liquidation, receivership, dissolution, winding-up or relief of debtors, or (ii)Β any general assignment for the benefit of creditors, formal or informal moratorium, composition, marshaling of assets for creditors or other, similar arrangement in respect of its creditors generally or any substantial portion of its creditors, in each case, undertaken under United States federal or state or non-United States legal requirements, including the Bankruptcy Code.
βIntellectual Propertyβ shall mean all present and future: trade secrets, know-how and other proprietary information; trademarks, internet domain names, service marks, trade dress, trade names, business names, designs, logos, slogans (and all translations, adaptations, derivations and combinations of the foregoing) indicia and other source and/or business identifiers, and the goodwill of the business relating thereto and all registrations or applications for registrations therefor throughout the world; works of authorship, copyrightable works, copyright registrations and copyright applications; and all tangible and intangible property embodied therein, unpatented inventions (whether or not patentable); patents and patent applications; industrial design applications and registered industrial designs; license agreements related to any of the foregoing and income therefrom; books, records, writings, computer tapes or disks, flow diagrams, specification sheets, computer software, source codes, object codes, executable code, data, databases and other physical manifestations, embodiments or incorporations of any of the foregoing; the right to xxx for all past, present and future infringements of any of the foregoing; all other intellectual property; and all common law and other rights throughout the world in and to all of the foregoing.
βIntercreditor Agreementβ shall mean an intercreditor agreement between the Collateral Agent and lenders under the Revolving Loan Agreement (or the Revolving Agent on behalf of such lenders) in form and substance reasonably acceptable to the Collateral Agent.
βInterest Payment Dateβ shall mean DecemberΒ 31, 2013 and the last day of each calendar quarter thereafter, provided if any such day is not a Business Day, such Interest Payment Date shall be extended to the next succeeding Business Day and interest shall accrue for each day of such extension.
βInterstate Commerce Actβ shall mean the Interstate Commerce Act of 1887, as amended from time to time.
βInvestmentβ shall mean (i)Β any direct or indirect purchase or other acquisition by Holdings, the Borrower or any of its Subsidiaries of, or of a beneficial interest in, any stocks, bonds, notes, debentures or other obligations or securities of any other Person; (ii)Β any direct or indirect redemption, retirement, purchase or other acquisition for value, by Holdings, the Borrower or any Subsidiary of the Borrower from any Person, of any Equity Interests of such Person; and (iii)Β any direct or indirect loan, advance
Β
13
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(other than loans or advances to employees for moving, entertainment and travel expenses, drawing accounts and similar expenditures in the ordinary course of business) or capital contributions by Holdings, the Borrower or any of its Subsidiaries to any other Person. The amount of any Investment shall be the original cost of such Investment plus the cost of all additions thereto (other than replacement or repair costs in connection with Casualty Events), without any adjustments for increases or decreases in value, or write ups, write downs or write offs with respect to such Investment and after giving effect to any return of capital, repayment or dividends or distributions in respect thereof received in cash with respect to such Investment and less all liabilities expressly assumed by another person in connection with the sale or other disposition of such Investment.
βInvestment Company Act of 1940β shall mean the Investment Company Act of 1940, as amended from time to time.
βIRSβ shall mean the United States Internal Revenue Service.
βLendersβ shall mean (a)Β the Persons listed on ScheduleΒ 2.01 (other than any such Person that has ceased to be a party hereto pursuant to an Assignment and Acceptance) and (b)Β any Person that has become a party hereto pursuant to an Assignment and Acceptance, in each case, in accordance and in compliance with SectionΒ 9.04 (including, without limitation, any consents required thereby); provided, however, that no Excluded Lender shall be a Lender.
βLibor Rateβ shall mean, for any date of determination, the greater of (x)Β 1.50%Β per annum and (y)Β the three-month London Interbank Offered Rate (rounded upward to the nearest 1/16 of one percent) that appears on Bloomberg as of approximately 11:00 a.m. (Los Angeles time) on such date of determination; provided, that if such index ceases to exist or is no longer published or announced, then the term βLibor Rateβ shall mean the three-month London Interbank Offered Rate (rounded upward to the nearest 1/16 of one percent) as published in The Wall Street Journal on such date of determination, and if this latter index ceases to exist or is no longer published or announced, then the term βLibor Rateβ shall mean the Prime Rate (rounded upward to the nearest 1/16 of one percent) as published in The Wall Street Journal on such date of determination. The Libor Rate shall be reasonably determined on the Closing Date and the first Business Day of each calendar quarter thereafter by the Administrative Agent or, if no Administrative Agent then exists, by the Required Lenders.
βLIBOR Unavailability Noticeβ shall have the meaning assigned to such term in Section 2.12(e).
βLienβ shall mean, with respect to any asset, (a)Β any mortgage, deed of trust, lien, pledge, encumbrance, charge or security interest in or on such asset or (b)Β the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset; provided that in no event shall an operating lease be deemed to be a Lien.
βLiquidityβ shall mean (i)Β the amount of Unrestricted Cash and Permitted Investments of the Loan Parties in the aggregate plus (ii)Β the aggregate amount of unused commitments under the Revolving Loan Agreement.
βLoan(s)β shall mean the term loans made by the Lenders to the Borrower pursuant to SectionΒ 2.01, together with PIK Interest, if any.
βLoan Commitment Percentageβ shall mean, as to any Lender at any time, the percentage of the aggregate outstanding principal amount of Loans then constituted by the aggregate outstanding principal amount of such Lenderβs Loans.
Β
14
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βLoan Documentsβ shall mean this Agreement, the Security Documents, the Intercreditor Agreement, the Notes and any other document or agreement executed in connection herewith or therewith.
βLoan Partiesβ shall mean the Borrower and the Guarantors.
βLocal Timeβ shall mean Los Angeles time.
βManagement Agreementβ shall mean any written agreement by and between Sponsor or its Affiliates and Holdings or Borrower entered into after the Closing Date in form and substance reasonably satisfactory to the Administrative Agent (it being understood and agreed that any provisions providing for cost and expense reimbursement and indemnification not in excess of the amount permitted under SectionΒ 6.06(a)(iii) of this Agreement shall be satisfactory to the Administrative Agent).
βManagement Fee Recipientβ shall have the meaning assigned to such term in the definition of βManagement Feesβ.
βManagement Feesβ shall mean any fees or other amounts (whether structured as a fee, an underwriting discount or otherwise) payable, directly or indirectly, to or for the benefit of any direct or indirect holder of Equity Interests of Holdings or any Affiliate of any such holder of Equity Interests (each of the foregoing, but excluding any Agent or any Lender, a βManagement Fee Recipientβ) or in respect of management, consulting, financial advisory, financing, underwriting or placement services or other investment banking activities provided by or on behalf of any Management Fee Recipient to or for the benefit, directly or indirectly, of any of Holdings or Holdingsβ Affiliates, whether payable, earned or otherwise provided for pursuant to a Management Agreement (howsoever denominated) or otherwise; provided, however, that Management Fees shall not include (i)Β any costs or expenses (including, without limitation, attorneyβs fees) incurred by, or any indemnities provided to, Sponsor and/or any of its Related Parties and (ii)Β any amounts accrued (or rights to present or future payments or amounts) but not actually paid.
βMargin Stockβ shall have the meaning assigned to such term in Regulation U.
βMaterial Adverse Effectβ shall mean (a)Β a materially adverse effect on and/or material adverse developments with respect to (i)Β the value of the Collateral (taken as a whole) or (ii)Β the business, operations, financial condition or properties of Holdings, the Borrower and its Subsidiaries, taken as a whole, (b)Β a material impairment of the ability of the Borrower or the other Loan Parties, taken as a whole, to perform any of its or their obligations under any Loan Document to which it is or they are a party or (c)Β a material impairment of the rights and remedies, taken as a whole, of the Administrative Agent, the Collateral Agent and the Lenders under the Loan Documents (other than to the extent a result of the action or inaction of the Administrative Agent, the Collateral Agent, the Lenders, the other secured parties under the Loan Documents or their respective Related Parties).
βMaterial Domestic Real Propertyβ shall mean any real property located in the United States with a fair market value in excess of $1,000,000.
βMaterial Foreign Assetsβ shall mean, (i)Β any foreign personal property (including, without limitation, any foreign registered Intellectual Property) of a Loan Party constituting Collateral with a value as of any date of determination in excess of 10% of Consolidated Total Assets and (ii)Β Equity Interests of any direct Foreign Subsidiary of any Loan Party that is a Wholly-Owned Subsidiary constituting Collateral solely to the extent such Foreign Subsidiary generates revenue in an amount in excess of 10% of the total revenues of Holdings and its Subsidiaries on a consolidated basis.
Β
15
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βMaterial Indebtednessβ shall mean Indebtedness (other than the Loans) of any one or more of Holdings, the Borrower or any Subsidiary in an aggregate principal amount exceeding $1,000,000. For purposes of determining Material Indebtedness, the βprincipal amountβ of the obligations of Holdings, the Borrower or any Subsidiary in respect of any Hedging Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements to the extent that such agreements) that Holdings, the Borrower or such Subsidiary would be required to pay if such Hedging Agreement were terminated at such time. For the avoidance of doubt, the Obligations shall not constitute Material Indebtedness.
βMaturity Dateβ shall mean SeptemberΒ 25, 2018.
βMaximum Rateβ shall have the meaning assigned to such term in Section 9.09.
βModificationβ shall have the meaning assigned to such term in the definition of βPermitted Refinancing.β
βMoodyβsβ shall mean Xxxxxβx Investors Service, Inc., or any successor thereto.
βMortgaged Propertiesβ shall mean each parcel of owned real property and improvements thereto with respect to which a Mortgage is granted pursuant to SectionΒ 5.12.
βMortgagesβ shall mean the mortgages, deeds of trust, assignments of leases and rents, modifications and other security documents delivered with respect to Mortgaged Properties pursuant to SectionΒ 5.12, in each case, utilized as security for the Obligations, each reasonably acceptable in form and substance to the Administrative Agent and the Borrower.
βMultiemployer Planβ shall mean a multiemployer plan within the meaning of SectionΒ 4001(a)(3) of ERISA; (a)Β to which Borrower or any ERISA Affiliate making or accruing an obligation to make contributions; or (b)Β with respect to which Borrower could reasonably be expected to incur liability.
βNet Asset Sale Proceedsβ shall mean the cash proceeds received by the Borrower or any of its Subsidiaries in respect of an Asset Sale (including cash proceeds subsequently received (as and when received) in respect of noncash consideration initially received but excluding (for the avoidance of doubt) any issuance of Equity Interests mentioned in the proviso of the definition of βAsset Saleβ), net of (a)Β actual and customary expenses (including customary brokerβs fees or commissions, legal fees, accounting fees, transfer and similar taxes and the Borrowerβs good faith estimate of income taxes, in each case paid or payable in connection with such sale), (b)Β amounts provided as a reserve, in accordance with GAAP, against any liabilities under any indemnification obligations or purchase price adjustment associated with such Asset Sale (provided that, to the extent and at the time any such amounts are released from such reserve, such amounts shall constitute Net Asset Sale Proceeds) and (c)Β the principal amount, premium or penalty, if any, interest and other amounts on any Indebtedness for borrowed money that is secured by the asset sold in such Asset Sale and that is required to be repaid with such proceeds (other than any such Indebtedness assumed by the purchaser of such asset and other than Indebtedness hereunder).
βNet Insurance/Condemnation Proceedsβ shall mean any net cash payments or net cash proceeds (after taking into account any fees, costs, expenses (including, without limitation, legal fees) and deductibles related thereto or incurred in connection therewith) received by the Borrower or any of its Subsidiaries (i)Β under any casualty insurance policy in respect of a covered loss of property thereunder or (ii)Β as a result of the taking of any assets of the Borrower or any of its Subsidiaries by any Person pursuant to the power of eminent domain or condemnation pursuant to any law, or by reason of the
Β
16
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
temporary requisition of the use or occupancy of all or any part of any real property of any Person or any part thereof by any Governmental Authority, civil or military, in each case, net of (a)Β customary costs and expenses (including customary brokerβs fees or commissions, legal fees, accounting fees, transfer and similar taxes and the Borrowerβs good faith estimate of income taxes, in each case paid or payable in connection therewith) and (b)Β the principal amount, premium or penalty, if any, interest and other amounts on any Indebtedness for borrowed money that is secured by the asset subject to such covered loss or taking and that is required to be repaid with such proceeds (other than Indebtedness hereunder).
βNet Securities Proceedsβ shall mean the cash proceeds (net of customary underwriting discounts and commissions and other customary costs and expenses associated therewith, including customary legal fees and expenses and taxes) from the incurrence of Indebtedness by Holdings, the Borrower or any of its Subsidiaries.
βNoteβ shall have the meaning assigned to such term in SectionΒ 2.04(d).
βNotice of Intent to Cureβ shall have the meaning assigned to such term in Section 7.02(c).
βObligationsβ shall mean all obligations of every nature of each Loan Party from time to time owed to the Administrative Agent, the Lenders or any of them under the Loan Documents, whether for principal, interest (including, without limitation, any PIK Interest and interest accruing after the commencement of any bankruptcy case or Insolvency Proceeding involving a Loan Party, whether or not such interest is an allowed claim in such case or proceeding), fees, premium, expenses, indemnification or otherwise.
βOFACβ shall have the meaning assigned to such term in SectionΒ 3.23.
βOIDβ shall have the meaning assigned to such term in SectionΒ 2.20.
βOrganizational Documentsβ shall mean with respect to any Person, its charter, certificate or articles of incorporation, bylaws, articles of organization, operating agreement, partnership agreement or similar agreement or instrument governing the formation or operation of such Person.
βOther Connection Taxesβ shall mean, with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such Tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).
βOther Taxesβ shall mean all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document.
βParticipant Registerβ shall have the meaning assigned to such term in Section 9.04(g).
βPayment Officeβ shall mean the office of the Administrative Agent located at 0000 00xx Xxxxxx, Xxxxx 0000, Xxxxx Xxxxxx, Xxxxxxxxxx 00000 or such other office as the Administrative Agent may hereafter designate in writing as such to the other parties hereto.
βPBGCβ shall mean the Pension Benefit Guaranty Corporation referred to and defined in ERISA.
Β
17
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βPerfection Certificateβ shall mean the Perfection Certificate substantially in the form of ExhibitΒ B to the Guarantee and Collateral Agreement.
βPermitted Acquisitionβ shall have the meaning assigned to such term in Section 6.04(vii).
βPermitted Capital Lease Amountβ shall mean $2,500,000, provided, however that if the Increase Conditions are met, the Permitted Capital Lease Amount shall mean $5,000,000.
βPermitted Founder Distributionsβ shall mean amounts payable to Xxxxxxx Xxxxxx, an individual, pursuant to SectionΒ 6.9(h) of the Acquisition Agreement.
βPermitted Holdersβ shall mean, collectively, Sponsor and its Controlled Investment Affiliates.
βPermitted Investmentsβ shall mean:
(a) direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed or insured by, the United States of America (or by any agency or instrumentality thereof to the extent such obligations are backed by the full faith and credit of the United States of America), in each case maturing within one year from the date of acquisition thereof;
(b) investments in commercial paper maturing within one year from the date of acquisition thereof and having, at such date of acquisition, the highest credit rating obtainable from S&P or from Moodyβs;
(c) investments in certificates of deposit, bankerβs acceptances and time deposits maturing within one year from the date of acquisition thereof issued or guaranteed by or placed with, and money market deposit accounts issued or offered by, the Administrative Agent or any domestic office of any commercial bank organized under the laws of the United States of America or any State thereof that has a combined capital and surplus and undivided profits of not less than $500,000,000;
(d) fully collateralized repurchase agreements with a term of not more than 30 days for securities described in clause (a)Β above and entered into with a financial institution satisfying the criteria of clause (c)Β above;
(e) investments in βmoney market fundsβ within the meaning of Rule 2a-7 of the Investment Company Act of 1940, at least 95% of whose assets are invested in investments of the type described in clauses (a)Β through (d)Β above;
(f) demand deposit accounts maintained in the ordinary course of business; and
(g) other short-term investments utilized by Foreign Subsidiaries in accordance with normal investment practices for cash management in investments of a type analogous to the foregoing.
βPermitted Non-Loan Party Investment Amountβ shall mean $5,000,000 provided, however that if the Increase Conditions are met, the Permitted Non-Loan Party Investment Amount shall mean $10,000,000.
βPermitted Refinancingβ shall mean, with respect to any Person, any modification, refinancing, refunding, replacement, renewal or extension (each, a βModificationβ) of any Indebtedness of such Person (such Indebtedness prior to giving effect to such Modification, βSubject Indebtednessβ and, after giving effect to such Modification, βRefinancing Indebtednessβ ); provided that (a)Β the principal amount
Β
18
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
thereof does not exceed the principal amount of such Subject Indebtedness except by an amount equal to unpaid accrued interest and premium thereon plus underwriting discounts, premiums paid, fees, costs and expenses (including, without limitation, attorneyβs fees) incurred, in connection with such Modification and by an amount equal to any existing commitments unutilized thereunder, (b)Β other than with respect to a Permitted Refinancing of Indebtedness permitted pursuant to SectionΒ 6.01(v) or SectionΒ 6.01(vi), such Refinancing Indebtedness has a final maturity date equal to or later than the final maturity date of, and has a Weighted Average Life to Maturity equal to or greater than the Weighted Average Life to Maturity of, the Subject Indebtedness, (c)Β to the extent such Subject Indebtedness is (i)Β subordinated in right of payment to the Obligations, such Refinancing Indebtedness is subordinated in right of payment to the Obligations on terms, taken as a whole, at least as favorable to the Lenders in all material respects as those contained in the documentation governing the subordination of the Subject Indebtedness, (ii)Β secured by a junior permitted lien on the Collateral (or portion thereof), in the case of this clause (ii)Β such Refinancing Indebtedness shall be unsecured or secured by a junior permitted lien on the Collateral (or portion thereof) or (iii)Β unsecured, such Refinancing Indebtedness shall be unsecured, (d)Β such Modification does not provide for the granting or obtaining of collateral security from, or obtaining any lien on any assets of, any Person, other than collateral security obtained from Persons that provided (or were required to provide) collateral security with respect to such Subject Indebtedness (so long as the assets subject to such liens were or would have been required to secure such Subject Indebtedness) (provided that additional Persons that would have been required to provide collateral security with respect to such Subject Indebtedness may provide collateral security with respect to such Refinancing Indebtedness), (e)Β any such Refinancing Indebtedness shall be subject to intercreditor provisions (including lien subordination provisions if such Refinancing Indebtedness is secured by a lien on the Collateral the priority of which is contractually subordinated to the Liens on the Collateral securing the Obligations) which are no less favorable, taken as a whole, to the Secured Parties than those contained in such Subject Indebtedness or are otherwise reasonably acceptable to the Administrative Agent, (f)Β neither Holdings nor any of its Subsidiaries shall be an obligor or guarantor of any such Refinancing Indebtedness except to the extent that such Person was such an obligor or guarantor in respect of the Subject Indebtedness and (g)Β with respect to any Subject Indebtedness concerning the Revolving Loans, the Modification thereof is permitted under the Intercreditor Agreement.
βPermitted Restricted Payment Amountβ shall mean $500,000 provided, however that if the Increase Conditions are met, the Permitted Restricted Payment Amount shall mean $1,000,000.
βPermitted Tax Distributionsβ shall mean for each tax year (or portion thereof) that the Borrower is a corporation for U.S. federal income tax purposes and is a member of an affiliated group filing consolidated or combined returns of which it is not the common parent, the direct or indirect payment by the Borrower to the common parent of such group of the consolidated or combined federal, state and local income Taxes payable by the common parent for such group; provided that the amount of such payments in any taxable year (or portion thereof) does not exceed the amount that Holdings and its Subsidiaries would be required to pay in respect of U.S. federal, state and local income Taxes for such taxable year (or portion thereof) were Holdings and its Subsidiaries to file as part of a consolidated or combined group for income tax purposes; provided further that any amounts paid solely with respect to Holdings shall be attributable to operations or actions of Holdings that are permitted by SectionΒ 6.13.
βPersonβ shall mean any natural person, corporation, business trust, joint venture, association, company, limited liability company, partnership, Governmental Authority or other entity.
βPIK Interestβ shall have the meaning assigned to such term in SectionΒ 2.06(a).
Β
19
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βPlanβ shall mean any employee pension benefit plan, as defined in SectionΒ 3(2) of ERISA (other than a Multiemployer Plan), subject to the provisions of Title IV of ERISA or SectionΒ 412 of the Code or SectionΒ 302 of ERISA which is maintained or contributed to by Borrower or any ERISA Affiliate or with respect to which Borrower could reasonably be expected to incur liability (including on account of an ERISA Affiliate).
βPrime Rateβ means, for any day, the rate of interest in effect for such day that is identified and normally published by The Wall Street Journal as the βPrime Rateβ (or, if more than one rate is published as the Prime Rate, then the highest of such rates), with any change in Prime Rate to become effective as of the date the rate of interest which is so identified as the βPrime Rateβ is different from that published on the preceding Business Day. If The Wall Street Journal no longer reports the Prime Rate, or if the Prime Rate no longer exists, or the Administrative Agent determines in good faith that the rate so reported no longer accurately reflects an accurate determination of the prevailing Prime Rate, then the Administrative Agent may select a reasonably comparable index or source to use as the basis for the Prime Rate.
βQualified Capital Stockβ of any Person shall mean any Equity Interest of such Person that is not Disqualified Stock.
βRecipientβ shall mean (a)Β the Administrative Agent and (b)Β any Lender, as applicable.
βRefinancing Indebtednessβ shall have the meaning assigned to such term in the definition of βPermitted Refinancing.β
βRegisterβ shall have the meaning assigned to such term in SectionΒ 9.04(d).
βRegulation Tβ shall mean Regulation T of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.
βRegulation Uβ shall mean Regulation U of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.
βRegulation Xβ shall mean Regulation X of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.
βRelated Documentsβ shall mean, collectively, the Warrants and the Warrant Agreement.
βRelated Fundβ shall mean, with respect to any Lender that is a fund or commingled investment vehicle that invests in bank loans, any other fund that invests in bank loans and is managed or advised by the same investment advisor as such Lender or by an Affiliate of such investment advisor.
βRelated Partiesβ shall mean, with respect to any specified Person, such Personβs Controlled Affiliates and the respective directors, trustees, officers, employees, agents, attorneys, representatives and advisors of such Person and such Personβs Controlled Affiliates; provided that an agent of a sub-agent shall not be a Related Party, unless (i)Β such agent is appointed as a sub-agent by an Agent in accordance with Article VIII, or (ii)Β such agent is appointed or retained by, or at the direction of, the Required Lenders.
βReleaseβ shall mean any release, spill, emission, leaking, dumping, injection, pouring, deposit, disposal, discharge, dispersal, leaching or migration into or through the environment or within or upon any building, structure, facility or fixture.
Β
20
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βRequired Lendersβ shall mean, at any time, Lenders having Loans and Commitments representing more than 50% of the sum of all Loans and Commitments at such time.
βResponsible Officerβ of any Person shall mean any executive officer (including, without limitation, the president, any vice president, secretary and assistant secretary), or Financial Officer of such Person and any other officer or similar official thereof responsible for the administration of the obligations of such Person in respect of this Agreement.
βRestricted Paymentβ shall mean (i)Β any cash dividend or other cash distribution with respect to any Equity Interests in Holdings, the Borrower or any Subsidiary and (ii)Β any cash payment, including any sinking fund or similar deposit, on account of the purchase, redemption, retirement, acquisition, cancellation or termination of any Equity Interests in Holdings, the Borrower or any Subsidiary.
βRevolving Agentβ shall mean the agent for the Revolving Loan Lenders under the Revolving Loan Agreement.
βRevolving Loan Agreementβ shall mean a revolving loan agreement to be entered into among the Loan Parties and lenders (and agents, if any) reasonably acceptable to the Administrative Agent and on terms and conditions reasonably satisfactory to the Administrative Agent (it being understood and agreed that representations, warranties, covenants, events of default or other terms or provisions that are substantially similar to those in this Agreement are acceptable and satisfactory to the Administrative Agent), subject to the terms of the Intercreditor Agreement and with aggregate commitments thereunder not to exceed $5,000,000 which commitments may be increased up to $10,000,000, so long as at the time of such increase, the Increase Conditions are satisfied.
βRevolving Loan Documentsβ shall mean the loan documents entered into in connection with the Revolving Loan Agreement as amended, amended and restated, supplemented or otherwise modified from time to time in accordance with the Intercreditor Agreement or any Permitted Refinancing thereof.
βRevolving Loan Lendersβ shall mean the lenders under the Revolving Loan Agreement.
βRevolving Loansβ shall mean the loans made pursuant to the Revolving Loan Agreement or any loans under any Permitted Refinancing thereof.
βS&Pβ shall mean StandardΒ & Poorβs Ratings Service, or any successor thereto.
βSECβ shall mean the Securities and Exchange Commission or any other similar or successor agency of the Federal government administering the Securities Act.
βSecured Partiesβ shall have the meaning assigned to such term in the Guarantee and Collateral Agreement.
βSecurities Accountβ is defined in the UCC.
βSecurities Actβ shall mean the Securities Act of 1933, as amended, or any successor Federal statute, and the rules and regulations of the SEC thereunder, all as the same shall be in effect from time to time.
Β
21
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βSecurity Documentsβ shall mean the Guarantee and Collateral Agreement, Control Agreements, the Mortgages (if any) and each of the security agreements, mortgages and other instruments and documents executed and delivered pursuant to any of the foregoing or pursuant to SectionΒ 5.12 and utilized to pledge or grant a security interest or Lien on any property as collateral for the Obligations.
βSPCβ shall have the meaning assigned to such term in SectionΒ 9.04(j).
βSponsorβ shall mean Silver Lake Sumeru Fund, L.P.
βSubject Indebtednessβ shall have the meaning assigned to such term in the definition of βPermitted Refinancing.β
βSubordinated Indebtednessβ shall mean any Indebtedness of a Loan Party (other than, to the extent then in effect, any Revolving Loans or any other obligations under the Revolving Loan Documents) incurred from time to time and subordinated in right of payment to the Obligations and subject to a subordination agreement in form and substance reasonably satisfactory to the Administrative Agent.
βSubsidiaryβ shall mean, with respect to any Person (herein referred to as the βparentβ), any corporation, partnership, limited liability company, association or other business entity (a)Β of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general partnership interests are, at the time any determination is being made, owned, Controlled or held, or (b)Β that is, at the time any determination is made, otherwise Controlled, by the parent or one or more subsidiaries of the parent or by the parent and one or more subsidiaries of the parent. Unless the context otherwise clearly requires, any reference to a βSubsidiaryβ is a reference to a Subsidiary of Holdings.
βSubsidiary Guarantorβ shall mean, on the Closing Date, each Subsidiary of the Borrower listed on ScheduleΒ 1.01(a), and thereafter each wholly-owned Domestic Subsidiary that is or becomes a party to the Guarantee and Collateral Agreement or otherwise provides a guarantee in respect of the Obligations.
βSynthetic Leaseβ shall mean, as to any Person, any lease (including leases that may be terminated by the lessee at any time) of any property (whether real, personal or mixed) (a)Β that is accounted for as an operating lease under GAAP but which, upon the application of any insolvency or bankruptcy laws to such Person, would be characterized as the indebtedness of such Person (without regard to accounting treatment) and (b)Β in respect of which the lessee retains or obtains ownership of the property so leased for U.S. federal income tax purposes, other than any such lease under which such Person is the lessor.
βSynthetic Lease Obligationsβ shall mean, as to any Person, an amount equal to the capitalized amount of the remaining lease payments under any Synthetic Lease that would appear on a balance sheet of such Person in accordance with GAAP if such obligations were accounted for as Capital Lease Obligations.
βTax Returnsβ shall mean (i)Β all returns, declarations, reports, schedules or information return or statement of, or with respect to, Taxes required to be filed with any Governmental Authority or depository and (ii)Β Form TD F 90-22.1.
βTaxesβ shall mean any and all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.
βTermination Dateβ shall have the meaning assigned to such term in Section 3.13.
Β
22
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βTerrorism Orderβ shall have the meaning assigned to such term in Section 3.25.
βTrancheβ shall mean (a)Β the Loans and (b)Β the Incremental Loans.
βTransactionsβ shall mean, collectively, the transactions to occur pursuant to the Loan Documents, including (a)Β the execution and delivery of the Loan Documents and the making of the borrowings hereunder; (b)Β the Existing Debt Refinancing; and (c)Β the payment of related fees, costs and expenses (including, without limitation, attorneyβs fees).
βUCCβ shall mean the Uniform Commercial Code, as in effect from time to time, of the State of New York or of any other state the laws of which are required as a result thereof to be applied in connection with the issue of perfection of security interests.
βUnrestricted Cash and Permitted Investmentsβ of any Person, shall mean cash or Permitted Investments of such Person, (a)Β that are not, and are not required to be, designated as βrestrictedβ on the financial statements of such Person, (b)Β that are not contractually required, and have not been contractually committed by such Person, to be used for a specific purpose, (c)Β that are not subject to (i)Β any provision of law, statute, rule or regulation, (ii)Β any provision of the Organizational Documents of such Person, (iii)Β any order of any Governmental Authority or (iv)Β any contractual restriction (including the terms of any Equity Interests), in each case of (i)Β through (iv), preventing such cash or Permitted Investments, as applicable, from being applied to the payment of the Obligations (other than with respect to any restrictions under the Intercreditor Agreement or the Revolving Loan Agreement), (d)Β in which no Person other than the Collateral Agent has a Lien, other than the Revolving Agent (to the extent applicable) and the depository institution or securities intermediary at where such cash or Permitted Investments are maintained (to the extent permitted under SectionΒ 6.02(xi)), and (e)Β that are held in a Deposit Account or Securities Account, as applicable, in which the Collateral Agent has a valid and enforceable security interest, perfected by βcontrolβ (within the meaning of the applicable Uniform Commercial Code) (or the Revolving Agent has βcontrolβ for both the Revolving Agent and the Collateral Agent pursuant to the terms of the Intercreditor Agreement); provided for the ninetyΒ (90) day period following the Closing Date (or such longer period as the Administrative Agent may agree in its reasonable discretion), such Unrestricted Cash and Permitted Investments shall not be required to be subject to βcontrolβ in favor of the Collateral Agent.
βU.S. Personβ shall mean any Person that is a βUnited States Personβ as defined in SectionΒ 7701(a)(30) of the Code.
βU.S. Tax Compliance Certificateβ shall have the meaning assigned to such term in Section 2.17(f)(ii)(B)(iii).
βUSA PATRIOT Actβ shall mean The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Title III of Pub. L. No.Β 107-56 (signed into law OctoberΒ 26, 2001)).
βWarrant Agreementβ shall mean the agreement to purchase up to a certain amount of Equity Interests of SLS Breeze Holdings, Inc., dated the date hereof, executed by SLS Breeze Holdings, Inc. in order to issue the Warrants in the form of Exhibit H.
βWarrantsβ shall mean the warrants, in the form of Exhibit I, issued by SLS Breeze Holdings, Inc. in favor of each Person that was a Lender on the Closing Date.
Β
23
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βWeighted Average Life to Maturityβ shall mean, when applied to any Indebtedness at any date, the number of years obtained by dividing: (a)Β the sum of the products obtained by multiplying (i)Β the amount of each then remaining installment, sinking fund, serial maturity or other required payments of principal, including payment at final maturity, in respect thereof, by (ii)Β the number of years (calculated to the nearest one-twelfth) that will elapse between such date and the making of such payment; by (b)Β the then outstanding principal amount of such Indebtedness.
βWholly Owned Subsidiaryβ of any Person shall mean a Subsidiary of such Person of which securities (except for (i)Β directorsβ qualifying shares or (ii)Β in the case of Foreign Subsidiaries, nominal shares required by law to be owned by a resident of the relevant jurisdiction) or other ownership interests representing 100% of the Equity Interests are, at the time any determination is being made, owned, Controlled or held by such Person or one or more Wholly Owned Subsidiaries of such Person or by such Person and one or more Wholly Owned Subsidiaries of such Person.
βWithdrawal Liabilityβ shall mean liability of any Loan Party or any ERISA Affiliate to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.
βWithholding Agentβ means any Loan Party and the Administrative Agent.
βYield Enhancement Feeβ shall have the meaning assigned to such term in Section 2.05(a).
SECTIONΒ 1.02. Terms Generally. The definitions in SectionΒ 1.01 shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words βincludeβ, βincludesβ and βincludingβ shall be deemed to be followed by the phrase βwithout limitationβ. The word βwillβ shall be construed to have the same meaning and effect as the word βshallβ; and the words βassetβ and βpropertyβ shall be construed as having the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights. All references herein to Articles, Sections, Exhibits and Schedules shall be deemed references to Articles and Sections of, and Exhibits and Schedules to, this Agreement unless the context shall otherwise require. Except as otherwise expressly provided herein, (a)Β any reference in this Agreement to any Loan Document or any other documents shall mean such document as amended, restated, supplemented or otherwise modified from time to time to the extent not prohibited or restricted hereunder and (b)Β all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time; provided, however, that (x)Β any obligations of a Person under a lease (whether existing now or entered into in the future) that is not (or would not be) a Capital Lease Obligation under GAAP as in effect on the Closing Date shall not be treated as a Capital Lease Obligation solely as a result of the adoption of changes in GAAP and (y)Β if the Borrower notifies the Administrative Agent that the Borrower wishes to amend any covenant in Article VI or any related definition to eliminate the effect of any change in GAAP occurring after the date of this Agreement on the operation of such covenant and the Administrative Agent consents (such consent not to be unreasonably withheld, delayed or conditioned) in writing (or if the Administrative Agent notifies the Borrower that the Required Lenders wish to amend Article VI or any related definition for such purpose and the Borrower consents in writing (such consent not to be unreasonably withheld, delayed or conditioned)), then the Borrowerβs compliance with such covenant shall be determined on the basis of GAAP in effect immediately before the relevant change in GAAP became effective and the Borrower shall provide to the Administrative Agent and the Lenders the reconciliation statements provided for in SectionΒ 5.04, until either such notice is withdrawn or such covenant is amended in a manner reasonably satisfactory to the Borrower and the Required Lenders. The term βenforceabilityβ and its derivatives when used to describe the enforceability of an agreement shall mean that such agreement is enforceable except as enforceability may be limited by any insolvency,
Β
24
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
bankruptcy or debtor relief law and by general equitable principles (whether enforcement is sought by proceedings in equity or at law). Any terms used in this Agreement that are defined in the UCC shall be construed and defined as set forth in the UCC unless otherwise defined herein; provided, that to the extent that the UCC is used to define any term herein and such term is defined differently in different Articles of the UCC, the definition of such term contained in Article 9 of the UCC shall govern.
SECTIONΒ 1.03. Independence of Covenants. All covenants hereunder shall be given independent effect so that if a particular action or condition is not permitted by any of such covenants, the fact that it would be permitted as an exception to, or would otherwise be within the limitations of, another covenants shall not avoid the occurrence of an Event of Default or Default of such action is taken or condition exists.
SECTIONΒ 1.04. Deliveries. Notwithstanding anything herein to the contrary, whenever any document, agreement or other item is required by any Loan Document to be delivered on a day that is not a Business Day, the due date thereof shall be extended to the next succeeding Business Day.
SECTIONΒ 1.05. Construction. Each of the parties hereto acknowledges that (i)Β it has been represented by counsel in the negotiation and documentation of the terms of this Agreement, (ii)Β it has had full and fair opportunity to review and revise the terms of this Agreement, (iii)Β this Agreement has been drafted jointly by all of the parties hereto, and (iv)Β no Lender has any fiduciary relationship with or duty to Holdings, the Borrower or any of its Subsidiaries arising out of or in connection with this Agreement or any of the other Loan Documents, and the relationship between the Lenders, on the one hand, and Holdings, the Borrower and its Subsidiaries, on the other hand, in connection herewith or therewith is solely that of debtor and creditor in respect of the Indebtedness represented hereby. Accordingly, each of the parties hereto acknowledges and agrees that the terms of this Agreement shall not be construed against or in favor of another party.
SECTIONΒ 1.06. Certain Pro Forma Calculations.
(a) For purposes of pro forma calculations of the Consolidated Leverage Ratio under SectionΒ 2.22 and SectionΒ 6.04(vii), Consolidated Revenue shall be calculated to give effect to any Permitted Acquisition or other Investments and Asset Sales or other dispositions permitted hereunder (other than any dispositions in the ordinary course of business), in each case, consummated at any time on or after the first day of the applicable measurement period and prior to the last day of such measurement period as if any such Permitted Acquisition or other Investments permitted hereunder, Asset Sale or other Disposition had been effected on the first day of such period.
(b) For purposes of calculations of the Consolidated Leverage Ratio under SectionΒ 6.10, Consolidated Revenue shall be calculated to give effect to any Permitted Acquisition or other Investments permitted hereunder funded (in whole or in part) with the proceeds of Incremental Loans or with respect to proceeds of cash common or preferred equity contributions to Holdings or issuance of Equity Interests by Holdings (other than Disqualified Stock) and Asset Sales or other dispositions (other than any dispositions in the ordinary course of business), in each case, consummated at any time on or after the first day of the applicable measurement period and prior to the last day of such measurement period as if such Permitted Acquisition or such other Investments permitted hereunder, Asset Sale or other Disposition had been effected on the first day of such period.
SECTIONΒ 1.07. Certain Increased Amounts. Notwithstanding anything to the contrary herein, to the extent any increased amount of (i)Β Indebtedness is incurred in respect of the Permitted Capital Lease Amount, (ii)Β Investments are made in respect of the Permitted Non-Loan Party Investment Amount or (iii)Β Restricted Payments are made in respect of the Permitted Restricted Payment Amount, in
Β
25
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
each case, as of a date on which the Increase Conditions are satisfied (or, in each case, pursuant to a binding commitment entered into with a Person (other than an Affiliate of a Loan Party) as of a date on which the Increase Conditions were satisfied), and after such date the Increase Conditions cease to be satisfied, such increased amount so incurred or made (or that was committed to be incurred or made) shall not constitute an Event of Default hereunder; provided, that, so long as such Increase Conditions are not so satisfied, no additional amounts may be incurred or made (other than those amounts that were committed to be incurred or made when the Increase Conditions were satisfied).
ARTICLE II
The Credits
SECTIONΒ 2.01. Commitments. Subject to the terms and conditions and relying upon the representations and warranties herein set forth, each Lender agrees, severally and not jointly, to make a Loan to the Borrower on the Closing Date in a principal amount equal to its Commitment at a purchase price of 100.0% of par. The Borrower may make only one borrowing of Loans. Amounts paid or prepaid in respect of Loans may not be reborrowed.
SECTIONΒ 2.02. Loans; Notice of Borrowing.
(a) The failure of any Lender to make any Loan shall not in itself relieve any other Lender of its obligation to lend hereunder (it being understood, however, that no Lender shall be responsible for the failure of any other Lender to make any Loan required to be made by such other Lender).
(b) Each Lender shall make the Loan to be made by it hereunder on the Closing Date by wire transfer of immediately available funds to such account as the Borrower may designate not later than 2:00 p.m., Pacific time.
(c) The Borrower shall give the Administrative Agent at least 1 Business Dayβs prior notice (unless waived by the Administrative Agent in its reasonable discretion) of its request to incur Loans hereunder, provided that any such notice shall be deemed to have been given on a certain day only if given before 1:00 p.m. (Pacific time) on such day. Such notice (the βNotice of Borrowingβ) shall be irrevocable and shall be in writing, or by telephone promptly confirmed in writing, in the form of ExhibitΒ A, appropriately completed to specify: (i)Β the aggregate principal amount of the Loan to be incurred and (ii)Β the date of such borrowing (which shall be (x)Β a Business Day and (y)Β the Closing Date). The Administrative Agent shall promptly give each Lender, notice of such proposed borrowing, of such Lenderβs proportionate share thereof and of the other matters required by the immediately preceding sentence to be specified in the Notice of Borrowing.
(d) Without in any way limiting the obligation of the Borrower to confirm in writing any telephonic notice of any borrowing or prepayment of Loans, the Administrative Agent may act without liability upon the basis of telephonic notice of such borrowing, as the case may be, believed by the Administrative Agent in good faith to be from the Borrower, prior to receipt of written confirmation. In each such case, the Borrower hereby waives the right to dispute the Administrative Agentβs record of the terms of such telephonic notice of such borrowing of Loans, as the case may be, absent manifest error.
SECTIONΒ 2.03. Disbursement of Funds.
No later than 2:00 P.M. (Pacific time) on the Closing Date, each Lender will make available its pro rata portion (determined based upon its Commitment) of the borrowing requested to be made. All such amounts will be made available in Dollars and in immediately available funds at the Payment Office,
Β
26
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
and the Administrative Agent will make available to the Borrower at the Payment Office the aggregate of the amounts so made available by the Lenders. Unless the Administrative Agent shall have been notified by any Lender prior to the Closing Date that such Lender does not intend to make available to the Administrative Agent such Lenderβs portion of any borrowing to be made on the Closing Date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on the Closing Date and the Administrative Agent may (but shall not be obligated to), in reliance upon such assumption, make available to the Borrower a corresponding amount. If such corresponding amount is not in fact made available to the Administrative Agent by such Lender, the Administrative Agent shall be entitled to recover such corresponding amount on demand from such Lender. If such Lender does not pay such corresponding amount forthwith upon the Administrative Agentβs demand therefor, the Administrative Agent shall promptly notify the Borrower and the Borrower shall promptly pay such corresponding amount to the Administrative Agent. The Administrative Agent shall be entitled to recover on demand from such Lender or the Borrower, as the case may be, interest on such corresponding amount in respect of each day from the date such corresponding amount was made available by the Administrative Agent to the Borrower until the date such corresponding amount is recovered by the Administrative Agent, at a rate per annum equal to (i)Β if recovered from such Lender, the overnight Federal Funds Effective Rate for the first three days and at the interest rate otherwise applicable to such Loans for each day thereafter and (ii)Β if recovered from the Borrower, the rate of interest applicable to the respective borrowing, as determined pursuant to SectionΒ 2.06. Nothing in this SectionΒ 2.03 shall be deemed to relieve any Lender from its obligation to make Loans hereunder or to prejudice any rights which the Borrower may have against any Lender as a result of any failure by such Lender to make Loans hereunder. This SectionΒ 2.03 is subject to SectionΒ 2.19.
SECTIONΒ 2.04. Evidence of Debt; Repayment of Loans.
(a) The Borrower hereby unconditionally promises to pay to each Lender the principal amount of each Loan of such Lender as provided in SectionΒ 2.09.
(b) Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Borrower to such Lender resulting from the Loans made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time under this Agreement.
(c) The entries made in the accounts maintained pursuant to paragraph (b)Β above shall be prima facie evidence absent manifest error of the existence and amounts of the obligations therein recorded; provided, however, that the failure of any Lender to maintain such accounts or any error therein shall not in any manner affect the obligations of the Borrower to repay the Loans in accordance with their terms.
(d) The Borrowerβs obligation to pay the principal of, and interest on, the Loans made by each Lender shall be evidenced in the Register maintained by the Administrative Agent pursuant to SectionΒ 9.04(d) and shall, if requested by such Lender, also be evidenced by a promissory note duly executed and delivered by the Borrower substantially in the form of ExhibitΒ B, with blanks appropriately completed in conformity herewith (each a βNoteβ and, collectively, the βNotesβ). To the extent of any conflict between the Register and the entries made in the accounts maintained pursuant to paragraphΒ (b) above, the entries made in the Register shall control.
(e) Notwithstanding anything to the contrary contained above in this SectionΒ 2.04 or elsewhere in this Agreement, Notes shall only be delivered to Lenders that at any time specifically request the delivery of such Notes. No failure of any Lender to request or obtain a Note evidencing its Loans to the Borrower shall affect or in any manner impair the obligations of the Borrower to pay the
Β
27
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Loans (and all related Obligations) incurred by the Borrower that would otherwise be evidenced thereby in accordance with the requirements of this Agreement, and shall not in any way affect the security or guaranties therefor provided pursuant to the Loan Documents. Any Lender that does not have a Note evidencing its outstanding Loans shall in no event be required to make the notations otherwise described in preceding clause (b). At any time when any Lender requests the delivery of a Note to evidence any of its Loans, the Borrower shall promptly execute and deliver to the respective Lender the requested Note in the appropriate amount or amounts to evidence such Loans; provided that, to the extent a Note was previously delivered to such Lender but such Lender has since lost or misplaced such Note or the Note cannot otherwise be found, such Lender shall execute and deliver to the Borrower a customary lost note affidavit in form and substance reasonably satisfactory to the Borrower and such Lender.
SECTIONΒ 2.05. Fees.
(a) The Borrower agrees to pay to the Administrative Agent for distribution to each Lender a yield enhancement fee (the βYield Enhancement Feeβ) on the Closing Date equal to 2.0% of the aggregate Commitments (to the extent the Loan related to such Commitments are outstanding on the Closing Date).
(b) All Fees shall be paid on the dates due, in immediately available funds, to the Administrative Agent or the Lenders, as applicable. Once paid, to the extent the Loans related to such Fees are actually funded in accordance with the Loan Documents, none of the Fees shall be refundable under any circumstances or subject to any right of setoff, counterclaim or any similar right (each of which is hereby waived by Holdings and the Borrower).
SECTIONΒ 2.06. Interest on Loans.
(a) Subject to the provisions of SectionΒ 2.07, the Loans shall bear interest (computed on the basis of the actual number of days elapsed over a year of 360 days) at a rate per annum equal to the sum of the Libor Rate plus 8.0%Β per annum (or, to the extent the Administrative Agent shall have delivered a LIBOR Unavailability Notice to the Borrower and the Lenders pursuant to SectionΒ 2.12(e), the Alternate Base Rate plus 7.0%Β per annum); provided, however, the Borrower may elect to pay, in kind, a portion of such accrued and unpaid interest (any such interest paid in kind, the βPIK Interestβ) due on any Interest Payment Date up to the maximum percentage set forth in the table below opposite the relevant period in which such Interest Payment Date occurs of the total accrued and unpaid interest payable on such Interest Payment Date; it being deemed that the Borrower has elected the maximum PIK Interest for each period during the term of this Agreement unless the Borrower shall have delivered a certificate executed by a Responsible Officer of the Borrower to the Administrative Agent certifying that the Borrower has elected to pay interest with respect to the Loans for the applicable period then ending (i)Β in such lesser percentage of PIK Interest and specifying the amount of such PIK Interest or (ii)Β in cash only. To change the type of payment of interest for any period, such officerβs certificate must be delivered to the Administrative Agent at least 5 Business Days prior to the applicable Interest Payment Date for such period. The Borrower may specify in such officerβs certificate whether such change in the type of payment of interest is just for a specific period or shall be applicable to all future periods during the term of the Agreement until another officerβs certificate is delivered specifying a different type of payment of interest for a period or periods.
Β
28
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Period |
Β Β | Maximum PercentageΒ ofΒ TotalΒ Interest That May be Paid In Kind |
Β | |
From and after the Closing Date to and including the second anniversary of the Closing Date |
Β Β | Β | 80.0 | %Β |
After the second anniversary of the Closing Date to and including the third anniversary of the Closing Date |
Β Β | Β | 70.0 | %Β |
After the third anniversary of the Closing Date |
Β Β | Β | 60.0 | %Β |
All interest due and payable hereunder that the Borrower elects to pay in the form of PIK Interest shall be capitalized, added to the then-outstanding principal amount of the Loans as additional principal obligations hereunder on and as of such Interest Payment Date and shall automatically constitute a part of the outstanding principal amount of the Loans for all purposes hereof (including the accrual of interest thereon at the rates applicable to the Loans generally). Any determination of the principal amount outstanding under the Loans after giving effect to any payment of PIK Interest hereunder or otherwise that is reasonably made by the Administrative Agent or the Lenders in good faith shall be prima facie evidence of the correctness of such determination in the absence of manifest error.
(b) Interest on each Loan shall be payable on the Interest Payment Dates except as otherwise provided in this Agreement.
SECTIONΒ 2.07. Default Interest. Upon the occurrence and during the continuation of any Event of Default, the outstanding principal amount of all Loans and, to the extent permitted by applicable law, any interest payments thereon not paid when due and any fees and other amounts then due and payable hereunder, shall thereafter, automatically in the case of an Event of Default under Sections 7.01(a), (g)Β or (h)Β and at the written election of the Administrative Agent (acting at the written direction of the Required Lenders) otherwise (it being understood that such election may apply retroactively to the date such other Event of Default occurred), bear interest (including post-petition interest in any proceeding under the Bankruptcy Code or other applicable bankruptcy laws) payable upon written demand at the rate otherwise applicable to a Loan pursuant to SectionΒ 2.06(a) plus 2.0%Β per annum. Payment or acceptance of the increased rates of interest provided for in this SectionΒ 2.07 is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of the Administrative Agent, the Collateral Agent or any Lender.
SECTIONΒ 2.08. Termination of Commitments. The Commitments shall automatically terminate upon the making of the Loans on the Closing Date.
SECTIONΒ 2.09. Repayment of Loans.
To the extent not previously paid, all Loans shall be due and payable on the Maturity Date (or, if such day is not a Business Day, on the next succeeding Business Day), in immediately available funds, together with accrued and unpaid interest on the principal amount to be paid to but excluding the date of payment.
Β
29
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 2.10. Optional Prepayment.
(a) The Borrower shall have the right at any time and from time to time to prepay any of the Loans and other Obligations, in whole or in part, at 100% of the principal amount so prepaid, plus the prepayment premium (expressed as percentages of principal amount) set forth below (the βApplicable Prepayment Premiumβ) determined for the prepayment date with respect to such principal amount to the applicable prepayment date (provided, however, that each partial prepayment shall be in an amount that is an integral multiple of $500,000 and not less than $1,000,000, in each case, unless the remaining outstanding amount of Loans is less than such amount):
Β
If Prepaid: |
Β Β | PercentageΒ ofΒ theΒ Principal | Β | |
From and after the Closing Date to but not including the second anniversary of the Closing Date |
Β Β | Β | 3.0 | %Β |
From and after the second anniversary of the Closing Date to but not including the third anniversary of the Closing Date |
Β Β | Β | 1.0 | %Β |
From and after the third anniversary of the Closing Date |
Β Β | Β | 0 | %Β |
(b) The Borrower will give at least 3 Business Daysβ prior written notice of each optional prepayment under this SectionΒ 2.10 to the Administrative Agent. Each such notice shall specify the prepayment date, the aggregate principal amount of the Loans to be prepaid on such date, and the interest to be paid on the prepayment date with respect to such principal amount being prepaid, and, solely to the extent any such prepayment is made prior to the third anniversary of the Closing Date, shall be accompanied by a certificate of a Financial Officer of the Borrower as to the estimated Applicable Prepayment Premium due in connection with such prepayment (calculated as if the date of such notice were the date of the prepayment), setting forth the details of such computation. Such notice shall be irrevocable and shall commit the Borrower to prepay the Loans by the amount stated therein on the date stated therein; provided that such notice may be contingent on the satisfaction of certain conditions set forth therein, and such notice shall be deemed revoked if the conditions set forth therein are not satisfied within the time periods set forth in such notice for the satisfaction thereof (or are waived in writing by the Borrower). All prepayments under this SectionΒ 2.10 shall be subject to SectionΒ 2.13. All prepayments under this SectionΒ 2.10 shall be accompanied by accrued and unpaid interest on the principal amount to be prepaid to but excluding the date of payment, but, for the avoidance of doubt, no Applicable Prepayment Premium shall be paid or due (i)Β on any interest (other than, for the avoidance of doubt, PIK Interest that has been capitalized and added to principal) or amounts other than the principal amount of the Loans so prepaid or (ii)Β on the proceeds of a Cure Contribution or Cure Securities that are used to prepay the Loans. Each prepayment pursuant to this SectionΒ 2.10 in respect of the Loans shall be applied pro rata among such Loans.
Β
30
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 2.11. Mandatory Prepayments.
(a) Net Asset Sale Proceeds. Not later than the tenth Business Day following the receipt of Net Asset Sale Proceeds by the Borrower or any of its Subsidiaries, the Borrower shall either (1)Β apply an amount equal to 100% of the Net Asset Sale Proceeds received with respect thereto to prepay outstanding Loans in accordance with SectionΒ 2.11(e) and SectionΒ 2.11(f) or (2)Β so long as no Event of Default shall have occurred and be continuing, deliver to the Administrative Agent a certificate of a Responsible Officer stating that the Borrower or such Subsidiary intends to reinvest or enter into a binding commitment to reinvest such Net Asset Sale Proceeds in assets used or that are useful in the business of the Borrower and its Subsidiaries within 270 days (or, in the case of a binding commitment to reinvest entered into within 270 days, within 405 days) of such date of receipt of such Net Asset Sale Proceeds. In addition, the Borrower shall, no later than 270 days (or, in the case of a binding commitment to reinvest entered into within 270 days, 405 days) after receipt of such Net Asset Sale Proceeds that have not theretofore been applied to the Obligations or that have not been so reinvested as provided above, make an additional prepayment of the Loans in an amount equal to the full amount of all such Net Asset Sale Proceeds in accordance with SectionΒ 2.11(e) and SectionΒ 2.11(f) within ten Business Days after the last day of the 270 or 405 day period, as applicable. Notwithstanding anything to the contrary herein, with respect to the Disposition of any Revolving Loan Priority Collateral, the Borrowerβs obligation to prepay the Loans under this SectionΒ 2.11(a) shall be deemed satisfied to the extent that the amount that would otherwise be required to be used to prepay the Loans under this SectionΒ 2.11(a) is (y)Β required to be applied and is in fact applied to prepay the loans (but without requiring any permanent reduction of the commitments under the Revolving Loan Agreement) within the time period required by the terms of the Revolving Loan Agreement (including any grace period provided in connection therewith) or (z)Β reinvested in the business of the Borrower and its Subsidiaries pursuant to the terms of the Revolving Loan Agreement.
(b) Net Insurance/Condemnation Proceeds. No later than the tenth Business Day following the date of receipt by the Borrower or any of its Subsidiaries of any Net Insurance/Condemnation Proceeds in excess of $500,000 for all Casualty Events in any fiscal year of the Borrower, the Borrower shall prepay the Loans in an aggregate amount equal to such excess; provided, so long as no Event of Default shall have occurred and be continuing, the Borrower shall have the option, directly or through one or more of its Subsidiaries to invest such excess amount within 270 days (or, in the case of a binding commitment to reinvest entered into within 270 days, 405 days) of receipt thereof (i)Β in assets used or that are useful in the business of the Borrower and its Subsidiaries or (ii)Β to repair, restore or replace the assets subject to the applicable Casualty Event; and provided, further, that an amount equal to any such Net Insurance/Condemnation Proceeds that have not been reinvested within 270 days (or, in the case of a binding commitment to reinvest entered into within 270 days, 405 days) of receipt thereof shall be applied by the Borrower to prepay the Loans in accordance with SectionΒ 2.11(e) and SectionΒ 2.11(f). Notwithstanding anything to the contrary herein, with respect to any Net Insurance/Condemnation Proceeds of any Revolving Loan Priority Collateral (as defined in the Intercreditor Agreement), the Borrowerβs obligation to prepay the Loans under this SectionΒ 2.11(b) shall be deemed satisfied to the extent that the amount that would otherwise be required to be used to prepay the Loans under this SectionΒ 2.11(b)(iii) is (y)Β required to be applied and is in fact applied to prepay the loans (but without requiring any permanent reduction of the commitments under the Revolving Loan Agreement) within the time period required by the terms of the Revolving Loan Agreement (including any grace period provided in connection therewith) or (z)Β reinvested in the business of the Borrower and its Subsidiaries pursuant to the terms of the Revolving Loan Agreement.
(c) Issuance of Indebtedness. On the date of receipt of the Net Securities Proceeds from the issuance of any Indebtedness of Holdings, the Borrower or any of its Subsidiaries after the Closing Date (other than Indebtedness permitted under SectionΒ 6.01), the Borrower shall prepay the Loans in accordance with SectionΒ 2.11(e) and SectionΒ 2.11(f) in an aggregate amount equal to such Net Securities Proceeds.
Β
31
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(d) Change of Control. Upon the occurrence of a Change of Control, the Borrower shall offer to prepay all Loans then outstanding at 100% of the principal amount, plus the prepayment premium (expressed as percentages of principal amount) set forth below (the βChange of Control Prepayment Premiumβ) determined for the prepayment date with respect to such principal amount (including, for the avoidance of doubt, PIK Interest that has been capitalized and added to principal) of such Loans outstanding on the applicable prepayment date:
Β
If Prepaid: |
Β Β | Percentage | Β | |
From and after the Closing Date up to but not including the first anniversary of the Closing Date |
Β Β | Β | 2.0 | %Β |
From and after the first anniversary of the Closing Date up to but not including the second anniversary of the Closing Date |
Β Β | Β | 1.0 | %Β |
From and after the second anniversary of the Closing Date up to but not including the third anniversary of the Closing Date |
Β Β | Β | 0.25 | %Β |
From and after the third anniversary of the Closing Date |
Β Β | Β | 0 | %Β |
(e) The Borrower shall deliver to the Administrative Agent, at the time of each prepayment required under this SectionΒ 2.11 a certificate signed by a Financial Officer of the Borrower setting forth in reasonable detail the calculation of the amount of such prepayment and to the extent practicable, at least three daysβ prior written notice of such prepayment. Each notice of prepayment shall specify the prepayment date, the principal amount of each Loan (or portion thereof) to be prepaid, and, if applicable, the Applicable Prepayment Premium or Change of Control Prepayment Premium due in connection with such prepayment. All prepayments of Loans under this SectionΒ 2.11 shall be subject to SectionΒ 2.11(f), SectionΒ 2.11(g) and SectionΒ 2.13 and shall be accompanied by accrued and unpaid interest on the principal amount to be prepaid to but excluding the date of payment. For the avoidance of doubt, no Applicable Prepayment Premium or Change of Control Prepayment Premium shall be due on interest (other than, for the avoidance of doubt, PIK Interest that has been capitalized and added to principal) or any amount other than the principal amount of the Loans so prepaid.
(f) Notwithstanding anything to the contrary herein, any Lender may elect, by notice to the Borrower, prior to any prepayment of Loans or an offer to prepay the Loans required to be made by the Borrower pursuant to paragraph (a), (b), (c)Β or (d), as applicable, of this SectionΒ 2.11, to decline all (but not a portion) of its pro rata share of such prepayment (such declined amounts, the βDeclined Proceedsβ). Any Declined Proceeds shall be offered on a pro rata basis to the Lenders not so declining such prepayment. To the extent such non-declining Lenders elect to decline their pro rata shares of such Declined Proceeds, such Declined Proceeds may be retained by the Borrower.
Β
32
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(g) With respect to any prepayment of Loans (including capitalized PIK Interest) required to be made by the Borrower pursuant to paragraph (d), the Borrower shall pay the Change of Control Prepayment Premium determined for the prepayment date with respect to such principal amount paid.
(h) With respect to any prepayment of Loans (including capitalized PIK Interest) required to be made by the Borrower pursuant to paragraph (c)Β of this SectionΒ 2.11 or Article VII (other than on account of an acceleration resulting solely from a breach of SectionΒ 6.10), the Borrower shall pay the Applicable Prepayment Premium determined for the prepayment date with respect to such principal amount paid. For the avoidance of doubt, no Applicable Prepayment Premium, Change of Control Prepayment Premium or any other prepayment premium shall be required to be paid with respect to any prepayment pursuant to paragraphs (a)Β or (b)Β of this SectionΒ 2.11.
SECTIONΒ 2.12. Reserve Requirements; Change in Circumstances.
(a) Notwithstanding any other provision of this Agreement, if any Change in Law shall:
(i) impose, modify or deem applicable any reserve, special deposit or similar requirement against assets of, deposits with or for the account of or credit extended by any Lender or shall impose on such Lender any other condition affecting this Agreement or Loans made by such Lender; or
(ii) subject any Recipient to any Taxes (other than (A)Β Indemnified Taxes, (B)Β Taxes described in clauses (b)Β through (d)Β of the definition of βExcluded Taxesβ and (C)Β Connection Income Taxes) on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto;
and the result of any of the foregoing shall be to increase the cost to such Lender of making, converting to, continuing or maintaining any Loan or to reduce the amount of any sum received or receivable by such Lender hereunder (whether of principal, interest or otherwise), then the Borrower will pay to such Lender, upon written demand, such additional amount or amounts as will compensate such Lender for such additional costs incurred or reduction suffered.
(b) If any Lender shall have reasonably determined that any Change in Law regarding capital adequacy or liquidity requirements has or would have the effect of reducing the rate of return on such Lenderβs capital or on the capital of such Lenderβs holding company, if any, as a consequence of this Agreement, the Commitments of such Lender or the Loans made by such Lender pursuant hereto to a level below that which such Lender or such Lenderβs holding company could have achieved but for such Change in Law (taking into consideration such Lenderβs policies and the policies of such Lenderβs holding company with respect to capital adequacy), then from time to time the Borrower shall pay to such Lender such additional amount or amounts as will compensate such Lender or such Lenderβs holding company for any such reduction suffered.
(c) A certificate of a Lender setting forth the amount or amounts necessary to compensate such Lender or its holding company, as applicable, as specified in paragraph (a)Β or (b)Β of this SectionΒ 2.12 shall be delivered to the Borrower and shall be prima facie evidence absent manifest error. The Borrower shall pay such Lender the amount shown as due on any such certificate delivered by it within 10 Business Days after its receipt of the same.
Β
33
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(d) Failure or delay on the part of any Lender to demand compensation for any increased costs or reduction in amounts received or receivable or reduction in return on capital pursuant to this SectionΒ 2.12 shall not constitute a waiver of such Lenderβs right to demand such compensation; provided that the Borrower shall not be under any obligation to compensate any Lender under paragraph (a)Β or (b)Β of this SectionΒ 2.12 with respect to increased costs incurred or reductions suffered more than six months prior to the date that such Lender notifies in writing the Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lenderβs intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the six-month period referred to above shall be extended to include the period of retroactive effect thereof). The protection of this SectionΒ 2.12(d) shall be available to each Lender and regardless of any possible contention of the invalidity or inapplicability of the Change in Law that shall have occurred or been imposed.
(e) Notwithstanding anything to the contrary, in the event that the Administrative Agent shall have reasonably determined that dollar deposits in the principal amounts of the Loan are not generally available in the London interbank market, or that the rates at which such dollar deposits are being offered will not adequately and fairly reflect the cost to the majority of Lenders of making or maintaining loans at the three-month London Interbank Offered Rate, or that reasonable means do not exist for ascertaining the Libor Rate, the Administrative Agent shall, as soon as practicable thereafter, give written or fax notice of such determination to the Borrower and the Lenders (a βLIBOR Unavailability Noticeβ). In the event of any such reasonable determination, until the Administrative Agent shall have advised the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist, interest on the Loan shall accrue by reference to the Alternate Base Rate. Each determination by the Administrative Agent under this SectionΒ 2.12(e) shall be prima facie evidence absent manifest error.
SECTIONΒ 2.13. Indemnity. Subject to the limitations set forth in SectionΒ 9.05(b) and the time period for payment set forth in SectionΒ 9.05(e), the Borrower shall indemnify each Lender against any loss or expense that such Lender may sustain or incur as a consequence of any default by the Borrower in the making of any payment or prepayment required to be made hereunder. A certificate of any Lender setting forth any amount or amounts which such Lender is entitled to receive pursuant to this SectionΒ 2.13 shall be delivered to the Borrower and shall be prima facie evidence absent manifest error.
SECTIONΒ 2.14. Pro Rata Treatment. Except as otherwise provided in this Agreement the Administrative Agent agrees that promptly after its receipt of each payment from or on behalf of the Borrower in respect of any Obligations hereunder, the Administrative Agent shall distribute such payment to the Lenders entitled thereto (other than any Lender that has consented in writing to waive its pro rata share of any such payment) pro rata based upon their respective shares, if any, of the Obligations with respect to which such payment was received. This SectionΒ 2.14 is subject to SectionΒ 2.19.
SECTIONΒ 2.15. Ratable Sharing. Each Lender agrees that if it shall, through the exercise of a right of bankerβs lien, setoff or counterclaim against the Borrower or any other Loan Party, or pursuant to a secured claim under SectionΒ 506 of the Bankruptcy Code or other security or interest arising from, or in lieu of, such secured claim, received by such Lender under any applicable bankruptcy, insolvency or other similar law or otherwise, or by any other means (but excluding any sale or participation of its Loans to a Person other than the Borrower or an Affiliate thereof, which shall be included), obtain payment (voluntary or involuntary) in respect of any principal of any Loan as a result of which the unpaid principal portion of its Loans shall be proportionately less than the unpaid principal portion of the Loans of any other Lender, it shall (a)Β notify the Administrative Agent of such fact and (b)Β be deemed simultaneously to have purchased from such other Lender at face value, and shall promptly pay to such other Lender the purchase price for, a participation in the Loans of such other Lender, so that the aggregate unpaid principal amount of the Loans and participations in Loans held by each Lender shall be in the same
Β
34
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
proportion to the aggregate unpaid principal amount of all Loans then outstanding as the principal amount of its Loans prior to such exercise of bankerβs lien, setoff or counterclaim or other event was to the principal amount of all Loans outstanding prior to such exercise of bankerβs lien, setoff or counterclaim or other event; provided, however, that if any such purchase or purchases or adjustments shall be made pursuant to this SectionΒ 2.15 and the payment giving rise thereto shall thereafter be recovered, such purchase or purchases or adjustments shall be rescinded to the extent of such recovery and the purchase price or prices or adjustment restored without interest. The Borrower and Holdings expressly consent to the foregoing arrangements and agree that any Lender holding a participation in a Loan deemed to have been so purchased may exercise any and all rights of bankerβs lien, setoff or counterclaim or other event with respect to any and all moneys owing by the Borrower and Holdings to such Lender by reason thereof as fully as if such Lender had made a Loan directly to the Borrower in the amount of such participation.
SECTIONΒ 2.16. Payments.
(a) Except with respect to any PIK Interest pursuant to SectionΒ 2.06, the Borrower shall make each payment (including principal of or interest on any Loan or any Fees or other amounts) hereunder and under any other Loan Document not later than 11:00 a.m., Local Time, on the date when due in immediately available Dollars, without setoff, defense (other than the defense of payment) or counterclaim. Subject to SectionΒ 2.19, each such payment shall be made to the Administrative Agent for distribution to the Lenders or other appropriate Person. Each such payment that is payable to a Lender shall be paid directly to such Lender at the office identified on ScheduleΒ 2.01 for such Lender or as otherwise directed by such Lender in writing from time to time, and each such payment that is payable to the Administrative Agent or the Collateral Agent shall be paid directly to the Administrative Agent or Collateral Agent, as applicable, at their respective offices identified on ScheduleΒ 2.01 or as otherwise directed by the Administrative Agent or Collateral Agent, as applicable, in writing from time to time.
(b) Except as otherwise expressly provided herein, whenever any payment (including principal of or interest on any Loan or any Fees or other amounts) hereunder or under any other Loan Document shall become due, or otherwise would occur, on a day that is not a Business Day, such payment may be made on the next succeeding Business Day, and such extension of time shall in such case be included in the computation of interest or Fees, if applicable.
SECTIONΒ 2.17. Taxes.
(a) Any and all payments by or on account of any obligation of any Loan Party under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by applicable law. If any applicable law (as determined in the good faith discretion of an applicable Withholding Agent) requires the deduction or withholding of any Tax from any such payment by a Withholding Agent, then the applicable Withholding Agent shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law and, if such Tax is an Indemnified Tax, then the sum payable by the applicable Loan Party shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section) the applicable Recipient receives an amount equal to the sum it would have received had no such deduction or withholding been made.
(b) Holdings and the Borrower shall, or shall cause each of the Loan Parties to, timely pay to the relevant Governmental Authority in accordance with applicable law, or at the option of the Administrative Agent timely reimburse it for the payment of, any Other Taxes.
Β
35
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(c) The Loan Parties shall jointly and severally indemnify each Recipient, within 10 days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section) payable or paid by such Recipient or required to be withheld or deducted from a payment to such Recipient and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error.
(d) Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i)Β any Indemnified Taxes attributable to such Lender (but only to the extent that the Administrative Agent has not already been indemnified by any of the Loan Parties for such Indemnified Taxes and without limiting the obligation of the Loan Parties to do so), (ii)Β any Taxes attributable to such Lenderβs failure to comply with the provisions of SectionΒ 9.04(g) relating to the maintenance of a Participant Register and (iii)Β any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this paragraph (d).
(e) As soon as practicable after any payment of Taxes by any Loan Party to a Governmental Authority pursuant to this SectionΒ 2.17, the Borrower shall, or shall cause such Loan Party to, deliver to the Administrative Agent or the applicable Lender, as the case may be, the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent or the applicable Lender, as the case may be.
(f) (i) Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments under any Loan Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the applicable Withholding Agent such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate. In addition, any Lender, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements. Notwithstanding anything the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in SectionΒ 2.17 (ii)(A), (ii)(B) and (ii)(D) below) shall not be required if in the Lenderβs reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.
(ii) Without limiting the generality of the foregoing, any Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the request of the Borrower or the Administrative Agent), whichever of the following is applicable:
Β
36
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(A) any Lender that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed originals of IRS Form W-9 certifying that such Lender is exempt from U.S. federal backup withholding tax;
(B) any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable:
(i) in the case of a Foreign Lender claiming the benefits of an income Tax treaty to which the United States is a party (x)Β with respect to payments of interest under any Loan Document, executed originals of IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the βinterestβ article of such Tax treaty and (y)Β with respect to any other applicable payments under any Loan Document, IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the βbusiness profitsβ or βother incomeβ article of such Tax treaty;
(ii) executed originals of IRS Form W-8ECI;
(iii) in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under SectionΒ 881(c) of the Code, (x)Β a certificate to the effect that (A)Β such Foreign Lender is not a βbankβ within the meaning of SectionΒ 881(c)(3)(A) of the Code, a β10 percent shareholderβ of the Borrower within the meaning of SectionΒ 881(c)(3)(B) of the Code, or a βcontrolled foreign corporationβ described in SectionΒ 881(c)(3)(C) of the Code and (B)Β the interest payments in question are not effectively connected with a U.S. trade or business conducted by such Foreign Lender (a βU.S. Tax Compliance Certificateβ) and (y)Β executed originals of IRS Form W-8BEN;
(iv) to the extent a Foreign Lender is not the beneficial owner (for example, where the Foreign Lender is a partnership), executed originals of IRS Form W-8IMY, accompanied by a Form W-8ECI, W-8BEN, U.S. Tax Compliance Certificate, Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that if one or more direct or indirect beneficial owners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender shall provide a U.S. Tax Compliance Certificate on behalf of each such direct and indirect beneficial owner; or
(C) any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the
Β
37
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
reasonable request of the Borrower or the Administrative Agent), executed originals of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made.
(D) If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in SectionΒ 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by SectionΒ 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lenderβs obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause (D), βFATCAβ shall include any amendments made to FATCA after the date of this Agreement.
Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so.
(g) If the Administrative Agent or any Lender determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this SectionΒ 2.17 (including by the payment of additional amounts pursuant to this SectionΒ 2.17), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this Section with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Such indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this paragraph (g)Β (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (g), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this paragraphΒ (g) the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts giving rise to such Tax had never been paid.
(h) Nothing contained in this SectionΒ 2.17 shall require any Lender (or any transferee or assignee) or either Agent to make available any of its Tax Returns or any other information that it deems to be confidential or proprietary.
Β
38
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 2.18. Assignment of Loans Under Certain Circumstances; Duty to Mitigate.
(a) Notwithstanding anything to the contrary set forth in this Agreement, in the event (i)Β any Lender delivers a certificate requesting compensation pursuant to SectionΒ 2.12, (ii)Β the Borrower is required to pay any Indemnified Taxes or any additional amount to any Lender or any Governmental Authority on account of any Lender pursuant to SectionΒ 2.17 or (iii)Β any Lender refuses to consent to any amendment, waiver or other modification of any Loan Document requested by the Borrower that requires the consent of a greater percentage of the Lenders than the Required Lenders and such amendment, waiver or other modification is consented to by the Required Lenders, and, in the case of clause (i)Β or (ii), such Lender has declined or is unable to designate a different lending office in accordance with SectionΒ 2.18(b) that would not require such compensation or requirement to pay such amounts, the Borrower, at its sole expense and effort (including with respect to the processing and recordation fee referred to in SectionΒ 9.04(b)), upon notice to such Lender and the Administrative Agent, mayΒ require such Lender to transfer and assign, without recourse (in accordance with and subject to the restrictions contained in SectionΒ 9.04), all of its interests, rights (other than its existing rights to payments pursuant to SectionΒ 2.12 or SectionΒ 2.17) and obligations under this Agreement and the related Loan Documents to an assignee that shall assume such assigned obligations (which assignee may be another Lender, if a Lender accepts such assignment); provided that, (x)Β such assignment shall not conflict with any law, rule or regulation or order of any court or other Governmental Authority having jurisdiction, (y)Β the Borrower shall have received the prior written consent of the Administrative Agent, which consent shall not unreasonably be withheld or delayed, and (z)Β the Borrower or such assignee shall have paid to the affected Lender in immediately available funds an amount equal to the sum of the principal of and interest accrued to the date of such payment on the outstanding Loans of such Lender, plus all Fees and other amounts that have accrued and have earned for the account of such Lender hereunder with respect thereto (including any amounts under SectionΒ 2.12 and SectionΒ 2.13); provided further that, if prior to any such transfer and assignment the circumstances or event that resulted in such Lenderβs claim for compensation under SectionΒ 2.12 or the amounts paid pursuant to SectionΒ 2.17, as the case may be, cease to cause such Lender to suffer increased costs or reductions in amounts received or receivable or reduction in return on capital or cease to result in amounts being payable under SectionΒ 2.17, as the case may be (including as a result of any action taken by such Lender pursuant to paragraph (b)Β of this SectionΒ 2.18), or if such Lender shall waive its right to claim further compensation under SectionΒ 2.12 in respect of such circumstances or event or shall waive its right to further payments under SectionΒ 2.17 in respect of such circumstances or event or shall consent to the proposed amendment, waiver, consent or other modification, as the case may be, then such Lender shall not thereafter be required to make any such transfer and assignment hereunder; provided, however, that any prior transfer or assignment shall still be in full force and effective. Each Lender hereby grants to the Administrative Agent an irrevocable power of attorney (which power is coupled with an interest) to execute and deliver, on behalf of such Lender as assignor, any Assignment and Acceptance necessary to effectuate any assignment of such Lenderβs interests hereunder in the circumstances contemplated by this Section 2.18.
(b) If (i)Β any Lender shall request compensation under SectionΒ 2.12 or (ii)Β the Borrower is required to pay any Indemnified Taxes or any additional amount to any Lender or any Governmental Authority on account of any Lender pursuant to SectionΒ 2.17, then such Lender shall (at the request of the Borrower) use reasonable efforts (which shall not require such Lender to incur an unreimbursed loss or unreimbursed cost or expense or otherwise take any action inconsistent with its internal policies or legal or regulatory restrictions or suffer any disadvantage or burden reasonably deemed by it to be significant) to assign (at the request of the Borrower) its rights and delegate and transfer its obligations hereunder to another of its offices, branches or affiliates, if such filing or assignment would reduce its claims for compensation under SectionΒ 2.12 or would reduce amounts payable pursuant to SectionΒ 2.17, as the case may be, in the future. The Borrower hereby agrees to pay all reasonable and documented out-of-pocket costs and expenses incurred by any Lender in connection with any such filing or assignment, delegation and transfer.
Β
39
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 2.19. Obsidian Agency Services as Administrative Agent. Notwithstanding anything to the contrary set forth in this Agreement or any other Loan Document, at any time that Obsidian Agency Services, Inc. serves as the Administrative Agent hereunder, (a)Β the Lenders shall directly fund the Loans to the Borrower, (b)Β each Lender shall provide wire instructions to the Borrower with respect to payments to be received from the Borrower hereunder and the Borrower shall directly make any payments required or permitted hereunder to the Lenders and (c)Β neither the Lenders nor the Borrower shall remit any funds to the Administrative Agent to forward to another party hereunder.
SECTIONΒ 2.20. Tax Treatment.
(a) Holdings, the Borrower and each of the Lenders agree, (i)Β that the Loans are debt for U.S. federal income tax purposes, (ii)Β that the Loans are issued with original issue discount (βOIDβ) solely on account of the PIK Interest and value allocated to the Warrants under SectionΒ 2.20(b), (iii)Β that the Loans are not governed by the rules set out in Treasury Regulations SectionΒ 1.1275-4 and (iv)Β not to file any Tax Return, report or declaration inconsistent with the foregoing, except as otherwise required pursuant to a βdeterminationβ within the meaning of SectionΒ 1313(a) of the Code (or any corresponding provision of state, local or foreign tax law).
(b) In connection with the Loans, each of the Lenders is receiving Warrants on the Closing Date. The Loans and Warrants are considered to be the issuance of an βinvestment unitβ under SectionΒ 1273(c)(2) of the Code, and the parties agree that the aggregate fair market value of the Warrants shall be $1,060,000 for purposes of the investment unit allocation rules under SectionΒ 1273(c)(2) of the Code. The Borrower and each of the Lenders agree to report in a manner that is consistent with this allocation for all tax purposes.
(c) The inclusion of this SectionΒ 2.20 is not an admission by any Lender that it is subject to United States taxation.
SECTIONΒ 2.21. AHYDO. Notwithstanding anythingΒ herein to the contrary, if (1)Β the Loans remain outstanding after the fifth anniversary of the initial issuance thereof and (2)Β the aggregate amount of the accrued but unpaid interest on the Loans (including any amounts treated as interest for U.S. federal income tax purposes, such as βoriginal issue discountβ) as of any Testing Date occurring after such fifth anniversary exceeds an amount equal to the Maximum Accrual, then all such accrued but unpaid interest on the Loans (including any amounts treated as interest for U.S. federal income tax purposes, such as βoriginal issue discountβ) as of such time in excess of an amount equal to the Maximum Accrual shall be paid in cash by the Borrower to the Lenders on such Testing Date, it being the intent of the parties hereto that the deductibility of interest under the Loans shall not be limited or deferred by reason of SectionΒ 163(e)(5) and SectionΒ 163(i) of the Code. For these purposes, the βMaximum Accrualβ is an amount equal to the product of such Loansβ issue price (as defined in Code Sections 1273(b) and 1274(a)) and their yield to maturity, and a βTesting Dateβ is the date on which any βaccrual periodβ (within the meaning of SectionΒ 1272(a)(5) of the Code) closes.
SECTIONΒ 2.22. Incremental Facility.
(a) From time to time after the Closing Date, but not more than three occasions during the term of the Loans, Borrower may by written notice to the Administrative Agent, elect prior to the Maturity Date, the establishment of one or more new term loan commitments (the βIncremental Commitmentsβ), by (1)Β an amount not in excess of $25,000,000 in the aggregate and (2)Β and not less than $1,000,000 individually (or such lesser amount which shall either (x)Β be approved by the Administrative Agent (which approval shall not be unreasonably delayed, withheld or conditioned) or (y)Β constitute the difference between $25,000,000 and all such Incremental Commitments obtained prior to such date), and integral multiples of $1,000,000 in excess of that amount (or such lesser amount which shall either (x)Β be approved by the Administrative Agent (which approval shall not be unreasonably delayed, withheld or
Β
40
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
conditioned) or (y)Β constitute the difference between $25,000,000 and all such Incremental Commitments obtained prior to such date). Each such notice shall specify (A)Β the date (each, an βIncreased Amount Dateβ) on which Borrower determines that the Incremental Commitments shall be effective, which shall be a date not less than ten (10)Β Business Days after the date on which such notice is delivered to the Administrative Agent (or such shorter period as shall be reasonably acceptable to the Administrative Agent) and (B)Β the identity of each Lender or other Person (each of which must be an Eligible Incremental Lender) (each, an βIncremental Lenderβ) to whom Borrower proposes any portion of such Incremental Commitments be allocated and the amounts of such allocations; provided, that each existing Lender shall first be afforded, by written notice to the Administrative Agent (which notice shall be promptly forwarded by the Administrative Agent to the applicable existing Lenders and the Administrative Agent agrees to promptly forward such notice to the Lenders prior to the Increased Amount Date, but any failure to deliver such notice shall not prevent the above-mentioned ten (10)Β Business Day period from running after the Administrative Agent has received such notice) , the opportunity to provide its Loan Commitment Percentage of any Incremental Commitments, as applicable; provided, further, that any Lender approached to provide all or a portion of the Incremental Commitments may elect or decline, in its sole discretion, to provide an Incremental Commitment. Each Lender may elect to provide all or a portion of its Loan Commitment Percentage of any Incremental Commitments, as applicable, by providing written notice (each, an βAcceptance Noticeβ) to the Administrative Agent and the Borrower no later than 5:00Β p.m. Local Time tenΒ (10) days after the date of the Administrative Agentβs receipt of notice from the Borrower.Β Each Acceptance Notice from a given Lender shall specify the principal amount of the Incremental Commitment to be provided by such Lender.Β If a Lender fails to deliver an Acceptance Notice to the Administrative Agent within the time frame specified above or such Acceptance Notice fails to specify the principal amount of the Incremental Commitments to be provided, any such failure will be deemed a rejection of the opportunity to provide any portion of the Incremental Commitment, and the Borrower may have other Persons provide the remaining uncommitted portion of the Incremental Commitments. Such Incremental Commitments shall become effective as of such Increased Amount Date; provided that after giving effect to the making of any Incremental Loans and the use of proceeds thereof, (I)Β no Default or Event of Default shall have occurred and be continuing under any of the Loan Documents; (II) each of the representations and warranties set forth in Article III shall remain true and correct in all material respects (without duplication of any materiality qualifiers contained therein); and (III) the Consolidated Leverage Ratio, calculated on a pro forma basis for the last twelve month period for which financial statements have been (or were required to be) delivered pursuant to SectionsΒ 5.04Β (a)Β orΒ (b) and after giving effect to any Permitted Acquisitions or Investments permitted under the Loan Documents or prepayments of the Loans, shall be no greater than 0.74:1.00. The Incremental Commitments, as applicable, shall be effected pursuant to one or more amendments (each, an βIncremental Loan Amendmentβ) executed and delivered by Borrower, the Incremental Lender and the Administrative Agent and each of which shall be recorded in the Register (provided that the Administrative Agent agrees to execute and deliver any Incremental Loan Amendment satisfying the requirements of this SectionΒ 2.22 and otherwise in compliance with the terms of this Agreement).
(b) Any Incremental Loans made on an Increased Amount Date shall be designated a separate Tranche of Incremental Loans for all purposes of this Agreement. On any Increased Amount Date on which any Incremental Commitments are effected, subject to the satisfaction or waiver of the foregoing terms and conditions, (i)Β each Incremental Lender shall make a loan to Borrower (an βIncremental Loanβ) in an amount equal to its Incremental Commitment, and (ii)Β each Incremental Lender shall become a Lender hereunder with respect to the Incremental Commitment and the Incremental Loans made pursuant thereto.
Β
41
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(c) The Administrative Agent shall notify the Lenders promptly upon receipt of Borrowerβs notice of each Increased Amount Date and in respect thereof the Incremental Commitments and the Incremental Lenders.
(d) The terms and provisions of the Incremental Loans and Incremental Commitments shall be as agreed between Borrower and the Incremental Lenders providing such Incremental Loans and Incremental Commitments and except as otherwise permitted pursuant to this clause (e), shall be either on terms (x)Β substantially consistent (taken as a whole) with the Loans made on the Closing Date or (y)Β no more favorable (taken as a whole) to the Incremental Lenders than the terms applicable to the Loans made on the Closing Date. In any event:
(i) the Incremental Loans shall rank pari passu in right of payment and be equal with respect to security with the Loans made on the Closing Date;
(ii) the Weighted Average Life to Maturity of the Incremental Loans shall be no shorter than the Weighted Average Life to Maturity of the Loans made on the Closing Date (except by virtue of prepayment of such Loans prior to the time of such incurrence);
(iii) the final maturity date of the Incremental Loans shall be no earlier than the Maturity Date of the Loans made on the Closing Date;
(iv) at the option and agreement of the Borrower and the Incremental Lenders, the Incremental Loans may share ratably in right of prepayment with the Loans on the Closing Date pursuant to Sections 2.10 and 2.11 or otherwise; and
(v) the all-in yield applicable to such Incremental Loans (including interest rate margins and interest rate floors with respect to such Incremental Loans (based on the lesser of a four-year average life to maturity and the remaining life to maturity) (but only to the extent an increase in the interest floor in the Loans made on the Closing Date would cause an increase in the interest rate then in effect hereunder, and in such case, the interest rate floor (but not the interest rate margin) applicable to such Loans made on the Closing Date shall be increased to the extent of such differential above the 0.50% threshold below between interest rate floors), but excluding arrangement, structuring, underwriting, amendment or other fees paid or payable to the Administrative Agent, the Collateral Agent, the Lenders on the Closing Date or their Affiliates or that are not generally paid to all lenders of such type of indebtedness) shall not be greater than the corresponding all-in yield applicable to the Loans made on the Closing Date plus 0.50%Β per annum (any such amount in excess of such 0.50% threshold, the βExcess Rateβ) unless the interest rate margin with respect to the Loans made on the Closing Date are increased by an amount equal to the Excess Rate.
(e) Each Incremental Loan Amendment may, without the consent of any other Lenders, effect such amendments to this Agreement and the other Credit Documents as may be necessary or appropriate, in the reasonable and mutual opinion of the Agents and Borrower to effect the provision of this SectionΒ 2.22, and for the avoidance of doubt, this SectionΒ 2.22 shall supersede any provisions in Sections 2.14 or 9.08 to the contrary.
(f) The Loans and Commitments extended or established pursuant to this SectionΒ 2.22 shall constitute Loans and Commitments under, and shall be entitled to all the benefits afforded by, this Agreement and the other Credit Documents, and shall, without limiting the foregoing, benefit equally and ratably from the guarantees and security interests created by the Security Documents. The Loan Parties shall take any actions reasonably required by the Administrative Agent to ensure or demonstrate that the
Β
42
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Lien and security interests granted in the Collateral by the Security Documents continue to be perfected under the Uniform Commercial Code or otherwise after giving effect to the extension or establishment of any such Loans or any such Commitments.
ARTICLE III
Representations and Warranties
In order to induce the Lenders to enter into this Agreement and to make the Loans, each of Holdings and the Borrower represents and warrants to the Administrative Agent, the Collateral Agent and each of the Lenders on the Closing Date that:
SECTIONΒ 3.01. Organization; Powers. Each of the Loan Parties and their respective Subsidiaries (a)Β is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (b)Β has all requisite power and authority to own its property and assets and to carry on its business as now conducted and as proposed to be conducted, (c)Β is qualified to do business in, and is in good standing in, every jurisdiction where such qualification is required, except where the failure so to qualify could not reasonably be expected to result in a Material Adverse Effect, and (d)Β has the power and authority to execute, deliver and perform its obligations under each of the Loan Documents to which it is or will be a party and, in the case of the Borrower, to borrow Loans hereunder.
SECTIONΒ 3.02. Authorization. The entering into the Loan Documents to which the Loan Parties are parties thereto (a)Β have been duly authorized by all requisite corporate or other entity and, if required, stockholder action and (b)Β will not (i)Β violate (A)Β any provision of law, statute, rule or regulation, except, in each case, as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (B)Β any provision of the certificate or articles of incorporation or other Organizational Documents or bylaws of Holdings, the Borrower or any Subsidiary, (C)Β any order of any Governmental Authority, except as would not reasonably be expected to have a Material Adverse Effect, or (D)Β any provision of any Contractual Obligation to which Holdings, the Borrower or any Subsidiary is a party or by which any of them or any of their property is or may be bound, except, in each case, as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (ii)Β be in conflict with, result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, or give rise to any right to accelerate or to require the prepayment, repurchase or redemption of any obligation under any Contractual Obligation relating to Material Indebtedness to which Holdings, the Borrower or any Subsidiary is a borrower or guarantor party thereunder or by which any of them or any of their property is or may be bound as a borrower or guarantor thereunder, or (iii)Β result in the creation or imposition of any Lien upon or with respect to any property or assets now owned or hereafter acquired by Holdings, the Borrower or any Subsidiary (other than any Lien created hereunder or under the Security Documents, or to the extent in existence at such time, under the Revolving Loan Documents).
SECTIONΒ 3.03. Enforceability. This Agreement has been duly executed and delivered by Holdings and the Borrower and constitutes, and each other Loan Document when executed and delivered by each Loan Party party thereto will constitute, a legal, valid and binding obligation of such Loan Party enforceable against such Loan Party in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditorsβ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.
SECTIONΒ 3.04. Governmental Approvals; Third Party Approvals. No action, consent or approval of, registration or filing with or any other action by any Governmental Authority or any other Person is or will be required in connection with entering into the Loan Documents to which the Loan Parties are parties thereto, except for (a)Β the filing of UCC financing statements and filings with the
Β
43
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
United States Patent and Trademark Office and the United States Copyright Office, (b)Β recordation of the Mortgages, (c)Β such as have been made or obtained and are in full force and effect, and (d)Β those the failure of which to obtain or make could not reasonably be expected to have a Material Adverse Effect.
SECTIONΒ 3.05. Financial Statements.
(a) The Borrower has heretofore furnished to the Administrative Agent (i)Β audited consolidated or combined, as applicable, balance sheets and related statements of income, stockholdersβ equity and cash flows of the Borrower and its Subsidiaries for the fiscal year ended DecemberΒ 31, 2012, audited by and accompanied by the opinion of Xxxx Xxxxx LLP, independent public accountants, (ii)Β unaudited consolidated or combined, as applicable, balance sheets and related statements of income, stockholdersβ equity and cash flows of the Borrower and its Subsidiaries for each fiscal quarter after DecemberΒ 31, 2012 and ended 46 days before the Closing Date and (iii)Β unaudited consolidated or combined, as applicable, balance sheets and related statements of income, stockholdersβ equity and cash flows of the Borrower and its Subsidiaries for each fiscal month after DecemberΒ 31, 2012 and ended 31 days before the Closing Date and, in each case, certified by a Financial Officer of the Borrower. Such financial statements present fairly, in all material respects, the financial condition and results of operations and cash flows of the Borrower and its Subsidiaries as of such dates and for such periods. Such balance sheets and the notes thereto disclose all material liabilities, direct or contingent, of the Borrower and its Subsidiaries as of the dates thereof required to be disclosed pursuant to GAAP. Such financial statements were prepared in accordance with GAAP (except (A)Β in the case of unaudited financial statements, for the lack of footnotes and being subject to yearβend or quarter-end audit adjustments, as applicable, and (B)Β in respect of any monthly financial statements).
(b) The consolidated forecasted balance sheet and related statements of income and cash flows of the Borrower and its Subsidiaries have been delivered to the Administrative Agent on or prior to the Closing Date and (a)Β have been prepared on good faith estimates and assumptions believed by the Loan Parties to be reasonable as of the date of such projections and as of the Closing Date, and (b)Β present fairly, in all material respects, the consolidated financial position and results of operations of the Borrower and its Subsidiaries described therein as of such date and for such periods set forth therein, on a pro forma basis assuming that the Transactions contemplated hereby had occurred at such dates (it being understood and agreed that (x)Β any financial or business projections or forecasts furnished are subject to significant uncertainties and contingencies, which may be beyond the control of any Loan Party, (y)Β no assurance is given by any Loan Party that the results or forecast in any such projections will be realized and (z)Β the actual results may differ from the forecast results set forth in such projections and such differences may be material).
SECTIONΒ 3.06. Title to Properties; Possession Under Leases.
(a) Each of the Loan Parties and their respective Subsidiaries has good and marketable title to, or valid leasehold interests in, substantially all its properties and assets, except for minor defects in title that do not interfere in any material respects with its ability to conduct its business as currently conducted or except as would not reasonably be expected to have a Material Adverse Effect. All such properties and assets are free and clear of Liens, other than Liens expressly permitted by SectionΒ 6.02.
(b) Each of the Loan Parties and their respective Subsidiaries has complied with its obligations under all leases (with respect to properties that are material to the business of the Loan Parties and their respective Subsidiaries taken as a whole) to which it is a party and all such leases are in full force and effect, in each case, except where the failure to comply or to be in full force or effect would not reasonably be expected to have a Material Adverse Effect. Each of the Loan Parties and their respective Subsidiaries enjoys peaceful and undisturbed possession under all such leases, except for Liens permitted by SectionΒ 6.02.
Β
44
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 3.07. Subsidiaries; Ownership Interests.
(a) ScheduleΒ 3.07(a) sets forth as of the Closing Date a list of all Subsidiaries of Holdings and the percentage ownership interest of Holdings, the Borrower and its Subsidiaries in such Subsidiaries of Holdings. As of the Closing Date, the shares of capital stock or other ownership interests so indicated on ScheduleΒ 3.07(a) are fully paid and non-assessable and are owned by Holdings, the Borrower or such Subsidiary, directly or indirectly, free and clear of all Liens (other than Liens created under the Security Documents and non-consensual Liens permitted by SectionΒ 6.02(iv)). All outstanding Equity Interests of each of Borrower and its Subsidiaries, as of the Closing Date, are duly and validly issued. All of the issued and outstanding Equity Interests of the Borrower are legally and beneficially owned and Controlled directly by Holdings
(b) Except as set forth in ScheduleΒ 3.07(c), the Borrower does not have and is not bound by any outstanding subscriptions, options, warrants, calls, commitments or agreement of any character calling for the purchase or issuance of any Equity Interests of the Borrower or any securities representing the right to purchase or otherwise receive any Equity Interests of the Borrower.
(c) The capitalization table attached as Exhibit F to this Agreement accurately reflects the ownership interests of SLS Breeze Holdings, Inc. (on a fully diluted basis) both immediately prior to and immediately following the Closing Date.
(d) In connection with the Acquisition, Holdings has received the cash equity contribution (inclusive of rollover equity) in an aggregate amount of not less than $190,000,000, directly or indirectly, from the Permitted Holders and the other co-investors in SLS Breeze Holdings, Inc.
SECTIONΒ 3.08. Litigation; Compliance with Laws.
(a) Except as set forth on Schedule 3.08, there are no actions, suits or proceedings at law or in equity or by or before any Governmental Authority now pending or, to the knowledge of Holdings or the Borrower, threatened in writing (including by email or other electronic means) against or affecting any of the Loan Parties or their respective Subsidiaries or any business, property or rights of any such Person that could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect
(b) None of the Loan Parties or their respective Subsidiaries or any of their respective material properties or assets is in violation of, nor will the continued operation of their material properties and assets as currently conducted violate, any law, rule or regulation (including any zoning, building, Environmental Law, ordinance, code or approval or any building permits) or any restrictions of record or agreements affecting any Mortgaged Property, or is in default with respect to any judgment, writ, injunction, decree or order of any Governmental Authority, where such violation or default could reasonably be expected to result in a Material Adverse Effect.
SECTIONΒ 3.09. Agreements. None of the Loan Parties or their respective Subsidiaries is in any material respect in default under or in violation of the performance of any of its obligations under any of its Organizational Documents.
Β
45
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 3.10. Federal Reserve Regulations.
(a) None of the Loan Parties or their respective Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of buying or carrying Margin Stock.
(b) No part of the proceeds of any Loan will be used, whether directly or indirectly, and whether immediately, incidentally or ultimately, for any purpose that entails a violation of, or that is inconsistent with, the provisions of the Regulations of the Board, including Regulation T, Regulation U or Regulation X.
SECTIONΒ 3.11. Government Regulation. None of the Loan Parties is an βinvestment companyβ as defined in, or subject to regulation under, the Investment Company Act of 1940. None of the Loan Parties is subject to regulation under the Federal Power Act, the Interstate Commerce Act, the ICC Termination Act, as amended, or under any other federal or state statute or regulation that may limit its ability to incur Indebtedness or which may otherwise render all or any portion of the Obligations unenforceable.
SECTIONΒ 3.12. Use of Proceeds. The Borrower will use the proceeds of the Loans only for the purposes specified in SectionΒ 5.08.
SECTIONΒ 3.13. Tax Returns. Each of the Loan Parties and their respective Subsidiaries has filed or caused to be filed all federal and material state, local and foreign Tax Returns required to have been filed by it and has paid or caused to be paid all Taxes due and payable by it, except Taxes that are being contested in good faith by appropriate proceedings and for which the applicable Loan Party or Subsidiary shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP. Except as would not reasonably be expected to have a Material Adverse Effect, no written claim has been asserted, with respect to any Taxes (other than any the amount or validity of which are currently being contested in good faith by appropriate proceedings and for which the applicable Loan Party or Subsidiary shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP). From the date of the Borrowerβs formation until the date of termination of the Borrowerβs βS Corporationβ status resulting from the Acquisition (the βTermination Dateβ), Borrower has qualified as an βS Corporationβ within the meaning of SectionΒ 1361 of the Code and, unless otherwise required by applicable law, under all state and local jurisdictions in which it is subject to income Tax (or franchise Tax in the nature of an income Tax). Each Subsidiary (if any) of the Borrower, from the date of its formation until the Termination Date, has either qualified as a βqualified subchapter S subsidiaryβ within the meaning of 1361(a)(3) of the Code or a βdisregarded entityβ within the meaning of Treasury Regulation SectionΒ 301.7701-2. Unless otherwise required by applicable law, the tax classification of the Borrower and each Subsidiary (if any) of the Borrower under all state and local jurisdictions have been at all times the same as their federal classification.
SECTIONΒ 3.14. No Material Misstatements. The information that the Loan Parties have provided, directly or indirectly, in writing, taken as a whole, to the Administrative Agent is not materially misleading and does not contain any material misstatement of fact or omit to state any material fact that is necessary to make the statements therein, in the light of the circumstances under which they were, not materially misleading as of the date such information is dated or certified.
Β
46
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 3.15. Employee Benefit Plans.
(a) Except as would not reasonably be expected to result in a Material Adverse Effect, each Employee Benefit Plan of the Borrower and its ERISA Affiliates is in compliance with its terms and the applicable provisions of ERISA and the Code and the regulations and published interpretations thereunder. No ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA Events, could reasonably be expected to result in a Material Adverse Effect. As of the Closing Date, none of the Borrower or any ERISA Affiliate contributes to, participates in or in any way, directly or indirectly, has any liability with respect to any plan subject to SectionΒ 412 of the Code, SectionΒ 302 of ERISA or Title IV of ERISA, including, without limitation, any βmultiemployer planβ (within the meaning of Sections 3(37) or 4001(a)(3) of ERISA or SectionΒ 414(f) of the Code) or any βsingle-employer planβ (within the meaning of SectionΒ 4001(a)(15) of ERISA) which is subject to Sections 4063, 4064 or 4069 of ERISA. There are no pending or threatened in writing (including by email or other electronic means) claims, sanctions, actions or lawsuits, asserted or instituted against any Employee Benefit Plan or any Person as fiduciary or sponsor of any such Employee Benefit Plan which could reasonably be expected to result in a Material Adverse Effect. Except as would not result in a Material Adverse Effect, none of the Borrower or any ERISA Affiliate has or could have any liability, whether for contributions, funding, benefits or otherwise, with respect to any Foreign Plan.
SECTIONΒ 3.16. Environmental Matters. None of the Loan Parties or their respective Subsidiaries (i)Β has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, except to the extent such failure could not reasonably be expected to result in a Material Adverse Effect, (ii)Β has become subject to any Environmental Liability that could reasonably be expected to result in a Material Adverse Effect, (iii)Β has received notice of any written claim with respect to any Environmental Liability or (iv)Β knows of any basis for any Environmental Liability, that could reasonably be expected to result in a Material Adverse Effect.
SECTIONΒ 3.17. Insurance. ScheduleΒ 3.17 sets forth a true, complete and correct description of all material insurance maintained by the Loan Parties and their respective Subsidiaries as of the Closing Date. As of such date, such insurance is in full force and effect and all premiums have been duly paid. The Loan Parties and their respective Subsidiaries have insurance in such amounts and covering such risks and liabilities as are customary for companies of a similar size engaged in similar businesses in similar locations.
SECTIONΒ 3.18. Security Documents.
(a) The Guarantee and Collateral Agreement, upon execution and delivery thereof by the parties thereto, will create in favor of the Collateral Agent, for the ratable benefit of the Secured Parties, a legal, valid and enforceable security interest in the Collateral (as defined in the Guarantee and Collateral Agreement) and the proceeds thereof except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditorsβ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law) and except with respect to any additional actions and documents that need to be entered into that are required under foreign law (with respect to any Equity Interests of a Foreign Subsidiary or assets or property located in a foreign jurisdiction) to create a legal, valid and enforceable security interest and (i)Β when the original Pledged Collateral (as defined in the Guarantee and Collateral Agreement), along with any necessary transfer documents or instruments, is delivered to the Collateral Agent, the Lien created under the Guarantee and Collateral Agreement shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Pledged Collateral, in each case prior and superior in right to any other Person (in each case, other than (y)Β Liens granted under the Revolving Loan Documents to the extent the Intercreditor Agreement provides such Liens prior or superior priority in right and (z)Β non-consensual Liens permitted under SectionΒ 6.02(iv)), and (ii)Β (A) for Collateral with respect to which a security interest may be perfected only by possession or control, upon the taking of possession or control by the Collateral Agent of such Collateral, (B)Β when financing
Β
47
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
statements in appropriate form are filed in the offices specified on ScheduleΒ 3.18(a), (C)Β the actions described in clause (i)Β above with respect to Pledged Collateral and (D)Β upon taking (1)Β any other perfection action as may be required under the UCC or any other applicable law and (2)Β any other action (including creation action) as may be required under foreign law, the Lien on the Collateral created under the Guarantee and Collateral Agreement will constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Collateral (other than federally registered copyrights) in which a security interest may be perfected pursuant to Article 9 of the UCC, in each case prior and superior in right to any other Person, other than with respect to Liens permitted by SectionΒ 6.02.
(b) Upon the recordation of the fully-executed Guarantee and Collateral Agreement (or a short-form security agreement in form and substance reasonably satisfactory to the Borrower and the Collateral Agent) with the United States Copyright Office, the Lien created under the Guarantee and Collateral Agreement shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in the federally registered Copyrights (as defined in the Guarantee and Collateral Agreement) in which a security interest may be perfected by filing in the United States, in each case prior and superior in right to any other Person, other than with respect to Liens permitted by SectionΒ 6.02 (it being understood that subsequent recordings in the United States Copyright Office may be necessary to perfect a Lien on registered copyrights acquired by the Loan Parties after the date hereof).
SECTIONΒ 3.19. Location of Real Property and Leased Premises.
(a) ScheduleΒ 3.19(a) lists completely and correctly as of the Closing Date all real property owned by each Loan Party and their respective Subsidiaries and the addresses thereof. As of the Closing Date, the Loan Parties and their Subsidiaries own in fee all the real property set forth on ScheduleΒ 3.19(a).
(b) ScheduleΒ 3.19(b) lists completely and correctly as of the Closing Date all real property leased by each Loan Party and their respective Subsidiaries and the addresses thereof. As of the Closing Date, the Borrower and the Subsidiaries have a valid leasehold interest in all the real property set forth on ScheduleΒ 3.19(b) that is material to the ordinary conduct of its business, except where failure to have such a valid leasehold interest could not reasonably be expected to have a Material Adverse Effect.
SECTIONΒ 3.20. Labor Matters. As of the Closing Date, there are no strikes, lockouts or slowdowns against any of the Loan Parties pending or, to the knowledge of Holdings or the Borrower, threatened (in writing (including by email or other electronic means)). The hours worked by and payments made to employees of the Loan Parties or their Subsidiaries have not been in material violation of the Fair Labor Standards Act or any other applicable Federal, state, local or foreign law dealing with such matters. All payments due from any of the Loan Parties or their Subsidiaries, or for which any claim has been made against any of the Loan Parties or their Subsidiaries, on account of wages and employee health and welfare insurance and other benefits, have been paid or accrued as a liability on the books of the Loan Parties or their Subsidiaries. The consummation of the Transactions will not give rise to any right of termination or right of renegotiation on the part of any union under any collective bargaining agreement to which any of the Loan Parties or their Subsidiaries is bound.
SECTIONΒ 3.21. Solvency. Immediately after the consummation of the Transactions to occur on the Closing Date and immediately following the making of the Loans and the Revolving Loans and immediately after giving effect to the application of the proceeds of the Loans and the Revolving Loans used on the Closing Date, (a)Β the fair value of the assets (measured on a going concern basis) of the Loan Parties and their respective Subsidiaries on a consolidated basis, at a fair valuation, will exceed their debts and liabilities, subordinated, contingent or otherwise; (b)Β the present fair saleable value of the property (measured on a going concern basis) of the Loan Parties and their respective Subsidiaries on a
Β
48
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
consolidated basis will be greater than the amount that will be required to pay the probable liability of their debts and other liabilities, subordinated, contingent or otherwise, as such debts and other liabilities become absolute and matured; (c)Β the Loan Parties and their respective Subsidiaries on a consolidated basis will be able to pay their debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured; and (d)Β the Loan Parties and their respective Subsidiaries on a consolidated basis will not have unreasonably small capital with which to conduct the business in which they are engaged as such business is now conducted and is proposed to be conducted following the Closing Date. Such foregoing determination has been made by the chief executive officer, chief financial officer or other Financial Officer, if any, of the Borrower and is based on such officerβs actual knowledge and such officer has not conveyed any information to the contrary to any other Person at any time on the date that this representation and warranty is being made or deemed made.
SECTIONΒ 3.22. No Material Adverse Effect. Since DecemberΒ 31, 2012, there has been no development or event, either individually or in the aggregate, that has had or would reasonably be expected to have a Material Adverse Effect.
SECTIONΒ 3.23. Sanctioned Persons. None of the Loan Parties or their respective Subsidiaries nor, to the knowledge of Holdings or the Borrower, any director, officer, agent, employee or Affiliate of any of the Loan Parties or any of their respective Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (βOFACβ); the Borrower will not directly or indirectly use the proceeds of the Loans or otherwise make available such proceeds to any Person, for the purpose of financing the activities of any Person currently subject to any U.S. sanctions administered by OFAC.
SECTIONΒ 3.24. Financial Advisors. Except as set forth in ScheduleΒ 3.24, no agent, broker, investment banker, finder, financial advisor or other Person is or will be entitled to any brokerβs or finderβs fee or any other commission or similar fee from any Loan Party or any of the Loan Partiesβ Subsidiaries with respect to this Agreement or any of the other Loan Documents or any of the Transactions occurring on the Closing Date, and the Borrower hereby indemnifies (subject to the same carve-outs that are in SectionΒ 9.05) the Lenders and the Administrative Agent against, and agrees that it will hold the Lenders and the Administrative Agent harmless from, any claim, demand or liability for any such brokerβs or finderβs fees alleged to have been incurred in connection herewith or therewith and any expenses (including reasonable and documented out-of-pocket fees, expenses and disbursements of counsel) arising in connection with any such claim, demand or liability, in each case, in accordance with SectionΒ 9.05.
SECTIONΒ 3.25. Foreign Assets Control Regulations, Etc.
(a) Neither the borrowing of the Loans by the Borrower hereunder nor its use of the proceeds thereof will violate (i)Β the United States Trading with the Enemy Act, as amended, (ii)Β any of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as amended) or any enabling legislation or executive order relating thereto, (iii)Β Executive Order No.Β 13,224, 66 Fed Reg 49,079 (2001), issued by the President of the United States (Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit or Support Terrorism) (the βTerrorism Orderβ) or (iv)Β the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, Public Law 107-56 (October 26, 2001). No part of the proceeds from the Loans will be used, directly or indirectly, for any payments to any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the United States Foreign Corrupt Practices Act of 1977, as amended.
Β
49
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(b) No Loan Party and no Subsidiary of a Loan Party (i)Β is or will become a βblocked personβ as described in SectionΒ 1.01 of the Terrorism Order or (ii)Β to its actual knowledge engages or will engage in any dealings or transactions, or is otherwise associated, with any such blocked person.
(c) Each of the Loan Parties and its Affiliates are in compliance, in all material respects, with the Uniting And Strengthening America By Providing Appropriate Tools Required To Intercept And Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, Public Law 107-56 (October 26, 2001).
SECTIONΒ 3.26. Deposit Accounts; Securities Accounts. Set forth on ScheduleΒ 3.26 is a listing of all of the Loan Partiesβ Deposit Accounts and Securities Accounts as of the Closing Date including, with respect to each bank or securities intermediary (a)Β the name and address of such Person, (b)Β the account numbers of the Deposit Accounts or Securities Accounts maintained with such Person, and (c)Β the relevant Loan Party or Loan Parties.
SECTIONΒ 3.27. Indebtedness. No Loan Party or Subsidiary of any Loan Party has any liability for any Indebtedness other than the Indebtedness permitted under SectionΒ 6.01.
SECTIONΒ 3.28. Intellectual Property; Copyright Matters.
(a) Except as set forth on ScheduleΒ 3.28(a) or as thereafter otherwise disclosed in writing to the Administrative Agent by the Borrower as required by SectionΒ 5.04(d), no Loan Party and no Subsidiary of any Loan Party owns any registered patents, patent applications, registered trademarks, trademark applications, registered trade names, registered service marks, service xxxx applications, registered copyrights or copyright applications. Each Loan Party and each of the Loan Partiesβ respective Subsidiaries owns directly, or is entitled to use by license (listed on ScheduleΒ 3.28(a)) or otherwise, all Intellectual Property material to the conduct of such Loan Partyβs businesses. All items listed on ScheduleΒ 3.28(a) and the further items disclosed pursuant to SectionΒ 5.04(d) are and, at all times (except to the extent no longer deemed material to the conduct of the business of the Loan Parties and the Loan Partiesβ Subsidiaries in the good faith business judgment of the Loan Parties) will be: (a)Β subsisting and have not been adjudged invalid or unenforceable, in whole or part; (b)Β to the extent that can be reasonably anticipated, valid, in full force and effect and not in known conflict with the rights of any Person, in each case and (c)Β free and clear of all Liens, security interests, or other encumbrances other than Liens permitted by SectionΒ 6.02. Each Loan Party and each of the Loan Partiesβ Subsidiaries has made all filings and recordings such Loan Party or Subsidiary deems necessary in the exercise of reasonable and prudent business judgment to protect its interest in the Intellectual Property of such Loan Party or Subsidiary material to the conduct of such Loan Partyβs businesses in the United States Patent and Trademark Office, and the United States Copyright Office, as appropriate. Except for not making filings or recordings in its exercise of such judgment, each Loan Party and each of the Loan Partiesβ Subsidiaries has performed all material acts and has paid all material required fees and taxes to maintain each and every item of the Intellectual Property of such Loan Party or Subsidiary in full force and effect, except such items of Intellectual Property as are no longer deemed material to the conduct of the businesses of the Loan Parties and the Loan Partiesβ Subsidiaries in the reasonable business judgment of the Loan Parties. There are no pending or, to the knowledge of the Loan Parties, threatened in writing (including by email or other electronic means) applications, proceedings or litigation, which, if successful, could reasonably be expected to materially and adversely affect any Intellectual Property of any Loan Party or any of its Subsidiaries material to the conduct of such Loan Partyβs or such Subsidiariesβ businesses, and, to the knowledge of the Loan Parties, no Person is infringing, misusing, violating or breaching such Intellectual Property in any material respect. Neither any Loan Party nor any of its Subsidiaries has received written notice of any claim of infringement, misuse, violation or breach by such Loan Party or any of its Subsidiaries of any Intellectual Property owned or controlled by another Person which infringement, misuse, violation or breach could reasonably be expected to result in,
Β
50
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
individually or in the aggregate, a Material Adverse Effect. To the actual knowledge of Holdings and the Borrower, no Loan Party and no Subsidiary of any Loan Party is in breach of or default under the provisions of any of the foregoing, nor is there any event, fact, condition or circumstance which, with notice or passage of time or both, would constitute, or result in a conflict, breach, default or event of default under, any of the foregoing that reasonably could be expected to result in, either individually or in the aggregate, a Material Adverse Effect.
SECTIONΒ 3.29. Activities of Holdings. Holdings is not engaged in any activities other than those activities permitted by SectionΒ 6.13.
ARTICLE IV
Conditions of Lending
SECTIONΒ 4.01. Conditions Precedent to Closing.
The obligations of the Lenders to make Loans hereunder are subject to the satisfaction or waiver of the following conditions on the Closing Date:
(a) Loan Party Documents. The Administrative Agent shall have received the following from or with respect to each Loan Party:
(i) A copy of the certificate or articles of incorporation or organization, including all amendments thereto, certified as of a recent date by either the Secretary of State of the state of its organization or such Governmental Authority, and, to the extent readily available with respect to franchise Taxes, a certificate certifying that such Loan Party has paid all franchise Taxes due and payable on or prior to the date of such certificate and such Loan Party is duly organized and in good standing under the laws of such jurisdiction;
(ii) A certificate of the Secretary, Assistant Secretary or other Responsible Officer of each Loan Party dated the Closing Date and certifying (A)Β that attached thereto are true and complete copies of the Organizational Documents of such Loan Party as in effect on the Closing Date and at all times since a date on or prior to the date of the resolutions described in clause (B)Β below, (B)Β that attached thereto is a true and complete copy of resolutions duly adopted by the Governing Body of such Loan Party authorizing the execution, delivery and performance of the Loan Documents and, in the case of the Borrower, the borrowing of the Loans hereunder, and that such resolutions have not been modified, rescinded or amended and are in full force and effect, (C)Β that the charter or articles or certificate of incorporation or organization of such Loan Party have not been amended since the date of the last amendment thereto shown on the certificate of good standing furnished pursuant to clause (i)Β above, and (D)Β as to the incumbency and specimen signature of each officer executing any Loan Documents or any other document delivered in connection herewith on behalf of such Loan Party;
(iii) a certificate of another officer as to the incumbency and specimen signature of the Secretary or Assistant Secretary executing the certificate pursuant to clause (ii)Β above;
(iv) executed originals (or photocopies with originals to follow after the Closing Date) of the Loan Documents to which such Person is a party;
(v) an executed original (or photocopies with originals to follow after the Closing Date) of the Intercreditor Agreement;
Β
51
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(vi) executed copies of the Acquisition Agreement and any exhibits, schedules and documents related thereto; and
(vii) executed copies of all Related Documents as in effect on the Closing Date, in each case in form and substance reasonably satisfactory to the Administrative Agent.
(b) Fees. The Administrative Agent and the Lenders shall have received all Fees and other amounts due and payable on or prior to the Closing Date that are required to be paid under the Loan Documents, including, to the extent invoiced, reimbursement or payment of all reasonable and documented out of pocket expenses required to be reimbursed or paid by the Borrower hereunder or under any other Loan Document.
(c) Intentionally Omitted.
(d) Representations and Warranties; Performance of Agreements. (i)Β The representations and warranties in Article III shall be true and correct in all material respects on and as of the Closing Date to the same extent as though made on and as of that date (or, to the extent such representations and warranties specifically relate to an earlier date, that such representations and warranties were true and correct in all material respects on and as of such earlier date), (ii)Β the Borrower shall have performed in all material respects all agreements and satisfied all conditions which this Agreement provides shall be performed or satisfied by it on or before the Closing Date except as otherwise disclosed to and agreed to in writing by the Administrative Agent, and (iii)Β the Borrower shall have delivered to the Administrative Agent an officerβs certificate, in form and substance reasonably satisfactory to the Administrative Agent, certifying as to the accuracy of each of clause (i)Β and clause (ii); provided that, if a representation and warranty, covenant or condition is qualified as to materiality, the applicable materiality qualifier set forth above shall be disregarded with respect to such representation and warranty, covenant or condition for purposes of this condition.
(e) Financial Statements. The Administrative Agent shall have received the financial statements and audit opinion referred to in Section 3.05(a).
(f) Intentionally Omitted.
(g) Solvency Certificate. The Administrative Agent shall have received a solvency certificate from a Financial Officer of Holdings or the Borrower, substantially in the form of Exhibit G hereto.
(h) Opinions of Counsel to the Loan Parties. The Administrative Agent shall have received, on behalf of itself, the Collateral Agent and the Lenders, a favorable written opinion of XxxxxxxxΒ & Xxxxx LLP, counsel for the Loan Parties (A)Β dated the Closing Date, (B)Β addressed to the Administrative Agent, the Collateral Agent and the Lenders, and (C)Β covering such other matters relating to the Loan Documents as the Administrative Agent shall reasonably request and that are customary to cover in transactions of this type, and the Borrower hereby requests such counsel to deliver such opinions.
(i) Evidence of Insurance. The Administrative Agent shall have received a copy of, or a certificate as to coverage under, the insurance policies required by Section 5.02.
(j) Necessary Governmental Authorizations and Consents; Expiration of Waiting Periods, etc. All requisite Governmental Authorities and other material third parties shall have approved or consented to the Transactions to the extent required, all applicable appeal periods shall have expired and there shall not be any pending or threatened litigation, governmental, administrative or judicial action, actual or threatened, that could reasonably be expected to restrain, prevent or impose materially burdensome conditions on the Transactions.
Β
52
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(k) Intentionally Omitted.
(l) Security Interests.
(i) The Guarantee and Collateral Agreement shall have been duly executed by each Loan Party that is to be a party thereto and shall be in full force and effect on the Closing Date. The Collateral Agent on behalf of the Secured Parties shall have been granted a security interest in the Collateral of the type and priority described herein and in the Guarantee and Collateral Agreement to the extent required thereby.
(ii) The Collateral Agent shall have received a Perfection Certificate with respect to the Loan Parties dated the Closing Date and duly executed by a Responsible Officer of the Borrower, and shall have received the results of a search of the UCC filings (or equivalent filings) made with respect to the Loan Parties in the states (or other jurisdictions) of formation of such Persons as reasonably required by the Collateral Agent, together with copies of the financing statements (or similar documents) disclosed by such search, and accompanied by evidence reasonably satisfactory to the Collateral Agent that the Liens indicated in any such financing statement (or similar document) would be permitted under SectionΒ 6.02 or have been or will be contemporaneously released or terminated on the Closing Date. Such search results shall include copyright, patent and trademark searches, and copyright, patent and trademark filings or recordations, necessary in the Collateral Agentβs reasonable determination to perfect the Collateral Agentβs security interest in the Collateral as of the Closing Date to the extent such perfection can be obtained by (a)Β the filing of a financing statement (or similar document), (b)Β any copyright filing or recordation with the United States Copyright Office and (c)Β or any patent or trademark filing or recordation with the United States Patent and Trademark Office.
(iii) The Collateral Agent shall have received all certificates, agreements or instruments representing or evidencing the Pledged Collateral (as defined in the Guarantee and Collateral Agreement), accompanied by instruments of transfer and stock powers undated and endorsed in blank, in each case, that are required pursuant to the Guarantee and Collateral Agreement to have been delivered to the Collateral Agent on the Closing Date.
(m) Existing Debt. The Borrower shall have (i)Β consummated the Existing Debt Refinancing; (ii)Β delivered to the Administrative Agent a βpay-offβ letter in form and substance reasonably satisfactory to the Administrative Agent and the Collateral Agent with respect to all Indebtedness being refinanced in the Existing Debt Refinancing, (iii)Β delivered to the Administrative Agent all documents or instruments necessary to release all Liens securing the Indebtedness being repaid in connection with the Existing Debt Refinancing, and (iv)Β made arrangements reasonably satisfactory to the Administrative Agent and Collateral Agent with respect to the cancellation or cash collateralization or backstopping of any letters of credit outstanding in connection with the Existing Debt Refinancing or the issuance of letters of credit to support the obligations of Holdings and its Subsidiaries with respect thereto.
(n) The Administrative Agent shall have received a customary closing certificate, dated the Closing Date and signed by a Financial Officer of the Borrower, in form and substance reasonably satisfactory to the Administrative Agent.
Β
53
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(o) Other Legal Matters.
(i) All corporate and other proceedings in connection with the Transactions contemplated by this Agreement and the other Loan Documents and all other agreements, documents and instruments incident to such Transactions shall be reasonably satisfactory to the Administrative Agent, and the Administrative Agent shall have received all such certified or other copies of such documents as the Administrative Agent may reasonably request.
(ii) The Administrative Agent and the Lenders shall have received all documentation and other information required by regulatory authorities under applicable βknow your customerβ and anti-money laundering rules and regulations, including the USA PATRIOT Act to the extent such documentation and other information has been requested in writing at least five (5)Β Business Days before the Closing Date.
(iii) All legal matters incident to this Agreement, the Loans hereunder and the other Loan Documents shall be reasonably satisfactory to the Administrative Agent.
(p) Funds Flow Memorandum. The Administrative Agent and the Borrower shall have agreed upon a funds flow memorandum duly executed by a Responsible Officer of the Borrower.
(q) Material Adverse Effect. Since DecemberΒ 31, 2012, there shall have occurred no Material Adverse Effect.
(r) Due Diligence. The Administrative Agent shall have completed a due diligence investigation of the Loan Parties in scope, and with results, reasonably satisfactory to the Administrative Agent, including without limitation, as to general affairs, environmental concerns, intellectual property, management, corporate structure, capital structure, other debt instruments, material contracts, governing documents, prospects, financial position, stockholdersβ equity and results of operations, and the tax, accounting, legal, regulatory, environmental and other issues relevant to the Loan Parties, and shall have been given access during normal business hours and with reasonable advance written notice to the external independent auditors, management, records, books of account, contracts and properties of the Loan Parties and shall have received such financial, business and other information regarding the Loan Parties as it shall have requested.
(s) No Injunction. No injunction or other restraining order shall have been issued and no hearing to cause an injunction or other restraining order to be issued shall be pending or noticed with respect to any action, suit or proceeding seeking to enjoin or otherwise prevent the consummation of, or to recover any damages or obtain relief as a result of, the Transactions or the making of Loans hereunder.
(t) Notice of Borrowing. Prior to the making of the Loans, the Administrative Agent shall have received a Notice of Borrowing meeting the requirements of Section 2.02(c).
(u) Ownership of Intellectual Property. Except as otherwise mutually and reasonably agreed by the Administrative Agent and the Borrower, substantially all of the Intellectual Property that is material to the business of the Borrower shall be owned by the Loan Parties and their Subsidiaries.
In determining the satisfaction of the conditions specified in this SectionΒ 4.01, (y)Β to the extent any item is required to be satisfactory to any Lender, such item shall be deemed satisfactory to each Lender which has not notified the Administrative Agent in writing prior to the occurrence of the Closing Date that the respective item or matter does not meet its satisfaction and (z)Β in determining whether any Lender is aware of any fact, condition or event that has occurred and which would reasonably be expected
Β
54
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
to have a Material Adverse Effect, each Lender which has not notified the Administrative Agent in writing prior to the occurrence of the Closing Date of such fact, condition or event shall be deemed not to be aware of any such fact, condition or event on the Closing Date. Upon the Administrative Agentβs good faith determination that the conditions specified in this SectionΒ 4.01 have been met (after giving effect to the preceding sentence), then the Closing Date shall have been deemed to have occurred, regardless of any subsequent determination that one or more of the conditions thereto had not been met. The conditions shall be deemed to have been satisfied on the date the Lenders provide the Loans.
SECTIONΒ 4.02. Post Closing Obligations. As an accommodation to the Borrower, the Administrative Agent and the Lenders have agreed to execute this Agreement and to make Loans on the Closing Date notwithstanding the failure by the Borrower to satisfy the conditions set forth below on or before the Closing Date. In consideration of such accommodation, the Lenders agree that, in addition to all other terms, conditions and provisions set forth in this Agreement and the other Loan Documents, including those conditions set forth in SectionΒ 4.01, Holdings and the Borrower shall, and shall cause each other Loan Party to, satisfy each of the conditions subsequent set forth below on or before the date applicable thereto (or such later date as agreed to by the Administrative Agent in its reasonable discretion), it being understood that (i)Β the failure by Holdings or the Borrower to perform or cause to be performed any such condition subsequent on or before the date applicable thereto shall constitute an immediate Event of Default and (ii)Β to the extent that the existence of any such condition subsequent would otherwise cause any representation, warranty or covenant in this Agreement or any other Loan Document to be breached, the Required Lenders hereby waive such breach for the period from the Closing Date until the date on which such condition subsequent is required to be fulfilled pursuant to this SectionΒ 4.02:
(i) Deliver to the Administrative Agent lenderβs loss payable and additional insured endorsements in respect of the insurance policies required by SectionΒ 5.02 in form and substance reasonably satisfactory to the Administrative Agent no later than ninetyΒ (90) days after the Closing Date (or such later date as the Administrative Agent may agree to in its sole and reasonable discretion).
(ii) Deliver to the Administrative Agent Control Agreements with financial institutions, securities intermediaries and other Persons in order to perfect Liens by βcontrolβ (within the meaning of the applicable Uniform Commercial Code) in respect of Deposit Accounts, Securities Accounts and other Collateral pursuant to the Security Documents in form and substance reasonably satisfactory to the Administrative Agent no later than ninetyΒ (90) days after the Closing Date (or such later date as the Administrative Agent may agree to in its sole and reasonable discretion).
(iii) Use commercially reasonable efforts to deliver to the Administrative Agent a collateral access agreement in form and substance reasonably satisfactory to the Administrative Agent in respect of each data center facility or other location at which any server owned or leased by the Borrower or any other Loan Party is maintained no later than ninetyΒ (90) days after the Closing Date (or such later date as the Administrative Agent may agree to in its sole and reasonable discretion).
Β
55
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE V
Affirmative Covenants
Each of Holdings and the Borrower covenants and agrees with each Lender that so long as this Agreement shall remain in effect and until the Commitments have been terminated and the principal of and interest on each Loan, all Fees and all other Obligations payable under any Loan Document shall have been paid in full (other than contingent indemnity claims or expense reimbursement obligations not yet asserted), each of Holdings and the Borrower will, and will cause each of the Subsidiaries to:
SECTIONΒ 5.01. Existence; Compliance with Laws; Businesses and Properties.
(a) Do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence, except as otherwise permitted under SectionΒ 6.05.
(b) Do or cause to be done all things necessary to obtain, protect, preserve, renew, extend and keep in full force and effect its rights, licenses, permits, franchises, authorizations, patents, copyrights, trademarks and trade names, except to the extent that the failure to do so could not reasonably be expected to result in a Material Adverse Effect; comply with all applicable laws, rules, regulations and decrees and orders of any Governmental Authority, whether now in effect or hereafter enacted, except as could not reasonably be expected to result in a Material Adverse Effect; and at all times maintain and preserve all property material to the conduct of the business of Holdings and its Subsidiaries and keep such property in good repair, working order and condition and from time to time make, or cause to be made, all needful and proper repairs, renewals, additions, improvements and replacements thereto necessary in order that the business carried on in connection therewith may be properly conducted at all times, except as could not reasonably be expected to result in a Material Adverse Effect.
SECTIONΒ 5.02. Insurance.
(a) Keep its insurable properties adequately insured at all times by financially sound and reputable insurers; maintain such other insurance, to such extent and against such risks, including fire and other risks insured against by extended coverage, as is customary with companies that are of the same or similar size and in the same or similar businesses operating in the same or similar locations; and maintain such other insurance as may be required by law.
(b) Cause all such policies (if any) covering any Collateral (but, for the avoidance of doubt, excluding any public property damage policy) to be endorsed or otherwise amended to include a customary lenderβs loss payable endorsement, in form and substance reasonably satisfactory to the Collateral Agent, which endorsement shall provide that, from and after the Closing Date, if the insurance carrier shall have received written notice from the Collateral Agent of the occurrence of an Event of Default, the insurance carrier shall pay all proceeds otherwise payable to the Borrower or the Loan Parties under such policies directly to the Collateral Agent or the Revolving Agent, as applicable; cause all such policies to provide that the Borrower shall be a coinsurer thereunder; upon written request by the Collateral Agent, deliver original or certified copies of all such policies to the Collateral Agent; cause each such policy to provide that it shall not be canceled or not renewed (i)Β by reason of nonpayment of premium upon not less than 10 daysβ prior written notice thereof by the insurer to the Collateral Agent (giving the Collateral Agent the right to cure defaults in the payment of premiums) or (ii)Β for any other reason upon not less than 30 daysβ prior written notice thereof by the insurer to the Collateral Agent; upon the written request of the Collateral Agent, deliver to the Collateral Agent, prior to the cancellation or nonrenewal of any such policy of insurance, a copy of a renewal or replacement policy (or other evidence of renewal of a policy previously delivered to the Collateral Agent) together with evidence reasonably satisfactory to the Collateral Agent of payment of the premium therefor.
(c) If at any time the area in which the Premises (as defined in the Mortgages or such other similar term) are located is designated (i)Β a βflood hazard areaβ in any Flood Insurance Rate Map published by the Federal Emergency Management Agency (or any successor agency), obtain flood insurance in such total amount as the Administrative Agent, the Collateral Agent or the Required Lenders
Β
56
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
may from time to time reasonably require, and otherwise comply with the National Flood Insurance Program as set forth in the Flood Disaster Protection Act of 1973, as it may be amended from time to time, or (ii)Β a βZone 1β area, obtain earthquake insurance in such total amount as the Administrative Agent, the Collateral Agent or the Required Lenders may from time to time reasonably require.
SECTIONΒ 5.03. Obligations and Taxes. Pay its Material Indebtedness in accordance with its terms and pay and discharge promptly when due all material Taxes, assessments and governmental charges or levies imposed upon it or upon its income or profits or in respect of its property, before the same shall become delinquent or in default, as well as all lawful claims for labor, materials and supplies or otherwise that, if unpaid, might give rise to a Lien upon such properties or any part thereof; provided, however, that such payment and discharge shall not be required with respect to any such Tax, assessment, charge, levy or claim so long as the validity or amount thereof shall be contested in good faith by appropriate proceedings and the Borrower shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP.
SECTIONΒ 5.04. Financial Statements, Reports, etc. In the case of Holdings and Borrower, furnish to the Administrative Agent and each Lender:
(a) within 120 days (or for the first fiscal year ending after the Closing Date, 150 days) after the end of each fiscal year of the Borrower, its consolidated balance sheet and related statements of income, stockholdersβ equity and cash flows showing the financial condition of Holdings, the Borrower and its consolidated Subsidiaries as of the close of such fiscal year and the results of its operations and the operations of Holdings and such Subsidiaries during such year, together with comparative figures for the immediately preceding fiscal year of the Borrower (but for comparative figures for any immediately preceding fiscal year occurring in 2013 or earlier, such comparative figures do not need to include Holdings), all audited by Xxxx Xxxxx LLP or other independent public accountants of recognized national standing reasonably acceptable to the Administrative Agent (it being understood and agreed that the βBig Fourβ accounting firms are acceptable to the Administrative Agent) and accompanied by an opinion of such accountants (which opinion shall be without a βgoing concernβ or like qualification or exception and without any qualification or exception as to the scope of such audit, except as related solely to the maturity of the Loans or the Revolving Loans (or any loans from a Permitted Refinancing of the Revolving Loans) during the immediately succeeding twelve-month period) to the effect that such consolidated financial statements fairly present in all material respects the financial condition and results of operations of Holdings, the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP or such other accounting principles as consented to by the Administrative Agent;
(b) within 45 days (or for the fiscal quarter ending SeptemberΒ 30,Β 2013, 90Β days) after the end of each of the first three fiscal quarters of each fiscal year of the Borrower (commencing with the fiscal quarter ending SeptemberΒ 30, 2013), its consolidated balance sheet and related statements of income, stockholdersβ equity and cash flows showing the financial condition of Holdings, the Borrower and its consolidated Subsidiaries as of the close of such fiscal quarter and the results of its operations and the operations of Holdings and such Subsidiaries during such fiscal quarter and the then-elapsed portion of the fiscal year of the Borrower, together with the comparative figures for the same periods in the immediately preceding fiscal year of the Borrower (but for comparative figures for any immediately preceding fiscal quarter occurring in the fiscal quarter ending SeptemberΒ 30,Β 2013 or earlier, such comparative figures do not need to include Holdings), all certified by one of the Financial Officers of Holdings or the Borrower, as the case may be, as fairly presenting the financial condition and results of operations of Holdings, the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP or such other accounting principles as consented to by the Administrative Agent, subject to normal year-end audit adjustments and the absence of footnotes;
Β
57
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(c) concurrently with any delivery of financial statements under paragraph (a)Β or (b)Β above, a certificate of the Financial Officer of the Borrower (a βCompliance Certificateβ) (i)Β certifying that no Event of Default has occurred or, if such an Event of Default has occurred, specifying the nature and extent thereof and any corrective action taken or proposed to be taken with respect thereto and (ii)Β setting forth computations in reasonable detail, together with supporting calculations, demonstrating compliance (or noncompliance) with the covenant contained in Section 6.10;
(d) (i) concurrently with any delivery of financial statements under paragraph (a)Β or (b)Β above, (A)Β a list of any Intellectual Property registered with the United States Patent and Trademark Office or the United States Copyright Office acquired since the last such list delivered pursuant to this SectionΒ 5.04(d) (or since the Closing Date, in the case of the first such list delivered after the Closing Date); and (B)Β an updated Schedule 3.28(a) (if necessary); and (ii)Β concurrently with any delivery of financial statements under paragraphΒ (a) above, a list of any Intellectual Property registered in countries other than the United States;
(e) within 30Β days after the beginning of each fiscal year of the Borrower, a detailed consolidated budget for such fiscal year presented on a quarter by quarter basis;
(f) promptly after the same become publicly available, copies of all periodic and other reports, proxy statements and other materials filed by Holdings, the Borrower or any Subsidiary with any Governmental Authority or securities exchange, or distributed to its shareholders generally in their capacity as shareholders, as the case may be;
(g) promptly after the receipt thereof by Holdings, the Borrower or any of their Subsidiaries, a copy of any final βmanagement letterβ received by any such Person from its certified public accountants and the managementβs response thereto;
(h) promptly after the request by any Lender, all documentation and other information that such Lender reasonably requests in order to comply with its ongoing obligations under applicable βknow your customerβ and anti-money laundering rules and regulations, including the USA PATRIOT Act; and
(i) promptly, from time to time, such other information regarding the operations, business affairs and financial condition of Holdings, the Borrower or any Subsidiary (including for purposes of obtaining and maintaining credit ratings in respect of the Borrower), or compliance with the terms of any Loan Document, in each case, as the Administrative Agent may reasonably request in writing.
SECTIONΒ 5.05. Litigation and Other Notices.
Furnish to the Administrative Agent prompt written notice of the following upon any Loan Partyβs knowledge thereof:
(a) the occurrence of any Default or Event of Default, specifying the nature and extent thereof, the date of occurrence thereof and the corrective action (if any) taken or proposed to be taken with respect thereto;
(b) the filing or commencement of, or any written (including by email or other electronic means) threat or notice of intention of any Person to file or commence, any action, suit or proceeding, whether at law or in equity or by or before any Governmental Authority, against the Borrower or any Affiliate thereof that could reasonably be expected to result in a Material Adverse Effect;
Β
58
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(c) the occurrence of any ERISA Event that, alone or together with any other ERISA Events that have occurred, could reasonably be expected to result in liability of Holdings, the Borrower and its Subsidiaries in an aggregate amount exceeding $1,000,000;
(d) any development or event that has resulted in, or could reasonably be expected to result in, a Material Adverse Effect;
(e) any default or event of default (in each case, after taking into account applicable cure or grace periods) under any Contractual Obligation (other than the Loan Documents) of Holdings, the Borrower or any of their respective Subsidiaries that would reasonably be expected to have a Material Adverse Effect;
(f) any notices of default received by any Loan Party from, or notices of default furnished to, any holder which is not an Affiliate of Holdings of Material Indebtedness and not otherwise required to be furnished to the Administrative Agent or the Lenders pursuant to any other clause of this SectionΒ 5.05 (together with copies thereof); and
(g) any damage or destruction to Collateral that is reasonably and in good faith determined by Borrower to be in an amount in excess of $1,000,000.
SECTIONΒ 5.06. Information Regarding Collateral. Furnish to the Administrative Agent prompt written notice of any change (i)Β in any Loan Partyβs legal name (as defined in SectionΒ 9-503(a) of the UCC), (ii)Β in the jurisdiction of organization or formation of any Loan Party, (iii)Β in any Loan Partyβs corporate structure or chief executive office location or (iv)Β in any Loan Partyβs Federal Taxpayer Identification Number (if any). Unless otherwise approved by the Administrative Agent in writing (which approval shall not be unreasonably withheld, delayed or conditioned), Holdings and the Borrower agree not to, and shall cause the other Loan Parties not to, effect or permit any change referred to in the preceding sentence unless any documents are delivered (or are substantially concurrently with the action effecting such change delivered) to the Collateral Agent that are required to be filed under the UCC so that the Collateral Agent, after the filing of such documents by the Collateral Agent, will continue at all times following such change to have a valid, legal and perfected security interest in all the Collateral, with the priority required hereunder and under the Security Documents.
SECTIONΒ 5.07. Maintaining Records; Access to Properties and Inspections. Keep proper books of record that are true and correct in all material respects and maintain a system of accounting that enables Holdings and the Borrower to produce financial statements in accordance with GAAP or such other accounting principles as may be consented to by the Administrative Agent. Holdings and the Borrower shall, and shall cause each of the Subsidiaries to, permit any representatives designated by the Administrative Agent to visit and inspect the financial records (other than the fee letter related to the Revolving Loans) and the properties of such Person at reasonable times up to one time during any twelve consecutive month period (but without such frequency limit during the continuance of an Event of Default) following reasonable prior written notice and to make extracts from and copies of such financial records, and permit any representatives designated by the Administrative Agent to discuss the affairs, finances and financial condition of such Person with the officers thereof and independent accountants therefor; provided that (a)Β the Administrative Agent shall give the Borrower and the Sponsor an opportunity for its representatives to participate in any such discussions and (b)Β so long as no Event of Default has occurred and is then continuing, the Borrower and the other Loan Parties shall not bear the cost of more than one such visit or inspection (combined) per any twelve consecutive month period by the Administrative Agent and Lenders (and their respective representatives and other Related Parties).
Β
59
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 5.08. Use of Proceeds. Use the proceeds of the Loans solely (i)Β to fund the Existing Debt Refinancing, (ii)Β to pay fees, costs and expenses (including, without limitation, attorneyβs fees) incurred in connection with the Loans, the Existing Debt Refinancing and the other Transactions, and (iii)Β for working capital and other general corporate purposes of Holdings and its Subsidiaries, and to make capital expenditures, acquisitions, Investments, distributions and Restricted Payments permitted by this Agreement from time to time.
SECTIONΒ 5.09. Employee Benefits.
(a) Cause each Employee Benefit Plan to comply in all respects with its terms and the applicable provisions of ERISA and the Code, except to the extent that such failure to comply could not reasonably be expected to result in a Material Adverse Effect, and furnish to the Administrative Agent as soon as possible after, and in any event within 10Β days after any Responsible Officer of Holdings, the Borrower or any Subsidiary knows that any ERISA Event has occurred that, alone or together with any other ERISA Event could reasonably be expected to result in liability of Holdings, the Borrower or any Subsidiary in an aggregate amount exceeding $1,000,000, a statement of a Financial Officer of Holdings or the Borrower setting forth details as to such ERISA Event and the action, if any, that Holdings or the Borrower proposes to take with respect thereto.
(b) Upon reasonable request by the Administrative Agent, furnish copies of (i)Β annual report (Form 5500 Series) filed by any Loan Party or any Subsidiary thereof or any of its ERISA Affiliates with respect to each Employee Benefit Plan; (ii)Β the most recent actuarial valuation report for each Plan, to the extent such exists; (iii)Β all notices received by any Loan Party or any of its ERISA Affiliates from a Multiemployer Plan sponsor or any governmental agency concerning an ERISA Event; and (iv)Β such other information, documents or governmental reports or filings relating to any Employee Benefit Plan as the Administrative Agent shall reasonably request in writing.
SECTIONΒ 5.10. Compliance with Environmental Laws. Comply with all Environmental Laws applicable to its operations and properties and obtain and renew all material environmental permits necessary for its operations and properties, except to the extent that such failure to comply could not reasonably be expected to result in a Material Adverse Effect; and conduct any remedial action required by Environmental Laws; provided, however, that none of Holdings, the Borrower or any Subsidiary shall be required to undertake any remedial action required by Environmental Laws to the extent that its obligation to do so is being contested in good faith and by proper proceedings and appropriate reserves are being maintained with respect to such circumstances in accordance with GAAP.
SECTIONΒ 5.11. Preparation of Environmental Reports. If an Event of Default caused by reason of a breach of SectionΒ 3.16 or SectionΒ 5.10 shall have occurred and be continuing for more than 20 days without Holdings, the Borrower or any Subsidiary commencing activities reasonably likely to cure such Default, at the written request of the Required Lenders through the Administrative Agent, provide to the Lenders within 45 days after such request, at the reasonable expense of the Loan Parties, an environmental site assessment report regarding the matters that are the subject of such Event of Default prepared by an environmental consulting firm reasonably acceptable to the Administrative Agent and the Borrower and indicating the presence or absence of Hazardous Materials and the estimated cost of any compliance or remedial action in connection with such Event of Default.
SECTIONΒ 5.12. Further Assurances.
(a) Subject to the Intercreditor Agreement, execute any and all further documents, agreements and instruments, and take all further action (including delivering UCC and other financing statements with respect to the Collateral to the Collateral Agent for filing to the extent required under
Β
60
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
applicable law or any Security Documents that may be required hereunder), or that the Required Lenders, the Administrative Agent or the Collateral Agent may reasonably request in writing, in order to effectuate the transactions contemplated by the Loan Documents and in order to grant and perfect the validity and first priority (subject to Liens permitted by SectionΒ 6.02) of the security interests created by the Security Documents to the extent required hereby or by the Security Documents. Subject to the Intercreditor Agreement, in addition, from time to time, the Borrower will, at its reasonable cost and expense, promptly secure the Obligations by pledging or creating, or causing to be pledged or created, perfected security interests with respect to such of its assets and properties and the assets and property of its Subsidiaries that are Loan Parties as the Administrative Agent or the Required Lenders shall designate in writing to the extent required hereby or by the Security Documents to constitute βCollateralβ (it being understood that it is the intent of the parties that the Obligations shall be secured by all the Collateral of the Loan Parties (including certain owned real property and other properties acquired subsequent to the Closing Date)). Subject to the Intercreditor Agreement, such security interests and Liens in the Collateral will be created under the Security Documents and other security agreements, mortgages, deeds of trust and other instruments and documents in form and substance reasonably satisfactory to the Collateral Agent and the Borrower, and the Borrower shall deliver or cause to be delivered to the Collateral Agent all such instruments and documents (it being understood that mortgages, deeds of trust, legal opinions and title insurance policies shall only be required with respect to Material Domestic Real Property) as the Collateral Agent shall reasonably request to effectuate the foregoing requirements in this SectionΒ 5.12. In furtherance of the foregoing, the Borrower will give prompt notice to the Administrative Agent of the acquisition by it or any of the Subsidiaries that are Loan Parties of (i)Β any owned Material Domestic Real Property and (ii)Β any Material Foreign Assets.
(b) Within tenΒ (10) Business days of the consummation of any Permitted Acquisition of any Person organized in the United States by any of the Loan Parties that is a Wholly Owned Subsidiary of such Loan Party (other than a Foreign Subsidiary Holdco), or within tenΒ (10) Business Days of the formation by any of the Loan Parties of any Person organized in the United States that is a Wholly Owned Subsidiary of such Loan Party (other than a Foreign Subsidiary Holdco), the Borrower shall cause such Person so acquired or formed to be designated as a Subsidiary Guarantor of the Obligations. Such Person shall become a Loan Party by executing the Guarantee and Collateral Agreement (or a joinder thereto). In addition, (i)Β such Person shall execute and deliver such Security Documents as the Administrative Agent, the Collateral Agent or the Required Lenders may reasonably request to xxxxx x Xxxx in respect of substantially all of its real and personal property in favor of the Collateral Agent and the Lenders as required hereby or by the Guarantee and Collateral Agreement to constitute βCollateralβ, and (ii)Β the Loan Parties directly owning Equity Interests in such Person shall pledge all such Equity Interests (other than Excluded Equity) in such Person, in each case, subject to the limitation in clauses (c)Β and (d)Β below. Notwithstanding anything to the contrary in any Loan Document, with respect to any assets or property (other than Material Foreign Assets) of any Loan Party not located in the United States (which shall, for the avoidance of doubt, include Intellectual Property registered in a jurisdiction outside the United States), no action to create or perfect a security interest or Lien shall be taken or required to be taken with respect to such assets, other than, to the extent required under the Guarantee and Collateral Agreement, the applicable Loan Party granting a security interest and Lien on such assets under the Guarantee and Collateral Agreement and the filing of UCC financing statements (including amendments thereto); provided, however, that the foregoing shall not limit any Loan Partyβs obligations to pledge Equity Interests in Foreign Subsidiaries (other than Excluded Equity) to the extent required hereunder or under the Guarantee and Collateral Agreement.
(c) Notwithstanding anything to the contrary, no Foreign Subsidiary shall be required to (i)Β grant a security interest in its assets to secure the Obligations or (ii)Β guarantee the Obligations.
Β
61
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(d) In the event that any Loan Party forms or acquires a Foreign Subsidiary or Foreign Subsidiary Holdco after the date hereof, the Borrower will promptly notify the Collateral Agent of that fact and cause such Loan Party to execute and deliver to the Collateral Agent such documents and instruments and take such further actions as may be necessary, or in the reasonable opinion of the Collateral Agent, desirable to create in favor of the Collateral Agent, for the benefit of the Secured Parties, a Lien on all of the Equity Interests in such Foreign Subsidiary or Foreign Subsidiary Holdco held by such Loan Party (other than, in each case, Excluded Equity). Notwithstanding anything herein to the contrary, (A)Β all Loan Documents covering any foreign assets that are Collateral (including, without limitation, any Equity Interests of Foreign Subsidiaries that are Collateral) shall be governed by New York law, (B)Β no foreign law creation actions, perfection actions or other actions shall be required with respect to any Collateral, and (C)Β no foreign law opinion letters or foreign law governed documents shall be required with respect to any Collateral, in each case, other than with respect to, at the option of the Collateral Agent, Material Foreign Assets.
ARTICLE VI
Negative Covenants
Each of Holdings and the Borrower covenants and agrees with each Lender that, so long as this Agreement shall remain in effect and until the Commitments have been terminated and the principal of and interest on each Loan, all Fees and all other Obligations payable under any Loan Document shall have been paid in full (other than contingent indemnity claims or expense reimbursement obligations not yet asserted), neither Holdings nor the Borrower will, nor will they cause or permit any of the Subsidiaries to:
SECTIONΒ 6.01. Indebtedness. Incur, create, assume or permit to exist any Indebtedness, except:
(i) Indebtedness existing on the date hereof and set forth in Schedule 6.01 and any Permitted Refinancings thereof;
(ii) Indebtedness created hereunder and under the other Loan Documents (including, without limitation, any Indebtedness incurred pursuant to SectionΒ 2.22);
(iii) Indebtedness incurred under either (a)Β the Revolving Loan Agreement and the Revolving Loan Documents (including, without limitation, guarantees of the Loan Parties in respect of such Indebtedness and cash management and swap obligations) and any Permitted Refinancing thereof subject in each case to the Intercreditor Agreement or (b)Β a letter of credit facility, on terms and conditions reasonably satisfactory to the Administrative Agent, providing for the issuance of letters of credit thereunder for an aggregate face amount not to exceed $5,000,000;
(iv) intercompany Indebtedness of the Borrower and the Subsidiaries to the extent permitted by SectionΒ 6.04(iii);
(v) Indebtedness of the Borrower or any Subsidiary incurred to finance the acquisition, construction or improvement of any fixed or capital assets (for the avoidance of doubt, in each case, excluding Capital Lease Obligations and Synthetic Lease Obligations) and Permitted Refinancings thereof; provided that (i)Β such Indebtedness is incurred prior to or within 90 days after such acquisition or the completion of such construction or improvement and (ii)Β the aggregate principal amount of Indebtedness permitted by this SectionΒ 6.01(v), when combined with the aggregate principal amount of all Capital Lease Obligations and Synthetic Lease Obligations incurred pursuant to SectionΒ 6.01(vi) shall not exceed the Permitted Capital Lease Amount at any time outstanding;
Β
62
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(vi) Capital Lease Obligations and Synthetic Lease Obligations in an aggregate principal amount, when combined with the aggregate principal amount of all Indebtedness incurred pursuant to SectionΒ 6.01(v), not in excess of the Permitted Capital Lease Amount at any time outstanding;
(vii) Indebtedness in respect of (x)Β appeal bonds or similar instruments and (y)Β payment, bid, performance or surety bonds, or other similar bonds, completion guarantees, or similar instruments, workersβ compensation claims, health, disability or other employee benefits, letters of credit and bankerβs acceptances issued for the account of Holdings or any of its Subsidiaries in each case listed under this clauseΒ (y), in the ordinary course of business, and including guarantees or obligations of Holdings or any of its Subsidiaries with respect to letters of credit supporting such appeal, payment, bid, performance or surety or other similar bonds, completion guarantees, or similar instruments, workersβ compensation claims, health, disability or other employee benefits (in each case other than for Indebtedness for money borrowed);
(viii) Indebtedness under any Hedging Agreement permitted under SectionΒ 6.04(vi); provided that if such Hedging Agreement relates to interest rates, (i)Β the obligations under such Hedging Agreement relate to payment obligations on Indebtedness otherwise permitted to be incurred by the Loan Documents and (ii)Β the notional principal amount of such obligations under such Hedging Agreement at the time incurred does not exceed the principal amount of the Indebtedness to which such obligations under such Hedging Agreement relate;
(ix) (A)Β Contingent Obligations of any Loan Party of Indebtedness of any other Loan Party, (B)Β Contingent Obligations by any Subsidiary that is not a Loan Party of Indebtedness of any Loan Party, its Subsidiaries or its joint ventures or (C)Β Contingent Obligations of any Loan Party of Indebtedness of any Subsidiary or joint venture of any Loan Party that is not a Loan Party with respect, in each case, to Indebtedness otherwise permitted to be incurred pursuant to this SectionΒ 6.01 (and with respect to clause (C)Β above only, when combined with the aggregate amount of Investments, loans or advances made by Loan Parties to Subsidiaries or joint ventures that are not Loan Parties pursuant to SectionΒ 6.04(i) and SectionΒ 6.04(iii), in each case without duplication, do not exceed the Permitted Non-Loan Party Investment Amount) (including, without limitation, guarantees in respect of any Permitted Refinancings thereof); provided, that if the Indebtedness that is being guarantied is unsecured and/or subordinated to the Obligations, the guaranty shall also be unsecured and/or subordinated to the Obligations, in each case on terms no less favorable (taken as a whole) to the Lenders than the subordination terms (taken as a whole) of the Indebtedness so guarantied;
(x) (A) Indebtedness of any Person that becomes a Subsidiary after the date hereof, which Indebtedness is existing at the time such Person becomes a Subsidiary of the Borrower (other than Indebtedness incurred in contemplation of or in connection with such Person becoming a Subsidiary) in an aggregate amount not in excess of $1,000,000 at any time outstanding and (B)Β Indebtedness secured by assets purchased by a Loan Party in a Permitted Acquisition that is assumed by such Loan Party (other than Indebtedness incurred in contemplation of or in connection with such purchase) in an aggregate amount not in excess of $1,000,000 at any time outstanding;
Β
63
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(xi) Indebtedness incurred in the ordinary course of business in connection with cash pooling arrangements, netting services, automatic clearinghouse arrangements, overdraft protections, employee credit card programs, cash management and other similar arrangements incurred in the ordinary course of business;
(xii) to the extent any such items constitute Indebtedness, Indebtedness arising from agreements of Holdings, the Borrower or any Subsidiary providing for indemnification, contribution, earn-out, adjustment of purchase price or similar obligations, in each case incurred or assumed in connection with any Permitted Acquisition or Disposition otherwise permitted under this Agreement; provided that the amount of all earn-outs shall not exceed $3,000,000 in the aggregate from the Closing Date to the Maturity Date;
(xiii) unsecured Indebtedness consisting of Indebtedness owing to a seller incurred in connection with a Permitted Acquisition in an aggregate amount outstanding not to exceed $2,000,000; provided that such Indebtedness is subordinated to the Obligations in a manner reasonably satisfactory to the Administrative Agent;
(xiv) Indebtedness representing any Taxes, assessments or governmental charges to the extent such Taxes are being contested in good faith and adequate reserves have been provided therefor in conformity with GAAP;
(xv) Indebtedness of Foreign Subsidiaries not in excess of $625,000 at any time outstanding;
(xvi) Indebtedness representing deferred compensation or similar obligations to employees of the Borrower and its Subsidiaries incurred in the ordinary course of business;
(xvii) Indebtedness consisting of obligations of the Borrower and its Subsidiaries under deferred compensation or other similar arrangements with employees incurred by such Person in connection with Permitted Acquisitions or any other Investments permitted hereunder constituting acquisitions of Persons or businesses or divisions;
(xviii) Indebtedness incurred in the ordinary course of business with respect to customer deposits and other unsecured current liabilities not the result of borrowing and not evidenced by any note or other evidence of Indebtedness;
(xix) Indebtedness consisting of (A)Β the financing of insurance premiums or (B)Β take or pay obligations contained in supply arrangements, in each case, in the ordinary course of business;
(xx) Indebtedness arising in connection with endorsement of instruments for deposit in the ordinary course of business;
(xxi) Indebtedness arising as a direct result of judgments, orders, awards or decrees against Holdings or any of its Subsidiaries, in each case not constituting an Event of Default;
(xxii) Indebtedness consisting of promissory notes issued by any Loan Party or its Subsidiaries to current or former officers, directors and employees (or their estates, spouses or former spouses) of any Loan Party or any Subsidiary issued to purchase or redeem capital stock of Holdings permitted by SectionΒ 6.06(a);
(xxiii) Subordinated Indebtedness in an aggregate principal amount not exceeding $500,000 at any time outstanding;
Β
64
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(xxiv) unsecured Indebtedness of Holdings to its Subsidiaries at such times and in such amounts necessary to permit Holdings to receive any Restricted Payment permitted to be made to Holdings pursuant to SectionΒ 6.06, so long as, as of the applicable date of determination, a Restricted Payment for such purposes would otherwise be permitted to be made pursuant to SectionΒ 6.06; provided that that any such Indebtedness shall be deemed to utilize on a dollar-for-dollar basis the relevant basket under SectionΒ 6.06;
(xxv) to the extent constituting Indebtedness, all premiums (if any), interest (including post-petition interest), fees, expenses, charges and additional or contingent interest on obligations described in SectionΒ 6.01(i) through (xxiv)Β above; and
(xxvi) other Indebtedness of the Borrower or its Subsidiaries in an aggregate principal amount not exceeding $1,000,000 at any time outstanding (of which $1,000,000 at any time can be secured).
For purposes of determining compliance with any Dollar-denominated restriction on the incurrence of Indebtedness, the Dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was incurred, in the case of term debt, or first committed, in the case of revolving credit debt; provided that if such Indebtedness is incurred to extend, replace, refund, refinance, renew or defease other Indebtedness denominated in a foreign currency, and such extension, replacement, refunding, refinancing, renewal or defeasance would cause the applicable Dollar-denominated restriction to be exceeded if calculated at the relevant currency exchange rate in effect on the date of such extension, replacement, refunding, refinancing, renewal or defeasance, such Dollar-denominated restriction shall be deemed not to have been exceeded so long as the principal amount of such extension, replacement, refunding, refinancing, renewal or defeasance of Indebtedness does not exceed the principal amount of such Indebtedness being extended, replaced, refunded, refinanced, renewed or defeased, plus an amount equal to unpaid accrued interest and premium thereon, plus the aggregate amount of fees, underwriting discounts, premiums and other costs and expenses (including, without limitation, attorneyβs fees) incurred in connection with such extension, replacement, refunding, refinancing, renewal or defeasance.
To the extent otherwise constituting Indebtedness, the accrual of interest, the accretion of accreted value and the payment of interest in the form of additional Indebtedness shall be deemed not to be Indebtedness for purposes of this SectionΒ 6.01. The principal amount of any non-interest bearing Indebtedness or other discount security constituting Indebtedness at any date shall be the principal amount thereof that would be shown on a balance sheet of the Borrower dated such date prepared in accordance with GAAP.
SECTIONΒ 6.02. Liens. Create, incur, assume or permit to exist any Lien on any property or assets (including Equity Interests or other securities of any Person, including the Borrower or any Subsidiary) now owned or hereafter acquired by it or on any income or revenues or rights in respect of any thereof, except:
(i) Liens on property or assets of the Borrower and the Subsidiaries existing on the date hereof and set forth in ScheduleΒ 6.02 and any Permitted Refinancing thereof; provided that such Liens shall secure only those obligations that they secure on the date hereof or Permitted Refinancing thereof as applicable;
(ii) any Lien created under the Security Documents or the other Loan Documents;
Β
65
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(iii) any Lien existing on any property or asset prior to the acquisition, construction or improvement thereof by the Borrower or any Subsidiary or existing on any property or assets of any Person that becomes a Subsidiary after the date hereof prior to the time such Person becomes a Subsidiary, as the case may be; provided that (i)Β such Lien is not created in contemplation of or in connection with such acquisition or such Person becoming a Subsidiary, (ii)Β such Lien does not apply to any other property or assets of Holdings, the Borrower or any Subsidiary and (iii)Β such Lien secures only those obligations (excluding the amount of any premiums or penalties and accrued and unpaid interest paid thereon and the amount of fees, costs and expenses incurred in connection therewith) that it secures on the date of such acquisition or the date such Person becomes a Subsidiary, as the case may be;
(iv) Liens for Taxes not yet due or that are being contested in compliance with SectionΒ 5.03;
(v) Landlordsβ, carriersβ, warehousemenβs, mechanicsβ, materialmenβs, repairmenβs, construction contractorβs or other like Liens arising in the ordinary course of business and securing obligations that are not overdue for a period of more than 30 days and payable or that are being contested in compliance with SectionΒ 5.03;
(vi) pledges and deposits made in the ordinary course of business in compliance with workmenβs compensation, unemployment insurance and other social security laws or regulations;
(vii) deposits to secure the performance of bids, trade contracts (other than for Indebtedness for borrowed money), governmental contracts and leases (other than Capital Lease Obligations or Synthetic Lease Obligations), statutory obligations, surety, stay, custom and appeal bonds, performance bonds and other obligations of a like nature (including those to secure health, safety and environmental obligations) incurred in the ordinary course of business;
(viii) zoning restrictions, easements, rights-of-way, title exceptions, survey exceptions, covenants, reservations, restrictions, encroachments, protrusions, conditions, licenses, building codes, minor defects or irregularities in title and other similar encumbrances affecting real property, restrictions on use of real property and other similar encumbrances incurred that, in the aggregate, do not materially adversely detract from the value and the use of the property subject thereto or interfere with the ordinary conduct of the business of the Borrower or any of its Subsidiaries (taken as a whole);
(ix) Liens with respect to Capital Lease Obligations and purchase money security interests in real property, improvements thereto or equipment hereafter acquired (or, in the case of improvements, constructed) by the Borrower or any Subsidiary; provided that (i)Β such security interests secure Indebtedness permitted by SectionΒ 6.01(v) or 6.01(vi), (ii)Β such security interests are incurred, and the Indebtedness secured thereby is created, within 90 days after such acquisition (or construction), (iii)Β the Indebtedness secured thereby does not exceed 100% of the cost of such real property, improvements or equipment at the time of such acquisition (or construction) plus unpaid accrued interest and premium thereon plus underwriting discounts, premiums paid, fees, costs and expenses (including, without limitation, attorneyβs fees) incurred in connection therewith and (iv)Β such security interests do not apply to any other property or assets of the Borrower or any Subsidiary other than any proceeds and/or replacements thereof;
(x) Liens on property or assets of a Person (other than any Equity Interests in any Person) existing at the time the assets of such Person are acquired or such Person is merged into or consolidated with the Holdings, the Borrower or any Subsidiary or becomes a Subsidiary of
Β
66
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Holdings, the Borrower or any Subsidiary; provided that any such Lien (i)Β was not created in contemplation of or in connection with such asset purchase, merger, consolidation or investment and (ii)Β does not extend to any assets (other than improvements thereon) other than those acquired in such asset purchase and those assets of the Person merged into or consolidated with Holdings, the Borrower or such Subsidiary or acquired by Holdings, the Borrower or such Subsidiary;
(xi) bankersβ Liens, rights of setoff and other similar Liens existing solely with respect to (i)Β cash and Permitted Investments on deposit in one or more accounts maintained by any Loan Party, in each case granted in the ordinary course of business in favor of the bank or banks with which such accounts are maintained, securing amounts owing to such bank or banks with respect to cash management and operating account arrangements, and (ii)Β financial assets on deposit in one or more securities accounts maintained by any Loan Party, in each case granted in the ordinary course of business in favor of the securities intermediaries with which such accounts are maintained, securing amounts owing to such securities intermediaries with respect to services rendered in connection with such securities accounts;
(xii) precautionary filings of financing statements under the Uniform Commercial Code of any applicable jurisdictions in respect of operating leases or consignments entered into by Holdings, the Borrower or the Subsidiaries in the ordinary course of business;
(xiii) Liens arising out of judgments, orders, attachments, decrees or awards not resulting in an Event of Default;
(xiv) either (a)Β Liens securing the Indebtedness under the Revolving Loan Agreement and the other Revolving Loan Documents and any Permitted Refinancing thereof, subject to the Intercreditor Agreement or (b)Β Liens on cash collateral securing Indebtedness permitted under SectionΒ 6.01(iii)(b); provided that the aggregate amount of cash collateral subject to the Liens permitted under this SectionΒ 6.02(xiv)(b) shall not exceed 105% of the aggregate face amount of all outstanding letters of credit issued and outstanding under the applicable letter of credit facility;
(xv) (A)Β Liens on insurance policies and the proceeds thereof securing insurance premium financing permitted hereunder and (B)Β pledges and deposits in the ordinary course of business securing liability for reimbursement or indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing property, casualty or liability insurance to Holdings or any of its Subsidiaries;
(xvi) Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods entered into by the Borrower or any Subsidiary in the ordinary course of business;
(xvii) Liens on the assets of Foreign Subsidiaries that secure Indebtedness permitted pursuant to SectionΒ 6.01(xv) (and related obligations);
(xviii) good xxxxx xxxxxxx money deposits made in connection with a Permitted Acquisition or any other Investment or letter of intent or purchase agreement permitted hereunder;
(xix) Leases and subleases of the properties of any Loan Party or their Subsidiaries granted by such Person to third parties;
(xx) non-exclusive licenses and sublicenses in the ordinary course of business;
Β
67
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(xxi) Liens to the extent arising out of judgments, orders, attachments, decrees or awards not resulting in an Event of Default;
(xxii) Liens (A)Β incurred in the ordinary course of business in connection with the purchase or shipping of goods or assets (or the related assets and proceeds thereof), which Liens are in favor of the seller or shipper of such goods or assets and only attach to such goods or assets, and (B)Β in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods; and
(xxiii) other Liens securing Indebtedness not to exceed $1,000,000 in the aggregate at any time outstanding.
Notwithstanding anything to contrary hereunder or under any other Loan Document, no Liens (other than Liens permitted under clauses (ii), (iv)Β and (xiv)Β shall be permitted on Equity Interests issued by the Borrower or any of its Subsidiaries which constitute Collateral.
SECTIONΒ 6.03. Sale and Lease-Back Transactions. Enter into any arrangement, directly or indirectly, with any Person whereby it shall sell or transfer all of its right, title and interest to any property, real or personal with a fair market value in excess of $1,000,000, used or useful in its business, whether now owned or hereafter acquired, contemporaneously or substantially contemporaneously therewith rent or lease such property or other property which it intends to use for substantially the same purpose or purposes as the property being sold or transferred, except to the extent (a)Β the sale or transfer of such property is permitted by SectionΒ 6.05 and, (b)Β any Capital Lease Obligations, Synthetic Lease Obligations or Liens arising in connection therewith are permitted by SectionΒ 6.01 and SectionΒ 6.02, as the case may be.
SECTIONΒ 6.04. Investments. Purchase, hold, make or acquire any Investments, any other Person, except:
(i) (A) Investments by Holdings, the Borrower and the Subsidiaries existing on the date hereof in the Equity Interests of the Borrower and the Subsidiaries and (B)Β additional Investments by Holdings, the Borrower and the Subsidiaries in the Equity Interests of the Borrower and the Subsidiaries; provided that (x)Β any such Equity Interests (other than Excluded Equity) held by a Loan Party shall be pledged pursuant to the Guarantee and Collateral Agreement (subject to the limitations and exclusions referred to therein) and (y)Β the aggregate amount of Investments made by Loan Parties after the date hereof in Subsidiaries that are not Loan Parties (determined without regard to any write downs or write-offs of such Investments), when combined with the aggregate amount of loans and advances made by Loan Parties to Subsidiaries or joint ventures that are not Loan Parties pursuant to SectionΒ 6.04(iii) and the aggregate amount of Contingent Obligations of Loan Parties with respect to Indebtedness of Subsidiaries and joint ventures that are not Loan Parties pursuant to SectionΒ 6.01(ix)(C), in each case without duplication, shall not exceed the Permitted Non-Loan Party Investment Amount;
(ii) Permitted Investments;
(iii) loans or advances made by any Loan Parties or their Subsidiaries to any other Loan Party (except with respect to SectionΒ 6.01(xxiv), other than Holdings), Subsidiary or a Subsidiary of a Loan Party or joint ventures thereof; provided that the aggregate amount of such loans and advances made by Loan Parties to Subsidiaries or joint ventures that are not Loan Parties (determined without regard to any write-downs or write-offs of such loans and advances), when combined with the aggregate amount of Investments made by Loan Parties after the date
Β
68
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
hereof in Subsidiaries or joint ventures that are not Loan Parties pursuant to SectionΒ 6.04(i) and the aggregate amount of Contingent Obligations of Loan Parties with respect to Indebtedness of Subsidiaries and joint ventures that are not Loan Parties pursuant to SectionΒ 6.01(ix)(C), in each case without duplication, shall not exceed the Permitted Non-Loan Party Investment Amount at any time outstanding and shall be evidenced by a promissory note to the extent required by the Guarantee and Collateral Agreement;
(iv) Investments received in connection with the bankruptcy or reorganization of, or settlement of delinquent accounts and disputes with, customers and suppliers, in each case in the ordinary course of business;
(v) Holdings, the Borrower and its Subsidiaries may make loans and advances in the ordinary course of business (including for travel, entertainment and relocation expenses) to their respective officers, directors and employees so long as the aggregate principal amount thereof at any time outstanding (determined without regard to any write-downs or write-offs of such loans and advances) shall not exceed $500,000;
(vi) the Borrower and its Subsidiaries may enter into Hedging Agreements that are not speculative in nature;
(vii) the Borrower and any Subsidiary may acquire all or substantially all the assets of a Person or line of business of such Person, or not less than 90% of the Equity Interests (other than directorsβ qualifying shares) of a Person (referred to herein as the βAcquired Entityβ) provided that (I)Β the Borrower shall comply, and shall cause the Acquired Entity to comply (in each case, to the extent applicable), with the applicable provisions of SectionΒ 5.12 and the Security Documents and (II) such transactions meet the following criteria (or such criteria is waived) in one of the three clausesΒ of (A),Β (B) and (C)Β below (any acquisition of an Acquired Entity meeting all the criteria in one of clauses ofΒ (A), (B)Β and (C)Β (or having any such criteria waived) of this SectionΒ 6.04(vii) being referred to herein as a βPermitted Acquisitionβ):
(A) Other than an acquisition satisfying the criteria set forth in clause (B)Β or clause (C), such acquisition satisfies the following:
(i) no Default or Event of Default exists at the time of such acquisition or would exist immediately after giving effect to such acquisition;
(ii) the Consolidated Leverage Ratio shall not be greater than 0.74 to 1 on a pro forma basis after giving effect to such acquisition; and
(iii) the Borrower shall have delivered a certificate of a Financial Officer, certifying as to compliance with paragraphs (A)(i) and (A)(ii) of this SectionΒ 6.04(vii) and containing reasonably detailed calculations in support of paragraph (A)(ii) of this SectionΒ 6.04(vii);
(B) such acquisition is funded solely with the Equity Interests of Holdings or proceeds from any issuance of Equity Interests by Holdings (in each case, not constituting Disqualified Stock); or
(C) such acquisition is funded with cash or Permitted Investments of Holdings, the Borrower or any Subsidiary, and both (a)Β no Default or Event of Default exists at the time of such acquisition or would exist immediately after giving effect to such acquisition and (b)Β immediately after giving effect to such acquisition and the use of any cash or Permitted Investments of Holdings, the Borrower or any Subsidiary for such acquisition, Liquidity shall not be less than $3,000,000;
Β
69
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(viii) Contingent Obligations permitted by SectionΒ 6.01;
(ix) prepaid expenses or lease, utility and other similar deposits, in each case made in the ordinary course of business;
(x) Investments consisting of any deferred portion (including promissory notes and non cash consideration) of the sales price received by Holdings, the Borrower or any Subsidiary in connection with any Disposition permitted hereunder;
(xi) advances of payroll payments to employees, officers, directors and managers of Holdings, the Borrower and any Subsidiaries in the ordinary course of business;
(xii) extensions of trade credit or the holding of receivables in the ordinary course of business and Investments received in satisfaction or partial satisfaction thereof from financially troubled account debtors and other credits to suppliers in the ordinary course of business or pursuant to any plan of reorganization or liquidation or similar arrangement upon the bankruptcy or insolvency of such account debtors or suppliers;
(xiii) the Borrower and its Subsidiaries may endorse negotiable instruments and other payment items for collection or deposit in the ordinary course of business or make lease, utility and other similar deposits in the ordinary course of business;
(xiv) Investments of any Person that becomes (or is merged or consolidated or amalgamated with) a Subsidiary of the Borrower on or after the date hereof on the date such Person becomes (or is merged or consolidated or amalgamated with) a Subsidiary of the Borrower; provided that (i)Β such Investments exist at the time such Person becomes (or is merged or consolidated or amalgamated with) a Subsidiary, and (ii)Β such Investments are not made in anticipation or contemplation of such Person becoming (or merging or consolidating or amalgamated with) a Subsidiary;
(xv) advances in connection with purchases of goods or services in the ordinary course of business;
(xvi) Investments to the extent that payment for such Investments is made solely with Qualified Capital Stock of Holdings or Equity Interests of any direct or indirect parent company of Holdings; and
(xvii) Investments consisting of good faith deposits made in accordance with SectionΒ 6.02(xviii);
(xviii) (i)Β Investments outstanding on the Closing Date and identified on ScheduleΒ 6.04Β and (ii)Β Investments consisting of any modification, replacement, renewal, reinvestment or extension of any Investment described in clauseΒ (i)Β above; provided that the amount of any Investment permitted pursuant to this clauseΒ (ii)Β is not increased from the amount of such Investment on the Closing Date except pursuant to the terms of such Investment as of the Closing Date or pursuant to another Investment otherwise permitted by this SectionΒ 6.04;
Β
70
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(xix) promissory notes or other obligations of directors (or comparable position), officers or other employees of a Loan Party or any of its Subsidiaries acquired in the ordinary course of business in connection with such directorsβ (or comparable position), officersβ or employeesβ acquisition of Equity Interests in such Loan Party or such Subsidiary (to the extent such acquisition is permitted under this Agreement), (A)Β so long as no cash is advanced by the Borrower or any of its Subsidiaries that are Loan Parties in connection with such Investment or (B)Β if paid in cash, in an aggregate amount not to exceed $1,000,000 at any time outstanding;
(xx) any Loan Party or any of its Subsidiaries may make a loan that could otherwise be made as a distribution permitted under SectionΒ 6.06 (with a commensurate dollar-for-dollar reduction of their ability to make additional distributions under such Section); provided that any such loan made by a Loan Party and shall be evidenced by a promissory note and pledged to the Collateral Agent to the extent required by the Guarantee and Collateral Agreement;
(xxi) Investments to the extent constituting the reinvestment of the Net Asset Sale Proceeds arising from any Asset Sale or Net Insurance/Condemnation Proceeds arising from any Casualty Event to repair, replace or restore any property in respect of which such proceeds were paid or to reinvest in other properties or assets that are used or are otherwise useful in the business of the Loan Parties and their Subsidiaries; and
(xxii) in addition to Investments permitted by paragraphs (i)Β through (xxi)Β above, additional Investments by the Borrower and the Subsidiaries so long as the aggregate amount invested pursuant to this paragraph (xxii)Β (determined without regard to any write-downs or write-offs of such Investments, but net of cash returns thereon) does not exceed $1,500,000.
SECTIONΒ 6.05. Consolidations, Dispositions of Assets and Acquisitions. Enter into any transaction of merger or consolidation, or liquidate, wind-up or dissolve itself (or suffer any liquidation or dissolution), or convey, sell, lease or sub-lease (as lessor or sublessor), transfer or otherwise Dispose of, in one transaction or a series of transactions, all or any part of its business, property or assets (including its notes or receivables and Equity Interests of a Subsidiary, whether newly issued or outstanding), whether now owned or hereafter acquired, except:
(i) any Subsidiary of the Borrower may be merged with or into the Borrower or any Wholly Owned Subsidiary of the Borrower that is a Guarantor, or be liquidated, wound up or dissolved, or all or any part of its business, property or assets may be conveyed, sold, leased, transferred or otherwise Disposed of, in one transaction or a series of transactions, to the Borrower or any Wholly Owned Subsidiary of the Borrower that is a Guarantor; provided that, in the case of such a merger, the Borrower or such Wholly Owned Subsidiary shall be the continuing or surviving Person;
(ii) any Subsidiary of the Borrower that is not a Guarantor may be merged with or into any Subsidiary of the Borrower that is not a Guarantor, or be liquidated, wound up or dissolved, or all or any part of its business, property or assets may be conveyed, sold, leased, transferred or otherwise Disposed of, in one transaction or a series of transactions, to any Subsidiary of the Borrower that is not a Guarantor;
(iii) the Borrower and its Subsidiaries may sell or otherwise Dispose of assets in transactions that do not constitute Asset Sales;
(iv) the Borrower and its Subsidiaries may Dispose of obsolete, worn out or surplus property in the ordinary course of business;
Β
71
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(v) the Borrower and its Subsidiaries may make Asset Sales; provided that (a)Β the consideration received for such assets shall be in an amount at least equal to the fair market value thereof; (b)Β at least 75% of such consideration received shall be cash; (c)Β no Event of Default shall have occurred or be continuing immediately after giving effect thereto; and (d)Β the proceeds of such Asset Sales shall be applied to the extent required by SectionΒ 2.11(a);
(vi) in order to resolve disputes that occur in the ordinary course of business, the Borrower and its Subsidiaries may sell, transfer, discount, forgive, cancel or otherwise compromise for less than the face value thereof, notes or accounts receivable;
(vii) the Borrower or a Subsidiary may Dispose of Equity Interests of any of its Subsidiaries solely to qualify directors of the Governing Body of the Subsidiary if, and to the extent, required by applicable law;
(viii) any Person may be merged with or into the Borrower or any Subsidiary if the acquisition of the Equity Interests of such Person by the Borrower or such Subsidiary would have been permitted pursuant to SectionΒ 6.04(vii); provided that (a)Β in the case of the Borrower, the Borrower shall be the continuing or surviving entity, (b)Β if a Subsidiary is not the surviving or continuing Person, the surviving Person becomes a Subsidiary and complies with the provisions of SectionΒ 5.12 (to the extent required thereby and subject to the limitations and exceptions set forth therein) and (c)Β no Event of Default shall have occurred or be continuing immediately after giving effect thereto;
(ix) the Loan Parties may engage in transactions that are excluded from the definition of βAsset Saleβ by the parenthetical following clause (iii)Β thereof;
(x) the lapse or abandonment in the ordinary course of business of any Intellectual Property that is, in the reasonable business judgment of the Borrower, immaterial or no longer economically practicable to maintain;
(xi) Dispositions of property to the Borrower or a Subsidiary; provided, that if the transferor of such property is a Loan Party (a)Β the transferee thereof must be a Loan Party (other than Holdings) or (b)Β such Investment must be a permitted Investment in a Subsidiary that is not a Loan Party in accordance with SectionΒ 6.04;
(xii) Dispositions of property to the extent that (i)Β such property is exchanged for credit against the purchase price of similar replacement property or (ii)Β the proceeds of such Disposition are promptly applied to the purchase price of such replacement property; provided that to the extent the property being transferred constitutes Collateral, such replacement property shall constitute Collateral;
(xiii) (A)Β Investments permitted pursuant to SectionΒ 6.04, (B)Β transactions permitted pursuant to SectionΒ 6.03, (C)Β Liens in compliance with SectionΒ 6.02 and (D)Β Restricted Payments in compliance with SectionΒ 6.06;
(xiv) (x) leases and subleases of real or personal property in the ordinary course of business and (y)Β non-exclusive licenses and sublicenses of Intellectual Property or other property;
(xv) sales of non-core assets acquired in connection with any Permitted Acquisitions;
Β
72
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(xvi) use of cash and Disposition of Permitted Investments in the ordinary course of business;
(xvii) Dispositions resulting from Casualty Events; and
(xviii) the unwinding or terminating of Hedging Agreement.
To the extent the Required Lenders or all the Lenders, as applicable, waive the provisions of this SectionΒ 6.05 with respect to the sale of any Collateral, or any Collateral is sold as permitted by this SectionΒ 6.05, such Collateral (unless sold to a Loan Party) shall be sold automatically free and clear of the Liens created by the Security Documents and the Agents shall, at the reasonable cost and expense of the Borrower, take all actions they reasonably deem appropriate in order to effect the foregoing.
SECTIONΒ 6.06. Restricted Payments; Restrictive Agreements.
(a) Declare or make, or agree to declare or make, directly or indirectly, any Restricted Payment, or incur any obligation (contingent or otherwise) to do so; provided, however, that (i)Β any Subsidiary of the Borrower may declare and pay dividends or make other distributions ratably to its equity holders, (ii)Β the Borrower may make Restricted Payments to Holdings in an amount not to exceed the Permitted Restricted Payment Amount in any fiscal year of the Borrower to the extent necessary to pay independent director fees incurred by Holdings in the ordinary course of business, (iii)Β the Borrower may make Restricted Payments to Holdings in an amount not to exceed $250,000 in any fiscal year of the Borrower, (and Holdings may make a corresponding Restricted Payment to the Sponsor or its Affiliates) to the extent necessary to pay reasonable general corporate or other entity and overhead expenses (including franchise or similar Taxes, other than Taxes in the nature of an income Tax, which is covered by Permitted Tax Distributions, but excluding fees to independent directors) incurred by Holdings or the Sponsor or its Affiliates (limited, in the case of the Sponsor and any of its Affiliates, to amounts directly related to its indirect ownership interests in the Borrower) or pay any indemnification amounts or other amounts described in SectionΒ 6.07(v) below owed to Holdings or the Sponsor or its Affiliates, pursuant to the Management Agreement or any other customary management or advisory arrangement (whether in writing, verbal or otherwise), (iv)Β the Borrower may pay to Holdings, and Holdings may pay to its direct or indirect parent companies, Permitted Tax Distributions; (v)Β Holdings, the Borrower and the Subsidiaries may make Restricted Payments in the form of distributions payable solely in the common stock, other common Equity Interests or other Qualified Capital Stock of such Person; (vi)Β the Borrower and Holdings may make (directly or indirectly) Permitted Founder Distributions; (vii)Β so long as no Event of Default has occurred and is continuing or would immediately result therefrom, payments may be made to Holdings (or any direct or indirect parent company of Holdings) to permit Holdings (or any such direct or indirect parent company of Holdings) to repurchase or redeem Qualified Capital Stock of Holdings (or any direct or indirect parent company) held by current or former officers, directors or employees (or their transferees, spouses, ex-spouses, estates or beneficiaries under their estates) of any Loan Party or their Subsidiaries, upon their death, disability, retirement, severance or termination of employment or service or to make payments on Indebtedness issued to buy such Qualified Capital Stock upon their death, disability, retirement, severance or termination of employment or service; provided that the aggregate cash consideration (for the avoidance of doubt excluding cancellation of Indebtedness owed by such person) paid for all such redemptions and payments shall not exceed, in any fiscal year, the sum of (I)Β $1,000,000, plus (II)Β the net cash proceeds of any βkey-manβ life insurance policies of any Loan Party or its Subsidiaries that have not been used to make any repurchases, redemptions or payments under this clauseΒ (vii) provided further, that any Restricted Payments or payments permitted to be made (but not made) pursuant to subclauseΒ (I)Β of this clauseΒ (vii)Β in a given fiscal year of Holdings may be carried forward and made in succeeding fiscal years of Holdings; provided further that during an Event of Default any payments described in this clauseΒ may accrue and shall be permitted to be paid when no
Β
73
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Event of Default is continuing at such time; (viii)Β Restricted Payments may be made solely in Equity Interests of Holdings (other than Disqualified Stock), (ix)Β repurchases of Equity Interests may be made by Holdings upon the occurrence of the exercise of Equity Interest options if the Equity Interests represent a portion of the exercise price thereof and (x)Β distributions of proceeds of the Loans to Holdings to effectuate the Existing Debt Refinancing on the Closing Date; provided, however, that (A)Β (x)Β the amount of cash dividends paid pursuant to clauses (iii)Β and (iv)Β to enable Holdings to pay Taxes at any time shall not exceed the amount of such Taxes actually owing by Holdings (or such applicable parent company) at such time and (y)Β any refunds (including in respect of Taxes) received by Holdings shall promptly be returned by Holdings to the Borrower as cash common equity contributions and (B)Β any Permitted Founder Distributions made pursuant to clause (vi)Β are subject to (1)Β the Loan Parties having no net operating losses (without taking into account any interest tax deduction) that have not been utilized to offset net income for any prior relevant period at the time such Permitted Founder Distribution is made, (2)Β the sum of (x)Β net income (determined in accordance with GAAP) of the Loan Parties and their Subsidiaries, on a consolidated basis, plus (y)Β interest expense (determined in accordance with GAAP) of the Loan Parties and their Subsidiaries, on a consolidated basis, for the most recently ended fiscal year, exceeding $0, (3)Β immediately after giving effect to any such distribution, Liquidity being greater than or equal to $3,000,000 and (4)Β the aggregate amount of all such Permitted Founder Distributions made during the term of this Agreement not exceeding $8,000,000.
(b) Enter into, incur or permit to exist any agreement or other arrangement that prohibits, restricts or imposes any condition upon (i)Β the ability of Holdings, the Borrower or any Wholly Owned Subsidiary to create, incur or permit to exist any Lien upon any of its property or assets, or (ii)Β the ability of any Subsidiary to pay dividends or other distributions with respect to any of its Equity Interests or to make or repay loans or advances to the Borrower or any other Subsidiary or to guarantee Indebtedness of the Borrower or any other Subsidiary; provided that (A)Β the foregoing shall not apply to restrictions and conditions imposed by law or regulation or by any Loan Document or the Revolving Loan Document or any Permitted Refinancing thereof, (B)Β the foregoing shall not apply to customary restrictions and conditions contained in agreements relating to the sale of a Subsidiary (or its assets) pending such sale, provided such restrictions and conditions apply only to the Subsidiary or such assets that is (or are) to be sold and such sale is permitted hereunder, (C)Β clause (i)Β of the foregoing shall not apply to restrictions or conditions imposed by any agreement relating to secured Indebtedness permitted by this Agreement if such restrictions or conditions apply only to the property or assets securing such Indebtedness, (D)Β clause (i)Β of the foregoing shall not apply to customary provisions in leases, subleases, licenses, sublicenses and other contracts restricting the assignment thereof, (E)Β the foregoing shall not apply with respect to (i)Β any agreement (including with respect to Indebtedness) in effect at the time any Person becomes a Subsidiary of the Borrower; provided, that such agreement was not entered into in contemplation of such Person becoming a Subsidiary of the Borrower, (ii)Β restrictions under agreements evidencing or governing or otherwise relating to Indebtedness of any Subsidiaries that are not Loan Parties permitted under SectionΒ 6.01; provided that such Indebtedness is only with respect to the assets of any Subsidiaries that are not Loan Parties, (iii)Β customary provisions in joint venture agreements, limited liability company operating agreements, partnership agreements, stockholders agreements, other Organizational Documents and other similar agreements, (iv)Β customary anti-assignment provisions in licenses and other contracts restricting the sublicensing or assignment thereof, (v)Β pursuant to Contractual Obligations that (y)Β exist on the Closing Date and (z)Β to the extent Contractual Obligations permitted by this clauseΒ (v) are set forth in an agreement evidencing Indebtedness or any agreement evidencing any Permitted Refinancing thereof so long as such Permitted Refinancing does not expand the scope of such Contractual Obligation, and (vi)Β restrictions in connection with cash or other deposits permitted under SectionΒ 6.02.
SECTIONΒ 6.07. Transactions with Affiliates. Except for (i)Β transactions between or among Loan Parties, (ii)Β Investments permitted by SectionΒ 6.04, and Indebtedness permitted by SectionΒ 6.01, and Liens permitted by SectionΒ 6.02, (iii)Β Dispositions, mergers, consolidations and dissolutions permitted by
Β
74
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SectionΒ 6.05(i), (iv)Β Restricted Payments permitted by SectionΒ 6.06, (v)Β reimbursements of costs and expenses of the Sponsor or its Affiliates or any indemnities provided to the Sponsor or its Affiliates, in each case, pursuant to the Management Agreement or any other customary management or advisory arrangement (whether in writing, verbal or otherwise), (vi)Β director, officer and employee compensation (including bonuses) and other benefits (including retirement, health, stock option and other benefit plans) and indemnification arrangements and severance agreements, in each case approved by the Governing Body of Holdings, any direct or indirect parent entity of Holdings or the applicable Subsidiary of Holdings, (vii)Β transactions under the Loan Documents, the Revolving Loan Documents (and any Permitted Refinancing thereof) and the Related Documents, (viii)Β Dispositions of Qualified Capital Stock of Holdings to Affiliates of Borrower or Holdings not otherwise prohibited by the Loan Documents and the granting of registration and other customary rights in connection therewith, (ix)Β the Transactions, (x)Β the transactions with Velocity Technology Solutions, Inc. or its Affiliates that are approved by all disinterested directors (or the equivalent thereof) (excluding any independent director that may have an interest in the particular transaction) of the appropriate Governing Body of Holdings and (xi)Β the transactions set forth on Schedule 6.07, and any amendment or modification with respect to such transactions, and the performance of obligations thereunder, so long as such amendment or modification is not materially adverse to the interests of the Lenders, sell or transfer any property or assets to, or purchase or acquire any property or assets from, or otherwise engage in any other transactions with, any of its Affiliates, except that the Borrower or any Subsidiary may engage in any of the foregoing transactions at prices and on terms and conditions not less favorable to the Borrower or such Subsidiary than could be obtained on an armβs-length basis from unrelated third parties; provided that if such Affiliate transaction both (1)Β does not meet one of the exceptions in clauses (i)Β through (xi)Β above and (2)Β involves aggregate payments or value in excess of $1,000,000, the Borrower shall either obtain written approval for such Affiliate transaction from (y)Β all of the disinterested directors (or the equivalent thereof) (excluding any independent director that may have an interest in the particular transaction) of the appropriate Governing Body of the Borrower or such Subsidiary, as applicable or (z)Β the Administrative Agent.
SECTIONΒ 6.08. Business of Holdings, Borrower and Subsidiaries.
(a) With respect to Holdings, engage in any business activities prohibited by SectionΒ 6.13; and
(b) With respect to the Borrower and each of its Subsidiaries, engage at any time in any business or business activity other than the business conducted by it on the date hereof and any business reasonably related, similar, ancillary, complementary or incidental thereto or reasonable extensions thereof.
SECTIONΒ 6.09. Other Indebtedness and Agreements, etc.
(a) Make any distribution, whether in cash, property, securities or a combination thereof, other than regularly scheduled payments of principal and interest and premiums and fees as and when due (to the extent not prohibited by applicable subordination provisions), in respect of, or pay, or directly or indirectly redeem, repurchase, retire or otherwise acquire for consideration, any Subordinated Indebtedness unless permitted by the applicable subordination agreement, except (i)Β with respect to any Permitted Refinancing thereof, (ii)Β to the extent made with the proceeds of Qualified Capital Stock of Holdings, (iii)Β with respect to the Existing Debt Refinancing on the Closing Date, (iv)Β with respect to converting (or exchanging) any Indebtedness to (or for) Qualified Capital Stock of Holdings, (v)Β any AHYDO payments with respect thereto so long as no Event of Default is continuing or would immediately result therefrom and (vi)Β so long as no Event of Default is continuing, making prepayments, redemptions, repurchases, retirement, defeasance or other satisfaction of Indebtedness in an amount not to exceed $500,000 per year; or
Β
75
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(b) Pay in cash any amount in respect of any Indebtedness (other than interest payable under this Agreement), Disqualified Stock or preferred Equity Interests that may at the obligorβs option be paid in kind or in other securities, in each case, at a time (but only at such time) when PIK Interest is being paid (as opposed to all cash interest) on the Loans pursuant to SectionΒ 2.06;
(c) Pay any Management Fees.
SECTIONΒ 6.10. Maximum Consolidated Leverage Ratio. Permit the Consolidated Leverage Ratio as of the last day of each period set forth below to be greater than the ratio set forth opposite such period below:
Β
Four Fiscal Quarters Ending |
Β Β | Ratio |
Four fiscal quarters ending SeptemberΒ 30, 2014 |
Β Β | 1.0Β toΒ 1.0 |
Four fiscal quarters ending DecemberΒ 31, 2014 |
Β Β | 1.0 to 1.0 |
Four fiscal quarters ending MarchΒ 31, 2015 |
Β Β | 0.99Β toΒ 1.0 |
Four fiscal quarters ending JuneΒ 30, 2015 |
Β Β | 0.99 to 1.0 |
Four fiscal quarters ending SeptemberΒ 30, 2015 |
Β Β | 0.99 to 1.0 |
Four fiscal quarters ending DecemberΒ 31, 2015 |
Β Β | 0.99 to 1.0 |
Four fiscal quarters ending MarchΒ 31, 2016 |
Β Β | 0.97 to 1.0 |
Four fiscal quarters ending JuneΒ 30, 2016 |
Β Β | 0.97 to 1.0 |
Four fiscal quarters ending SeptemberΒ 30, 2016 |
Β Β | 0.97 to 1.0 |
Four fiscal quarters ending DecemberΒ 31, 2016 |
Β Β | 0.97 to 1.0 |
Four fiscal quarters ending MarchΒ 31, 2017 |
Β Β | 0.94 to 1.0 |
EachΒ fourΒ fiscalΒ quarterΒ periodΒ endingΒ onΒ MarchΒ 31,Β JuneΒ 30, SeptemberΒ 30 and DecemberΒ 31 thereafter |
Β Β | 0.94 to 1.0 |
SECTIONΒ 6.11. Fiscal Year. Permit any of Holdings, the Borrower or any Subsidiary to change its fiscal year end to a date other than DecemberΒ 31.
Β
76
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 6.12. Amendments or Waivers of Documents Relating to Subordinated Indebtedness, Certain Documents and Equity Interests.
(a) Amendments of Documents Relating to Certain Indebtedness. Amend, waive, supplement, modify or otherwise change the terms of (i)Β any Subordinated Indebtedness in a way that is expressly prohibited by the terms of the applicable subordination agreement (as in effect the date the Borrower acknowledges or agrees in writing to the terms of such subordination agreement or as amended in an amendment approved in writing by the Borrower), or (ii)Β the Revolving Loan Documents except pursuant to the terms of the Intercreditor Agreement or pursuant to a Permitted Refinancing thereof.
(b) Amendments of Certain Documents. Make any amendment, waiver, restatement, supplement or other modification to such Personβs Organizational Documents in any manner materially adverse to the Lenders without in each case obtaining the prior written consent of the Administrative Agent to such amendment, waiver, restatement, supplement or other modification; provided that, for the avoidance of doubt, Holdings may issue Equity Interests so long as such issuance is not otherwise prohibited by this Agreement, and may amend or modify its Organizational Documents to authorize the issuance of any such Equity Interests.
SECTIONΒ 6.13. Conduct of Business by Holdings. With respect to Holdings, engage in any business or activity, hold any assets or incur any Indebtedness or other liabilities, other than (i)Β the ownership of all outstanding Equity Interests in the Borrower, (ii)Β maintaining its corporate existence, (iii)Β participating in tax, accounting and other administrative activities as a member of the consolidated group of companies including the Loan Parties, (iv)Β executing, delivering and the performance of rights and obligations under the Loan Documents, the Revolving Loan Documents, the Related Documents, the Acquisition Agreement and related documents to which it is a party, (v)Β performance of rights and obligations under the Management Agreement or any other customary management or advisory arrangement (whether in writing, verbal or otherwise), (vi)Β making any Restricted Payment permitted by SectionΒ 6.06, (vii)Β purchasing Qualified Capital Stock of Borrower, (viii)Β making capital contributions to Borrower, (ix)Β executing, delivering and the performance of rights and obligations under any employment agreements and any documents related thereto, (x)Β the making of loans to officers, the Governing Body, and employees in exchange for Equity Interests of Holdings purchased by such officers, Governing Body, or employees pursuant to SectionΒ 6.04 and the acceptance of notes related thereto and (xi)Β activities incidental to the businesses or activities described in clausesΒ (i)-(x)Β above.
ARTICLE VII
Events of Default
SECTIONΒ 7.01. Events of Default. In case of the happening of any of the following events (βEvents of Defaultβ):
(a) default shall be made in the payment of any principal of any Loan when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or by acceleration thereof or otherwise;
(b) default shall be made in the payment of any interest or premium on any Loan or any Fee or any other amount (other than an amount referred to in (a)Β above) due under any Loan Document, when and as the same shall become due and payable, and such default shall continue unremedied for a period of three days;
Β
77
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(c) any representation or warranty made or deemed made to any Agent or Lender in or in connection with or pursuant to any Loan Document or the Loans made hereunder, or any representation, warranty, statement or information contained in any report, certificate, financial statement or other instrument furnished in connection with or pursuant to any Loan Document, shall be false or misleading in any material respect when so made, deemed made or furnished (except to the extent already qualified by materiality, in which case it shall not be false or misleading in any respect);
(d) default shall be made in the due observance or performance by Holdings, the Borrower or any Subsidiary of any covenant or agreement contained in SectionΒ 4.02, SectionΒ 5.01(a), SectionΒ 5.01(b) (solely to the extent the failure to comply has resulted in a Material Adverse Effect), SectionΒ 5.04(b) (and such default shall continue unremedied for a period of ten days), SectionΒ 5.05(a), SectionΒ 5.08, or in Article VI (provided that any failure to comply with SectionΒ 6.10 shall be subject to cure pursuant to SectionΒ 7.02);
(e) default shall be made in the due observance or performance by Holdings, the Borrower or any Subsidiary of any covenant or agreement contained in any Loan Document (other than those specified in (b), (c)Β or (d)Β above) or any Related Document and such default shall continue unremedied for a period of 30 days after the earlier of (i)Β written notice thereof from the Administrative Agent or any Lender to the Borrower and (ii)Β knowledge thereof by a Responsible Officer of Holdings or the Borrower;
(f) (i) Holdings, the Borrower or any Subsidiary shall fail to pay any principal or interest, regardless of amount, due in respect of any Material Indebtedness, when and as the same shall become due and payable (after giving effect to any cure periods); or (ii)Β any other event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables or permits (with or without the giving of notice, the lapse of time or both) the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material Indebtedness to become due, or to require the prepayment (other than customary mandatory prepayments), repurchase, redemption or defeasance thereof, prior to its scheduled maturity; provided that this clause (ii)Β shall not apply to secured Indebtedness that becomes due solely as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness;
(g) an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking (i)Β relief in respect of Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary), or of all or substantially all of the property or assets of Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary), under the Bankruptcy Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii)Β the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary) or for all or substantially all of the property or assets of Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary) or (iii)Β the winding-up or liquidation of Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary); and such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered;
(h) Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary) shall (i)Β voluntarily commence any proceeding or file any petition seeking relief under the Bankruptcy Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii)Β consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or the filing of any petition described in (g)Β above, (iii)Β apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for
Β
78
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary) or for all or substantially all of the property or assets of Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary), (iv)Β file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v)Β make a general assignment for the benefit of creditors, or (vi)Β become unable, admit in writing its liability or fail generally to pay its debts as they become due or (vii)Β take any action for the purpose of effecting any of the foregoing;
(i) one or more judgments shall be rendered against Holdings, the Borrower, any Subsidiary (other than any Immaterial Subsidiary) or any combination thereof and the same shall remain undischarged, unstayed, unvacated and unbonded for a period of 45 consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to levy upon assets or properties of Holdings, the Borrower or any Subsidiary (other than any Immaterial Subsidiary) to enforce any such judgment and such judgment either (i)Β is for the payment of money in an aggregate amount in excess of $1,125,000 generally and $3,000,000 with respect to unpaid state taxes (after giving effect to insurance (and taking into account any deductibles) as to which Holdings, the Borrower or any Subsidiary has promptly submitted or will promptly submit a written claim in respect thereof to the applicable insurance carrier and the insurance carrier has not denied liability by an appropriate proceeding and is solvent and not an Affiliate of Holdings, the Borrower or any of its Subsidiaries) or (ii)Β is for injunctive relief and could reasonably be expected to result in a Material Adverse Effect;
(j) an ERISA Event shall have occurred that, in the reasonable opinion of the Required Lenders, when taken together with all other such ERISA Events, could reasonably be expected to result in liability of the Borrower, Holdings or any Subsidiary in an aggregate amount exceeding $1,000,000;
(k) any guarantee under the Guarantee and Collateral Agreement for any reason shall cease to be in full force and effect (other than in accordance with its terms), or any Guarantor shall deny in writing that it has any further liability under the Guarantee and Collateral Agreement (other than as a result of the discharge of such Guarantor in accordance with the terms of the Loan Documents);
(l) any security interest purported to be created by any Security Document shall cease to be, or shall be asserted by the Borrower or any other Loan Party not to be, a valid, perfected, first priority (subject to Lien permitted by SectionΒ 6.02) security interest in the securities, assets or properties purported to be covered thereby (other than any Collateral that both (x)Β has a fair market value of not more than $375,000 in the aggregate, and (y)Β is not material to the operations, business or prospects of any Loan Party) other than by reason of action or inaction by the Collateral Agent, the Administrative Agent, the Lenders, the other Secured Parties or their Related Parties;
(m) any Subordinated Indebtedness of Holdings, the Borrower or any Subsidiary constituting Material Indebtedness shall cease (or any Loan Party or an Affiliate of any Loan Party shall so assert), for any reason, to be validly subordinated to the Obligations as provided in the agreements evidencing such Subordinated Indebtedness; or
(n) the Acquisition shall be unwound by a final, non-appealable judgment of a court of competent jurisdiction;
then, and in every such event (other than an event with respect to any of the Loan Parties described in paragraphΒ (g) or (h)Β above), and at any time thereafter during the continuance of such an Event of Default, the Administrative Agent may, and at the written request of the Required Lenders shall, by written notice to the Borrower, take either or both of the following actions, at the same or different times: (i)Β terminate forthwith the Commitments and (ii)Β declare the Loans then outstanding to be forthwith due and payable in
Β
79
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
whole or in part, whereupon the principal of the Loans so declared to be due and payable (and accrued interest thereon), together with the Applicable Prepayment Premium (other than in the case of acceleration of the Loans due to the Loan Partiesβ breach of the covenant set forth in SectionΒ 6.10) for the prepayment date with respect to such principal amount paid and accrued interest thereon, and any unpaid accrued Fees and all other liabilities of the Loan Parties accrued hereunder and under any other Loan Document, shall become forthwith due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by each of Holdings and the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding; and in any event with respect to any of the Loan Parties described in paragraph (g)Β or (h)Β above, the Commitments shall automatically terminate and the principal of the Loans then outstanding (and accrued interest thereon), together with the Applicable Prepayment Premium for the prepayment date with respect to such principal amount paid and accrued interest thereon and any unpaid accrued Fees and all other liabilities of the Loan Parties accrued hereunder and under any other Loan Document, shall automatically become due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by each of Holdings and the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding, and the Collateral Agent shall have the right to enforce all of the Liens created pursuant to the Security Documents and exercise on behalf of itself and the other Secured Parties all rights and remedies available to it and the other Secured Parties under the Loan Documents or applicable law, including the right to appoint a receiver.
If the Obligations are accelerated for any reason, including because of default, Disposition or encumbrance (including that by operation of law or otherwise), the Applicable Prepayment Premium will also be due and payable on the outstanding principal amount (including, for the avoidance of doubt, PIK Interest that has been capitalized and added to principal) of the Loans (but not any other amounts) as though said indebtedness was voluntarily prepaid and shall constitute part of the Obligations, in view of the impracticability and extreme difficulty of ascertaining actual damages and by mutual agreement of the parties as to a reasonable calculation of each Lenderβs lost profits as a result thereof. Any Applicable Prepayment Premium payable above shall be presumed to be the liquidated damages sustained by each Lender as the result of the early termination and the Borrower agrees that it is reasonable under the circumstances currently existing. The Applicable Prepayment Premium shall also be payable in the event the Obligations (and/or this Agreement or the Notes evidencing the Obligations) are satisfied or released by foreclosure (whether by power of judicial proceeding), deed in lieu of foreclosure or by any other means. THE BORROWER EXPRESSLY WAIVES THE PROVISIONS OF ANY PRESENT OR FUTURE STATUTE OR LAW THAT PROHIBITS OR MAY PROHIBIT THE COLLECTION OF THE FOREGOING APPLICABLE PREPAYMENT PREMIUM IN CONNECTION WITH ANY SUCH ACCELERATION. The Borrower expressly agrees that: (A)Β the Applicable Prepayment Premium is reasonable and is the product of an armβs length transaction between sophisticated business people, ably represented by counsel; (B)Β the Applicable Prepayment Premium shall be payable notwithstanding the then prevailing market rates at the time payment is made; (C)Β there has been a course of conduct between Lenders and the Borrower giving specific consideration in this transaction for such agreement to pay the Applicable Prepayment Premium; and (D)Β the Borrower shall be estopped hereafter from claiming differently than as agreed to in this paragraph. The Borrower expressly acknowledges that its agreement to pay the Applicable Prepayment Premium to Lenders as herein described is a material inducement to Lenders to make the Loans.
SECTIONΒ 7.02. Right to Cure.
(a) Notwithstanding anything to the contrary contained in SectionΒ 7.01, in the event that the Borrower fails to comply with the requirements of the covenant set forth in SectionΒ 6.10, during the period beginning on the first day following the applicable fiscal quarter (i.e., the last fiscal quarter in the period of non-compliance with the covenant set forth in SectionΒ 6.10) until the expiration of the 15th day
Β
80
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
subsequent to the date the Compliance Certificate to be delivered pursuant to SectionΒ 5.04(c) for such fiscal quarter is required to be delivered (the βCure Dateβ), Holdings shall have the right to use cash proceeds of any equity contribution (in the form of Qualified Capital Stock) to Holdings during such period (any such equity contribution to Holdings to exercise the Cure Right pursuant to this Section, a βCure Contributionβ) or any issuance of Equity Interests by Holdings (other than any issuance of Disqualified Stock) during such period (any such Equity Interests issued by Holdings to exercise the Cure Right pursuant to this Section, βCure Securitiesβ) to make an equity contribution to, or purchase equity of, the Borrower in each case, in the form of Qualified Capital Stock (collectively, the βCure Rightβ), and upon the receipt by the Borrower of such cash (the βCure Amountβ) pursuant to the exercise by Holdings of such Cure Right and written request to the Administrative Agent to effect such recalculation, the covenant set forth in SectionΒ 6.10 shall be recalculated giving effect to the following pro forma adjustments:
(i) Consolidated Revenue shall be increased for such fiscal quarter (and any four fiscal quarter-period that includes such fiscal quarter), solely for the purpose of measuring the covenant set forth in SectionΒ 6.10 and not for any other purpose under this Agreement, by an amount equal to the Cure Amount; and
(ii) if, after giving effect to the foregoing recalculations, the Borrower shall then be in compliance with the requirements of the covenant set forth in SectionΒ 6.10, the Borrower shall be deemed to have satisfied the requirements of the covenant set forth in SectionΒ 6.10 as of the relevant date of determination with the same effect as though there had been no failure to comply therewith at such date, and the applicable breach or default of the covenant set forth in SectionΒ 6.10 that had occurred shall be deemed cured for the purposes of this Agreement.
(b) Notwithstanding anything herein to the contrary (i)Β in each four consecutive fiscal-quarter period there shall be at least two fiscal quarters in which the Cure Right is not exercised, (ii)Β during the term of this Agreement, the Cure Right may be exercised no more than four times, (iii)Β the Cure Amount shall be no greater than the amount required for purposes of causing the Borrower to comply with the covenant set forth in SectionΒ 6.10, (iv)Β the proceeds of a Cure Contribution or Cure Securities shall be used to prepay the Loans (and such prepayment shall not be subject to the Applicable Prepayment Premium) and the Loans shall be deemed repaid for the purposes of recalculating the covenant set forth in SectionΒ 6.10.
(c) Upon the Administrative Agentβs receipt of a notice from the Borrower that it intends to exercise the Cure Right (a βNotice of Intent to Cureβ), until the 15th day subsequent to the date of required delivery of the related Compliance Certificate delivered pursuant to SectionΒ 5.04(c) to which such Notice of Intent to Cure relates, neither the Administrative Agent nor any Lender shall exercise the right to accelerate payment of the Loans or terminate or suspend the Commitments nor take any other remedy pursuant to SectionΒ 7.01 or otherwise and neither the Collateral Agent nor any other Lender shall exercise any right to foreclose on or take possession of the Collateral solely on the basis of an allegation of an Event of Default having occurred and being continuing under SectionΒ 7.01 due to failure by the Borrower to comply with the requirements of the covenant set forth in SectionΒ 6.10 for the applicable period.
Β
81
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE VIII
The Administrative Agent and the Collateral Agent
Each of the Lenders hereby irrevocably appoints the Administrative Agent and the Collateral Agent (for purposes of this Article VIII, the Administrative Agent and the Collateral Agent are referred to collectively as the βAgentsβ) its agent and authorizes the Agents to take such actions on its behalf and to exercise such powers as are delegated to such Agent by the terms of the Loan Documents, together with such actions and powers as are reasonably incidental thereto. Without limiting the generality of the foregoing, the Agents are hereby expressly authorized to execute any and all documents (including releases) with respect to the Collateral and the rights of the Secured Parties with respect thereto, as contemplated by and in accordance with the provisions of this Agreement and the Security Documents.
The Person serving as the Administrative Agent and/or the Collateral Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not an Agent, and such Person and its affiliates may provide debt financing, equity capital or other services (including financial advisory services) to any of the Loan Parties (or any Person engaged in similar business as that engaged in by any of the Loan Parties) as if such Person was not performing the duties specified herein, and may accept fees and other consideration from any of the Loan Parties for services in connection with this Agreement and otherwise without having to account for the same to the Lenders.
Neither Agent shall have any duties or obligations except those expressly set forth in the Loan Documents. Without limiting the generality of the foregoing, (a)Β neither Agent shall be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing, (b)Β neither Agent shall have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby that such Agent is instructed in writing to exercise by the Required Lenders (or such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in SectionΒ 9.08), and (c)Β except as expressly set forth in the Loan Documents, neither Agent shall have any duty to disclose, nor shall it be liable for the failure to disclose, any information relating to Holdings, the Borrower or any of the Subsidiaries that is communicated to or obtained by the Person serving as the Administrative Agent and/or Collateral Agent or any of its Affiliates in any capacity. Neither Agent shall be liable for any action taken or not taken by it with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in SectionΒ 9.08) or in the absence of its own gross negligence or willful misconduct as finally judicially determined by a court of competent jurisdiction. Neither Agent nor any Lender shall be deemed to have knowledge of any Default unless and until written notice thereof is given to such Agent or such Lender by Holdings, the Borrower or a Lender, and neither Agent nor any Lender shall be responsible for or have any duty to ascertain or inquire into (i)Β any statement, warranty or representation made in or in connection with any Loan Document, (ii)Β the contents of any certificate, report or other document delivered thereunder or in connection therewith, (iii)Β the performance or observance of any of the covenants, agreements or other terms or conditions set forth in any Loan Document, (iv)Β the validity, enforceability, effectiveness or genuineness of any Loan Document or any other agreement, instrument or document, or (v)Β the satisfaction of any condition set forth in Article IV or elsewhere in any Loan Document, other than to confirm receipt of items expressly required to be delivered to such Agent or such Lender.
Each Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing believed by it to be genuine and to have been signed or sent by the proper Person. Each Agent may also rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. Each Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.
Β
82
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Each Agent may perform any and all its duties and exercise its rights and powers by or through any one or more sub-agents appointed by it. Each Agent and any such sub-agent may perform any and all its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of the preceding paragraphs shall apply to any such sub-agent and to the Related Parties of each Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the Credit Facility as well as activities as Agent.
Subject to the appointment and acceptance of a successor Agent as provided below, either Agent may resign at any time by notifying the Lenders and the Borrower. Upon any such resignation, the Required Lenders shall have the right, with the written consent of the Borrower (such consent not to be unreasonably withheld, delayed or conditioned and such consent not to be required during the continuance of a Designated Event of Default), to appoint a successor other than any Excluded Lender. If no successor shall have been so appointed by the Required Lenders (with the Borrowerβs written consent, subject to the limitations on consent in the immediately preceding sentence) and shall have accepted such appointment within 30 days after the retiring Agent gives notice of its resignation, then the retiring Agent may, on behalf of the Lenders, appoint a successor Agent (other than any Excluded Lender) with the written consent of the Borrower (such consent not to be unreasonably withheld, delayed or conditioned and such consent not to be required during the continuance of a Designated Event of Default) which shall be a bank with an office in New York, New York, or an Affiliate of any such bank. Upon the acceptance of its appointment as Agent hereunder by a successor (who shall not be an Excluded Lender and any attempted appointment of an Excluded Lender shall be absolutely void ab initio), such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Agent, and the retiring Agent shall be discharged from its duties and obligations hereunder. If within 30 days after written notice is given of the resigning Agentβs resignation under this ArticleΒ VIII no successor Agent shall have been appointed and shall have accepted such appointment, then on such 30th day (a)Β the retiring Agentβs resignation shall become effective, (b)Β the retiring Agent shall thereupon be discharged from its duties and obligations under the Loan Documents and (c)Β the Required Lenders shall thereafter perform all duties of the retiring Agent under the Loan Documents until such time, if any, as the Required Lenders appoint a successor Agent that is not an Excluded Lender as provided above. The Borrower shall pay the reasonable and documented out-of-pocket fees of a successor Agent that is not an Excluded Lender and that is not appointed in violation of this paragraph. After an Agentβs resignation hereunder, the provisions of this Article VII and SectionΒ 9.05 shall continue in effect for the benefit of such retiring Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while acting as Agent.
Each Lender acknowledges that it has, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement or any other Loan Document, any related agreement or any document furnished hereunder or thereunder.
Each Lender hereby further authorizes the Collateral Agent, on behalf of and for the benefit of Lenders, to enter into the Intercreditor Agreement and into each Security Document as secured party and to be the agent for and representative of the Lenders thereunder, and each Lender agrees to be bound by the terms of each Security Document and the Intercreditor Agreement; provided that the Collateral Agent shall not (i)Β enter into or consent to any material amendment, modification, termination or waiver of any provision contained in any Security Document or the Intercreditor Agreement or (ii)Β release any Collateral (except as otherwise expressly permitted or required pursuant to the terms of this Agreement, the Intercreditor Agreement or the applicable Security Document), in the case of each of clauses (i)Β and
Β
83
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(ii) without the prior consent of Required Lenders (or, if required pursuant to SectionΒ 9.08, all Lenders); provided further, however, that, without further written consent or authorization from the Lenders, the Collateral Agent may execute any documents or instruments necessary to (a)Β release any Lien encumbering any item of Collateral (1)Β that is the subject of a sale or other Disposition of assets permitted by this Agreement, the other Loan Documents or to which Required Lenders have otherwise consented or (2)Β upon the payment in full of the Obligations (other than contingent indemnity claims or expense reimbursement obligations not yet asserted), (b)Β release any Subsidiary Guarantor from the Guarantee and Collateral Agreement if all of the Equity Interests of such Subsidiary Guarantor are sold or otherwise Disposed of to any Person (other than an Affiliate of a Loan Party) pursuant to a sale or other Disposition permitted hereunder or under any of the other Loan Documents or to which Required Lenders have otherwise consented or (c)Β subordinate the Liens of the Collateral Agent, on behalf of the Secured Parties, to any Liens permitted by SectionΒ 6.02. Anything contained in any of the Loan Documents to the contrary notwithstanding, Holdings, the Borrower, the Collateral Agent and each Lender hereby agree that (1)Β no Lender shall have any right individually to realize upon any of the Collateral under or otherwise enforce any Security Document or the Intercreditor Agreement, it being understood and agreed that all powers, rights and remedies under the Security Documents and the Intercreditor Agreement may be exercised solely by the Collateral Agent for the benefit of the Secured Parties in accordance with the terms thereof, and (2)Β in the event of a foreclosure by either on any of the Collateral pursuant to a public or private sale, either Agent or any Lender may be the purchaser of any or all of such Collateral at any such sale and the Collateral Agent, as agent for and representative of Lenders (but not any Lender or Lenders in its or their respective individual capacities unless Required Lenders shall otherwise agree in writing) shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such public sale, to use and apply any of the Obligations as a credit on account of the purchase price for any Collateral payable by the Collateral Agent at such sale. Notwithstanding anything to the contrary herein, the Collateral Agent shall be permitted to take any action it is authorized to take under any Loan Document or the Intercreditor Agreement.
In case of the pendency of any case or proceeding under the Bankruptcy Code or any other judicial proceeding relative to any Loan Party, the Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered (but not obligated) by intervention in such proceeding or otherwise:
(i) to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and the Agents (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders and the Agents and their respective agents and counsel and all other amounts due the Lenders and the Administrative Agent under SectionΒ 2.05, SectionΒ 2.13, SectionΒ 2.17, and SectionΒ 9.05) allowed in such judicial proceeding; and
(ii) to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same; and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under SectionΒ 2.05 and SectionΒ 9.05.
Β
84
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE IX
Miscellaneous
SECTIONΒ 9.01. Notices. Notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by fax, as follows:
(i) if to Holdings or the Borrower, to them at Blackline Systems, Inc., 00000 Xxxxxxx Xxxx., 00xx Xxxxx, Xxxxxxxx Xxxxx, XX 00000, Attention: Controller (Fax No.: (000 000-0000) and Email: accounting @xxxxxxxxx.xxx), with a copy (which shall not constitute notice) to: (a)Β Silver Lake Sumeru Fund, L.P., 0000 Xxxx Xxxx Xxxx, Xxxxx 000, Xxxxx Xxxx, XX 00000, Attention: Xxxxx Xxxxxxx (Fax No.: (000) 000-0000 and Email: Xxxxx.Xxxxxxx@XxxxxxXxxx.xxx and (2)Β XxxxxxxxΒ & Xxxxx LLP, 000 Xxxxxxxxxx Xxxxxx, Xxx Xxxxxxxxx, XX 00000, Attention: Xxxxxxxxxxx Xxxxxxx (Fax No.: (000) 000-0000 and
Email: xxxxxxxxxxx.xxxxxxx@xxxxxxxx.xxx);
(ii) if to the Administrative Agent, to Obsidian Agency Services, Inc., c/x Xxxxxxxxxx Capital Partners, LLC, 0000 00xx Xxxxxx, Xxxxx 0000, Xxxxx Xxxxxx, Xxxxxxxxxx 00000, Attention: Xxxxx Xxxxx (Fax No. (000) 000-0000 and
Email: xxxxx.xxxxx@xxxxxxxxxxxxxxxxx.xxx), with a copy (which shall not constitute notice) to Proskauer Rose LLP, 0000 Xxxxxxx Xxxx Xxxx, Xxxxx 0000, Xxx Xxxxxxx, Xxxxxxxxxx 00000, Attention: Xxxxxx X. Xxxxx and Xxxx X. Xxx (Fax No. (000) 000-0000 and Email: xxxxxx@xxxxxxxxx.xxx and xxxx@xxxxxxxxx.xxx); and
(iii) if to a Lender, to it at its address (or fax number) set forth on ScheduleΒ 2.01 or in the Assignment and Acceptance pursuant to which such Lender shall have become a party hereto.
All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt if delivered by hand or overnight courier service or sent by fax or on the date 5 Business Days after dispatch by certified or registered mail if mailed, in each case delivered, sent or mailed (properly addressed) to such party as provided in this SectionΒ 9.01 or in accordance with the latest unrevoked direction from such party given in accordance with this SectionΒ 9.01. As agreed to among Holdings, the Borrower, the Administrative Agent and the applicable Lenders from time to time, notices and other communications may also be delivered by e-mail to the e-mail address of a representative of the applicable Person provided from time to time by such Person.
SECTIONΒ 9.02. Survival of Agreement. All covenants, agreements, representations and warranties made by Holdings or the Borrower herein and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the Lenders and shall survive the making by the Lenders of the Loans, regardless of any investigation made by the Lenders or on their behalf, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any Fee or any other Obligation (other than contingent indemnity claims or expense reimbursement obligations not yet asserted) payable under this Agreement or any other Loan Document is outstanding and unpaid and so long as the Commitments have not been terminated. The provisions of SectionΒ 2.12, SectionΒ 2.13, SectionΒ 2.17 and SectionΒ 9.05 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Loans, the expiration of the Commitments, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent, the Collateral Agent or any Lender.
Β
85
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 9.03. Binding Effect. This Agreement shall become effective when it shall have been executed by Holdings, the Borrower, the Collateral Agent and the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto.
SECTIONΒ 9.04. Successors and Assigns.
(a) Whenever in this Agreement any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and assigns of such party; and all covenants, promises and agreements by or on behalf of Holdings, the Borrower, the Administrative Agent, the Collateral Agent or the Lenders that are contained in this Agreement shall bind and inure to the benefit of their respective successors and assigns.
(b) Each Lender may assign to one or more Eligible Assignees (which, for the avoidance of doubt, shall not be any Excluded Lender) all or a portion of its interests, rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans at the time owing to it), with the prior written consent of the Borrower and the Administrative Agent (not to be unreasonably withheld or delayed); provided, however, that (i)Β the consent of the Borrower shall not be required to any such assignment made (A)Β to another Lender or an Affiliate of a Lender, or (B)Β after the occurrence and during the continuance of any Designated Event of Default; provided that, notwithstanding anything to the contrary in this Agreement, the Borrower shall retain its right to consent in writing to an assignment to any Excluded Lender at all times, (ii)Β unless otherwise consented to in writing by the Borrower and the Administrative Agent, the amount of the Commitment or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Acceptance with respect to when such assignment is delivered to the Administrative Agent) shall be in an integral multiple of, and not less than, $1,000,000 (or, if less, the entire remaining amount of such Lenderβs Commitment or Loans), (iii)Β the parties to each such assignment shall manually execute and deliver to the Administrative Agent an Assignment and Acceptance, together with, unless waived by the Administrative Agent, a processing and recordation fee of $3,500 (provided that only one such fee shall be payable in the case of concurrent assignments to Persons that, after giving effect to such assignments, will be Related Funds), and (iv)Β the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire and all applicable tax forms. Upon acceptance and recording pursuant to paragraph (e)Β of this SectionΒ 9.04, from and after the effective date specified in each Assignment and Acceptance, (A)Β the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Acceptance, have the rights and obligations of a Lender under this Agreement and (B)Β the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Acceptance, be released from its obligations under this Agreement (and, in the case of an Assignment and Acceptance covering all or the remaining portion of an assigning Lenderβs rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of, and subject to the requirements of, SectionΒ 2.12, SectionΒ 2.13, SectionΒ 2.17 and Section 9.05).
(c) By executing and delivering an Assignment and Acceptance, the assigning Lender thereunder and the assignee thereunder shall be deemed to confirm to and agree with each other and the other parties hereto (including the Borrower) as follows: (i)Β such assigning Lender warrants that it is the legal and beneficial owner of the interest being assigned thereby free and clear of any adverse claim; (ii)Β except as set forth in (i)Β above, such assigning Lender makes no representation or warranty and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with this Agreement or any other Loan Document, or the execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement, any other Loan Document or any other instrument or document furnished pursuant hereto, or the financial condition of Holdings, the Borrower or any Subsidiary or the performance or observance by Holdings, the Borrower or any
Β
86
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Subsidiary of any of its obligations under this Agreement, any other Loan Document or any other instrument or document furnished pursuant hereto; (iii)Β such assignee represents and warrants that it is legally authorized to enter into such Assignment and Acceptance; (iv)Β such assignee confirms that it has received a copy of this Agreement, together with copies of the most recent financial statements referred to in SectionΒ 3.05(a) or delivered pursuant to SectionΒ 5.04 and such other documents and information as it has deemed reasonably appropriate to make its own credit analysis and decision to enter into such Assignment and Acceptance; (v)Β such assignee will independently and without reliance upon the Administrative Agent, the Collateral Agent, such assigning Lender or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Loan Documents; (vi)Β such assignee appoints and authorizes the Administrative Agent and the Collateral Agent to take such action as agent on its behalf and to exercise such powers under this Agreement as are delegated to the Administrative Agent and the Collateral Agent, respectively, by the terms hereof, together with such powers as are reasonably incidental thereto; and (vii)Β such assignee agrees that it will perform in accordance with their terms all the obligations which by the terms of the Loan Documents are required to be performed by it as a Lender.
(d) The Administrative Agent shall maintain at its principal executive offices a copy of each Assignment and Acceptance delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the βRegisterβ). Absent manifest error, the Borrower, the Administrative Agent, the Collateral Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the Borrower, the Collateral Agent and any Lender, at any reasonable time and from time to time upon reasonable prior notice.
(e) Upon its receipt of, and consent to, a duly completed Assignment and Acceptance executed by an assigning Lender and an assignee, an Administrative Questionnaire completed in respect of the assignee (unless the assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b)Β above, if applicable, and, if required, the written consent of the Administrative Agent and, if required, the Borrower to such assignment and any applicable tax forms, the Administrative Agent shall (i)Β accept such Assignment and Acceptance and (ii)Β notify the Borrower of such acceptance. The Administrative Agent shall promptly record the information contained therein in the Register. No assignment shall be effective unless it has been recorded in the Register as provided in this paragraph (e). This SectionΒ 9.04(e) shall be construed so that any Commitment, Loan or other Obligation under the Loan Documents is in registered form under SectionΒ 5f103-1(c) of the United States Treasury Regulations.
(f) Each Lender may without the consent of the Borrower or the Administrative Agent sell participations to one or more banks or other Persons (in each case, other than to an Excluded Lender) in all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans owing to it); provided, however, that (i)Β such Lenderβs obligations under this Agreement shall remain unchanged, (ii)Β such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, (iii)Β the participating banks or other Persons shall be entitled to the benefit of the cost protection provisions contained in SectionΒ 2.12 and SectionΒ 2.17 (subject to the requirements and limitations therein, including the requirements under SectionΒ 2.17 and it being understood that the documentation required under SectionΒ 2.17 shall be delivered to the participating Lender) to the same extent as if they were Lenders (but, with respect to any particular participant), to no greater extent than the Lender that sold the participation to such participant, except to the extent such entitlement to receive a greater payment results from a Change in Law that occurs after
Β
87
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
the participant acquired the applicable participation, (iv)Β the Borrower, the Administrative Agent and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lenderβs rights and obligations under this Agreement, and such Lender shall retain the sole right to enforce the obligations of the Borrower relating to the Loans and to approve any amendment, modification or waiver of any provision of this Agreement (other than amendments, modifications or waivers decreasing any fees payable to such participating bank or Person hereunder or the amount of principal of or the rate at which interest is payable on the Loans in which such participating bank or Person has an interest, extending any scheduled principal payment date or date fixed for the payment of interest on the Loans in which such participating bank or Person has an interest, increasing or extending the Commitments in which such participating bank or Person has an interest or releasing any Guarantor (other than in connection with the sale of such Guarantor in a transaction permitted by SectionΒ 6.05) or all or substantially all of the Collateral) and (v)Β such bank or other Person shall not be an Excluded Lender. Notwithstanding anything to the contrary, no Lender shall enter into any agreement with any participant that will permit such participant to influence or control the voting rights of such Lender with respect to the Loans or Obligations (and no participant shall have or receive any voting rights with respect to the Loans or Obligations) except with regard to (i)Β decreases in the principal amount of, or extending the maturity of or any scheduled principal payment date or date for the payment of any interest or premium on any Loan, or waiving or excusing any such payment or any part thereof, or decreasing the rate of interest or premium on any Loan, without the prior written consent of each Lender directly adversely affected thereby (other than any waiver of any increase in the interest rate applicable to the Loans as a result of the occurrence of an Event of Default and other than any waiver or extension of any mandatory prepayment), (ii)Β increasing or extending the Commitment or decreasing or extending the date for payment of any Fees or premiums of any Lender (other than any waiver or extension of any mandatory prepayment) without the prior written consent of such participant, or (iii)Β amending or modifying the pro rata requirements of SectionΒ 2.14, the provisions of SectionΒ 9.04(k) or the provisions of SectionΒ 9.08(b)(i)β(iii).
(g) Each Lender that sells a participation shall, acting solely for this purpose as an agent of the Borrower, maintain a register on which it enters the name and address of each participant and the principal amounts (and stated interest) of each participantβs interest in the Loans or other obligations under the Loan Documents (the βParticipant Registerβ); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any participant or any information relating to a participantβs interest in any Commitments, Loans or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such Commitment, Loan or other obligation is in registered form under SectionΒ 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be prima facie evidence absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.
(h) Any Lender or participant may, in connection with any assignment or participation or proposed assignment or participation pursuant to this SectionΒ 9.04, disclose to the assignee or participant or proposed assignee or participant any information relating to the Borrower furnished to such Lender by or on behalf of the Borrower; provided that, prior to any such disclosure of information designated by the Borrower as confidential, each such assignee or participant or proposed assignee or participant shall execute an agreement whereby such assignee or participant shall agree (subject to customary and commercially reasonable exceptions) to bound by or preserve the confidentiality of such confidential information on terms no less restrictive than those applicable to the Lenders pursuant to SectionΒ 9.16.
Β
88
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(i) Any Lender may at any time assign all or any portion of its rights under this Agreement to secure extensions of credit to such Lender or in support of obligations owed by such Lender; provided that no such assignment shall release a Lender from any of its obligations hereunder or substitute any such assignee for such Lender as a party hereto.
(j) Notwithstanding anything to the contrary contained herein, any Lender (a βGranting Lenderβ) may grant to a special purpose funding vehicle that is not an Excluded Lender (an βSPCβ), identified as such in writing from time to time by the Granting Lender to the Administrative Agent and the Borrower, the option to provide to the Borrower all or any part of any Loan that such Granting Lender would otherwise be obligated to make to the Borrower pursuant to this Agreement; provided that (i)Β nothing herein shall constitute a commitment by any SPC to make any Loan and (ii)Β if an SPC elects not to exercise such option or otherwise fails to provide all or any part of such Loan, the Granting Lender shall be obligated to make such Loan pursuant to the terms hereof. The making of a Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent, and as if, such Loan were made by such Granting Lender. Each party hereto hereby agrees that no SPC shall be liable for any indemnity or similar payment obligation under this Agreement (all liability for which shall remain with the Granting Lender). In furtherance of the foregoing, each party hereto hereby agrees (which agreement shall survive the termination of this Agreement) that, prior to the date that is one year and one day after the payment in full of all outstanding commercial paper or other senior indebtedness of any SPC, it will not institute against, or join any other Person in instituting against, such SPC any bankruptcy, reorganization, arrangement, insolvency or liquidation proceedings under the laws of the United States or any State thereof. In addition, notwithstanding anything to the contrary contained in this SectionΒ 9.04, any SPC may (i)Β with notice to, but without the prior written consent of, the Borrower and the Administrative Agent and without paying any processing fee therefor, assign all or a portion of its interests in the Loans to the Granting Lender or to any financial institutions that are not Excluded Lenders (consented to by the Borrower and the Administrative Agent) providing liquidity and/or credit support to or for the account of such SPC to support the funding or maintenance of Loans and (ii)Β disclose on a confidential basis (upon receiving a signed agreement to be bound to confidentiality provisions similar to those in SectionΒ 9.16) any non-public information relating to its Loans to any rating agency, commercial paper dealer or provider of any surety, guarantee or credit or liquidity enhancement to such SPC. A Granting Lender that transfers all or any portion of its Loan to an SPC shall maintain a register that complies with the requirements set forth in SectionΒ 9.04(g).
(k) Neither Holdings nor the Borrower shall assign or delegate any of its rights or duties hereunder without the prior written consent of the Administrative Agent and each Lender. Notwithstanding anything to the contrary, any attempted assignment that is not permitted by the terms hereunder shall be absolutely void ab initio.
SECTIONΒ 9.05. Expenses; Indemnity.
(a) Holdings and the Borrower agree, jointly and severally, to pay all reasonable and documented out-of-pocket costs and expenses, including reasonable and documented attorneysβ fees (limited to one transactional counsel and one local counsel in each relevant jurisdiction) and reasonable and documented out-of-pocket fees, costs and expenses of accountants, advisors and consultants, incurred by the Administrative Agent, the Collateral Agent and their one counsel in the negotiation, preparation and administration of this Agreement and the other Loan Documents including reasonable and documented out-of-pocket travel costs and costs and expenses (not to exceed $7,500 in any fiscal year of Holdings related to the obtaining and maintenance of credit ratings) or in connection with any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions hereby or thereby contemplated shall be consummated) or relating to efforts to evaluate or assess any Loan Party, its business or financial condition or protect, evaluate, assess or Dispose of any of
Β
89
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
the Collateral; and all reasonable and documented out-of-pocket costs and expenses, including reasonable and documented attorneysβ fees (limited to one transactional counsel and one local counsel in each relevant jurisdiction), fees, costs and expenses of accountants, advisors and consultants and costs of settlement, incurred by the Administrative Agent, the Collateral Agent and Lenders in enforcing any Obligations of or in collecting any payments due from any Loan Party hereunder or under the other Loan Documents (including in connection with the sale of, collection from, or other realization upon any of the Collateral or the enforcement of the Loan Documents) or in connection with any refinancing or restructuring of the credit arrangements provided under this Agreement in the nature of a βwork-outβ or pursuant to any insolvency or bankruptcy proceedings. Notwithstanding the foregoing, the parties hereto agree that Holdings, the Borrower and the other Loan Parties shall not be required to pay costs and expenses incurred on or prior to the Closing Date in connection with the primary syndication of the Credit Facility and the negotiation, preparation and administration of this Agreement and the other Loan Documents in excess of $300,000.
(b) Holdings and the Borrower agree, jointly and severally, to indemnify the Administrative Agent, the Collateral Agent, each Lender and each Related Party of any of the foregoing Persons (each such Person being called an βIndemniteeβ) against, and to hold each Indemnitee harmless from, any and all losses (other than lost profits), claims, damages, liabilities and related expenses, including reasonable and documented out-of-pocket counsel fees of one counsel and one local counsel in each relevant jurisdiction, charges and disbursements, incurred by or asserted against any Indemnitee arising out of, in any way connected with, or as a result of (i)Β the execution or delivery of this Agreement or any other Loan Document or any agreement or instrument contemplated thereby, the performance by the parties thereto of their respective obligations thereunder or the consummation of the Transactions and the other transactions contemplated thereby, (ii)Β the use of the proceeds of the Loans, (iii)Β any claim, litigation, investigation or proceeding relating to any of the foregoing, whether or not any Indemnitee is a party thereto or the plaintiff or defendant thereunder (and regardless of whether such matter is initiated by a third party, a Lender, or by Holdings, the Borrower, any other Loan Party or any of their respective Affiliates), or (iv)Β any actual or alleged presence or Release of Hazardous Materials on any property currently or formerly owned or operated by the Borrower or any of the Subsidiaries, or any Environmental Liability related in any way to the Borrower or the Subsidiaries; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (A)Β areΒ determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence, bad faith or willful misconduct of such Indemnitee or its Affiliates, (B)Β result from a successful claim brought by the Borrower or any other Loan Party against an Indemnitee for a material breach of such Indemniteeβs material obligations hereunder or under any other Loan Document or (C)Β arise from disputes arising solely among Indemnitees that do not involve any act or omission by any Loan Party or its Affiliates (other than claims, damages, liabilities and related expenses against an Agent acting solely in its capacity as such, but not with respect to any other Person that is party to such dispute with an Agent).
(c) To the extent that Holdings and the Borrower fail to pay any amount required to be paid by them to the Administrative Agent or the Collateral Agent under paragraph (a)Β or (b)Β of this SectionΒ 9.05(c), each Lender severally agrees to pay to the Administrative Agent or the Collateral Agent, as the case may be, such Lenderβs pro rata share (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount; provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent or the Collateral Agent in its capacity as such. For purposes hereof, a Lenderβs βpro rata shareβ shall be determined based upon its share of the sum of the outstanding Loans and unused Commitments at the time.
Β
90
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(d) To the extent permitted by applicable law, neither Holdings nor the Borrower shall assert, and each hereby waives, any claim against any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the Transactions, any Loan or the use of the proceeds thereof.
(e) The provisions of this SectionΒ 9.05 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Loans, the expiration of the Commitments, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent, the Collateral Agent or any Lender. All amounts due under this SectionΒ 9.05 shall be payable within 10 Business Days of demand therefor.
SECTIONΒ 9.06. Right of Setoff. If an Event of Default shall have occurred and be continuing, each Secured Party is hereby authorized at any time and from time to time, except to the extent prohibited by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other indebtedness at any time owing by such Secured Party to or for the credit or the account of Holdings or the Borrower against any of and all the obligations of Holdings or the Borrower now or hereafter existing under this Agreement and other Loan Documents held by such Secured Party, irrespective of whether or not such Secured Party shall have made any demand under this Agreement or such other Loan Document and although such obligations may be unmatured. The rights of each Secured Party under this SectionΒ 9.06 are in addition to other rights and remedies (including other rights of setoff) which such Secured Party may have.
SECTIONΒ 9.07. Applicable Law. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS (OTHER THAN AS EXPRESSLY SET FORTH IN OTHER LOAN DOCUMENTS) SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK.
SECTIONΒ 9.08. Waivers; Amendment.
(a) No failure or delay of the Administrative Agent, the Collateral Agent or any Lender in exercising any power or right hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent, the Collateral Agent and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Agreement or any other Loan Document or consent to any departure by the Borrower or any other Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b)Β below, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice or demand on Holdings or the Borrower in any case shall entitle Holdings or the Borrower to any other or further notice or demand in similar or other circumstances.
(b) Neither this Agreement nor any provision hereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by the Borrower, Holdings and the Required Lenders; provided, however, that no such agreement shall (i)Β decrease the principal amount of, or extend the maturity of or any scheduled principal payment date or date for the payment of any interest or premium on any Loan, or waive or excuse any such payment or any part thereof, or decrease the rate of interest or premium on any Loan, without the prior written consent of each Lender directly adversely affected thereby (other than any waiver of any increase in the interest rate applicable to the Loans as a
Β
91
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
result of the occurrence of an Event of Default and other than any waiver or extension of any mandatory prepayment), (ii)Β increase or extend the Commitment or decrease or extend the date for payment of any Fees or premiums of any Lender (other than any waiver or extension of any mandatory prepayment) without the prior written consent of such Lender, (iii)Β amend or modify the pro rata requirements of SectionΒ 2.14, the provisions of SectionΒ 9.04(k) or the provisions of this SectionΒ 9.08(b) or release any Guarantor (other than in connection with the sale or other disposition of such Guarantor in a transaction permitted by SectionΒ 6.05) or all or substantially all of the Collateral, without the prior written consent of each Lender, (iv)Β modify the protections afforded to an SPC pursuant to the provisions of SectionΒ 9.04(j) without the written consent of such SPC, or (v)Β reduce the percentage contained in the definition of the term βRequired Lendersβ without the prior written consent of each Lender (it being understood that with the consent of the Required Lenders, additional extensions of credit pursuant to this Agreement may be included in the determination of the Required Lenders on substantially the same basis as the Commitments on the date hereof); provided further that no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent or the Collateral Agent hereunder or under any other Loan Document without the prior written consent of the Administrative Agent or the Collateral Agent.
SECTIONΒ 9.09. Interest Rate Limitation. Notwithstanding anything herein to the contrary, if at any time the interest rate applicable to any Loan, together with all fees, charges and other amounts that are treated as interest on such Loan under applicable law (collectively the βChargesβ), shall exceed the maximum lawful rate (the βMaximum Rateβ) that may be contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable law, the rate of interest payable in respect of such Loan hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan but were not payable as a result of the operation of this SectionΒ 9.09 shall be cumulated and the interest and Charges payable to such Lender in respect of other periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall have been received by such Lender.
SECTIONΒ 9.10. Entire Agreement. This Agreement and the other Loan Documents constitute the entire contract between the parties relative to the subject matter hereof. Any other previous agreement among the parties with respect to the subject matter hereof is superseded by this Agreement and the other Loan Documents. Nothing in this Agreement or in the other Loan Documents, expressed or implied, is intended to confer upon any Person (other than the parties hereto and thereto, their respective successors and assigns permitted hereunder and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Collateral Agent and the Lenders) any rights, remedies, obligations or liabilities under or by reason of this Agreement or the other Loan Documents.
SECTIONΒ 9.11. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE OTHER LOAN DOCUMENTS. EACH PARTY HERETO (A)Β CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)Β ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTIONΒ 9.11.
Β
92
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTIONΒ 9.12. Severability. In the event any one or more of the provisions contained in this Agreement or in any other Loan Document should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
SECTIONΒ 9.13. Counterparts. This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but all of which when taken together shall constitute a single contract, and shall become effective as provided in SectionΒ 9.03. Delivery of an executed signature page to this Agreement by facsimile transmission or other electronic means shall be as effective as delivery of a manually signed counterpart of this Agreement.
SECTIONΒ 9.14. Headings. ArticleΒ and SectionΒ headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement.
SECTIONΒ 9.15. Jurisdiction; Consent to Service of Process.
(a) Each party hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the other Loan Documents, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement shall affect any right that the Administrative Agent, the Collateral Agent or any Lender may otherwise have to bring any action or proceeding relating to this Agreement or the other Loan Documents against Holdings, the Borrower, or their respective properties in the courts of any jurisdiction.
(b) Each party hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or the other Loan Documents in any court located in the City of New York, Borough of Manhattan, or of the United States of America sitting in the Southern District of New York. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.
(c) Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in SectionΒ 9.01. Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by law.
SECTIONΒ 9.16. Confidentiality. Each of the Administrative Agent, the Collateral Agent and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a)Β to its and its Affiliatesβ officers, directors, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom
Β
93
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b)Β to the extent requested by any regulatory authority or quasi-regulatory authority (such as the National Association of Insurance Commissioners), (c)Β to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d)Β in connection with the exercise of any remedies hereunder or under the other Loan Documents or any suit, action or proceeding relating to the enforcement of its rights hereunder or thereunder, but only to the extent required or desirable in connection with such exercise or enforcement, (e)Β subject to an agreement containing provisions substantially the same as those of this SectionΒ 9.16, to (i)Β to the extent not an Excluded Lender, any actual or prospective assignee of or participant in any of its rights or obligations under this Agreement and the other Loan Documents or (ii)Β any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to Holdings, the Borrower or any Subsidiary or any of their respective obligations, (f)Β with the written consent of the Borrower or (g)Β to the extent such Information becomes publicly available other than as a result of a breach of this SectionΒ 9.16 by any Agent, any Lender or any of their Related Parties. For the purposes of this SectionΒ 9.16, βInformationβ shall mean all information received from Holdings, the Borrower or any Subsidiary and related to Holdings, the Borrower or any Subsidiary or their business, other than any such information that was available to the Administrative Agent, the Collateral Agent or any Lender on a nonconfidential basis prior to its disclosure by Holdings, the Borrower or any Subsidiary; provided that with respect to clause (c)Β above, if the Administrative Agent, the Collateral Agent or any Lender receives a subpoena, interrogatory or other request (verbal or otherwise) for any Information, or believes that it is legally required to disclose any of the Information to a third party, it shall, in advance of such disclosure, to the extent practicable and legally permissible, promptly provide to the Borrower written notice of any such request or requirement so that Borrower or the applicable Loan Party (or Subsidiary thereof) may seek a protective order or other remedy; provided, further, that it shall (1)Β exercise reasonable efforts to preserve the confidentiality of such Information, (2)Β to the extent legally permissible and practicable, use commercially reasonable efforts to provide Borrower, in advance of such disclosure, with copies of any Information it intends to disclose (and, if applicable, the text of the disclosure language itself), and (3)Β reasonably cooperate at the reasonable cost and expense of the Borrower with the Borrower or applicable Loan Party (or Subsidiary thereof) to the extent Borrower or such Loan Party (or Subsidiary thereof) seeks to limit such disclosures. Notwithstanding anything to the contrary herein or in any other Loan Document or otherwise, each of the Administrative Agent, the Collateral Agent and the Lenders agrees not to disclose any Information to any Excluded Lender under any circumstance. Except with respect to disclosing any Information to an Excluded Lender, any Person required to maintain the confidentiality of Information as provided in this SectionΒ 9.16 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord its own confidential information.
SECTIONΒ 9.17. USA PATRIOT Act Notice. Each Lender and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies Holdings, the Borrower and the Subsidiary Guarantors that pursuant to the requirements of the USA PATRIOT Act, it is required to obtain, verify and record information that identifies Holdings, the Borrower and the Subsidiary Guarantors, which information includes the name and address of Holdings, the Borrower and the Subsidiary Guarantors and other information that will allow such Lender or the Administrative Agent, as applicable, to identify Holdings, the Borrower and the Subsidiary Guarantors in accordance with the USA PATRIOT Act.
[Signature pages follow]
Β
94
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.
Β
SLS BREEZE INTERMEDIATE HOLDINGS, INC., as Holdings | ||||
By: | Β | Β | /s/ Xxxxxxx Xxxx | |
Β | Name: | Β | Xxxxxxx Xxxx | |
Β | Title: | Β | Vice President, Chief Financial Officer and Treasurer |
Β
BLACKLINE SYSTEMS, INC., as Borrower | ||||
By: | Β | Β | /s/ Xxxxxxx Xxxx | |
Β | Name: | Β | Xxxxxxx Xxxx | |
Β | Title: | Β | Vice President, Chief Financial Officer and Treasurer |
[Signature Page to Credit Agreement]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
OBSIDIAN AGENCY SERVICES, INC., as Administrative Agen n Collateral Agent | ||||
By: | Β | /s/ Xxxxx Xxxxxxxxx | ||
Β | Name: | Β | Xxxxx Xxxxxxxxx | |
Β | Title: | Β | Vice President |
[Signature page to Credit Agreement]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SPECIAL VALUE CONTINUATION PARTNERS, LP | ||||
By: | Β | Xxxxxxxxxx Capital Partners, LLC | ||
Its: | Β | Investment Manager | ||
By: | Β | /s/ Xxxx Xxxxx | ||
Β | Name: | Β | Xxxx Xxxxx | |
Β | Title: | Β | Managing Director |
[Signature page to Credit Agreement]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
TENNENBAUM OPPORTUNITIES FUND VI, LLC | ||
By: Xxxxxxxxxx Capital Partners, LLC Its: Investment Manager | ||
By:Β Β Β Β | Β | /s/ Xxxx Xxxxx |
Β | Name: Xxxx Xxxxx | |
Β | Title:Β Β Β Managing Director |
[Signature Page to Credit Agreement]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
XXXXXXXXXX SENIOR LOAN FUND II, LP | ||
By: Xxxxxxxxxx Capital Partners, LLC Its: Investment Manager | ||
By:Β Β Β Β | Β | /s/ Xxxx Xxxxx |
Β | Name: Xxxx Xxxxx | |
Β | Title:Β Β Β Managing Director |
[Signature Page to Credit Agreement]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
TENNENBAUM SENIOR LOAN SPV III, LLC | ||
By: Xxxxxxxxxx Capital Partners, LLC Its: Investment Manager | ||
By: | Β | /s/ Xxxx Xxxxx |
Β | Name: Xxxx Xxxxx | |
Β | Title: Managing Director |
[Signature Page to Credit Agreement]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
XXXXXXXXXX SENIOR LOAN FUND IV-B, LP | ||
By: Xxxxxxxxxx Capital Partners, LLC | ||
Its: Investment Manager | ||
By: | Β | /s/ Xxxx Xxxxx |
Name: | Β | Xxxx Xxxxx |
Title: | Β | Managing Director |
[Signature Page to Credit Agreement]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 1.01(a)βSubsidiary Guarantors
None
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 1.01(c)βExisting Debt to Be Repaid
Loan and Security Agreement, dated AprilΒ 19, 2011, between the Borrower and Silicon Valley Bank, as amended by the First Amendment, dated AprilΒ 17, 2012 and the Second Amendment, dated MayΒ 19, 2013. ($6,353.37 in fees outstanding thereunder were repaid in full and all commitments thereunder were canceled on SeptemberΒ 24, 2013)
Β
2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 2.01βLenders and Commitments
Β
Lender |
Β Β | Address |
Β Β | Commitment Amount |
Β | |
Special Value Continuation Partners, LP |
Β Β | c/o Tennenbaum Capital Partners, LLC 0000 00xx Xxxxxx, Xxxxx 0000 Xxxxx Xxxxxx, XX 00000 |
Β Β | $ | [ | ***]Β |
Tennenbaum Opportunities Fund VI, LLC |
Β Β | c/o Tennenbaum Capital Partners, LLC 0000 00xx Xxxxxx, Xxxxx 0000 Xxxxx Xxxxxx, XX 00000 |
Β Β | $ | [ | ***]Β |
Tennenbaum Senior Loan Fund II, LP |
Β Β | c/o Tennenbaum Capital Partners, LLC 0000 00xx Xxxxxx, Xxxxx 0000 Xxxxx Xxxxxx, XX 00000 |
Β Β | $ | [ | ***]Β |
Tennenbaum Senior Loan SPV III, LLC |
Β Β | c/o Tennenbaum Capital Partners, LLC 0000 00xx Xxxxxx, Xxxxx 0000 Xxxxx Xxxxxx, XX 00000 |
Β Β | $ | [ | ***]Β |
Tennenbaum Senior Loan Fund IV-B, LP |
Β Β | c/o Tennenbaum Capital Partners, LLC 0000 00xx Xxxxxx, Xxxxx 0000 Xxxxx Xxxxxx, XX 00000 |
Β Β | $ | [ | ***]Β |
Β
3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.07(a)βSubsidiaries
Β
CurrentΒ Legal EntitiesΒ Owned |
Β Β | Record Owner |
Β Β | Cert. Number |
Β Β | Shares | Β | Β Β | Percentage Owned/Pledged |
Β | ||
BlackLineΒ Systems, Inc. |
Β Β | SLS Breeze Intermediate Holdings,Β Inc. | Β Β | 001 | Β Β | Β | 1,000 | Β Β | Β Β | Β | 100 | %Β |
Blackline Systems Limited |
Β Β | BlackLine Systems,Β Inc. | Β Β | 002 | Β Β | Β | 100 | Β Β | Β Β | Β | 100 | %Β |
BlackLine Systems Pty Ltd |
Β Β | BlackLine Systems, Inc. | Β Β | 002 | Β Β | Β | 100 | Β Β | Β Β | Β | 100 | %Β |
Β
4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.07(c)βStock Appreciation Rights, Phantom Stock Plans or Similar Plans
None
Β
5
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.08βLitigation
None
Β
6
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.17βInsurance
Β
Blackline Systems Summary of Commercial Insurance Policies | ||||||
Coverage Description |
Β Β | Policy Number |
Β | Insurance Carrier |
Β Β | Effective/Expiration Dates |
Commercial Package: Property, General Liability, Auto, Umbrella, KidnapΒ & Xxxxxx |
Β Β | ### | Β | Atlantic Specialty Insurance Co. | Β Β | 9/13/2013Β βΒ 9/13/2014 |
Executive Protection: DirectorsΒ & Officers, Employment Practices Liability, Fiduciary Liability |
Β Β | ### | Β | LloydβsΒ ofΒ London | Β Β | 9/3/2013 β 9/3/2014 |
ErrorsΒ & Omissions / Cyber Liability |
Β Β | ### | Β | Lloydβs of London | Β Β | 9/13/2013 βΒ 9/13/2014 |
Workersβ Compensation |
Β Β | ### | Β | Atlantic Specialty Insurance Co. | Β Β | 9/13/2013 β 9/14/2014 |
Workersβ Compensation β UK |
Β Β | ### | Β | AmlinΒ UKΒ Limited | Β Β | 7/2/2013 β 7/2/2014 |
Β
7
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.18(a)βUCC Filing Offices
Β
Loan Party |
Β | UCC Filing Office |
SLS Breeze Intermediate Holdings, Inc. |
Β | Office of the Secretary of State of the State of Delaware |
BlackLine Systems, Inc. |
Β | Office of the Secretary of State of the State of California |
Β
8
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.19(a)βOwned Real Property
None
Β
9
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.19(b)βLeased Real Property
00000 Xxxxxxx Xxxxxxxxx, Xxxxxx 0000 and 1200, Xxxxxxxx Xxxxx, Xxxxxxxxxx 00000
Β
Β | β’ | Β | 00 Xxxxxx Xxxxxx, Xxxxx 00, Xxxxxx, XXX 0000, Xxxxxxxxx |
Β
Β | β’ | Β | 0 Xxxxxxxxx Xxxxxxxxx, Xxxxxxxxx Xxxx, Xxxxxxxxx, XXX 0000, Xxxxxxxxx |
Β
Β | β’ | Β | The Company has entered into office service agreements for the following locations: |
Β
Β | β’ | Β | Riverbridge House Business Centre, Xxxxxxxx Xxxx, Xxxxxxxxxxx, Xxxxxx XX00 0XX, Xxxxxx Xxxxxxx; |
Β
Β | β’ | Β | Regus Properties, 000 Xxxx Xxxx, Xx. Xxxxx, Xxxxxx XX0X 0XX, Xxxxxx Xxxxxxx; |
Β
Β | β’ | Β | Regus Properties, 000 Xxxxx Xxx., #000, Xxx Xxxx, XX; |
Β
Β | β’ | Β | Regus Properties, Park 80 Xxxx/000 Xxxxx Xxx., #00-00, Xxxxxxxxxx. XX; |
Β
Β | β’ | Β | Regus Properties, 00000 Xxxxxxxxx Xxxx, #0000, Xxxxxxx, XX; |
Β
Β | β’ | Β | Regus Properties, Congress Center #1005, 0000 XX 0xx Xxx., Xxxxx 0000, Xxxxxxxx, XX; and |
Β
Β | β’ | Β | Regus Properties, 000 X. Xxxxxxxx Xxx., #0000XX, Xxxxxxx, XX. |
Β
10
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.24βFinancial Advisors
None
Β
11
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.26βDeposit Accounts and Securities Accounts
Β
Account Holder |
Β Β | NamesΒ andΒ Address |
Β Β | AccountΒ Type |
Β Β | Account Number |
BlackLine Systems, Inc. |
Β Β | SiliconΒ ValleyΒ Bank | Β Β | Checking | Β Β | ### |
Β Β | 0000Β XxxxxxΒ Xxxxx | Β Β | Β Β | |||
Β Β | XxxxxΒ XxxxxΒ ,Β XXΒ 00000 | Β Β | Β Β | |||
BlackLine Systems, Inc. |
Β Β | SiliconΒ ValleyΒ Bank | Β Β | ZBA | Β Β | ### |
Β Β | 0000Β XxxxxxΒ Xxxxx | Β Β | Β Β | |||
Β Β | XxxxxΒ XxxxxΒ ,Β XXΒ 00000 | Β Β | Β Β | |||
BlackLine Systems, Inc. |
Β Β | XxxxxΒ FargoΒ Bank | Β Β | Checking | Β Β | ### |
Β Β | P.O.Β BankΒ 6995 | Β Β | Β Β | |||
Β Β | Xxxxxxxx,Β XXΒ 00000 | Β Β | Β Β | |||
BlackLine Systems, Inc. |
Β Β | WestpacΒ BankingΒ Corporation | Β Β | Checking | Β Β | ### |
Β Β | XxxxxΒ 00,Β 000Β XxxxΒ Xxxxxx | Β Β | Β Β | |||
Β Β | Xxxxxx,Β XXXΒ 0000 | Β Β | Β Β | |||
BlackLine Systems, Inc. |
Β Β | NationalΒ WestminsterΒ Bank | Β Β | Checking | Β Β | ### |
Β Β | CityΒ ofΒ LondonΒ Office | Β Β | Β Β | |||
Β Β | P.O.Β BoxΒ 12258 | Β Β | Β Β | |||
Β Β | 0Β XxxxxxxΒ Xxxxxx | Β Β | Β Β | |||
Β Β | XxxxxxΒ XX0XΒ 0XX | Β Β | Β Β | |||
BlackLine Systems, Inc. |
Β Β | LloydsΒ TSBΒ BankΒ PLC | Β Β | Checking | Β Β | ### |
Β Β | CornΒ Street | Β Β | Β Β | |||
Β Β | Bristol,Β UK | Β Β | Β Β | |||
BlackLine Systems, Inc. |
Β Β | SiliconΒ ValleyΒ Bank | Β Β | MoneyΒ Market | Β Β | ### |
Β Β | 0000Β XxxxxxΒ Xxxxx | Β Β | Xxxxxxxxxx | Β Β | ||
Β Β | XxxxxΒ XxxxxΒ ,Β XXΒ 00000 | Β Β | Β Β |
Β
12
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 3.28(a)βIntellectual Property
Β
Jurisdiction |
Β Β | Registered Owner |
Β Β | Xxxx |
Β Β | RegistrationΒ No. (ApplicationΒ No.) |
Β | |
U.S. β Federal |
Β Β | Blackline Systems, Inc. | Β Β | Itβs Accounted For | Β Β | Β | 0000000 | Β Β |
U.S. β Federal |
Β Β | Blackline Systems, Inc. | Β Β | No More Bullsheet | Β Β | Β | 4084274 | Β Β |
U.S. β Federal |
Β Β | Blackline Systems, Inc. | Β Β | Design Xxxx | Β Β | Β | 4022105 | Β Β |
U.S. β Federal |
Β Β | Blackline Systems, Inc. | Β Β | Blackline Systems & Design Xxxx | Β Β | Β | 4360338 | Β Β |
U.S. β Federal |
Β Β | Blackline Systems, Inc. | Β Β | Blackline Systems | Β Β | Β | (86004666 | )Β |
U.S. β Federal |
Β Β | Blackline Systems, Inc. | Β Β | Blackline | Β Β | Β | (86004675 | )Β |
E.U. |
Β Β | Blackline Systems, Inc. | Β Β | Blackline | Β Β | Β | 10322709 | Β Β |
E.U. |
Β Β | Blackline Systems, Inc. | Β Β | Blackline Systems | Β Β | Β | 10322758 | Β Β |
Australia |
Β Β | Blackline Systems, Inc. | Β Β | Blackline | Β Β | Β | 1453761 | Β Β |
Australia |
Β Β | Blackline Systems, Inc. | Β Β | Blackline Systems | Β Β | Β | 1453766 | Β Β |
Β
REGISTEREDΒ DOMAINΒ NAMES | Β Β | |
Xxxxxxxxx.xxx | Β Β | |
Xxxxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxxxx.xx | Β Β | |
Xxxxxxxxx.xx | Β Β | |
Xxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxx-xxxxxxxxxxxxxx.xxx | Β Β | |
Xxxx-xxx.xxx | Β Β | |
Xxxx-xxxx.xxx | Β Β | |
Xxxxxxxxx.xx | Β Β | |
Xxxxxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxxxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxxxxxx.xxx | Β Β | |
Xxxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxxxxx-xxxxxxxxxxxxxxx.xxx | Β Β | |
Xxxx-xxx.xxx | Β Β | |
Xxxxxxxxxxxxxxxxxxxxxx.xxx | Β Β |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 6.01βExisting Indebtedness
Irrevocable Standby Letter of Credit ####, dated JanuaryΒ 13, 2011 for $[***] in favor of Xxxxxxx Xxxxx 2008 LLC issued by Silicon Valley Bank with respect to lease at 00000 Xxxxxxx Xxxxxxxxx, Xxxxx 0000, Xxxxxxxx Xxxxx XX (100% Cash Collateralized and Undrawn as of the Closing Date)
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 6.02βExisting Lien
Borrower has granted Silicon Valley Bank a security interest in Collateral Money Market Account #### with Silicon Valley Bank and all renewals, substitutions, additions, replacements and proceeds thereof to secure no more than 100% of Borrowerβs payment and performance obligations related to that certain Irrevocable Standby Letter of Credit ####, dated JanuaryΒ 13, 2011, for $[***] in favor of Xxxxxxx Xxxxx 2008 LLC issued by Silicon Valley Bank with respect to lease at 00000 Xxxxxxx Xxxxxxxxx, Xxxxx 0000, Xxxxxxxx Xxxxx XX (Undrawn as of the Closing Date)
Liens recorded under the following UCC filings:
Β
Debtor: |
Β Β | Secured Party: |
Β Β | Type of Filing: |
Β Β | Filing Date/ File No.: |
Β Β | Jurisdiction |
Β Β | CollateralΒ Description: |
BlacklineΒ Systems,Β Inc. 00000 Xxxxxxxxx Xxxx Xxxxx 000 Xxxxxxxxx, XX 00000 |
Β Β | CiscoΒ Systems Capital Corporation 0000 Xxx Xxxxx Xxxxxx Xxxx Xxxxx, XX 00000 |
Β Β | UCC | Β Β | 03/16/11 11-7263676403 |
Β Β | California Secretary of State | Β Β | EquipmentΒ listedΒ on Schedule A attached thereto. |
BlacklineΒ Systems,Β Inc. 00000 Xxxxxxx XxxxΒ 00xxΒ XX Xxxxxxxx Xxxxx, XX 00000 |
Β Β | Dell Financial Services L.L.C. Mail stop-PS2DF-23 Xxx Xxxx Xxx Xxxxx Xxxx, XX 00000 | Β Β | UCC | Β Β | 05/23/11 11-7270595592 |
Β Β | CaliforniaΒ Secretary of State | Β Β | Equipment pursuantΒ toΒ Lease #000-0000000-000, datedΒ May 20, 2011. |
BlacklineΒ Systems,Β Inc. 00000 Xxxxxxx Xxxx 00xx XX Xxxxxxxx Xxxxx, XX 00000 |
Β Β | Dell Financial Services L.L.C. Mail stop-PS2DF-23 Xxx Xxxx Xxx Xxxxx Xxxx, XX 00000 | Β Β | UCC | Β Β | 08/23/11 11-7282005995 |
Β Β | California Secretary of State | Β Β | Equipment pursuant to Lease #000-0000000-000, dated August 22, 2011. |
Β
2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 6.04βExisting Investments
None
Β
3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule 6.07βTransactions with Affiliates
UK Intercompany Services Agreement, entered into as of JuneΒ 1, 2012, between BlackLine Systems, Inc. and BlackLine Systems Ltd.
Β
4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT A
FORM OF NOTICE OF BORROWING
Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β , Β Β Β Β Β Β Β Β
Obsidian Agency Services, Inc.,
as Administrative Agent under the
Credit Agreement referred to below
c/o Tennenbaum Capital Partners, LLC
0000 00xx Xxxxxx, Xxxxx 0000
Xxxxx Xxxxxx, XX 00000
Attention: Xxxxx Xxxxx
Fax: (000)Β 000-0000
Re: BLACKLINE SYSTEMS, INC.
Reference is made to that certain Credit Agreement, dated as of September Β Β Β Β Β Β Β Β , 2013 (as the same may be amended, restated, supplemented or otherwise modified from time to time, the βCredit Agreementβ), by and among BLACKLINE SYSTEMS, INC., a California corporation (the βBorrowerβ), SLS BREEZE INTERMEDIATE HOLDINGS, INC., a Delaware corporation, the lenders from time to time party thereto (the βLendersβ), and OBSIDIAN AGENCY SERVICES, INC., as the administrative agent (in such capacity, including any successor thereto, the βAdministrative Agentβ) and as collateral agent for the Lenders. Capitalized terms used herein and not otherwise defined herein are used herein as defined in the Credit Agreement.
The Borrower hereby gives you notice, irrevocably, pursuant to SectionΒ 2.02(c) of the Credit Agreement that the undersigned hereby requests a borrowing (the βProposed Borrowingβ) under the Credit Agreement and, in connection therewith, sets forth below the information relating to the Proposed Borrowing as required by SectionΒ 2.02(c) of the Credit Agreement:
(a)Β The date of the Proposed Borrowing is the Closing Date.
(b) The aggregate principal amount of the Proposed Borrowing is $ 25,000,000.
At the time of the Proposed Borrowing and also immediately after giving effect thereto, (i)Β there is no Default or Event of Default and (ii)Β all representations and warranties contained in Article III of the Credit Agreement are true and correct in all material respects (it being understood and agreed that any representation or warranty which by its terms is made as of a specified date shall be required to be true and correct in all material respects only as of such specified date); provided, that, if a representation and warranty is qualified as to materiality, the materiality qualifier set forth above shall be disregarded with respect to such representation and warranty for purposes of this condition.
At the time of the Proposed Borrowing, no injunction or other restraining order has been issued and no hearing to cause an injunction or other restraining order to be issued is pending or noticed with respect to any action, suit or proceeding seeking to enjoin or otherwise prevent the consummation of, or to recover any damages or obtain relief as a result of, the Transactions or the making of Loans under the Credit Agreement.
Delivery of an executed counterpart of this Notice of Borrowing by telecopier or other electronic means shall be effective as delivery of an original executed counterpart of this Notice of Borrowing.
[Remainder of page intentionally left blank]
Β
A-1
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
BLACKLINE SYSTEMS, INC. | ||
By: |
Β | Β |
Name: |
Β | |
Title: |
Β |
[SIGNATURE PAGE TO NOTICE OF BORROWING]
Β
A-2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT B
FOR PURPOSES OF SECTIONS 1272, 1273 AND 1275 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, THIS TERM NOTE WAS ISSUED WITH βORIGINAL ISSUE DISCOUNT.β BLACKLINE SYSTEMS, INC. WILL PROMPTLY MAKE AVAILABLE TO THE HOLDER HEREOF INFORMATION REGARDING THE ISSUE PRICE, ISSUE DATE, YIELD TO MATURITY, AMOUNT OF ORIGINAL ISSUE DISCOUNT (AND ANY OTHER INFORMATION REQUIRED TO BE MADE AVAILABLE TO THE HOLDER PURSUANT TO U.S. TREASURY REGULATIONS), UPON THE WRITTEN REQUEST OF SUCH HOLDER DIRECTED TO [Β Β Β Β Β Β Β Β Β Β Β Β ]1
FORM OF NOTE2
Β
$[Β Β Β Β Β Β Β Β ] | Β | [Β Β Β Β Β Β Β Β Β Β Β Β ], 2013 |
FOR VALUE RECEIVED, the undersigned, BLACKLINE SYSTEMS, INC., a California corporation (the βBorrowerβ, together with all successors and assigns), promises to pay Β Β Β Β Β Β Β Β Β Β Β Β (hereinafter, together with its successors in title and permitted assigns, the βLenderβ), the principal sum of [Β Β Β Β ] ($[Β Β Β Β ]), or such lesser amount as is outstanding from time to time, on the dates and in the amounts set forth in the Credit Agreement (as hereafter defined), with interest, fees, expenses and costs at the rate and payable in the manner stated in the Credit Agreement. As used herein, the βCredit Agreementβ means and refers to that certain Credit Agreement, dated as of September Β Β Β Β , 2013 (as such may be amended, restated, supplemented or otherwise modified from time to time) by and among the Borrower, SLS BREEZE INTERMEDIATE HOLDINGS, INC., a Delaware corporation, the Lenders from time to time party thereto, and OBSIDIAN AGENCY SERVICES, INC., as the administrative agent (in such capacity, including any successor thereto, the βAdministrative Agentβ) and as collateral agent for the Lenders. Capitalized terms used herein and not otherwise defined herein are used herein as defined in the Credit Agreement.
This Note is a βNoteβ to which reference is made in the Credit Agreement and is subject to all terms and provisions thereof. This Note is also entitled to the benefits of the Guarantee and Collateral Agreement and is secured by the Collateral. The principal of, and interest on, this Note shall be payable at the times, in the manner, and in the amounts as provided in the Credit Agreement and shall be subject to prepayment and acceleration as provided therein. The Administrative Agentβs books and records concerning the Loans, the accrual of interest and fees thereon and the repayment of such Loans shall be prima facie evidence of the indebtedness to the Lender hereunder, absent manifest error.
No delay or omission by the Administrative Agent, the Collateral Agent or the Lender in exercising or enforcing any of the Administrative Agentβs, the Collateral Agentβs or the Lenderβs powers, rights, privileges, remedies or discretions hereunder shall operate as a waiver thereof on that occasion nor on any other occasion. No waiver of any Event of Default shall operate as a waiver of any other Event of Default, nor as a continuing waiver.
The Borrower waives presentment, demand, notice and protest, and also waives any delay on the part of the holder hereof. The Borrower assents to any extension or other indulgence (including, without limitation, the release or substitution of Collateral) permitted by the Administrative Agent, the Collateral Agent and/or the Lender with respect to this Note and/or any Security Document or any extension or other indulgence with respect to any other liability or any collateral given under the Loan Documents to secure any other liability of the Borrower or any other Person obligated on account of this Note.
Β
1Β | Blackline to Confirm. |
2Β | [NTD: This Form assumes the Credit Agreement will contemplate more than one Lender/Noteholder and to give consideration to possible future assignments breaking up the amount of Loans. To be updated pending Credit Agreement revisions.] |
Β
B-1
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
This Note shall be binding upon the Borrower and upon its permitted successors, assigns, and representatives, and shall inure to the benefit of the Lender and its permitted successors, endorsees and assigns. There are certain restrictions on the assignment and transfer of this Note and the obligations evidenced by this Note in the Credit Agreement (including, without limitation, in SectionΒ 9.04 of the Credit Agreement).
Each of the Borrower and, by its acceptance hereof, the Lender, hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Note or the other Loan Documents, or for recognition or enforcement of any judgment, and each of the Borrower and, by its acceptance hereof, the Lender, hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the Borrower and, by its acceptance hereof, the Lender, agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Note shall affect any right that the Administrative Agent, the Collateral Agent or any Lender may otherwise have to bring any action or proceeding relating to this Note or the other Loan Documents against Holdings, the Borrower, or their respective properties in the courts of any jurisdiction. Each of the Borrower and, by its acceptance hereof, the Lender, irrevocably and unconditionally waives, to the fullest extent that it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Note in any court located in the City of New York, Borough of Manhattan, or the United States of America sitting in the Southern District of New York. Each of the Borrower and, by its acceptance hereof, the Lender, hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.
THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK.
Each of the Borrower and, by its acceptance hereof, the Lender, makes the following waiver knowingly, voluntarily, and intentionally, and understands that the Administrative Agent and the Lender or the Borrower, as applicable, are each relying thereon. EACH OF THE BORROWER AND THE LENDER BY ITS ACCEPTANCE HEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS NOTE.
[Remainder of page intentionally left blank]
Β
B-2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
IN WITNESS WHEREOF, the undersigned has caused this Note to be duly executed and delivered by its duly authorized officer as of the date first above written.
Β
BLACKLINE SYSTEMS, INC. | ||
By: | Β | Β |
Name: | Β | |
Title: | Β |
[SIGNATURE PAGE TO FORM OF NOTE]
Β
B-3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
LOANS AND PAYMENTS
Β
Date |
Β Β | Amount of Loan |
Β Β | Maturity Date |
Β Β | Payments of Principal/Interest |
Β Β | Principal Balance of Note |
Β Β | Name of Person Making this Notation |
Sept. Β Β Β Β , 2013 |
Β Β | $[Β Β Β Β ] | Β Β | Β Β Β Β Β Β Β Β Β Β Β Β Β ,Β 2018 | Β Β | Β Β | Β Β |
Β
B-4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT C
[AGENT LOGO]
ADMINISTRATIVE QUESTIONNAIRE
BLACKLINE SYSTEMS, INC.
Β
Agent | Β Β | Return form |
Address: | Β Β | to: |
Β
Β | Obsidian Agency Services, Inc. | Β Β | Β Β | Β | ||
Β | c/o Tennenbaum Capital | Β Β | Telephone: | Β Β | (000)000-0000 | |
Β | Partners, LLC | Β Β | Facsimile: | Β Β | Β | |
Β | 0000 00xx Xxxxxx, Xxxxx 0000 | Β Β | E-mail: | Β Β | Β | |
Β | Xxxxx Xxxxxx, XX 00000 | Β Β | Β Β | Β |
It is very important that all of the requested information be completed accurately and that this questionnaire be returned promptly. If your institution is sub-allocating its allocation, please fill out an administrative questionnaire for each legal entity.
Legal Name of Lender to appear in Documentation:
Β
Β
TaxΒ IDΒ Number: Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β
Β
SignatureΒ BlockΒ Information: | Β | Β |
Β
Β Β | β’Β Β Β Β Β Β SigningΒ CreditΒ Agreement |
  | ¨ Yes        |   | ¨ No | |
Β Β | β’Β Β Β Β Β Β ComingΒ inΒ viaΒ Assignment |
  | ¨ Yes |   | ¨ No |
Type of Lender:
Bank Asset Manager Broker/Dealer CLO/CDO Finance Company Hedge Fund Insurance Mutual Fund Pension Fund Other Regulated Investment Fund Special Purpose Vehicle Other-please specify)
Β
LenderΒ Parent: | Β | Β |
Β
Address |
Β |
Β |
Β |
Β |
Β
C-1
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Contacts/Notification Methods: Borrowings, Paydowns, Interest, Fees, etc.
Β
Β | Β Β | Primary Credit Contact |
Β Β | Secondary Credit Contact |
Β Syndicate-level information (which may contain material non-public information about the Borrower and its related parties or their respective securities) will be made available to the Credit Contact(s). The Credit Contacts identified must be able to receive such information in accordance with his/her institutionβs compliance procedures and applicable laws, including Federal and state securities laws. |
Β
Name: | Β Β | Β |
Β Β | Β |
Company: |
Β Β | Β |
Β Β | Β |
Title: |
Β Β | Β |
Β Β | Β |
Address: |
Β Β | Β |
Β Β | Β |
Β Β | Β |
Β Β | Β | |
Telephone: |
Β Β | Β |
Β Β | Β |
Facsimile: |
Β Β | Β |
Β Β | Β |
Address: |
Β Β | Β |
Β Β | Β |
Β | Β Β | PrimaryΒ OperationsΒ Contact |
Β Β | SecondaryΒ OperationsΒ Contact |
Name: |
Β Β | Β |
Β Β | Β |
Company: |
Β Β | Β |
Β Β | Β |
Title: |
Β Β | Β |
Β Β | Β |
Address: |
Β Β | Β |
Β Β | Β |
Β Β | Β |
Β Β | Β | |
Telephone: |
Β Β | Β |
Β Β | Β |
Facsimile: |
Β Β | Β |
Β Β | Β |
Address: |
Β Β | Β |
Β Β | Β |
Β
C-2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Lenderβs Domestic Wire Instructions
Β
Bank Name: | Β Β | Β |
ABA/RoutingΒ No.: |
Β Β | Β |
Account Name: | Β Β | Β |
Account No.: |
Β Β | Β |
FFCΒ AccountΒ Name: |
Β Β | Β |
FFC Account No.: |
Β Β | Β |
Attention: |
Β Β | Β |
Reference: |
Β Β | Β |
Lenderβs Foreign Wire Instructions
Β
Currency: | Β Β | Β |
Bank Name: | Β Β | Β |
Swift/RoutingΒ No.: |
Β Β | Β |
Account Name: |
Β Β | Β |
Account No.: |
Β Β | Β |
FFCΒ AccountΒ Name: |
Β Β | Β |
FFC Account No.: |
Β Β | Β |
Attention: |
Β Β | Β |
Reference: |
Β Β | Β |
Administrative Agentβs Wire Instructions
Β
Bank Name: | Β Β | Β |
ABA/RoutingΒ No.: | Β Β | Β |
Account Name: | Β Β | Β |
Account No.: | Β Β | Β |
FFCΒ AccountΒ Name: | Β Β | Β |
FFC Account No.: | Β Β | Β |
Attention: | Β Β | Β |
Reference: | Β Β | Β |
Β
C-3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Tax Documents
NON-U.S. LENDER INSTITUTIONS:
I. Corporations:
If your institution is incorporated outside of the United States for U.S. federal income tax purposes, and is the beneficial owner of the interest and other income it receives, you must complete one of the following three tax forms, as applicable to your institution: a.) Form W-8BEN (Certificate of Foreign Status of Beneficial Owner), b.) Form W-8ECI (Income Effectively Connected to a U.S. Trade or Business), or c.) Form W-8EXP (Certificate of Foreign Government or Governmental Agency).
A U.S. taxpayer identification number is required for any institution submitting Form W-8ECI. It is also required on Form W-8BEN for certain institutions claiming the benefits of a tax treaty with the U.S. Please refer to the instructions when completing the form applicable to your institution. In addition, please be advised that U.S. tax regulations do not permit the acceptance of faxed forms. An original tax form must be submitted.
II. Flow-Through Entities:
If your institution is organized outside the U.S., and is classified for U.S. federal income tax purposes as either a Partnership, Trust, Qualified or Non-Qualified Intermediary, or other non-U.S. flow-through entity, an original Form W-8IMY (Certificate of Foreign Intermediary, Foreign Flow-Through Entity, or Certain U.S. Branches for United States Tax Withholding) must be completed by the intermediary together with a withholding statement. Flow-through entities other than Qualified Intermediaries are required to include tax forms for each of the underlying beneficial owners.
Please refer to the instructions when completing this form. In addition, please be advised that U.S. tax regulations do not permit the acceptance of faxed forms. Original tax form(s) must be submitted.
U.S. LENDER INSTITUTIONS:
If your institution is incorporated or organized within the United States, you must complete and return Form W-9 (Request for Taxpayer Identification Number and Certification). Please be advised that we request that you submit an original Form W-9.
Pursuant to the language contained in the tax section of the Credit Agreement, the applicable tax form for your Non-U.S. or U.S. institution must be completed and returned on or prior to the date on which your institution becomes a Lender under the Credit Agreement. Failure to provide the proper tax form when requested may subject your institution to U.S. tax withholding.
Β
C-4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT D
FORM OF ASSIGNMENT AND ACCEPTANCE
This Assignment and Acceptance (this βAssignment and Acceptanceβ) is dated as of the Effective Date set forth below and is entered into by and between [the][each]1 Assignor identified in item 1 below ([the][each, an] βAssignorβ) and [the][each]2 Assignee identified in item 2 below ([the][each, an] βAssigneeβ). [It is understood and agreed that the rights and obligations of [the Assignors][the Assignees]3 hereunder are several and not joint.]4 Capitalized terms used but not defined herein shall have the meanings given to them in the Credit Agreement identified below (the βCredit Agreementβ), receipt of a copy of which is hereby acknowledged by the Assignee. The Standard Terms and Conditions set forth in Annex 1 attached hereto are hereby agreed to and incorporated herein by reference and made a part of this Assignment and Acceptance as if set forth herein in full.
For an agreed consideration set forth below as the βPurchase Priceβ, [the][each] Assignor hereby irrevocably sells and assigns to [the Assignee][the respective Assignees], and[the][each] Assignee hereby irrevocably purchases and assumes from [the Assignor][the respective Assignors], subject to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the Effective Date inserted by the Administrative Agent as contemplated below (i)Β all of [the Assignorβs][the respective Assignorsβ] rights and obligations in [its capacity as a Lender][their respective capacities as Lenders] under the Credit Agreement and any other documents or instruments delivered pursuant thereto to the extent related to the amount and percentage interest identified below of all of such outstanding rights and obligations of [the Assignor][the respective Assignors] under the respective facilities identified below and (ii)Β to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of [the Assignor (in its capacity as a Lender)][the respective Assignors (in their respective capacities as Lenders)] against any Person, whether known or unknown, arising under or in connection with the Credit Agreement, any other documents or instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including, but not limited to, contract claims, tort claims, malpractice claims, statutory claims and all other claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (i)Β above (the rights and obligations sold and assigned by [the][any] Assignor to [the][any] Assignee pursuant to clauses (i)Β and (ii)Β above being referred to herein collectively as [the][an] βAssigned Interestβ). Each such sale and assignment is without recourse to [the][any] Assignor and, except as expressly provided in this Assignment and Acceptance, without representation or warranty (express or implied) by [the][any] Assignor.
Β
1.Β Β Β Β Β Β | Β | Assignor[s]: | Β | Β |
Β | |
2.Β Β Β Β Β Β | Β | Assignee[s]: | Β | Β |
Β | |
Β | Β | Β |
Β | |||
Β | [for each Assignee identify Lender] | Β | ||||
3. | Β | Borrower: | Β | BLACKLINE SYSTEMS, INC. | Β |
Β
1Β | For bracketed language here and elsewhere in this form relating to the Assignor(s), if the assignment is from a single Assignor, choose the first bracketed language. If the assignment is from multiple Assignors, choose the second bracketed language. |
2Β | For bracketed language here and elsewhere in this form relating to the Assignee(s), if the assignment is to a single Assignee, choose the first bracketed language. If the assignment is to multiple Assignees, choose the second bracketed language. |
3Β | Select as appropriate. |
4Β | Include bracketed language if there are either multiple Assignors or multiple Assignees. |
Β
D-1
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
4. | Administrative Agent: Obsidian Agency Services, Inc., including any successor thereto, as the administrative agent under the Credit Agreement |
Β
5. | Credit Agreement: The Credit Agreement, dated as of September Β Β Β Β , 2013, among BLACKLINE SYSTEMS, INC., a California corporation, as the Borrower, SLS BREEZE INTERMEDIATE HOLDINGS, INC., a Delaware corporation, as Holdings and a Guarantor, the Lenders from time to time party thereto, and OBSIDIAN AGENCY SERVICES, INC., as the Administrative Agent and as Collateral Agent for the Lenders. |
Β
6. | Assigned Interest: |
Β
Assignor[s]5 |
Β Β | Assignee[ s]6 |
Β Β | Aggregate Amount of Loans for all |
Β | Β Β | Amount of Loans Assigned |
Β | Β Β | Percentage AssignedΒ of Loans8 |
Β | Β Β | CUSIP Number | |||
Β Β | Β Β | Β Β | Β Β | Β Β | ||||||||||||
Β Β | Β Β | Β | $ | Β Β | Β Β | Β | $ | Β Β | Β Β | Β | % | Β Β | Β Β | |||
Β Β | Β Β | Β | $ | Β Β | Β Β | Β | $ | Β Β | Β Β | Β | % | Β Β | Β Β | |||
Β Β | Β Β | Β | $ | Β Β | Β Β | Β | $ | Β Β | Β Β | Β | % | Β Β | Β Β |
7. Purchase Price: $Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β
[8. Trade Date: Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β 9
Effective Date:Β Β Β Β Β Β Β Β , 20Β Β Β Β [TO BE INSERTED BY THE ADMINISTRATIVE AGENT AND WHICH SHALL BE THE EFFECTIVE DATE OF RECORDATION OF TRANSFER IN THE REGISTER THEREFOR.]
[Remainder of page intentionally left blank]
Β
5Β | List each Assignor, as appropriate. |
6Β | List each Assignee, as appropriate. |
7Β | Amounts in this column and in the column immediately to the right to be adjusted by the counterparties to take into account any payments or prepayments made between the Trade Date and the Effective Date. |
8Β | Set forth, to at least 9 decimals, as a percentage of the Loans of all Lenders thereunder. |
9Β | To be completed if the Assignor and the Assignee intend that the minimum assignment amount is to be determined as of the Trade Date. |
Β
D-2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
The terms set forth in this Assignment and Acceptance are hereby agreed to:
Β
ASSIGNOR | ||
Β [NAME OF ASSIGNOR] | ||
By: | Β | Β |
Β | Name: | |
Β | Title: | |
ASSIGNEE | ||
Β [NAME OF ASSIGNEE] | ||
By: | Β | Β |
Β | Name: | |
Β | Title: |
Β
[Consented to and Accepted: | ||
OBSIDIAN AGENCY SERVICES, INC., as Administrative Agent Β | ||
By: | Β | Β |
Β | Name: | |
Β | Title:]10 | |
Β [Consented to: BLACKLINE SYSTEMS, INC. | ||
By: | Β | Β |
Β | Name: | |
Β | Title: ]11 |
[SIGNATURE PAGE TO ASSIGNMENT AND ACCEPTANCE]
Β
10Β | Administrative Agentβs signature to be provided only to the extent required by SectionΒ 9.04 of the Credit Agreement. |
11 | Borrowerβs signature to be provided only to the extent required by SectionΒ 9.04 of the Credit Agreement. |
Β
D-3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Annex 1
STANDARD TERMS AND CONDITIONS FOR
ASSIGNMENT AND ACCEPTANCE
1. Representations and Warranties.
1.1. Assignor. [The][Each] Assignor (a)Β represents and warrants that it is the legal and beneficial owner of the interest being assigned thereby free and clear of any adverse claim; and (b)Β except as set forth in (a)Β above, makes no representation or warranty and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with the Credit Agreement or any other Loan Document, or the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement, any other Loan Document or any other instrument or document furnished pursuant to the Credit Agreement, or the financial condition of Holdings, the Borrower or any Subsidiary or the performance or observance by Holdings, the Borrower or any Subsidiary of any of its obligations under the Credit Agreement, any other Loan Document or any other instrument or document furnished pursuant to the Credit Agreement.
1.2. Assignee. [The][Each] Assignee (a)Β represents and warrants that (i)Β it is legally authorized to enter into such Assignment and Acceptance; (ii)Β it meets all the requirements to be an assignee under SectionΒ 9.04(b) and (c)Β of the Credit Agreement (subject to such consents, if any, as may be required under SectionΒ 9.04(b) of the Credit Agreement); (iii)Β from and after the Effective Date referred to in this Assignment and Acceptance, it shall be bound by the provisions of the Credit Agreement as a Lender thereunder and, to the extent of [the][the relevant] Assigned Interest, shall have the obligations of a Lender thereunder; (iv)Β it is sophisticated with respect to decisions to acquire assets of the type represented by [the][such] Assigned Interest and either it, or the Person exercising discretion in making its decision to acquire [the][such] Assigned Interest, is experienced in acquiring assets of such type; (v)Β it has, independently and without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Assignment and Acceptance and to purchase [the][such] Assigned Interest and (vi)Β attached hereto is any documentation required to be delivered by it pursuant to the terms of the Credit Agreement, including but not limited to any documentation required pursuant to SectionΒ 2.17 of the Credit Agreement, duly completed and executed by [the][such] Assignee; (b)Β confirms that it has received a copy of the Credit Agreement, together with copies of the most recent financial statements referred to in SectionΒ 3.05(a) and SectionΒ 3.05(b) of the Credit Agreement or delivered pursuant to SectionΒ 5.04 of the Credit Agreement and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and Acceptance; (c)Β will independently and without reliance upon the Administrative Agent, the Collateral Agent, such assigning Lender or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Loan Documents; (d)Β appoints and authorizes the Administrative Agent and the Collateral Agent to take such action as agent on its behalf and to exercise such powers under the Credit Agreement as are delegated to the Administrative Agent and the Collateral Agent, respectively, by the terms of the Credit Agreement, together with such powers as are reasonably incidental thereto; and (e)Β agrees that it will perform in accordance with their terms all the obligations which by the terms of the Loan Documents are required to be performed by it as a Lender.
2. Payments. From and after the Effective Date, the Administrative Agent shall make all payments in respect of [the][each] Assigned Interest (including payments of principal, interest, fees and other amounts) to [the][the relevant] Assignor for amounts which have accrued to but excluding the Effective Date and to [the][the relevant] Assignee for amounts which have accrued from and after the Effective Date.
Β
D-i
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
3. General Provisions. This Assignment and Acceptance shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and assigns. This Assignment and Acceptance may be executed in any number of counterparts (and by different parties hereto indifferent counterparts), each of which shall constitute an original, but all of which together shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Assignment and Acceptance by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Assignment and Acceptance. This Assignment and Acceptance shall be governed by, and construed in accordance with, the internal laws of the State of New York.
4. Eligible Assignee. Each Person who is to become a Lender under the Credit Agreement is required to meet the requirements in SectionΒ 9.04 of the Credit Agreement and to be an βEligible Assigneeβ. [The][each] Assignor and [the][each] Assignee represent and warrant that they have each taken the necessary actions to confirm that [the][each] Assignee meets the requirements to be an βEligible Assigneeβ under the Credit Agreement and the assignment evidence by this Assignment and Acceptance is in accordance with all provisions in the Credit Agreement, including, without limitation, SectionΒ 9.04 of the Credit Agreement.
Β
D-ii
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT E
Β
Β
FORM OF GUARANTEE AND COLLATERAL AGREEMENT
dated as of
[β]
among
BLACKLINE SYSTEMS, INC.,
SLS BREEZE INTERMEDIATE HOLDINGS, INC.,
the Subsidiaries of the Borrower
from time to time party hereto
and
OBSIDIAN AGENCY SERVICES, INC.,
as Collateral Agent
Β
Β
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
TABLE OF CONTENTS
Β
Β | Β Β | Β | Β Β | Page | Β | |
ARTICLE I | Β Β | |||||
Definitions | Β Β | |||||
SECTIONΒ 1.01. |
Β Β | Credit Agreement | Β Β | Β | 1 | Β Β |
SECTIONΒ 1.02. |
Β Β | Other Defined Terms | Β Β | Β | 1 | Β Β |
SECTIONΒ 1.03. |
Β Β | Independence of Covenants | Β Β | Β | 6 | Β Β |
ARTICLE II | Β Β | |||||
Guarantee | Β Β | |||||
SECTIONΒ 2.01. |
Β Β | Guarantee | Β Β | Β | 6 | Β Β |
SECTIONΒ 2.02. |
Β Β | Guarantee of Payment | Β Β | Β | 6 | Β Β |
SECTIONΒ 2.03. |
Β Β | No Limitations, Etc | Β Β | Β | 6 | Β Β |
SECTIONΒ 2.04. |
Β Β | Reinstatement | Β Β | Β | 9 | Β Β |
SECTIONΒ 2.05. |
Β Β | Agreement To Pay; Subrogation | Β Β | Β | 9 | Β Β |
SECTIONΒ 2.06. |
Β Β | Information | Β Β | Β | 10 | Β Β |
ARTICLE III | Β Β | |||||
Pledge of Securities | Β Β | |||||
SECTIONΒ 3.01. |
Β Β | Pledge | Β Β | Β | 10 | Β Β |
SECTIONΒ 3.02. |
Β Β | Perfection of the Pledged Collateral | Β Β | Β | 11 | Β Β |
SECTIONΒ 3.03. |
Β Β | Representations, Warranties and Covenants | Β Β | Β | 12 | Β Β |
SECTIONΒ 3.04. |
Β Β | Certification of Limited Liability Company Interests and Limited Partnership Interests | Β Β | Β | 13 | Β Β |
SECTIONΒ 3.05. |
Β Β | Registration in Nominee Name; Denominations | Β Β | Β | 13 | Β Β |
SECTIONΒ 3.06. |
Β Β | Voting Rights; Dividends and Interest, Etc | Β Β | Β | 13 | Β Β |
ARTICLE IV | Β Β | |||||
Security Interests in Personal Property | Β Β | |||||
SECTIONΒ 4.01. |
Β Β | Security Interest | Β Β | Β | 15 | Β Β |
SECTIONΒ 4.02. |
Β Β | Representations and Warranties | Β Β | Β | 17 | Β Β |
SECTIONΒ 4.03. |
Β Β | Covenants | Β Β | Β | 18 | Β Β |
SECTIONΒ 4.04. |
Β Β | Other Actions | Β Β | Β | 20 | Β Β |
SECTIONΒ 4.05. |
Β Β | Perfection or Other Action Cost vs. Benefit Determination; Exceptions to Control Agreements | Β Β | Β | 23 | Β Β |
SECTIONΒ 4.06. |
Β Β | Covenants Regarding Patent, Trademark and Copyright Collateral | Β Β | Β | 23 | Β Β |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE V | Β Β | |||||
Remedies | Β Β | |||||
SECTIONΒ 5.01. |
Β Β | Remedies Upon Default | Β Β | Β | 25 | Β Β |
SECTIONΒ 5.02. |
Β Β | Application of Proceeds | Β Β | Β | 27 | Β Β |
SECTIONΒ 5.03. |
Β Β | Grant of License to Use Intellectual Property | Β Β | Β | 28 | Β Β |
SECTIONΒ 5.04. |
Β Β | Securities Act, Etc | Β Β | Β | 28 | Β Β |
ARTICLE VI | Β Β | |||||
Indemnity, Subrogation and Subordination | Β Β | |||||
SECTIONΒ 6.01. |
Β Β | Indemnity and Subrogation | Β Β | Β | 29 | Β Β |
SECTIONΒ 6.02. |
Β Β | Contribution and Subrogation | Β Β | Β | 29 | Β Β |
SECTIONΒ 6.03. |
Β Β | Subordination | Β Β | Β | 29 | Β Β |
ARTICLE VII | Β Β | |||||
Miscellaneous | Β Β | |||||
SECTIONΒ 7.01. |
Β Β | Notices | Β Β | Β | 30 | Β Β |
SECTIONΒ 7.02. |
Β Β | Security Interest Absolute | Β Β | Β | 30 | Β Β |
SECTIONΒ 7.03. |
Β Β | Survival of Agreement | Β Β | Β | 30 | Β Β |
SECTIONΒ 7.04. |
Β Β | Limitation by Law | Β Β | Β | 31 | Β Β |
SECTIONΒ 7.05. |
Β Β | Binding Effect; Several Agreement | Β Β | Β | 31 | Β Β |
SECTIONΒ 7.06. |
Β Β | Successors and Assigns | Β Β | Β | 31 | Β Β |
SECTIONΒ 7.07. |
Β Β | Collateral Agentβs Fees and Expenses; Indemnification | Β Β | Β | 31 | Β Β |
SECTIONΒ 7.08. |
Β Β | Collateral Agent Appointed Attorney-in-Fact | Β Β | Β | 31 | Β Β |
SECTIONΒ 7.09. |
Β Β | Applicable Law | Β Β | Β | 32 | Β Β |
SECTIONΒ 7.10. |
Β Β | Waivers; Amendment | Β Β | Β | 32 | Β Β |
SECTIONΒ 7.11. |
Β Β | WAIVER OF JURY TRIAL | Β Β | Β | 33 | Β Β |
SECTIONΒ 7.12. |
Β Β | Severability | Β Β | Β | 33 | Β Β |
SECTIONΒ 7.13. |
Β Β | Counterparts | Β Β | Β | 33 | Β Β |
SECTIONΒ 7.14. |
Β Β | Headings | Β Β | Β | 33 | Β Β |
SECTIONΒ 7.15. |
Β Β | Jurisdiction; Consent to Service of Process | Β Β | Β | 33 | Β Β |
SECTIONΒ 7.16. |
Β Β | Termination or Release | Β Β | Β | 34 | Β Β |
SECTIONΒ 7.17. |
Β Β | Additional Subsidiaries | Β Β | Β | 35 | Β Β |
SECTIONΒ 7.18. |
Β Β | [Reserved] | Β Β | Β | 35 | Β Β |
SECTIONΒ 7.19. |
Β Β | Conflicts | Β Β | Β | 35 | Β Β |
SECTIONΒ 7.20. |
Β Β | Revolving Loan Agreement and Intercreditor Agreement | Β Β | Β | 35 | Β Β |
Β
ii
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedules | Β Β | |
Schedule I |
Β Β | Subsidiary Guarantors |
Schedule II |
Β Β | Equity Interests; Pledged Debt Securities |
Schedule III |
Β Β | Intellectual Property |
Schedule IV |
Β Β | Commercial Tort Claims |
Exhibits | Β Β | |
Exhibit A |
Β Β | Form of Supplement |
Exhibit B |
Β Β | Form of Perfection Certificate |
Exhibit C |
Β Β | Form of Copyright Security Agreement |
Exhibit D |
Β Β | Form of Patent Security Agreement |
Exhibit E |
Β Β | Form of Trademark Security Agreement |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
GUARANTEE AND COLLATERAL AGREEMENT dated as of SeptemberΒ 25, 2013 (this βAgreementβ), among BLACKLINE SYSTEMS, INC., a California corporation (the βBorrowerβ), SLS BREEZE INTERMEDIATE HOLDINGS, INC., a Delaware corporation (βHoldingsβ), the Subsidiaries of the Borrower from time to time party hereto (the βSubsidiary Guarantorsβ) and OBSIDIAN AGENCY SERVICES, INC. (βObsidianβ), as collateral agent (in such capacity, the βCollateral Agentβ).
PRELIMINARY STATEMENT
Reference is made to the Credit Agreement dated as of SeptemberΒ 25, 2013 (as amended, restated, supplemented or otherwise modified from time to time, the βCredit Agreementβ), among the Borrower, Holdings, the lenders from time to time party thereto (the βLendersβ) and Obsidian, as administrative agent (in such capacity, the βAdministrative Agentβ) and Collateral Agent.
The Lenders have agreed to extend credit to the Borrower pursuant to, and upon the terms and conditions specified in, the Credit Agreement. The obligations of the Lenders to extend credit to the Borrower are conditioned upon, among other things, the execution and delivery of this Agreement by the Borrower and each Guarantor (such term and each other capitalized term used but not defined in this preliminary statement having the meaning given or ascribed to it in Article I). Each Guarantor is an affiliate of the Borrower, will derive substantial benefits from the extension of credit to the Borrower pursuant to the Credit Agreement and is willing to execute and deliver this Agreement in order to induce the Lenders to extend such credit. Accordingly, the parties hereto agree as follows:
ARTICLE I
Definitions
SECTION 1.01. Credit Agreement. Unless otherwise defined herein or in the Credit Agreement, capitalized terms used herein that are defined in the New York UCC shall have the meanings assigned to them in the New York UCC; provided that to the extent that the New York UCC is used to define any capitalized terms used herein and if such term is defined differently in different Articles of the New York UCC, the definition of such term contained in Article 9 of the New York UCC shall govern. Capitalized terms used in this Agreement and not otherwise defined shall have the meanings assigned to them in the Credit Agreement.
(a) The rules of construction specified in SectionΒ 1.02 of the Credit Agreement also apply to this Agreement.
SECTION 1.02. Other Defined Terms. As used in this Agreement, the following terms have the meanings specified below:
βAdministrative Agentβ shall have the meaning assigned to such term in the preliminary statement.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βArticle 9 Collateralβ shall have the meaning assigned to such term in SectionΒ 4.01.
βBankruptcy Lawβ shall mean the Bankruptcy Code or any other foreign, federal or state bankruptcy, insolvency, receivership or similar law.
βBorrowerβ shall have the meaning assigned to such term in the preamble.
βBorrower Obligationsβ shall mean all Obligations of the Borrower.
βCollateralβ shall mean the Article 9 Collateral and the Pledged Collateral.
βCollateral Agentβ shall have the meaning assigned to such term in the preamble.
βCopyright Licenseβ shall mean any written agreement, now or hereafter in effect, granting any right to any third person under any Copyright now or hereafter owned by any Grantor or that such Grantor otherwise has the right to license, or granting any right to any Grantor under any Copyright now or hereafter owned by any third person, and all rights of such Grantor under any such agreement.
βCopyrightsβ shall mean all of the following now owned or hereafter acquired by any Grantor: (a)Β all copyright rights in any work subject to the copyright laws of the United States or any other country, whether as author, assignee, transferee or otherwise and all tangible and intangible property embodied therein, and (b)Β all registrations and applications for registration of any such copyright in the United States or any other country, including registrations, recordings, supplemental registrations and pending applications for registration in the United States Copyright Office (or any successor office or any similar office in any other country), including those listed on Schedule III.
βCredit Agreementβ shall have the meaning assigned to such term in the preliminary statement.
βExcluded Accountsβ shall mean (i)Β deposit accounts or securities accounts which have been established and are used in the ordinary course for the sole purpose of making payroll and withholding tax payments related thereto and other employee wage and benefit payments to or for the benefit of a Grantorβs employees and unpaid employee compensation (including salaries, wages, benefits, health savings and expense reimbursements); provided that, with respect to payroll accounts only, the aggregate amount on deposit in all such deposit accounts or securities accounts does not exceed 150% of the payment obligations described in this clause (i)Β for the current pay period), (ii)Β zero balance accounts, (iii)Β any βpolitical action committeeβ account that contains solely proceeds of donations from third parties and employees of Holdings or any of its Subsidiaries, (vi)Β trust accounts and (v)Β any deposit account or securities account for the sole purpose of holding cash that serves as collateral or security for letters of credit issued under agreements permitted under SectionΒ 6.01(iii)(b) of the Credit Agreement; provided that the aggregate amount on deposit in all such deposit accounts or securities accounts does not exceed 105% of the aggregate face amount of such letters of credit.
Β
2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βExcluded Assetsβ shall mean (a)Β property subject to a purchase money security interest or Capital Lease Obligations permitted under the Credit Agreement, (b)Β any governmental licenses or state or local franchises, charters and authorizations, to the extent security interests in such licenses, franchises, charters or authorizations are prohibited or restricted thereby (other than to the extent that any such term would be rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the New York UCC (or any successor provision or provisions) of any relevant jurisdiction, in each case, unless preempted), (c)Β any lease, license, contract, property rights or agreement to which any Grantor is a party or any of its rights, properties or interests thereunder if and for so long as the grant of such security interest shall constitute or result in (i)Β the abandonment, invalidation, unenforceability or violation of any right, title or interest of any Grantor or any of its Affiliates therein or (ii)Β in a breach or termination pursuant to the terms of, or otherwise require consent under, any such lease, license, contract property rights or agreement (other than, in either case, to the extent that any such term would be rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the New York UCC (or any successor provision or provisions) of any relevant jurisdiction), (d)Β any assets or property to the extent granting, creating or perfecting a pledge, security interest or Lien on such asset or property is prohibited or restricted by applicable law, order or regulation (including, without limitation, any requirement to obtain the consent or approval of any Governmental Authority or third Person); provided, that the foregoing exclusions in this clause (d)Β shall in no way be construed to apply to the extent that the prohibition is unenforceable under Sections 9406, 9-407, 9-408 or 9-409 of the New York UCC (or any successor provision or provisions) of any relevant jurisdiction), (e)Β any Excluded Accounts, (f)Β any Excluded Equity Interests (g)Β any real property or real property interests (including, without limitation, leasehold interests) other than Material Domestic Real Property, (h)Β any asset or property with respect to which the Collateral Agent and the Borrower mutually determine that the costs of obtaining a security interest or Lien therein exceeds the practical benefit to the Lenders of the security afforded thereby, (i)Β any Identified Excluded Assets, (j)Β all commercial tort claims (as defined in the UCC) in an amount less than or equal to $750,000 in the aggregate, and (k)Β any intent-to-use trademark application, solely during the period in which the grant of a security interest therein would impair the validity or enforceability of, or render void or voidable or result in the abandonment or cancellation of the applicable Grantorβs right, title or interest in, such intent-to-use trademark application or any Trademark issued as a result of such use trademark application under applicable federal law, after which period such application shall be automatically subject to the security interest granted herein and deemed to be included in the Article 9 Collateral.
βFederal Securities Lawsβ shall have the meaning assigned to such term in SectionΒ 5.04.
βGrantorsβ shall mean the Borrower and the Guarantors.
βGuaranteed Obligationsβ shall have the meaning assigned to such term in SectionΒ 2.01.
βGuarantor Obligationsβ shall mean, with respect to any Guarantor, all Obligations of such Guarantor (including Obligations which may arise under Article II).
βGuarantorsβ shall mean Holdings and the Subsidiary Guarantors.
Β
3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βHoldingsβ shall have the meaning assigned to such term in the preamble.
βIdentified Excluded Assetsβ shall mean foreign assets (other than Equity Interest) of the Grantors the granting of a Security Interest under this Agreement in which (together with the filing of a UCC financing statement) could reasonably be expected to result in adverse tax consequences to the Loan Parties and previously identified in writing to the Collateral Agent; provided, that, to the extent one or more foreign assets so identified would cause the aggregate value of all βIdentified Excluded Assetsβ to exceed 10% of Consolidated Total Assets, such foreign assets shall have been reasonably approved by the Collateral Agent (acting in good faith); provided, that, in no event shall any Material Foreign Asset constitute an Identified Excluded Asset.
βLicenseβ shall mean any Patent License, Trademark License, Copyright License or other license or sublicense agreement relating to Intellectual Property to which any Grantor is a party, including those listed on Schedule III.
βMotor Vehiclesβ shall mean all cars, trucks, trailers, construction and earth moving equipment and other vehicles covered by a certificate of title under the laws of any state, all tires and all other appurtenances to any of the foregoing.
βNew York UCCβ shall mean the Uniform Commercial Code as from time to time in effect in the State of New York.
βPatent Licenseβ shall mean any written agreement, now or hereafter in effect, granting to any third person any right to make, use or sell any invention on which a Patent, now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, is in existence, or granting to any Grantor any right to make, use or sell any invention on which a Patent, now or hereafter owned by any third person, is in existence, and all rights of any Grantor under any such agreement.
βPatentsβ shall mean all of the following now owned or hereafter acquired by any Grantor: (a)Β all letters patent of the United States or the equivalent thereof in any other country, all registrations and recordings thereof, and all applications for letters patent of the United States or the equivalent thereof in any other country, including registrations, recordings and pending applications in the United States Patent and Trademark Office (or any successor or any similar offices in any other country), including those listed on Schedule III, and (b)Β all reissues, continuations, divisions, continuations-in-part, renewals or extensions thereof, and the inventions disclosed or claimed therein, including the right to make, use and/or sell the inventions disclosed or claimed therein.
βPerfection Certificateβ shall mean a certificate substantially in the form of Exhibit B, completed and supplemented with the schedules and attachments contemplated thereby, and duly executed by a Responsible Officer of the applicable Grantor.
βPledged Collateralβ shall have the meaning assigned to such term in SectionΒ 3.01.
Β
4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βPledged Debt Securitiesβ shall have the meaning assigned to such term in SectionΒ 3.01.
βPledged Securitiesβ shall mean any promissory notes, stock certificates or other securities now or hereafter included in the Pledged Collateral, including all certificates, instruments or other documents representing or evidencing any Pledged Collateral.
βPledged Stockβ shall have the meaning assigned to such term in SectionΒ 3.01.
βSecured Obligationsβ shall mean (i)Β in the case of the Borrower, the Borrower Obligations and (ii)Β in the case of any Guarantor, its Guarantor Obligations.
βSecured Partiesβ shall mean (a)Β the Lenders, (b)Β the Administrative Agent, (c)Β the Collateral Agent, (d)Β the beneficiaries of each indemnification obligation undertaken by any Loan Party under any Loan Document and (e)Β the successors and assigns of each of the foregoing.
βSecurity Interestβ shall have the meaning assigned to such term in SectionΒ 4.01.
βSubsidiary Guarantorβ shall mean (a)Β each Subsidiary of the Borrower identified on Schedule I hereto as a Subsidiary Guarantor and (b)Β each other Wholly-Owned Subsidiary that is a Domestic Subsidiary that becomes a party to this Agreement as a Subsidiary Guarantor after the Closing Date in accordance with the Credit Agreement.
βTrademark Licenseβ shall mean any written agreement, now or hereafter in effect, granting to any third person any right to use any Trademark now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, or granting to any Grantor any right to use any Trademark now or hereafter owned by any third person, and all rights of any Grantor under any such agreement.
βTrademarksβ shall mean all of the following now owned or hereafter acquired by any Grantor: (a)Β all trademarks, service marks, trade names, internet domain names, corporate names, company names, business names, fictitious business names, trade styles, trade dress, designs, logos, slogans (and all translations, adaptations, derivations and combinations of the foregoing), indicia and other source or business identifiers, designs and general intangibles of like nature, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all registration and recording applications filed in connection therewith, including registrations and registration applications in the United States Patent and Trademark Office (or any successor office) or any similar offices in any State of the United States or any other country or any political subdivision thereof, and all extensions or renewals thereof, including those listed on Schedule III, (b)Β all goodwill associated therewith or symbolized thereby and (c)Β all other assets, rights and interests that uniquely reflect or embody such goodwill.
βTrademark Security Agreementβ shall mean an agreement substantially in the form of Exhibit E hereto.
Β
5
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βUnfunded Advancesβ shall mean with respect to the Administrative Agent, the aggregate amount, if any (i)Β made available to the Borrower on the assumption that each Lender has made its portion of the applicable borrowing available to the Administrative Agent as contemplated by SectionΒ 2.02(b) of the Credit Agreement and (ii)Β with respect to which a corresponding amount shall not in fact have been returned to the Administrative Agent by the Borrower or made available to the Administrative Agent by any such Lender.
SECTION 1.03. Independence of Covenants. All covenants hereunder shall be given independent effect so that if a particular action or condition is not permitted by any of such covenants, the fact that it would be permitted as an exception to, or would otherwise be within the limitations of, another covenant shall not avoid the occurrence of an Event of Default or Default of such action is taken or condition exists.
ARTICLE II
Guarantee
SECTION 2.01. Guarantee. Each Guarantor unconditionally guarantees, jointly with the other Guarantors and severally, as a primary obligor and not merely as a surety, the due and punctual payment and performance of the Borrower Obligations (the βGuaranteed Obligationsβ) when the same shall become due, whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise (including amounts that would become due but for the operation of the automatic stay under SectionΒ 362(a) of the Bankruptcy Code). Each Guarantor further agrees that the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice to or further assent from it, and that it will remain bound upon its guarantee notwithstanding any extension or renewal of any Guaranteed Obligation. Each Guarantor waives presentment to, demand of payment from and protest to the Borrower or any other Loan Party of any Guaranteed Obligation, and also waives notice of acceptance of its guarantee and notice of protest for nonpayment. Notwithstanding anything contained herein to the contrary, the Obligations of each Subsidiary Guarantor at any time shall be limited to the maximum amount as will result in the Obligations of such Subsidiary Guarantor under this Agreement not constituting a fraudulent transfer or conveyance for purposes of any Bankruptcy Law to the extent applicable to this Agreement and the Obligations of such Subsidiary Guarantor hereunder
SECTION 2.02. Guarantee of Payment. Each Guarantor further agrees that its guarantee hereunder constitutes a guarantee of payment when due and not of collection, and waives any right to require that any resort be had by the Collateral Agent or any other Secured Party to any security held for the payment of the Guaranteed Obligations or to any balance of any Deposit Account or credit on the books of the Collateral Agent or any other Secured Party in favor of the Borrower or any other Person.
SECTION 2.03. No Limitations, Etc. (a)Β Except for termination of a Guarantorβs obligations hereunder as expressly provided in SectionΒ 7.16, the obligations of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason (other than the payment in full in cash of the Guaranteed Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations) and a partial payment in cash of the Guaranteed Obligations), including any claim of
Β
6
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
waiver, release, surrender, alteration or compromise, and shall not be subject to any defense or setoff, counterclaim, recoupment or termination whatsoever by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, the obligations of each Guarantor hereunder shall be valid and enforceable and shall not be discharged, terminated, reduced, impaired or otherwise affected by, whether Guarantor shall have had notice or knowledge of any of them, (i)Β the failure or omission of the Collateral Agent or any other Secured Party to assert any claim or demand or to enforce any right or remedy under the provisions of any Loan Document or applicable law, (ii)Β any rescission, waiver, amendment or modification of, or any release from any of the terms or provisions of, any Loan Document, including with respect to any other Guarantor under this Agreement, (iii)Β the release of, or any impairment of or failure to perfect any Lien on or security interest in, any security held by the Collateral Agent or any other Secured Party for the Guaranteed Obligations or any of them, (iv)Β any default, failure or delay, willful or otherwise, in the performance of the Guaranteed Obligations, (v)Β the existence of any dispute between the Borrower and any Secured Party with respect to the existence of any Event of Default, (vi)Β any defenses, set offs or counterclaims which the Borrower may allege or assert against any Secured Party in respect of the Obligations, including failure of consideration, breach of warranty, payment, statute of frauds, statute of limitations, accord and satisfaction and usury or (vii)Β any other act or omission that may or might in any manner or to any extent vary the risk of any Guarantor or otherwise operate as a discharge of any Guarantor as a matter of law or equity (other than the payment in full in cash of all the Guaranteed Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations)). Each Guarantor expressly authorizes the Collateral Agent to take and hold security for the payment and performance of the Guaranteed Obligations, to exchange, waive or release any or all such security (with or without consideration), to enforce or apply such security and direct the order and manner of any sale thereof in its sole discretion or to release or substitute any one or more other guarantors or obligors upon or in respect of the Guaranteed Obligations, all without affecting the obligations of any Guarantor hereunder.
(b) To the fullest extent permitted by applicable law, each Guarantor waives any defense based on or arising out of any defense of the Borrower or any other Loan Party or the unenforceability of the Guaranteed Obligations or any part thereof from any cause, or the cessation from any cause of the liability of the Borrower or any other Loan Party, other than a defense (i)Β of the payment in full in cash of all the Guaranteed Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations) or (ii)Β that no Guaranteed Obligations are yet due and payable. The Collateral Agent may, at its election, upon the occurrence and during the continuance of an Event of Default, in accordance with the Loan Documents and applicable law, foreclose on any security held by any Secured Party by one or more judicial or nonjudicial sales, accept an assignment of any such security in lieu of foreclosure, compromise or adjust any part of the Guaranteed Obligations, make any other accommodation with the Borrower or any other Loan Party or exercise any other right or remedy available to it against the Borrower or any other Loan Party, without affecting or impairing in any way the liability of any Guarantor hereunder except to the extent the Guaranteed Obligations have been fully and paid in full in cash (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations). To the fullest extent permitted by applicable law, each Guarantor waives for the benefit of the Secured Parties: (i)Β any right to
Β
7
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
require any Secured Party, as a condition of payment or performance by such Guarantor, to (A)Β proceed against the Borrower, any other guarantor (including any other Guarantor) of the Obligations or any other Person, (B)Β proceed against or exhaust any security held from the Borrower, any such other guarantor or any other Person, (C)Β proceed against or have resort to any balance of any Deposit Account or credit on the books of any Secured Party in favor of the Borrower or any other Person, or (D)Β pursue any other remedy in the power of any Secured Party whatsoever; (ii)Β any defense arising by reason of the incapacity, lack of authority or any disability or other defense of the Borrower or any other Guarantor including any defense based on or arising out of the lack of validity or the unenforceability of the Obligations or any agreement or instrument relating thereto or by reason of the cessation of the liability of the Borrower or any other Guarantor from any cause other than the payment in full in cash of the Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations); (iii)Β any defense based upon any statute or rule of law which provides that the obligation of a surety must be neither larger in amount nor in other respects more burdensome than that of the principal; (iv)Β any defense based upon any Secured Partyβs errors or omissions in the administration of the Obligations; (v)Β (A)Β any principles or provisions of law, statutory or otherwise, which are or might be in conflict with the terms hereof and any legal or equitable discharge of such Guarantorβs obligations hereunder, (B)Β the benefit of any statute of limitations affecting such Guarantorβs liability hereunder or the enforcement hereof, (C)Β any rights to set offs, recoupments and counterclaims, and (D)Β promptness, diligence and any requirement that any Secured Party protect, secure, perfect or insure any security interest or lien or any property subject thereto; (vi)Β notices, demands, presentments, protests, notices of protest, notices of dishonor and notices of any action or inaction, including acceptance hereof, notices of default hereunder, notices of any renewal, extension or modification of the Obligations or any agreement related thereto, notices of any extension of credit to the Borrower and notices of any of the matters referred to in this SectionΒ 2.03 and any right to consent to any thereof; and (vii)Β any defenses or benefits that may be derived from or afforded by law which limit the liability of or exonerate guarantors or sureties, or which may conflict with the terms hereof.
(c) Each Guarantor agrees that its obligations hereunder are irrevocable, absolute, independent and unconditional and shall not be affected by any circumstance which constitutes a legal or equitable discharge of a guarantor or surety other than the payment in full in cash of the Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations). In furtherance of the foregoing and without limiting the generality thereof, each Guarantor agrees as follows:
(i)Β Each Guarantor agrees the obligations of each Guarantor hereunder are independent of the obligations of the Borrower and the obligations of any other guarantor (including any other Guarantor) of the obligations of the Borrower, and a separate action or actions may be brought and prosecuted against such Guarantor whether or not any action is brought against the Borrower or any of such other guarantors and whether or not the Borrower is joined in any such action or actions;
(ii)Β payment by any Guarantor of a portion, but not all, of the Obligations shall in no way limit, affect, modify or abridge any Guarantorβs liability for any portion of the Obligations which has not been paid; and without limiting the generality of the foregoing, if the Collateral Agent is awarded a judgment in any suit brought to enforce
Β
8
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
any Guarantorβs covenant to pay a portion of the Obligations, such judgment shall not be deemed to release such Guarantor from its covenant to pay the portion of the Obligations that is not the subject of such suit, and such judgment shall not, except to the extent satisfied by such Guarantor, limit, affect, modify or abridge any other Guarantorβs liability hereunder in respect of the Obligations; and
(iii)Β any Secured Party, upon such terms as it deems appropriate, without notice or demand and without affecting the validity or enforceability hereof or giving rise to any reduction, limitation, impairment, discharge or termination of any Guarantorβs liability hereunder, from time to time may (a)Β renew, extend, accelerate, increase the rate of interest on, or otherwise change the time, place, manner or terms of payment of the Obligations; (b)Β settle, compromise, release or discharge, or accept or refuse any offer of performance with respect to, or substitutions for, the Obligations or any agreement relating thereto and/or subordinate the payment of the same to the payment of any other obligations; (c)Β request and accept other guaranties of the Obligations and take and hold security for the payment hereof or the Obligations; (d)Β release, surrender, exchange, substitute, compromise, settle, rescind, waive, alter, subordinate or modify, with or without consideration, any security for payment of the Obligations, any other guaranties of the Guaranteed Obligations, or any other obligation of any Person (including any other Guarantor) with respect to the Obligations; (e)Β enforce and apply any security now or hereafter held by or for the benefit of such Secured Party in respect hereof or the Obligations and direct the order or manner of sale thereof, or exercise any other right or remedy that such Secured Party may have against any such security, in each case as such Secured Party in its discretion may determine consistent herewith and any applicable security agreement, including foreclosure on any such security pursuant to one or more judicial or nonjudicial sales, whether or not every aspect of any such sale is commercially reasonable, and even though such action operates, pursuant to applicable law, to impair or to extinguish any right of reimbursement or subrogation or other right or remedy of any Guarantor against the Borrower or any security for the Obligations; and (f)Β exercise any other rights or remedies available to it under the Loan Documents.
SECTION 2.04. Reinstatement. Each Guarantor agrees that its guarantee hereunder shall continue to be effective or be reinstated, as the case may be, if at any time payment, or any part thereof, of any Guaranteed Obligation is rescinded or must otherwise be restored by the Collateral Agent or any other Secured Party upon the bankruptcy or reorganization of the Borrower, any other Loan Party or otherwise.
SECTION 2.05. Agreement To Pay; Subrogation. In furtherance of the foregoing and not in limitation of any other right that the Collateral Agent or any other Secured Party has at law or in equity against any Guarantor by virtue hereof, upon the failure of the Borrower or any other Loan Party to pay any Guaranteed Obligation when and as the same shall become due and payable, whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise (including amounts that would become due but for the operation of the automatic stay under SectionΒ 362(a) of the Bankruptcy Code), each Guarantor hereby promises to and will forthwith pay, or cause to be paid, to the Collateral Agent for distribution to the applicable Secured Parties in cash the amount of such unpaid Obligation plus any accrued and unpaid interest on such Obligation (including interest which, but for the
Β
9
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Borrowerβs becoming the subject of a case under the Bankruptcy Code, would have accrued on such Obligations whether or not a claim is allowed against the Borrower for such interest in the related bankruptcy case). Upon payment by any Guarantor of any sums to the Collateral Agent as provided above, all rights of such Guarantor against the Borrower or any other Guarantor arising as a result thereof by way of right of subrogation, contribution, reimbursement, indemnity or otherwise shall in all respects be subject to Article VI. If any payment shall be required to be made to any Secured Party under this Agreement, each Guarantor hereby unconditionally and irrevocably agrees it will contribute, to the maximum extent permitted by law, such amounts to each other Guarantor and the Borrower so as to maximize the aggregate amount paid to the Secured Parties under or in connection with the Loan Documents.
SECTION 2.06. Information. Each Guarantor assumes all responsibility for being and keeping itself informed of the Borrowerβs and each other Loan Partyβs financial condition and assets and of all other circumstances bearing upon the risk of nonpayment of the Guaranteed Obligations and the nature, scope and extent of the risks that such Guarantor assumes and incurs hereunder, and agrees that neither the Collateral Agent nor any other Secured Party will have any duty to advise such Guarantor of information known to it or any of them regarding such circumstances or risks.
ARTICLE III
Pledge of Securities
SECTION 3.01. Pledge. As security for the payment or performance, as the case may be, in full of the Secured Obligations, each Grantor hereby assigns and pledges to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Parties, and hereby grants to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Parties, a security interest in, all of such Grantorβs right, title and interest in, to and under (a)(i) the Equity Interests owned by such Grantor on the date hereof (including all such Equity Interests listed on Schedule II), (ii)Β any other Equity Interests obtained in the future by such Grantor and (iii)Β the certificates representing all such Equity Interests (all the foregoing collectively referred to herein as the βPledged Stockβ); provided that, notwithstanding anything to the contrary, βPledged Stockβ shall not include any Excluded Equity, (b)(i) the debt securities held by such Grantor on the date hereof (including all such debt securities listed opposite the name of such Grantor on Schedule II), (ii)Β any debt securities in the future issued to such Grantor and (iii)Β the promissory notes and any other instruments evidencing such debt securities (all the foregoing collectively referred to herein as the βPledged Debt Securitiesβ), (c)Β subject to SectionΒ 3.06, all payments of principal or interest, dividends, cash, instruments and other property from time to time received, receivable or otherwise distributed in respect of, in exchange for or upon the conversion of, and all other Proceeds received in respect of, the securities referred to in clauses (a)Β and (b)Β above, (d)Β subject to SectionΒ 3.06, all rights and privileges of such Grantor with respect to the securities and other property referred to in clauses (a), (b)Β and (c)Β above, and (e)Β all Proceeds of any of the foregoing (the items referred to in clauses (a)Β through (e)Β above being collectively referred to as the βPledged Collateralβ); subject, however, to the terms, covenants and conditions hereinafter set forth.
Β
10
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 3.02. Perfection of the Pledged Collateral.
(a) Each Grantor agrees promptly (and in any event within five (5)Β Business Days of issuance (or such later date as permitted by Collateral Agent in its sole discretion)) to deliver or cause to be delivered to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement) any and all βsecurity certificatesβ (as defined in Article 8 of the New York UCC) representing or evidencing Pledged Stock of a Person that is a corporation, or if such Person is a limited liability company or limited partnership, solely to the extent its Equity Interests constitute βsecuritiesβ governed by Article 8 of the New York UCC (such Pledged Stock so represented by security certificates, the βCertificated Pledged Stockβ).
(b) Each Grantor agrees promptly (and in any event within five (5)Β Business Days of issuance (or such later date as permitted by Collateral Agent in its sole discretion)) to deliver or cause to be delivered to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement) any and all Pledged Debt Securities (other than (i)Β intercompany notes between Grantors and (ii)Β intercompany notes with a principal amount of less than $500,000) with a principal amount of at least $250,000 (provided that in no event shall the principal amount of all Pledged Debt Securities excluded by operation of the foregoing minimum threshold exceed $1,000,000 in the aggregate); provided that, notwithstanding the foregoing, Instruments evidencing loans and advances to officers and employees of any Grantor permitted under Sections 6.04(v) and 6.04(xi) of the Credit Agreement, shall not be required to be delivered to the Collateral Agent unless requested by the Collateral Agent following an Event of Default.
(c) Upon delivery to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement), (i)Β any Certificated Pledged Stock shall be accompanied by undated stock powers duly executed in blank or other undated instruments of transfer reasonably satisfactory to the Collateral Agent and duly executed in blank and by such other instruments and documents as the Collateral Agent may reasonably request and (ii)Β subject to Sections 3.02(a) and (b), all other property comprising part of the Pledged Collateral which is required to be delivered to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement) shall be accompanied by proper instruments of assignment duly executed by the applicable Grantor and such other instruments or documents as the Collateral Agent may reasonably request. To the extent necessary to maintain the accuracy of Schedule II, each delivery of Certificated Pledged Stock shall be accompanied with an update to Schedule II; provided that failure to update such schedule hereto shall not affect the validity of the pledge of such Certificated Pledged Stock.
(d) Each Grantor hereby agrees that if any of the Pledged Stock is at any time not evidenced by securities certificates (βUncertificated Pledged Stockβ), then each applicable Grantor shall, to the extent permitted by applicable law and upon the reasonable request of the Collateral Agent, cause such pledge to be recorded on the equityholder register or the books of the issuer, execute customary pledge forms or other documents necessary to perfect the Collateral Agentβs Lien in such Uncertificated Pledged Stock and give the Collateral Agent the right to transfer such Uncertificated Pledged Stock under the terms hereof, or alternatively, the applicable Grantor may issue βsecurity certificatesβ (as defined in Article 8 of the New York UCC) for such Pledged Stock. To the extent necessary to maintain the accuracy of Schedule II, Schedule II shall be updated upon each such action with respect to Uncertificated Pledged Stock; provided that failure to update such schedule hereto shall not affect the validity of the pledge of such Uncertificated Pledged Stock.
Β
11
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 3.03. Representations, Warranties and Covenants. The Grantors jointly and severally represent, warrant and covenant to and with the Collateral Agent, for the benefit of the Secured Parties, that:
(a)Β Schedule II correctly sets forth the percentage of the issued and outstanding shares of each class of the Equity Interests of the issuer thereof represented by such Pledged Stock and includes all Equity Interests, debt securities and promissory notes required to be pledged hereunder;
(b)Β the Pledged Stock and Pledged Debt Securities have been duly and validly authorized and issued by the issuers thereof and (i)Β in the case of Pledged Stock, are fully paid and nonassessable and (ii)Β in the case of Pledged Debt Securities, are legal, valid and binding obligations of the issuers thereof;
(c)Β except for the security interests granted hereunder, each Grantor (i)Β is and, subject to any transfers made in compliance with the Credit Agreement, will continue to be the direct owner, beneficially and of record, of the Pledged Securities indicated on Schedule II as owned by such Grantor, (ii)Β holds the same free and clear of all Liens, other than Liens created under the Revolving Loan Documents and Liens permitted by SectionΒ 6.02 of the Credit Agreement, (iii)Β will make no assignment, pledge, hypothecation or transfer of, or create or permit to exist any security interest in or other Lien on, the Pledged Collateral, other than as made in compliance with the Credit Agreement, and (iv)Β subject to SectionΒ 3.02(a) and (b)Β and SectionΒ 3.06, will cause any and all Pledged Collateral, whether for value paid by such Grantor or otherwise, to be forthwith (and in any event within five (5)Β Business Days of issuance (or such later date as permitted by Collateral Agent in its sole discretion)) deposited with the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement) and pledged or assigned hereunder;
(d)Β except for restrictions and limitations imposed by the Loan Documents or securities laws generally, the Pledged Collateral is and will continue to be freely transferable and assignable, and none of the Pledged Collateral is or will be subject to any option, right of first refusal, shareholders agreement, charter or by-law provisions or contractual restriction of any nature that might prohibit, impair, delay or otherwise affect the pledge of such Pledged Collateral hereunder, the sale or disposition thereof pursuant hereto or the exercise by the Collateral Agent of rights and remedies hereunder;
(e)Β each Grantor (i)Β has the power and authority to pledge the Pledged Collateral pledged by it hereunder in the manner hereby done or contemplated and (ii)Β will defend its title or interest thereto or therein against any and all Liens (other than any Lien created hereunder, any Lien created under the Revolving Loan Documents, or otherwise permitted by SectionΒ 6.02 of the Credit Agreement), however arising, of all Persons whomsoever;
Β
12
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(f) no consent or approval of any Governmental Authority, any securities exchange or any other Person is necessary with respect to the validity of the pledge effected hereby (other than such as have been obtained and are in full force and effect);
(g)Β by virtue of the execution and delivery by each Grantor of this Agreement, when any Pledged Collateral that is required to be delivered to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement) in accordance with this Agreement is delivered to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement) in accordance with this Agreement, together with such undated powers (or other relevant document of transfer reasonably acceptable to Borrower and Collateral Agent) endorsed in blank as shall be requested by the Collateral Agent, the Collateral Agent will obtain a legal, valid and perfected first priority (subject to the Intercreditor Agreement) lien and security interest in such Pledged Collateral as security for the payment and performance of the Secured Obligations (other than Liens otherwise permitted under SectionΒ 6.02 of the Credit Agreement); and
(h)Β the pledge effected hereby is effective to vest in the Collateral Agent, for the ratable benefit of the Secured Parties, the rights of the Collateral Agent in the Pledged Collateral as set forth herein and all action by any Grantor necessary to protect and perfect the Lien on the Pledged Collateral has been duly taken.
SECTION 3.04. Certification of Limited Liability Company Interests and Limited Partnership Interests. No interest in any limited liability company or limited partnership that is a Subsidiary and pledged hereunder shall be represented by a certificate or shall be a βsecurityβ within the meaning of Article 8 of the New York UCC.
SECTION 3.05. Registration in Nominee Name; Denominations. The Collateral Agent, on behalf of the Secured Parties, shall have the right (in its sole and absolute discretion) to hold the Pledged Securities in its own name as pledgee, the name of its nominee (as pledgee or as sub-agent) or the name of the applicable Grantor, endorsed or assigned in blank or in favor of the Collateral Agent. Each Grantor will promptly (and in any event within ten (10)Β Business Days (or such later date as permitted by Collateral Agent in its sole discretion)) give to the Collateral Agent copies of any material notices or other material communications received by it with respect to Pledged Securities in its capacity as the registered owner thereof. The Collateral Agent shall at all times have the right to exchange the certificates representing Certificated Pledged Stock for certificates of smaller or larger denominations for any purpose consistent with this Agreement.
SECTION 3.06. Voting Rights; Dividends and Interest, Etc. (a)Β Unless and until an Event of Default shall have occurred and be continuing and the Collateral Agent shall have given the Grantors not less than two (2)Β Business Daysβ prior written notice of its intent to exercise its rights under this Agreement, subject to the Intercreditor Agreement:
(i)Β Each Grantor shall be entitled to exercise any and all voting and/or other consensual rights and powers inuring to an owner of Pledged Securities or any part thereof for any purpose consistent with the terms of this Agreement, the Credit Agreement and the other Loan Documents;
Β
13
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(ii) The Collateral Agent shall execute and deliver to each Grantor, or cause to be executed and delivered to each Grantor, all such proxies, powers of attorney and other instruments as such Grantor may reasonably request for the purpose of enabling such Grantor to exercise the voting and/or consensual rights and powers it is entitled to exercise pursuant to paragraph (i)Β above.
(iii) Each Grantor shall be entitled to receive and retain any and all dividends, interest, principal and other distributions paid on or distributed in respect of the Pledged Securities to the extent and only to the extent that such dividends, interest, principal and other distributions are not prohibited by, and otherwise paid or distributed in accordance with, the terms and conditions of the Credit Agreement, the other Loan Documents and applicable law; provided, however, that any noncash dividends, interest, principal or other distributions that would constitute Pledged Stock or Pledged Debt Securities of the type required to be delivered to the Collateral Agent (or the Revolving Loan Agent) in accordance with paragraphs (a)Β and (b)Β of SectionΒ 3.02, whether resulting from a subdivision, combination or reclassification of the outstanding Equity Interests of the issuer of any Pledged Securities or received in exchange for Pledged Securities or any part thereof, or in redemption thereof, or as a result of any merger, consolidation, acquisition or other exchange of assets to which such issuer may be a party or otherwise, shall, subject to the terms and conditions of this Agreement, be and become part of the Pledged Collateral, and, if received by any Grantor, shall be held separate and apart by such Grantor from any of its other funds or property, shall be held in trust for the ratable benefit of the Secured Parties and the Revolving Loan Agent and shall be promptly (and in any event within ten (10)Β Business Days (or such later date as permitted by Collateral Agent in its sole discretion)) delivered to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement) in the same form as so received (with any necessary endorsement or instrument of assignment).
(iv) The Collateral Agent shall execute and deliver to each Grantor, or cause to be executed and delivered to each Grantor, all such instruments as such Grantor may reasonably request for the purpose of enabling such Grantor to receive the dividends, interest, principal and other distributions which it is entitled to exercise pursuant to paragraph (iii)Β above.
(b) Upon the occurrence and during the continuance of an Event of Default, after the Collateral Agent shall have given the Grantors not less than two (2)Β Business Daysβ prior written notice, subject to the Intercreditor Agreement, of the suspension of their rights under paragraph (a)(iii) of this SectionΒ 3.06, then all rights of any Grantor to dividends, interest, principal or other distributions that such Grantor is authorized to receive pursuant to paragraph (a)(iii) of this SectionΒ 3.06 shall cease, and, subject to the Intercreditor Agreement, all such rights shall thereupon become vested in the Collateral Agent and the Revolving Loan Agent subject to the provisions of the Intercreditor Agreement, which, together, shall have the sole and exclusive right and authority to receive and retain such dividends, interest, principal or other distributions. After such an Event of Default is no longer continuing, each Grantor shall have the right to receive the dividends, interest, principal or other distributions which it would be authorized to
Β
14
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
receive and retain pursuant to paragraph (a)(iii) of this SectionΒ 3.06. All dividends, interest, principal or other distributions received by any Grantor contrary to the provisions of this SectionΒ 3.06 shall be held separate and apart by such Grantor from any of its other funds or property and shall be held in trust for the benefit of the Collateral Agent and the Revolving Loan Agent shall be forthwith delivered to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement)in the same form as so received (with any necessary endorsement or instrument of assignment). Any and all money and other property paid over to or received by the Collateral Agent pursuant to the provisions of this paragraph (b)Β shall be retained by the Collateral Agent in an account to be established by the Collateral Agent upon receipt of such money or other property and shall be applied in accordance with the provisions of SectionΒ 5.02. After all Events of Default have been cured or waived and each applicable Grantor has delivered to the Administrative Agent certificates to that effect, the Collateral Agent shall, promptly after all such Events of Default have been cured or waived, repay to each applicable Grantor (without interest) all dividends, interest, principal or other distributions that such Grantor would otherwise be permitted to retain pursuant to the terms of paragraph (a)(iii) of this SectionΒ 3.06 and that remain in such account.
(c) Upon the occurrence and during the continuance of an Event of Default, after the Collateral Agent shall have given the Grantors not less than two (2)Β Business Daysβ prior written notice, subject to the Intercreditor Agreement, of the suspension of their rights under paragraph (a)(i) of this SectionΒ 3.06, then all rights of any Grantor to exercise the voting and consensual rights and powers it is entitled to exercise pursuant to paragraph (a)(i) of this SectionΒ 3.06, and the obligations of the Collateral Agent under paragraph (a)(ii) of this SectionΒ 3.06, shall cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall have the sole and exclusive right and authority to exercise such voting and consensual rights and powers, until no Event of Default is continuing; provided that the Collateral Agent shall have the right, in its sole discretion, from time to time following the occurrence and continuance of an Event of Default and after providing the two (2)Β Business Daysβ notice mentioned above to permit such Grantor to exercise such rights under paragraph (a)(i) of this SectionΒ 3.06. After such Event of Default is no longer continuing, each Grantor shall have the right to exercise the voting and consensual rights and powers that it would otherwise be entitled to pursuant to paragraph (a)(i) of this SectionΒ 3.06
ARTICLE IV
Security Interests in Personal Property
SECTION 4.01. Security Interest. (a)Β As security for the payment or performance, as the case may be, in full of the Secured Obligations, each Grantor hereby assigns and pledges to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Parties, and hereby grants to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Parties, a security interest (the βSecurity Interestβ), in all right, title or interest in or to any and all of the following assets and properties now owned or at any time hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the βArticle 9 Collateralβ):
Β
15
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(i) all Accounts;
(ii)Β all Chattel Paper;
(iii) all cash and Deposit Accounts;
(iv)Β all Documents;
(v)Β all Equipment;
(vi)Β all Fixtures;
(vii)Β all General Intangibles;
(viii)Β all Instruments;
(ix)Β all Inventory;
(x)Β all Investment Property;
(xi)Β all Intellectual Property;
(xii)Β all Letter-of-Credit Rights;
(xiii) all Commercial Tort Claims as set forth in Schedule IV;
(xiv)Β all Motor Vehicles;
(xv)Β all books and records pertaining to the Article 9 Collateral; and
(xvi)Β to the extent not otherwise included, all other personal property of each Grantor, all Proceeds and products of any and all of the foregoing and all collateral security and guarantees given by any Person with respect to any of the foregoing;
provided, that, (a)Β notwithstanding anything to the contrary, βArticle 9 Collateralβ shall not include Excluded Assets and (b)Β notwithstanding the foregoing, unless requested by the Collateral Agent following the occurrence and during the continuation of an Event of Default, no Grantor shall be required to take any action to perfect the Security Interest in Motor Vehicles to the extent such Security Interest cannot be perfected solely by the filing of financing statements (or similar documents).
(b) Each Grantor hereby irrevocably (until this Agreement is terminated in accordance with SectionΒ 7.16) authorizes the Collateral Agent at any time and from time to time to file in any relevant jurisdiction as determined by the Collateral Agent in its good faith discretion any initial financing statements (including fixture filings) with respect to the Article 9 Collateral or any part thereof and amendments thereto that (i)Β describe the collateral in the same manner as described herein or contain a description of collateral that describes such property in any other manner as the Collateral Agent may determine, in its sole discretion, is necessary,
Β
16
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
advisable or prudent to ensure the perfection or priority of the security interest in the collateral granted to the Collateral Agent in connection herewith, including, describing such property as βall assets whether now owned or hereafter acquiredβ or βall personal property whether now owned or hereafter acquiredβ (regardless of whether any particular asset comprised in the Collateral falls within the scope of Article 9 of the Uniform Commercial Code) and (ii)Β contain the information required by Article 9 of the Uniform Commercial Code of each applicable jurisdiction for the filing of any financing statement or amendment, including (A)Β whether such Grantor is an organization, the type of organization and any organizational identification number issued to such Grantor and (B)Β in the case of a financing statement filed as a fixture filing, a sufficient description of the real property to which such Article 9 Collateral relates; provided that the Collateral Agent agrees to provide, upon request of any Grantor, written evidence to any Person that a security interest in favor of the Collateral Agent does not extend to any Excluded Assets. Each Grantor agrees to provide such information to the Collateral Agent promptly (and in any event within ten (10)Β Business Days, or such later date as the Agent may agree in its sole discretion) upon reasonable written request.
The Collateral Agent is further authorized to file with the United States Patent and Trademark Office or United States Copyright Office (or any successor office or any similar office in any other country) such documents as may be necessary or advisable for the purpose of perfecting, confirming, continuing, enforcing or protecting the Security Interest granted by each Grantor, and naming any Grantor or the Grantors as debtors and the Collateral Agent as secured party, including the Copyright Security Agreement, the Patent Security Agreement and the Trademark Security Agreement.
(c) The Security Interest is granted as security only and shall not subject the Collateral Agent or any other Secured Party to, or in any way alter or modify, any obligation or liability of any Grantor with respect to or arising out of the Article 9 Collateral.
SECTION 4.02. Representations and Warranties. The Grantors jointly and severally represent and warrant to the Collateral Agent, for the benefit of the Secured Parties, on each date that the representations and warranties in Article III of the Credit Agreement are made, that:
(a)Β The Article 9 Collateral is owned by the Grantors free and clear of any Lien, except for Liens expressly permitted pursuant to SectionΒ 6.02 of the Credit Agreement. No Grantor has filed or consented to the filing of (i)Β any financing statement or analogous document under the Uniform Commercial Code or any other applicable laws covering any Article 9 Collateral, (ii)Β any assignment in which any Grantor assigns any Collateral or any security agreement or similar instrument covering any Article 9 Collateral with the United States Patent and Trademark Office or the United States Copyright Office, (iii)Β any notice under the Assignment of Claims Act, or (iv)Β any assignment in which any Grantor assigns any Article 9 Collateral or any security agreement or similar instrument covering any Article 9 Collateral with any foreign governmental, municipal or other office, which financing statement or analogous document, assignment, security agreement or similar instrument is still in effect, except, in each case, for Liens expressly permitted pursuant to SectionΒ 6.02 of the Credit Agreement. No Grantor holds any Commercial Tort Claims in an amount reasonably estimated to exceed $250,000 individually or $750,000 in the aggregate except as indicated on Schedule IV.
Β
17
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(b) As of the date hereof, each Grantor has good and valid rights in and title to substantially all of the Article 9 Collateral with respect to which it has purported to grant a Security Interest hereunder and no consent or approval of any other Person is required for the grant of the security interest by such Grantor of the Collateral pledged by it pursuant to this Security Agreement, except for (a)Β such consents which have been obtained prior to the date hereof and (b)Β in the case of any Collateral located in or governed by law in a jurisdiction outside the United States, such actions as may be required by applicable foreign laws affecting the grant of the security interest in such Collateral.
(c) The Perfection Certificate has been duly executed and the information set forth therein (including (x)Β the exact legal name of each Grantor and (y)Β the jurisdiction of organization of each Grantor) is correct and complete in all material respects as of the Closing Date (or as of such earlier date to the extent such information relates to an earlier date).
(d) On the date hereof, the fair market value of all Motor Vehicles owned by the Grantors does not exceed $200,000.
SECTION 4.03. Covenants.
(a) Each Grantor shall, at its own expense, take any and all actions necessary to defend title to the Article 9 Collateral against all Persons and to defend the Security Interest of the Collateral Agent in the Article 9 Collateral and the priority thereof (subject to the Intercreditor Agreement), against any Lien not otherwise permitted pursuant to SectionΒ 6.02 of the Credit Agreement.
(b) Subject to the limitations expressly set forth herein or in the Credit Agreement, and except where the cost exceeds the practical benefits to the Secured Parties as reasonably and mutually agreed by Borrower and Collateral Agent in accordance with SectionΒ 4.05, each Grantor agrees, at its own expense, promptly to execute, acknowledge, deliver and cause to be duly filed all such further instruments and documents and take all other actions as the Collateral Agent may from time to time reasonably request to better assure, obtain, preserve, protect and perfect the Security Interest and the rights and remedies created hereby, including the payment of any fees and Taxes required in connection with the execution and delivery of this Agreement, the granting of the Security Interest and the filing of any financing or continuation statements (including fixture filings) or other documents in connection herewith or therewith.
Without limiting the generality of the foregoing, each Grantor hereby authorizes the Collateral Agent, with prior written notice thereof to the Grantors, to supplement this Agreement by supplementing Schedule III or adding additional schedules hereto to identify specifically any asset or item of a Grantor that may, in the Collateral Agentβs reasonable judgment, constitute Copyrights, Licenses, Patents or Trademarks; provided that any Grantor shall have the right, exercisable within 10 days after it has been notified by the Collateral Agent of the specific identification of such Collateral, to advise the Collateral Agent in writing of any inaccuracy of the representations and warranties made by such Grantor hereunder with respect to such Collateral. Each Grantor agrees that it will use its best efforts to take such action as shall be necessary in order that all representations and warranties hereunder shall be true and correct with respect to such Collateral within 30 days after the date it has been notified by the Collateral Agent of the specific identification of such Collateral.
Β
18
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Notwithstanding anything herein to the contrary, no foreign law perfection actions or foreign law opinion letters shall be required with respect to any Collateral other than Material Foreign Assets.
(c) At its option, during the continuance of an Event of Default, subject to any applicable provisions in the Interecreditor Agreement, the Collateral Agent may discharge past due Taxes, assessments, charges, fees, Liens, security interests or other encumbrances at any time levied or placed on the Article 9 Collateral and not expressly permitted pursuant to SectionΒ 5.03 or SectionΒ 6.02 of the Credit Agreement, and may pay for the maintenance and preservation of the Article 9 Collateral to the extent any Grantor fails to do so as required by the Credit Agreement or this Agreement, and each Grantor jointly and severally agrees to reimburse the Collateral Agent within ten (10)Β Business Days of demand for any payment made or any expense incurred by the Collateral Agent pursuant to the foregoing authorization; provided, however, that nothing in this paragraph shall be interpreted as excusing any Grantor from the performance of, or imposing any obligation on the Collateral Agent or any Secured Party to cure or perform, any covenants or other promises of any Grantor with respect to Taxes, assessments, charges, fees, Liens, security interests or other encumbrances and maintenance as set forth herein or in the other Loan Documents. All sums disbursed by the Collateral Agent in connection with this paragraph, including reasonable and documented out-of-pocket attorneyβs fees, court costs, expenses and other charges relating thereto and incurred in accordance with SectionΒ 9.05 of the Credit Agreement, shall be additional Secured Obligations secured hereby.
(d) Each Grantor, at its own expense, shall maintain or cause to be maintained insurance covering physical loss or damage to the Inventory and Equipment in accordance with the requirements set forth in SectionΒ 5.02 of the Credit Agreement. Subject to the Intercreditor Agreement, each Grantor irrevocably makes, constitutes and appoints the Collateral Agent (and all officers, employees or agents designated by the Collateral Agent) as such Grantorβs true and lawful agent (and attorney-in-fact) for the purpose, upon the occurrence and only during the continuance of an Event of Default, of making, settling and adjusting claims in respect of Article 9 Collateral under policies of insurance, endorsing the name of such Grantor on any check, draft, instrument or other item of payment for the proceeds of such policies of insurance and for making all determinations and decisions with respect thereto. In the event that any Grantor at any time or times shall fail to obtain or maintain any of the policies of insurance required under the Credit Agreement or to pay any premium in whole or part relating thereto that would rise to a level of an Event of Default existing under SectionΒ 5.02 of the Credit Agreement, the Collateral Agent may, without waiving or releasing any obligation or liability of any Grantor hereunder or any Default or Event of Default, in its sole discretion, obtain and maintain such policies of insurance and pay such premium and take any other reasonable actions with respect thereto as the Collateral Agent deems advisable. All sums disbursed by the Collateral Agent in connection with this paragraph, including reasonable and documented out-of-pocket attorneysβ fees, court costs, expenses and other charges relating thereto and incurred in accordance with SectionΒ 9.05 of the Credit Agreement, shall be payable, upon demand, by the Grantors to the Collateral Agent and shall be additional Secured Obligations secured hereby.
Β
19
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(e) Each Grantor shall maintain, in form and manner reasonably satisfactory to the Collateral Agent, records of its Chattel Paper and its books, records and documents evidencing or pertaining thereto.
(f) Without limiting any provisions contained herein or in any other Loan Documents, at its option, upon the occurrence and during the continuance of an Event of Default, the Collateral Agent may make βprotective advancesβ to pay for any obligation of any Grantor or to make any payments necessary to maintain or preserve value (including going concern value) of the Collateral; provided, however, that nothing in this paragraph shall be interpreted as imposing any obligation on the Collateral Agent or any Secured Party to (i)Β make any such βprotective advanceβ, or any similar advance or disbursement, or otherwise to establish any course of dealing between the Secured Parties and the Grantors of any kind or nature or (ii)Β cure or perform any obligations or other promises of any Grantor. The making of any such βprotective advanceβ shall not be construed as a waiver of any Defaults or Events of Default nor shall the making of any such βprotective advanceβ be construed as a satisfaction, reinstatement, modification, amendment or extension by any Secured Party of the Loans or the Loan Documents, or as a waiver, relinquishment or forbearance by any Secured Party of any of its rights and remedies under the Loans or the Loan Documents. All βprotective advancesβ disbursed by the Collateral Agent in connection with this paragraph, including reasonable and documented out-of-pocket attorneysβ fees, court costs, expenses and other charges relating thereto, shall be payable, within ten (10)Β Business Daysβ written demand, by the Grantors to the Collateral Agent and shall be additional Secured Obligations secured hereby and shall bear interest until paid at the applicable interest rate specified in the Credit Agreement.
SECTION 4.04. Other Actions. In order to further insure the attachment, perfection and priority (subject to the Intercreditor Agreement and the Liens permitted by SectionΒ 6.02 of the Credit Agreement) of, and the ability of the Collateral Agent to enforce, the Security Interest in the Article 9 Collateral, each Grantor agrees, in each case at such Grantorβs own expense, to take the following actions with respect to the following Article 9 Collateral:
(a)Β [Reserved].
(b) Deposit Accounts. Subject to SectionΒ 4.05(b), for each Deposit Account (other than Excluded Accounts) that any Grantor at any time opens or maintains, such Grantor shall, upon the Collateral Agentβs written request, cause the depositary bank to execute and deliver an agreement in form and substance satisfactory to the Collateral Agent pursuant to which such depository bank agrees to comply at any time with instructions from the Collateral Agent to such depositary bank directing the disposition of funds from time to time credited to such Deposit Account, without further consent of such Grantor or any other Person (other than the Revolving Loan Agent pursuant to the Intercreditor Agreement). The Collateral Agent agrees with each Grantor that the Collateral Agent shall not give any such instructions unless (i)Β an Event of Default has occurred and is continuing or (ii)Β the Collateral Agent has received notice of the applicable depository bankβs intention to terminate such agreement and such Grantor has not, within five (5)Β Business Days of receipt by the Collateral Agent of such notice, entered into arrangements reasonably satisfactory to the Collateral Agent ensuring Collateral Agentβs continued perfected security interest in the relevant Deposit Account or the transfer of funds from the Specified Account to another Deposit Account as to which the Collateral Agent
Β
20
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
has a perfected security interest, or such other arrangement as may be agreed by the Collateral Agent. The provisions of this paragraph shall not apply to any Deposit Account for which any Grantor, the depositary bank, the Collateral Agent and the Revolving Loan Agent have entered into a cash collateral agreement specially negotiated among such Grantor, the depositary bank, the Collateral Agent and the Revolving Loan Agent for the specific purpose set forth therein.
(c) Investment Property. Except to the extent otherwise provided in Article III, if any Grantor shall at any time hold or acquire any βsecurities certificatesβ (as defined in Article 8 of the New York UCC), other than Excluded Equity, such Grantor shall promptly (and in any event within five (5)Β Business Days of issuance (or such later date as permitted by Collateral Agent in its sole discretion)) endorse, assign and deliver the same to the Collateral Agent (or the Revolving Loan Agent pursuant to the Intercreditor Agreement), accompanied by such undated instruments of transfer or assignment duly executed in blank as the Collateral Agent may from time to time specify. Subject to SectionΒ 4.05(b), if any securities (other than securities or other Investment Property constituting Excluded Assets) now or hereafter acquired by any Grantor are βuncertificated securitiesβ (as defined in Article 8 of the New York UCC) and are issued to such Grantor or its nominee directly by the issuer thereof, such Grantor shall promptly (and in any event within ten (10)Β Business Days (or such later date as permitted by Collateral Agent in its sole discretion)) notify the Collateral Agent thereof and, at the Collateral Agentβs written request and in its reasonable discretion, do one of the following: (w)Β pursuant to an agreement in form and substance reasonably satisfactory to the Collateral Agent, cause the issuer to agree to comply with instructions from the Collateral Agent as to such securities, without further consent of any Grantor or such nominee (x)Β cause a security entitlement with respect to such uncertificated securities to be held in a securities account with respect to which the Collateral Agent has Control, (y)Β arrange for the Collateral Agent (or the Revolving Loan Agent as agent for the Collateral Agent pursuant to the Intercreditor Agreement) to become the registered owner of the uncertificated securities or (z)Β issue βsecurities certificatesβ (as defined in Article 8 of the New York UCC) for such Equity Interests. Subject to SectionΒ 4.05(b), if any securities, whether certificated or uncertificated, or other Investment Property (other than securities or other Investment Property constituting Excluded Assets) now or hereafter acquired by any Grantor are held by such Grantor or its nominee through a Securities Intermediary or Commodity Intermediary, such Grantor shall promptly (and in any event within ten (10)Β Business Days (or such later date as permitted by Collateral Agent in its sole discretion)) notify the Collateral Agent thereof and, at the Collateral Agentβs written request cause such Securities Intermediary or Commodity Intermediary to execute and deliver an agreement in form and substance reasonably satisfactory to the Collateral Agent pursuant to which such Securities Intermediary or Commodity Intermediary, as the case may be, agrees to comply with Entitlement Orders from the Collateral Agent to such Securities Intermediary as to such securities or other Investment Property, or (as the case may be) to apply any value distributed on account of any commodity contract as directed by the Collateral Agent to such Commodity Intermediary, in each case without further consent of any Grantor or such nominee. The Collateral Agent agrees with each Grantor that the Collateral Agent shall not give any such Entitlement Orders or instructions or directions to any such issuer, Securities Intermediary or Commodity Intermediary unless and until an Event of Default shall have occurred and be continuing and the Collateral Agent shall have given the Grantors not less than two (2)Β Business Daysβ prior written notice of its intent to exercise its rights under this Agreement. The provisions of this paragraph shall not apply to any
Β
21
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Financial Assets credited to a Securities Account for which the Collateral Agent is the Securities Intermediary. The Collateral Agent agrees with each Grantor that the Collateral Agent shall not give any instructions or directions to any Securities Intermediary, and shall not withhold its consent to the exercise of any withdrawal rights by such Grantor, unless an Event of Default has occurred and is continuing. The Collateral Agent agrees with each Grantor that the Collateral Agent shall not give any entitlement orders to any issuer of βuncertificated securitiesβ (as defined in Article 8 of the New York UCC) unless an Event of Default has occurred and is continuing and the Collateral Agent has provided at least two (2)Β Business Daysβ prior written notice to the applicable Grantor before exercising any remedies with respect thereto.
(d) Electronic Chattel Paper and Transferable Records. If any Grantor at any time holds or acquires an interest in any Electronic Chattel Paper or any βtransferable recordβ, as that term is defined in SectionΒ 201 of the Federal Electronic Signatures in Global and National Commerce Act, or in SectionΒ 16 of the Uniform Electronic Transactions Act as in effect in any relevant jurisdiction, in each case to the extent that the aggregate value or face amount of such electronic Chattel Paper equals or exceeds $500,000, such Grantor shall notify the Collateral Agent thereof concurrently with the delivery of the financial statements referred to in paragraphs (a)Β or (b)Β of SectionΒ 5.04 of the Credit Agreement that are next due and, at the written request of the Collateral Agent, shall take such action as the Collateral Agent may reasonably request in writing to vest in the Collateral Agent control under New York UCC SectionΒ 9 105 of such Electronic Chattel Paper or control under SectionΒ 201 of the Federal Electronic Signatures in Global and National Commerce Act or, as the case may be, SectionΒ 16 of the Uniform Electronic Transactions Act, as so in effect in such jurisdiction, of such transferable record. The Collateral Agent agrees with such Grantor that the Collateral Agent will arrange, pursuant to procedures satisfactory to the Collateral Agent and so long as such procedures will not result in the Collateral Agentβs loss of control, for the Grantor to make alterations to the Electronic Chattel Paper or transferable record permitted under New York UCC SectionΒ 9 105 or, as the case may be, SectionΒ 201 of the Federal Electronic Signatures in Global and National Commerce Act or SectionΒ 16 of the Uniform Electronic Transactions Act for a party in control to allow without loss of control, unless an Event of Default has occurred and is continuing or would immediately occur after taking into account any action by such Grantor with respect to such Electronic Chattel Paper or transferable record.
(e) Letter-of-Credit Rights. If any Grantor is at any time a beneficiary under any letters of credit now or hereafter issued in favor of such Grantor having a face amount or value of $500,000 or more in the aggregate, such Grantor shall notify the Collateral Agent thereof concurrently with the delivery of the financial statements referred to in paragraphs (a)Β or (b)Β of SectionΒ 5.04 of the Credit Agreement that are next due and, at the written request of the Collateral Agent, such Grantor shall (within five (5)Β Business Days), use its commercially reasonably efforts to have executed and delivered an agreement in form and substance reasonably satisfactory to the Collateral Agent, pursuant to which either (i)Β the issuer and any confirmer of such letter of credit consents to an assignment to the Collateral Agent of the proceeds of any drawing under the letter of credit or (ii)the Collateral Agent becomes the transferee beneficiary of the letter of credit, with the Collateral Agent agreeing, in each case, that the proceeds of any drawing under the letter of credit are to be paid to the applicable Grantor unless an Event of Default has occurred or is continuing.
Β
22
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(f) Commercial Tort Claims. If any Grantor shall at any time hold or acquire a Commercial Tort Claim (other than Excluded Assets), the Grantor shall notify the Collateral Agent thereof concurrently with the delivery of the financial statements referred to in paragraphs (a)Β or (b)Β of SectionΒ 5.04 of the Credit Agreement that are next due in a writing signed by such Grantor including a summary description of such claim and supplemental Schedule IV to include any such Commercial Tort Claim.
SECTION 4.05. Perfection or Other Action Cost vs. Benefit Determination; Exceptions to Control Agreements.
(a)Β Notwithstanding anything to the contrary herein or in any other Loan Document, although such property and assets shall still be considered Collateral, the Grantors shall not be required to perfect the security interest granted to the Collateral Agent under this Security Agreement or any other Loan Document or to take any other action with respect to any property, asset or right to use any property or any asset to the extent the burden or cost of perfecting a Lien in favor of the Collateral Agent or taking any other action is excessive in relation to the benefit of the security afforded thereby, as reasonably and mutually agreed by Borrower and Collateral Agent. Any property, asset or right to use any property or any asset that is subject to the conditions set forth in the immediately preceding sentence of this SectionΒ 4.05 shall be an exception or carve-out to any representation, warranty or covenant in any Loan Document relating to the perfection, priority or actions taken on the Collateral.
(b) Notwithstanding anything to the contrary in the first sentence of SectionΒ 4.04(b) and the second and third sentences of SectionΒ 4.04(c) or in any other Loan Document, the Grantors shall not be required to deliver an agreement granting Control to the Collateral Agent or otherwise provide Control, arrange for the Collateral Agent (or the Revolving Loan Agent as agent for the Collateral Agent) to become the registered owner of the relevant uncertificated securities or issue βsecurities certificatesβ in respect of the relevant uncertificated securities or take any other perfection action with respect to (i)Β any Excluded Account or (ii)Β Deposit Accounts, securities accounts, uncertificated securities and other Investment Property (excluding, in each case, Excluded Assets) the value of which or the amount on credited thereto, as the case may be, does not exceed $750,000 in the aggregate (for all such assets in this clause (ii)Β taken as a whole).
SECTION 4.06. Covenants Regarding Patent, Trademark and Copyright Collateral. (a)Β Each Grantor agrees that it will not, and will take commercially reasonable steps to not permit any of its licensees to, do any act, or omit to do any act, whereby any Patent that is material to the conduct of such Grantorβs business may become invalidated, unenforceable or dedicated to the public, in whole or in part, and agrees that it shall continue to xxxx any products covered by a Patent with the relevant patent number as necessary and sufficient to establish and preserve its maximum rights under applicable patent laws, in each case except as would not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect.
(b) Each Grantor (either itself or through its licensees or its sublicensees) will, for each Trademark material to the conduct of such Grantorβs business (i)Β maintain such Trademark as valid and in full force and effect free from any claim of abandonment or invalidity for non-use, (ii)Β maintain the quality of products and services offered under such Trademark, (iii)Β display such
Β
23
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Trademark with notice of Federal or foreign registration to the extent necessary and sufficient to establish and preserve its maximum rights under applicable law and (iv)Β not knowingly use or knowingly permit the use of such Trademark in violation of any third party rights, in each case, except as could not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect.
(c) Each Grantor (either itself or through its licensees or sublicensees) will, for each work covered by a material Copyright, continue to publish, reproduce, display, adopt and distribute the work with appropriate copyright notice as necessary and sufficient to establish and preserve its maximum rights under applicable copyright laws in each case except as could not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect.
(d) Each Grantor shall notify the Collateral Agent promptly if it knows or has reason to believe that any Patent, Trademark or Copyright material to the conduct of its business may become invalidated, unenforceable, abandoned, lost or dedicated to the public, in whole or in part, or of any adverse determination or development (including the institution of, or any such determination or development in, any proceeding in the United States Patent and Trademark Office, United States Copyright Office or any court or similar office of any country) regarding such Grantorβs ownership of any Patent, Trademark or Copyright, its right to register the same, or its right to keep and maintain the same.
(e) In no event shall any Grantor, either itself or through any agent, employee, licensee or designee, file an application for any Patent, Trademark or Copyright necessary for or material to the conduct of such Grantorβs businesses (or for the registration of any Trademark or Copyright necessary for or material to the conduct of such Grantorβs businesses) with the United States Patent and Trademark Office, United States Copyright Office or any office or agency in any political subdivision of the United States, unless it notifies (or will notify) the Collateral Agent in accordance with SectionΒ 5.04 of the Credit Agreement, and, upon request of the Collateral Agent, executes and delivers any and all agreements, instruments, documents and papers as the Collateral Agent may request to evidence the Security Interest in such Patent, Trademark or Copyright, and each Grantor hereby appoints the Collateral Agent as its attorney-in-fact to execute and file such writings for the foregoing purposes, all acts of such attorney being hereby ratified and confirmed; such power, being coupled with an interest, is irrevocable.
(f) Each Grantor will take all necessary steps, in such Grantorβs reasonable business judgment, that are consistent with the practice in any proceeding before the United States Patent and Trademark Office, United States Copyright Office or any office or agency in any political subdivision of the United States or in any other country or any political subdivision thereof, to maintain and pursue each material application relating to the Patents, Trademarks and/or Copyrights (and to obtain the relevant grant or registration) and to maintain each issued Patent and each registration of the Trademarks and Copyrights that is material to the conduct of any Grantorβs business, including timely filings of applications for renewal, affidavits of use, affidavits of incontestability and payment of maintenance fees, and, if consistent with good business judgment, to initiate opposition, interference and cancellation proceedings against third parties.
Β
24
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(g) In the event that any Grantor knows that any Article 9 Collateral consisting of a Patent, Trademark or Copyright necessary for or material to the conduct of such Grantorβs businesses has been infringed or misappropriated by a third person, such Grantor shall, if consistent with good business judgment in such Grantorβs reasonable discretion, xxx for infringement, misappropriation or dilution and to recover damages for such infringement, misappropriation or dilution.
(h) Upon the occurrence and during the continuance of an Event of Default, each Grantor shall use its best efforts to obtain all requisite consents or approvals by the licensor of each Copyright License, Patent License or Trademark License, and each other material License, to effect the assignment of all such Grantorβs right, title and interest thereunder to the Collateral Agent, for the ratable benefit of the Secured Parties, or its designee.
ARTICLE V
Remedies
SECTION 5.01. Remedies Upon Default. Upon the occurrence and during the continuance of an Event of Default, each Grantor agrees to deliver each item of Collateral to the Collateral Agent (or to the Revolving Loan Agent pursuant to the Intercreditor Agreement) on demand, and it is agreed that the Collateral Agent shall have the right to take any of or all the following actions at the same or different times (subject, in each case, to the Intercreditor Agreement): (a)Β with respect to any Article 9 Collateral consisting of Intellectual Property, on demand, to cause the Security Interest to become an assignment, transfer and conveyance of any of or all such Article 9 Collateral by the applicable Grantor to the Collateral Agent, or to license or sublicense, whether general, special or otherwise, and whether on an exclusive or nonexclusive basis, any such Article 9 Collateral throughout the world on such terms and conditions and in such manner as the Collateral Agent shall determine (other than in violation of any then-existing licensing arrangements to the extent that waivers cannot be obtained), and (b)Β with or without legal process and with or without prior notice or demand for performance, to take possession of the Article 9 Collateral and without liability for trespass to enter any premises where the Article 9 Collateral may be located for the purpose of taking possession of or removing the Article 9 Collateral and, generally, to exercise any and all rights afforded to a secured party under the Uniform Commercial Code or other applicable law. Without limiting the generality of the foregoing, each Grantor agrees that the Collateral Agent shall have the right, subject to the mandatory requirements of applicable law and the notice required in the immediately following paragraph, to sell or otherwise dispose of all or any part of the Collateral at a public or private sale or at any brokerβs board or on any securities exchange, for cash, upon credit or for future delivery as the Collateral Agent shall deem appropriate. The Collateral Agent shall be authorized at any such sale (if it deems it advisable to do so) to restrict the prospective bidders or purchasers to Persons who will represent and agree that they are purchasing the Collateral for their own account for investment and not with a view to the distribution or sale thereof, and upon consummation of any such sale the Collateral Agent shall have the right to assign, transfer and deliver to the purchaser or purchasers thereof the Collateral so sold. Each such purchaser at any such sale shall hold the property sold absolutely, free from any claim or right on the part of any Grantor, and each Grantor hereby waives (to the extent permitted by
Β
25
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
applicable law) all rights of redemption, stay and appraisal which such Grantor now has or may at any time in the future have under any rule of law or statute now existing or hereafter enacted. Notwithstanding anything to the contrary herein, the Collateral Agent agrees that it shall give the Borrower at least two (2)Β Business Daysβ written notice prior to enforcing (including the exercise of voting rights in respect thereof) on the portion of the Collateral constituting Equity Interests.
The Collateral Agent shall give each applicable Grantor ten (10)Β daysβ written notice (which each Grantor agrees is reasonable notice within the meaning of SectionΒ 9-611 of the New York UCC or its equivalent in other jurisdictions) of the Collateral Agentβs intention to make any sale of Collateral. Such written notice, in the case of a public sale, shall state the time and place for such sale and, in the case of a sale at a brokerβs board or on a securities exchange, shall state the board or exchange at which such sale is to be made and the day on which the Collateral, or portion thereof, will first be offered for sale at such board or exchange. Any such public sale shall be held at such time or times within ordinary business hours and at such place or places as the Collateral Agent may fix and state in the notice (if any) of such sale. At any such sale, the Collateral, or portion thereof, to be sold may be sold in one lot as an entirety or in separate parcels, as the Collateral Agent may (in its sole and absolute discretion) determine. The Collateral Agent shall not be obligated to make any sale of any Collateral if it shall determine not to do so, regardless of the fact that notice of sale of such Collateral shall have been given. The Collateral Agent may, without notice or publication, adjourn any public or private sale or cause the same to be adjourned from time to time by announcement at the time and place fixed for sale, and such sale may, without further notice, be made at the time and place to which the same was so adjourned. In case any sale of all or any part of the Collateral is made on credit or for future delivery, the Collateral so sold may be retained by the Collateral Agent until the sale price is paid by the purchaser or purchasers thereof, but the Collateral Agent shall not incur any liability in case any such purchaser or purchasers shall fail to take up and pay for the Collateral so sold and, in case of any such failure, such Collateral may be sold again upon like notice. At any public (or, to the extent permitted by applicable law, private) sale made pursuant to this Agreement, any Secured Party may bid for or purchase, free (to the extent permitted by applicable law) from any right of redemption, stay, valuation or appraisal on the part of any Grantor (all said rights being also hereby waived and released to the extent permitted by applicable law), the Collateral or any part thereof offered for sale and may make payment on account thereof by using any claim then due and payable to such Secured Party from any Grantor as a credit against the purchase price, and such Secured Party may, upon compliance with the terms of sale, hold, retain and dispose of such property without further accountability to any Grantor therefor. For purposes hereof, a written agreement to purchase the Collateral or any portion thereof shall be treated as a sale thereof; the Collateral Agent shall be free to carry out such sale pursuant to such agreement and no Grantor shall be entitled to the return of the Collateral or any portion thereof subject thereto, notwithstanding the fact that after the Collateral Agent shall have entered into such an agreement all Events of Default shall have been remedied and the Secured Obligations paid in full. As an alternative to exercising the power of sale herein conferred upon it, the Collateral Agent may proceed by a suit or suits at law or in equity to foreclose this Agreement and to sell the Collateral or any portion thereof pursuant to a judgment or decree of a court or courts having competent jurisdiction or pursuant to a proceeding by a court-appointed receiver. Any sale pursuant to the provisions of this SectionΒ 5.01 shall be deemed to conform to the commercially reasonable standards as provided in SectionΒ 9-610(b) of the New York UCC or its equivalent in other jurisdictions.
Β
26
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 5.02. Application of Proceeds. Subject to the Intercreditor Agreement, the Collateral Agent shall apply the proceeds of any collection, sale, foreclosure or other realization upon any Collateral, including any Collateral consisting of cash, as follows:
FIRST, to the payment of all costs and expenses incurred by the Administrative Agent or the Collateral Agent (in their respective capacities as such hereunder or under any other Loan Document) in connection with such collection, sale, foreclosure or realization or otherwise in connection with this Agreement, any other Loan Document or any of the Secured Obligations, including all court costs and the reasonable fees and out-of-pocket expenses of its agents and legal counsel, the repayment of all advances made by the Administrative Agent and/or the Collateral Agent hereunder, or under any other Loan Document on behalf of any Grantor and any other costs or expenses incurred in connection with the exercise of any right or remedy hereunder or under any other Loan Document;
SECOND, to the payment in full of Unfunded Advances (the amounts so applied to be distributed to the Administrative Agent in accordance with the amount of Unfunded Advances owed to it on the date of any such distribution);
THIRD, to the payment in full of interest due and payable in respect of any Loans (the amounts so applied to be distributed among the Lenders pro rata in accordance with the amounts of interest owed to them on the date of any such distribution);
FOURTH, to the payment in full of principal on the Loans (the amounts so applied to be distributed among the Lenders pro rata in accordance with the amounts of principal owed to them on the date of any such distribution);
FIFTH, to the payment in full of all other Secured Obligations (the amounts so applied to be distributed among the Secured Parties pro rata in accordance with the amounts of the Secured Obligations owed to them on the date of any such distribution); and
SIXTH, to the Grantors, their successors or assigns, or as a court of competent jurisdiction may otherwise direct.
The Collateral Agent shall have absolute discretion as to the time of application of any such proceeds, moneys or balances in accordance with this Agreement. Upon any sale of Collateral by the Collateral Agent (including pursuant to a power of sale granted by statute or under a judicial proceeding), the receipt of the Collateral Agent or of the officer making the sale shall be a sufficient discharge to the purchaser or purchasers of the Collateral so sold and such purchaser or purchasers shall not be obligated to see to the application of any part of the purchase money paid over to the Collateral Agent or such officer or be answerable in any way for the misapplication thereof.
Β
27
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 5.03. Grant of License to Use Intellectual Property. For the purpose of enabling the Collateral Agent to exercise rights and remedies under this Agreement at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor hereby grants, effective solely upon the occurrence and during the continuation of an Event of Default, to the Collateral Agent an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to the Grantors), to use, license or sublicense any of the Article 9 Collateral consisting of Intellectual Property now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof. The use of such license by the Collateral Agent may be exercised, at the option of the Collateral Agent, only upon the occurrence and during the continuation of an Event of Default; provided, however, that any license, sublicense or other transaction entered into by the Collateral Agent in accordance herewith shall be binding upon each Grantor notwithstanding any subsequent cure of an Event of Default.
SECTION 5.04. Securities Act, Etc. In view of the position of the Grantors in relation to the Pledged Collateral, or because of other current or future circumstances, a question may arise under the U.S. Securities Act of 1933, as now or hereafter in effect, or any similar statute hereafter enacted analogous in purpose or effect (such Act and any such similar statute as from time to time in effect being called the βFederal Securities Lawsβ) with respect to any disposition of the Pledged Collateral permitted hereunder. Each Grantor understands that compliance with the Federal Securities Laws might very strictly limit the course of conduct of the Collateral Agent if the Collateral Agent were to attempt to dispose of all or any part of the Pledged Collateral, and might also limit the extent to which or the manner in which any subsequent transferee of any Pledged Collateral could dispose of the same. Similarly, there may be other legal restrictions or limitations affecting the Collateral Agent in any attempt to dispose of all or part of the Pledged Collateral under applicable βblue skyβ or other state securities laws or similar laws analogous in purpose or effect. Each Grantor recognizes that in light of such restrictions and limitations the Collateral Agent may, with respect to any sale of the Pledged Collateral during the continuance of an Event of Default after two (2)Β Business Daysβ prior written notice has been delivered to such Grantor, reasonably limit the purchasers to those who will agree, among other things, to acquire such Pledged Collateral for their own account, for investment, and not with a view to the distribution or resale thereof. Each Grantor acknowledges and agrees that in light of such restrictions and limitations, during the continuance of an Event of Default after two (2)Β Business Daysβ prior written notice has been delivered to such Grantor, the Collateral Agent, in its sole, absolute and commercially reasonable discretion (a)Β may proceed to make such a sale whether or not a registration statement for the purpose of registering such Pledged Collateral or part thereof shall have been filed under the Federal Securities Laws and (b)Β may approach and negotiate with a limited number of potential purchasers (including a single potential purchaser) to effect such sale. Each Grantor acknowledges and agrees that any such sale might result in prices and other terms less favorable to the seller than if such sale were a public sale without such restrictions. In the event of any such sale, the Collateral Agent shall incur no responsibility or liability for selling all or any part of the Pledged Collateral at a price that the Collateral Agent, in its sole and absolute discretion, may in good xxxxx xxxx reasonable under the circumstances, notwithstanding the possibility that a substantially higher price might
Β
28
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
have been realized if the sale were deferred until after registration as aforesaid or if more than a limited number of purchasers (or a single purchaser) were approached. The provisions of this SectionΒ 5.04 will apply notwithstanding the existence of a public or private market upon which the quotations or sales prices may exceed substantially the price at which the Collateral Agent sells.
ARTICLE VI
Indemnity, Subrogation and Subordination
SECTION 6.01. Indemnity and Subrogation. In addition to all such rights of indemnity and subrogation as the Guarantors may have under applicable law (but subject to SectionΒ 6.03), the Borrower agrees that (a)Β in the event a payment shall be made by any Guarantor under this Agreement, the Borrower shall indemnify such Guarantor for the full amount of such payment and such Guarantor shall be subrogated to the rights of the Person to whom such payment shall have been made to the extent of such payment and (b)Β in the event any assets of any Guarantor shall be sold pursuant to this Agreement or any other Security Document to satisfy in whole or in part a claim of any Secured Party, the Borrower shall indemnify such Guarantor in an amount equal to the greater of the book value or the fair market value of the assets so sold.
SECTION 6.02. Contribution and Subrogation. Each Guarantor (a βContributing Guarantorβ) agrees (subject to SectionΒ 6.03) that, in the event a payment shall be made by any other Guarantor hereunder in respect of any Secured Obligation, or assets of any other Guarantor shall be sold pursuant to any Security Document to satisfy any Secured Obligation owed to any Secured Party, and such other Guarantor (the βClaiming Guarantorβ) shall not have been fully indemnified by the Borrower as provided in SectionΒ 6.01, the Contributing Guarantor shall indemnify the Claiming Guarantor in an amount equal to (i)Β the amount of such payment or (ii)Β the greater of the book value or the fair market value of such assets, as the case may be, in each case multiplied by a fraction of which the numerator shall be the net worth of the Contributing Guarantor on the date hereof and the denominator shall be the aggregate net worth of all the Guarantors on the date hereof (or, in the case of any Guarantor becoming a party hereto pursuant to SectionΒ 7.17, the date of the supplement hereto executed and delivered by such Guarantor). Any Contributing Guarantor making any payment to a Claiming Guarantor pursuant to this SectionΒ 6.02 shall be subrogated to the rights of such Claiming Guarantor under SectionΒ 6.01 to the extent of such payment.
SECTION 6.03. Subordination. (a)Β Notwithstanding any provision of this Agreement to the contrary, all rights of the Guarantors under Sections 6.01 and 6.02 and all other rights of indemnity, contribution or subrogation under applicable law or otherwise shall be fully subordinated to, shall not be paid prior to and shall not be asserted prior to the payment in full in cash of the Secured Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations). No failure on the part of the Borrower or any Guarantor to make the payments required by Sections 6.01 and 6.02 (or any other payments required under applicable law or otherwise) shall in any respect limit the obligations and liabilities of any Guarantor with respect to its obligations hereunder, and each Guarantor shall remain liable for the full amount of its obligations hereunder.
Β
29
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(b) The Borrower and each Guarantor hereby agree that all Indebtedness and other monetary obligations owed by it to the Borrower or any Subsidiary shall be fully subordinated to, shall not be paid prior to and shall not be asserted prior to the payment in full in cash of the Secured Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations).
ARTICLE VII
Miscellaneous
SECTION 7.01. Notices. All communications and notices hereunder shall (except as otherwise expressly permitted herein) be in writing and given as provided in SectionΒ 9.01 of the Credit Agreement. All communications and notices hereunder to any Subsidiary Guarantor shall be given to it in care of the Borrower as provided in SectionΒ 9.01 of the Credit Agreement.
SECTION 7.02. Security Interest Absolute. All rights of the Collateral Agent hereunder, the Security Interest, the grant of a security interest in the Pledged Collateral and all obligations of each Grantor hereunder shall be absolute and unconditional irrespective of (a)Β any lack of validity or enforceability of the Credit Agreement, any other Loan Document, any agreement with respect to any of the Secured Obligations or any other agreement or instrument relating to any of the foregoing, (b)Β any change in the time, manner or place of payment of, or in any other term of, all or any of the Secured Obligations, or any other amendment or waiver of or any consent to any departure from the Credit Agreement, any other Loan Document or any other agreement or instrument relating to the foregoing, (c)Β any exchange, release or non-perfection of any Lien on other collateral, or any release or amendment or waiver of or consent under or departure from any guarantee, securing or guaranteeing all or any of the Secured Obligations, or (d)Β any other circumstance that might otherwise constitute a defense available to, or a discharge of, any Grantor in respect of the Secured Obligations or this Agreement (other (i)Β the payment in full of the Secured Obligations (other than unasserted contingent indemnification Obligations and unasserted expense reimbursement Obligations) and the termination of the Commitments and (ii)Β the termination of this Agreement in accordance with SectionΒ 7.16 hereof.).
SECTION 7.03. Survival of Agreement. All covenants, agreements, representations and warranties made by the Loan Parties in the Loan Documents and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the Lenders and shall survive the execution and delivery of the Loan Documents and the making of any Loans, regardless of any investigation made by any Lender or on their behalf and notwithstanding that the Collateral Agent or any Lender may have had notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended under the Credit Agreement, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount payable under any Loan Document is outstanding and unpaid and so long as the Commitments have not expired or terminated.
Β
30
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 7.04. Limitation by Law. All rights, remedies and powers provided in this Agreement may be exercised only to the extent that the exercise thereof does not violate any applicable provision of law, and all the provisions of this Agreement are intended to be subject to all mandatory provisions of law that may be controlling and to be limited to the extent necessary so that they shall not render this Agreement invalid, unenforceable, in whole or in part, or not entitled to be recorded, registered or filed under the provisions of any applicable law.
SECTION 7.05. Binding Effect; Several Agreement. This Agreement shall become effective when it shall have been executed by each Loan Party and the Collateral Agent and when the Collateral Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon such Loan Party and the Collateral Agent and their respective permitted successors and assigns, and shall inure to the benefit of such Loan Party, the Collateral Agent and the other Secured Parties and their respective successors and assigns, except as expressly contemplated or permitted by this Agreement or the Credit Agreement. This Agreement shall be construed as a separate agreement with respect to each Loan Party and may be amended, modified, supplemented, waived or released with respect to any Loan Party without the approval of any other Loan Party and without affecting the obligations of any other Loan Party hereunder.
SECTION 7.06. Successors and Assigns. Whenever in this Agreement any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and assigns of such party; and all covenants, promises and agreements by or on behalf of any Grantor or the Collateral Agent that are contained in this Agreement shall bind and inure to the benefit of their respective successors and assigns.
SECTION 7.07. Collateral Agentβs Fees and Expenses; Indemnification. The parties hereto agree that the Collateral Agent shall be entitled to reimbursement of its expenses incurred hereunder as provided in SectionΒ 9.05 of the Credit Agreement.
SECTION 7.08. Collateral Agent Appointed Attorney-in-Fact. Each Grantor hereby appoints the Collateral Agent as the attorney-in-fact of such Grantor for the purpose of carrying out the provisions of this Agreement and taking any action and executing any instrument that the Collateral Agent may deem reasonably necessary or advisable to accomplish the purposes hereof (subject to the Intercreditor Agreement), which appointment coupled with an interest and is irrevocable until the Secured Obligations have been paid in full (other than unasserted contingent indemnification Obligations and unasserted expense reimbursement Obligations) and the termination of the Commitments. Without limiting the generality of the foregoing, ands subject in each case to the Intercreditor Agreement, the Collateral Agent shall have the right, upon the occurrence and during the continuance of an Event of Default, with full power of substitution either in the Collateral Agentβs name or in the name of such Grantor (a)Β to receive, endorse, assign and/or deliver any and all notes, acceptances, checks, drafts, money orders or other evidences of payment relating to the Collateral or any part thereof, (b)Β to demand, collect, receive payment of, give receipt for and give discharges and releases of all or any of the Collateral, (c)Β to sign the name of any Grantor on any invoice or xxxx of lading relating to any of
Β
31
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
the Collateral, (d)Β to send verifications of Accounts, Chattel Paper, Instruments and General Intangibles to any Account Debtor or any other Person obligated thereon, (e)Β to commence and prosecute any and all suits, actions or proceedings at law or in equity in any court of competent jurisdiction to collect or otherwise realize on all or any of the Collateral or to enforce any rights in respect of any Collateral, (f)Β to settle, compromise, compound, adjust or defend any actions, suits or proceedings relating to all or any of the Collateral, (g)Β to notify, or to require any Grantor to notify, Account Debtors to make payment directly to the Collateral Agent, and (h)Β to use, sell, assign, transfer, pledge, make any agreement with respect to or otherwise deal with all or any of the Collateral, and to do all other acts and things necessary to carry out the purposes of this Agreement in accordance with its terms, as fully and completely as though the Collateral Agent were the absolute owner of the Collateral for all purposes; provided, however, that nothing herein contained shall be construed as requiring or obligating the Collateral Agent to make any commitment or to make any inquiry as to the nature or sufficiency of any payment received by the Collateral Agent, or to present or file any claim or notice, or to take any action with respect to the Collateral or any part thereof or the moneys due or to become due in respect thereof or any property covered thereby. The Collateral Agent and the other Secured Parties shall be accountable only for amounts actually received as a result of the exercise of the powers granted to them herein, and neither they nor their officers, directors, employees or agents shall be responsible to any Grantor for any act or failure to act hereunder, except to the extent that such act or failure is determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted primarily from their own gross negligence or willful misconduct or the gross negligence or willful misconduct of its respective Affiliates.
SECTION 7.09. Applicable Law. THIS AGREEMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK.
SECTION 7.10. Waivers; Amendment. (a)Β No failure or delay by the Collateral Agent, the Administrative Agent or any Lender in exercising any power or right hereunder or under any other Loan Document shall operate as a waiver hereof or thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Collateral Agent, the Administrative Agent and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Agreement or any other Loan Document or consent to any departure by any Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b)Β of this SectionΒ 7.10, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the making of a Loan shall not be construed as a waiver of any Default, regardless of whether the Collateral Agent or any Lender may have had notice or knowledge of such Default at the time. No notice or demand on any Loan Party in any case shall entitle any Loan Party to any other or further notice or demand in similar or other circumstances.
(b) Neither this Agreement nor any provision hereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by the Collateral Agent and the Loan Party or Loan Parties with respect to which such waiver, amendment or modification is to apply, subject to any consent required in accordance with SectionΒ 9.08 of the Credit Agreement.
Β
32
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 7.11. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE OTHER LOAN DOCUMENTS. EACH PARTY HERETO (A)Β CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)Β ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 7.11.
SECTION 7.12. Severability. In the event any one or more of the provisions contained in this Agreement or in any other Loan Document should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
SECTION 7.13. Counterparts. This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but all of which when taken together shall constitute a single contract, and shall become effective as provided in SectionΒ 7.05. Delivery of an executed signature page to this Agreement by facsimile transmission or other electronic means shall be as effective as delivery of a manually signed counterpart of this Agreement.
SECTION 7.14. Headings. Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement.
SECTION 7.15. Jurisdiction; Consent to Service of Process. (a)Β Each party hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America, sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the other Loan Documents, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding
Β
33
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement shall affect any right that the Collateral Agent, the Administrative Agent or any Lender may otherwise have to bring any action or proceeding relating to this Agreement or the other Loan Documents against any Grantor or its properties in the courts of any jurisdiction.
(b) Each party hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or the other Loan Documents in any court located in the City of New York, Borough of Manhattan, or of the United States of America sitting in the Southern District of New York. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.
(c) Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in SectionΒ 7.01. Nothing in this Agreement or any other Loan Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law.
SECTION 7.16. Termination or Release. (a)Β This Agreement, the guarantees made herein, the Security Interest, the pledge of the Pledged Collateral and all other security interests granted hereby shall immediately and automatically terminate when all the Secured Obligations have been paid in full (other than contingent indemnity claims not yet asserted and unasserted expense reimbursement obligations) and the Lenders have no further commitment to lend under the Credit Agreement.
(b) A Subsidiary Guarantor shall immediately and automatically be released from its obligations hereunder and the Security Interests created hereunder in the Collateral of such Subsidiary Guarantor shall be immediately and automatically released upon the consummation of any transaction permitted by the Credit Agreement as a result of which such Subsidiary Guarantor ceases to be a Subsidiary.
(c) Upon any sale or other transfer by any Grantor of any Collateral that is permitted under the Credit Agreement to any Person that is not the Borrower or a Guarantor, or, upon the effectiveness of any written consent to the release of the Security Interest granted hereby in any Collateral pursuant to SectionΒ 9.08 of the Credit Agreement, the Security Interest in such Collateral shall be immediately and automatically released.
(d) In connection with any termination or release pursuant to paragraph (a), (b)Β or (c)Β above, the Collateral Agent shall promptly (and in any case no more than five (5)Β Business Days from the date of such termination or release) execute and deliver to any Grantor, at such Grantorβs expense, all Uniform Commercial Code termination statements and similar documents that such Grantor shall reasonably request to evidence such termination or release. Any execution and delivery of documents pursuant to this SectionΒ 7.16 shall be without recourse to or representation or warranty by the Collateral Agent or any Secured Party. Without limiting the provisions of SectionΒ 7.07, the Borrower shall reimburse the Collateral Agent upon demand for all reasonable and documented out-of-pocket costs and expenses, including the reasonable and documented fees, charges and expenses of counsel, incurred by it in connection with any action contemplated by this SectionΒ 7.16.
Β
34
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 7.17. Additional Subsidiaries. Any Subsidiary that is required to become a party hereto pursuant to SectionΒ 5.12 of the Credit Agreement shall enter into this Agreement as a Subsidiary Guarantor and a Grantor upon becoming such a Subsidiary. Upon execution and delivery by the Collateral Agent and such Subsidiary of a supplement in the form of Exhibit A hereto, such Subsidiary shall become a Subsidiary Guarantor and a Grantor hereunder with the same force and effect as if originally named as a Subsidiary Guarantor and a Grantor herein. The execution and delivery of any such instrument shall not require the consent of any other Loan Party hereunder. The rights and obligations of each Loan Party hereunder shall remain in full force and effect notwithstanding the addition of any new Loan Party as a party to this Agreement.
SECTION 7.18. [Reserved].
SECTION 7.19. Conflicts. This Agreement is subject in all respects to the Intercreditor Agreement. In the case of any conflict or inconsistency between any terms of this Agreement, on the one hand, and any of the terms and provisions of the Intercreditor Agreement, on the other hand, then the terms and provisions of the Intercreditor Agreement shall control. The parties hereto agree that, for so long as the Intercreditor Agreement remains in effect, any obligation of any Grantor hereunder with respect to delivery or control of Revolving Credit Priority Collateral (as defined in the Intercreditor Agreement) shall be deemed satisfied if such Grantor delivers or provides control of such Revolving Loan Priority Collateral to the Revolving Loan Agent.
SECTION 7.20. Revolving Loan Agreement and Intercreditor Agreement. Notwithstanding anything herein to the contrary, each of the Grantors and the Collateral Agent acknowledges and agrees that, as of the date hereof, neither the Revolving Loan Agreement nor the Intercreditor Agreement has been entered into and, accordingly, all references herein to such documents (and references to βthe Revolving Loan Agentβ) shall have no force and effect until such documents have been executed and delivered to the Administrative Agent and the Collateral Agent and all conditions to the effectiveness thereunder have been satisfied or waived in accordance with their respective terms.
[Remainder of page intentionally left blank]
Β
35
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.
Β
BLACKLINEΒ SYSTEMS,Β INC. | ||
Β Β Β Β Β Β Β Β by |
Β | Β |
Β | Name: | |
Β | Title: | |
SLS BREEZE INTERMEDIATE HOLDINGS, INC. | ||
Β Β Β Β Β Β Β Β by | Β | Β |
Β | Name: | |
Β | Title: | |
OBSIDIAN AGENCY SERVICES, INC., as Collateral Agent | ||
Β Β Β Β Β Β Β Β by | Β | Β |
Β | Name: | |
Β | Title: |
Β
36
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule I to the Guarantee and
Collateral Agreement
SUBSIDIARY GUARANTORS
[None.]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule II to the Guarantee and
Collateral Agreement
EQUITY INTERESTS
Β
Β | Β | Β | Β | Β | Β | Number and | Β | Percentage |
Β | Β | Number of | Β | Registered | Β | Class of | Β | of Equity |
Issuer |
Β | Certificate |
Β | Owner |
Β | Equity Interest |
Β | Interests |
PLEDGED DEBT SECURITIES
Β
Β | Β | Principal | Β | Β | Β | Β |
Issuer |
Β | Amount |
Β | DateΒ ofΒ Note |
Β | MaturityΒ Date |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule III to the Guarantee and
Collateral Agreement
U.S. COPYRIGHTS OWNED BY [NAME OR GRANTOR]
[Make a separate page of Schedule III for each Grantor and state if no copyrights are owned. List in numerical order by Registration No.]
U.S. Copyright Registrations
Β
Title |
Β | Reg. No. |
Β | Author |
Pending U.S. Copyright Applications for Registration
Β
Title |
Β | Author |
Β | Class |
Β | Date Filed |
Non-U.S. Copyright Registrations
[List in alphabetical order by country/numerical order by Registration No. within each country.]
Β
Country |
Β | Title |
Β | Reg. No. |
Β | Author |
Non-U.S. Pending Copyright Applications for Registration
[List in alphabetical order by country.]
Β
Country |
Β | Title |
Β | Author |
Β | Class |
Β | Date Filed |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
MATERIAL LICENSES
[Make a separate page of Schedule III for each Grantor, and state if any Grantor is not a party to a license/sublicense.]
I. Material Licenses/Sublicenses of [Name of Grantor] as Licensor/Sublicensor on Date Hereof
A. Copyrights
[List U.S. copyrights in numerical order by Registration No. List non-U.S. copyrights by country in alphabetical order with Registration Nos. within each country in numerical order.]
U.S. Copyrights
Β
Β | Β | Β | Β | Title of | Β | Β | Β | Β |
Licensee Name | Β | Date of License/ | Β | U.S. | Β | Β | Β | Β |
and Address |
Β | Sublicense |
Β | Copyright |
Β | Author |
Β | Reg. No. |
Non-U.S. Copyrights
Β
Β | Β | Β | Β | Date of | Β | Title of | Β | Β | Β | Β |
Β | Β | Licensee Name | Β | License/ | Β | Non-U.S. | Β | Β | Β | Β |
Country |
Β | and Address |
Β | Sublicense |
Β | Copyrights |
Β | Author |
Β | Reg. No. |
Β
III-2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
B. Patents
[List U.S. patent Nos. and U.S. patent application Nos. in numerical order. List non-U.S. patent Nos. and non-U.S. application in alphabetical order by country, with numbers within each country in numerical order.]
U.S. Patents
Β
Licensee Name and Address |
Β | Date ofΒ License/ Sublicense |
Β | Issue Date |
Β | Patent No. |
U.S. Patent Applications
Β
Licensee Name and Address |
Β | Date ofΒ License/ Sublicense |
Β | Date Filed |
Β | Application No. |
Non-U.S. Patents
Β
Country |
Β | LicenseeΒ Name and Address |
Β | DateΒ ofΒ License/ Sublicense |
Β | Issue Date |
Β | Non-U.S. Patent No. |
Non-U.S. Patent Applications
Β
Country |
Β | LicenseeΒ Name and Address |
Β | Date of License/ Sublicense |
Β | Date Filed |
Β | Application No. |
Β
III-3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
C. Trademarks
[List U.S. trademark Nos. and U.S. trademark application Nos. in numerical order. List non-U.S. trademark Nos. and non-U.S. application Nos. with trademark Nos. within each country in numerical order.]
U.S. Trademarks
Β
Licensee Name | Β | Date of License/ | Β | Β | Β | Β | Β | Β |
and Address |
Β | Sublicense |
Β | U.S. Xxxx |
Β | Reg. Date |
Β | Reg. No. |
U.S. Trademark Applications
Β
Licensee Name | Β | Date of License/ | Β | Β | Β | Β | Β | Β |
and Address |
Β | Sublicense |
Β | U.S. Xxxx |
Β | Date Filed |
Β | Application No. |
Non-U.S. Trademarks
Β
Β | Β | Licensee Name | Β | Date of License/ | Β | Non-U.S. | Β | Β | Β | Β |
Country |
Β | and Address |
Β | Sublicense |
Β | Xxxx |
Β | Reg. Date |
Β | Reg. No. |
Non-U.S. Trademark Applications
Β
Β | Β | Licensee Name | Β | Date of License/ | Β | Non-U.S. | Β | Date | Β | Β |
Country |
Β | and Address |
Β | Sublicense |
Β | Xxxx |
Β | Filed |
Β | Application No. |
Β
III-4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
D. Others
Β
Licensee Name and Address |
Β | Date of License/ Sublicense |
Β | Subject Matter |
Β
III-5
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
II. Material Licenses/Sublicenses of [Name of Grantor] as Licensee/Sublicensee on Date Hereof
A. Copyrights
[List U.S. copyrights in numerical order by Registration No. List non-U.S. copyrights by country in alphabetical order, with Registration Nos. within each country in numerical order.]
U.S. Copyrights
Β
Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | Title of U.S. Copyright |
Β | Author |
Β | Reg. No. |
Non-U.S. Copyrights
Β
Country |
Β | Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | Title of Non-U.S. Copyrights |
Β | Author |
Β | Reg. No. |
Β
III-6
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
B. Patents
[List U.S. patent Nos. and U.S. patent application Nos. in numerical order. List non-U.S. patent Nos. and non-U.S. application Nos. in alphabetical order by country with patent Nos. within each country in numerical order.]
U.S. Patents
Β
Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | Issue Date |
Β | Patent No. |
U.S. Patent Applications
Β
Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | Date Filed |
Β | Application No. |
Non-U.S. Patents
Β
Country |
Β | Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | Issue Date |
Β | Non-U.S. Patent No. |
Non-U.S. Patent Applications
Β
Country |
Β | Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | Date Filed |
Β | Application No. |
Β
III-7
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
C. Trademarks
[List U.S. trademark Nos. and U.S. trademark application Nos. in numerical order. List non-U.S. trademark Nos. and non-U.S. application Nos. with trademark Nos. within each country in numerical order.]
U.S. Trademarks
Β
Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | U.S. Xxxx |
Β | Reg. Date |
Β | Reg. No. |
U.S. Trademark Applications
Β
Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | U.S. Xxxx |
Β | Date Filed |
Β | Application No. |
Non-U.S. Trademarks
Β
Country |
Β | Licensor Name and Address |
Β | Date of License/ |
Β | Non-U.S. Xxxx |
Β | Reg. Date |
Β | Reg. No. |
Non-U.S. Trademark Applications
Β
Country |
Β | Licensor Name and Address |
Β | Date of License/ |
Β | Non-U.S. Xxxx |
Β | Date Filed |
Β | Application No. |
Β
III-8
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
D. Others
Β
Licensor Name and Address |
Β | Date of License/ Sublicense |
Β | Subject Matter |
Β
III-9
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
PATENTS OWNED BY [NAME OF GRANTOR]
[Make a separate page of Schedule III for each Grantor and state if no patents are owned. List in numerical order by Patent No./Patent Application No.]
U.S. Patents
Β
Patent No. |
Β | Issue Date |
U.S. Patent Applications
Β
Patent Application No. |
Β | Filing Date |
Non-U.S. Patents
[List non-U.S. patents and non-U.S. patent applications by country in alphabetical order, with patent Nos. and patent application Nos. within each country in numerical order.]
Β
Country |
Β | Issue Date |
Β | Patent No. |
Non-U.S. Patent Applications
Β
Country |
Β | Filing Date |
Β | Patent Application No. |
Β
III-10
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
TRADEMARK/TRADE NAMES OWNED BY [NAME OF GRANTOR]
[Make a separate page of Schedule III for each Grantor and state if no trademarks/trade names are owned. List in numerical order by trademark Registration/application No.]
U.S. Trademark Registrations
Β
Xxxx |
Β | Reg. Date |
Β | Reg. No. |
U.S. Trademark Applications
Β
Xxxx |
Β | Filing Date |
Β | Application No. |
State Trademark Registrations
[List in alphabetical order by state/numerical order by trademark No. within each state.]
Β
State |
Β | Xxxx |
Β | Reg. Date |
Β | Reg. No. |
Non-U.S. Trademark Registrations
[List non-U.S. trademarks and non-U.S. trademark applications by country in alphabetical order, with Registration Nos. and application Nos. within each country in numerical order.]
Β
Country |
Β | Xxxx |
Β | Reg. Date |
Β | Reg. No. |
Β
III-11
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Non-U.S. Trademark Applications
Β
Country |
Β | Xxxx |
Β | Application Date |
Β | Application No. |
Trade Names
Β
Country(s) Where Used |
Β | Trade Names |
Β
III-12
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule IV to the Guarantee and
Collateral Agreement
COMMERCIAL TORT CLAIMS
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Exhibit A to the Guarantee and
Collateral Agreement
SUPPLEMENT NO. [β’] (this βSupplementβ) dated as of [β’] to the Guarantee and Collateral Agreement dated as of [Β Β Β Β Β Β Β Β Β Β Β Β ], 2013 (the βGuarantee and Collateral Agreementβ), among BLACKLINE SYSTEMS, INC., a California corporation (the βBorrowerβ), SLS BREEZE INTERMEDIATE HOLDINGS, INC., a Delaware company (βHoldingsβ), each Subsidiary of the Borrower from time to time party thereto (each such Subsidiary individually a βSubsidiary Guarantorβ and collectively, the βSubsidiary Guarantorsβ; the Subsidiary Guarantors, the Borrower and Holdings are referred to collectively herein as the βGrantorsβ) and OBSIDIAN AGENCY SERVICES, INC. (together with its affiliates, βObsidianβ), as collateral agent (in such capacity, the βCollateral Agentβ) for the Secured Parties (as defined therein).
A. Reference is made to the Credit Agreement dated as of [Β Β Β Β Β Β Β Β Β Β Β Β ], 2013 (as amended, restated, supplemented or otherwise modified from time to time, the βCredit Agreementβ), among the Borrower, Holdings, the lenders from time to time party thereto (the βLendersβ) and Obsidian, as administrative agent for the Lenders and as Collateral Agent.
B. Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement or the Guarantee and Collateral Agreement referred to therein, as applicable.
C. The Grantors have entered into the Guarantee and Collateral Agreement in order to induce the Lenders to make Loans. SectionΒ 7.16 of the Guarantee and Collateral Agreement provides that additional Subsidiaries of the Borrower may become Subsidiary Guarantors and Grantors under the Guarantee and Collateral Agreement by execution and delivery of an instrument in the form of this Supplement. The undersigned Subsidiary (the βNew Subsidiaryβ) is executing this Supplement in accordance with the requirements of the Credit Agreement to become a Subsidiary Guarantor and a Grantor under the Guarantee and Collateral Agreement in order to induce the Lenders to make additional Loans and as consideration for Loans previously made.
Accordingly, the Collateral Agent and the New Subsidiary agree as follows:
SECTION 1. In accordance with SectionΒ 7.16 of the Guarantee and Collateral Agreement, the New Subsidiary by its signature below becomes a Grantor and Subsidiary Guarantor under the Guarantee and Collateral Agreement with the same force and effect as if originally named therein as a Grantor and Subsidiary Guarantor and the New Subsidiary hereby (a)Β agrees to all the terms and provisions of the Guarantee and Collateral Agreement applicable to it as a Grantor and Subsidiary Guarantor thereunder and (b)Β represents and warrants that the representations and warranties made by it as a Grantor and Subsidiary Guarantor thereunder are true and correct on and as of the date hereof. In furtherance of the foregoing, the New Subsidiary, as security for the payment and performance in full of the Secured Obligations (as defined in the Guarantee and Collateral Agreement), does hereby create and grant to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Parties, their successors and assigns, a security interest in and lien on all of the New Subsidiaryβs right, title and interest in and to the Collateral (as defined in the Guarantee and Collateral Agreement) of the New Subsidiary. Each reference to a βGrantorβ or a βSubsidiary Guarantorβ in the Guarantee and Collateral Agreement shall be deemed to include the New Subsidiary. The Guarantee and Collateral Agreement is hereby incorporated herein by reference.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 2. The New Subsidiary represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms.
SECTION 3. This Supplement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received counterparts of this Supplement that, when taken together, bear the signatures of the New Subsidiary and the Collateral Agent. Delivery of an executed signature page to this Supplement by facsimile transmission or other electronic means shall be as effective as delivery of a manually signed counterpart of this Supplement.
SECTION 4. The New Subsidiary hereby represents and warrants that (a)Β set forth on Schedule I attached hereto is a true and correct schedule of (i)Β any and all Equity Interests and Pledged Debt Securities now owned by the New Subsidiary and (ii)Β any and all Intellectual Property now owned by the New Subsidiary and (b)Β set forth under its signature hereto, is the true and correct legal name of the New Subsidiary and its jurisdiction of organization.
SECTION 5. Except as expressly supplemented hereby, the Guarantee and Collateral Agreement shall remain in full force and effect.
SECTION 6. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK.
SECTION 7. In case any one or more of the provisions contained in this Supplement should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and in the Guarantee and Collateral Agreement shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
SECTION 8. All communications and notices hereunder shall (except as otherwise expressly permitted by the Guarantee and Collateral Agreement) be in writing and given as provided in SectionΒ 9.01 of the Credit Agreement. All communications and notices hereunder to the New Subsidiary shall be given to it in care of the Borrower as provided in SectionΒ 9.01 of the Credit Agreement.
Β
A-2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SECTION 9. The New Subsidiary agrees to reimburse the Collateral Agent for its reasonable and documented out-of-pocket expenses in connection with this Supplement, including the reasonable and documented out-of-pocket fees, other charges and disbursements of counsel for the Collateral Agent, in each case, in accordance with SectionΒ 9.05 of the Credit Agreement.
Β
A-3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
IN WITNESS WHEREOF, the New Subsidiary and the Collateral Agent have duly executed this Supplement to the Guarantee and Collateral Agreement as of the day and year first above written.
Β
[NAME OF NEW SUBSIDIARY] | ||
Β Β Β Β Β Β Β Β By: |
Β | |
Β | Β | |
Β | Name: | |
Β | Title: | |
Β | Address: | |
Β | Legal Name: | |
Β | Jurisdiction of Formation: | |
OBSIDIAN AGENCY SERVICES, INC., as Collateral Agent | ||
Β Β Β Β Β Β Β Β By: |
Β | |
Β | Β | |
Β | Name: | |
Β | Title: |
Β
A-4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Schedule I to
Supplement No. [β’] to the
Guarantee and
Collateral Agreement
Collateral of the New Subsidiary
EQUITY INTERESTS
Β
Issuer |
Β Β | Number of |
Β Β | Registered Owner |
Β Β | Number and Class of Equity Interest |
Β Β | Percentage of Equity Interests |
PLEDGED DEBT SECURITIES
Β
Issuer |
Β Β | Principal Amount |
Β Β | DateΒ ofΒ Note |
Β Β | MaturityΒ Date |
INTELLECTUAL PROPERTY
[Follow format of Schedule III to the
Guarantee and Collateral Agreement.]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
FORM OF PERFECTION CERTIFICATE
[Provided separately]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Exhibit C to the
Guarantee and
Collateral Agreement
[Form of]
Copyright Security Agreement
Copyright Security Agreement, dated as of [Β Β Β Β Β Β Β Β ], by [Β Β Β Β Β Β Β Β Β Β Β Β ] and [Β Β Β Β Β Β Β Β Β Β Β Β ] (individually, a βGrantorβ, and, collectively, the βGrantorsβ), in favor of [NAME OF COLLATERAL AGENT], [ADDRESS OF COLLATERAL AGENT], in its capacity as collateral agent pursuant to the Credit Agreement (in such capacity, the βCollateral Agentβ).
W I T N E S S E T H:
WHEREAS, the Grantors are party to a Guarantee and Collateral Agreement, dated as of [DATE OF AGREEMENT] (as amended, amended and restated, supplemented or otherwise modified from time to time, the βGCAβ), in favor of the Collateral Agent pursuant to which the Grantors are required to execute and deliver this Copyright Security Agreement;
NOW, THEREFORE, in consideration of the premises and to induce the Collateral Agent, for the benefit of the Secured Parties, to enter into the Credit Agreement, the Grantors hereby agree with the Collateral Agent as follows:
SECTION 1. Defined Terms. Unless otherwise defined herein, terms defined in the GCA and used herein have the meaning given to them in the GCA.
SECTION 2. Grant of Security Interest in Copyright Collateral. Each Grantor hereby pledges and grants to the Collateral Agent for the benefit of the Secured Parties a lien on and security interest in and mortgage on all of its right, title and interest in, to and under all the following Collateral of such Grantor:
A. all Copyrights and Copyright Licenses of such Grantor listed on Schedule I attached hereto; and
B. all Proceeds of any and all of the foregoing; and
C. all rights to xxx for past, present or future infringements thereof.
Notwithstanding anything to the contrary contained in clauses A, B and C above, the security interest created by this Copyright Security Agreement shall not extend to any Collateral excluded from the GCA.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Exhibit C to the
Guarantee and
Collateral Agreement
SECTION 3. Guarantee and Collateral Agreement. The security interest granted pursuant to this Copyright Security Agreement is granted in conjunction with the security interest granted to the Collateral Agent pursuant to the GCA and the Grantors hereby acknowledge and affirm that the rights and remedies of the Collateral Agent with respect to the security interest in the Copyrights and Copyright Licenses made and granted hereby are more fully set forth in the GCA, the terms and provisions of which are incorporated by reference herein as if fully set forth herein. In the event that any provision of this Copyright Security Agreement is deemed to conflict with the GCA, the provisions of the GCA shall control unless the Collateral Agent shall otherwise determine.
SECTION 4. Termination. Upon the payment in full of the Secured Obligations and termination of the GCA, the Collateral Agent shall execute, acknowledge, and deliver to the Grantors an instrument in writing in recordable form releasing the collateral pledge, grant, assignment, lien and security interest in the Copyrights and Copyright Licenses under this Copyright Security Agreement.
SECTION 5. Counterparts. This Copyright Security Agreement may be executed in any number of counterparts, all of which shall constitute one and the same instrument, and any party hereto may execute this Copyright Security Agreement by signing and delivering one or more counterparts.
[signature page follows]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Exhibit C to the
Guarantee and
Collateral Agreement
IN WITNESS WHEREOF, each Grantor has caused this Copyright Security Agreement to be executed and delivered by its duly authorized officer as of the date first set forth above.
Β
Very truly yours, | ||
[GRANTORS] | ||
By: |
Β | Β |
Name: |
Β | |
Title: |
Β |
Β
Β | Β | Accepted and Agreed: |
Β | [NAME OF COLLATERAL AGENT], as Collateral Agent | |
Β |
By:Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β | |
Β | Β Β Β Β Β Β Β Β Name: | |
Β | Β Β Β Β Β Β Β Β Title: |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Exhibit D to the
Guarantee and
Collateral Agreement
SCHEDULE I
to
COPYRIGHT SECURITY AGREEMENT
COPYRIGHT REGISTRATIONS, COPYRIGHT APPLICATIONS
AND COPYRIGHT LICENSES
Copyright Registrations:
Β
OWNER |
Β Β | REGISTRATION NUMBER |
Β Β | TITLE |
Β Β | Β Β |
Copyright Applications:
Β
OWNER |
Β Β | TITLE |
Β Β |
Copyright Licenses:
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Exhibit D to the
Guarantee and
Collateral Agreement
[Form of]
Patent Security Agreement
Patent Security Agreement, dated as of [Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β ], by [Β Β Β Β Β Β Β Β Β Β Β Β ] and [Β Β Β Β Β Β Β Β Β Β Β Β ] (individually, a βGrantorβ, and, collectively, the βGrantorsβ), in favor of [NAME OF COLLATERAL AGENT], [ADDRESS OF COLLATERAL AGENT], in its capacity as collateral agent pursuant to the Credit Agreement (in such capacity, the βCollateral Agentβ).
W I T N E S S E T H:
WHEREAS, the Grantors are party to a Guarantee and Collateral Agreement, dated as of [DATE OF AGREEMENT] (as amended, amended and restated, supplemented or otherwise modified from time to time, the βGCAβ), in favor of the Collateral Agent pursuant to which the Grantors are required to execute and deliver this Patent Security Agreement;
NOW, THEREFORE, in consideration of the premises and to induce the Collateral Agent, for the benefit of the Secured Parties, to enter into the Credit Agreement, the Grantors hereby agree with the Collateral Agent as follows:
SECTION 1. Defined Terms. Unless otherwise defined herein, terms defined in the GCA and used herein have the meaning given to them in the GCA.
SECTION 2. Grant of Security Interest in Patent and Patent License Collateral. Each Grantor hereby pledges and grants to the Collateral Agent for the benefit of the Secured Parties a lien on and security interest in and mortgage on all of its right, title and interest in, to and under all the following Collateral of such Grantor:
A. all Patents and Patent Licenses of such Grantor listed on Schedule I attached hereto;
B. all Proceeds of any and all of the foregoing; and
C. all rights to xxx for past, present or future infringements thereof.
Notwithstanding anything to the contrary contained in clauses A, B and C above, the security interest created by this Patent Security Agreement shall not extend to any Collateral excluded from the GCA.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Exhibit D to the
Guarantee and
Collateral Agreement
Β
SECTION 3. Guarantee and Collateral Agreement. The security interest granted pursuant to this Patent Security Agreement is granted in conjunction with the security interest granted to the Collateral Agent pursuant to the GCA and the Grantors hereby acknowledge and affirm that the rights and remedies of the Collateral Agent with respect to the security interest in the Patents and Patent Licenses made and granted hereby are more fully set forth in the GCA, the terms and provisions of which are incorporated by reference herein as if fully set forth herein. In the event that any provision of this Patent Security Agreement is deemed to conflict with the GCA, the provisions of the GCA shall control unless the Collateral Agent shall otherwise determine.
SECTION 4. Termination. Upon the payment in full of the Secured Obligations and termination of the GCA, the Collateral Agent shall execute, acknowledge, and deliver to the Grantors an instrument in writing in recordable form releasing the collateral pledge, grant, assignment, lien and security interest in the Patents and Patent Licenses under this Patent Security Agreement.
SECTION 5. Counterparts. This Patent Security Agreement may be executed in any number of counterparts, all of which shall constitute one and the same instrument, and any party hereto may execute this Patent Security Agreement by signing and delivering one or more counterparts.
[signature page follows]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Exhibit D to the
Guarantee and
Collateral Agreement
Β
IN WITNESS WHEREOF, each Grantor has caused this Patent Security Agreement to be executed and delivered by its duly authorized officer as of the date first set forth above.
Β
Very truly yours, | ||
[GRANTORS] | ||
By: | Β | Β |
Name: | Β | |
Title: | Β |
Β
Accepted and Agreed: | ||
[NAME OF COLLATERAL AGENT], as Collateral Agent | ||
By: | Β | Β |
Β | Name: | |
Β | Title: |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Exhibit D to the
Guarantee and
Collateral Agreement
Β
SCHEDULE I
to
PATENT SECURITY AGREEMENT
PATENT REGISTRATIONS , PATENT APPLICATIONS AND PATENT LICENSES
Patent Registrations:
Β
Β | Β Β | REGISTRATION | Β Β | Β |
OWNER |
Β Β | NUMBER | Β Β | NAME |
Patent Applications:
Β
Β | Β Β | APPLICATION | Β Β | Β |
OWNER |
Β Β | NUMBER | Β Β | NAME |
Patent Licenses:
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Exhibit E to the
Guarantee and
Collateral Agreement
[Form of]
Trademark Security Agreement
Trademark Security Agreement, dated as of [Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β ], by [Β Β Β Β Β Β Β Β Β Β Β Β ] and [Β Β Β Β Β Β Β Β Β Β Β Β ] (individually, a βGrantorβ, and, collectively, the βGrantorsβ), in favor of [NAME OF COLLATERAL AGENT], [ADDRESS OF COLLATERAL AGENT], in its capacity as collateral agent pursuant to the Credit Agreement (in such capacity, the βCollateral Agentβ).
W I T N E S S E T H:
WHEREAS, the Grantors are party to a Guarantee and Collateral Agreement, dated as of [DATE OF AGREEMENT] (as amended, amended and restated, supplemented or otherwise modified from time to time, the βGCAβ), in favor of the Collateral Agent pursuant to which the Grantors are required to execute and deliver this Trademark Security Agreement;
NOW, THEREFORE, in consideration of the premises and to induce the Collateral Agent, for the benefit of the Secured Parties, to enter into the Credit Agreement, the Grantors hereby agree with the Collateral Agent as follows:
SECTION 1. Defined Terms. Unless otherwise defined herein, terms defined in the GCA and used herein have the meaning given to them in the GCA.
SECTION 2. Grant of Security Interest in Trademark Collateral. Each Grantor hereby pledges and grants to the Collateral Agent for the benefit of the Secured Parties a lien on and security interest in and mortgage on all of its right, title and interest in, to and under all the following Collateral of such Grantor:
A. all Trademarks and Trademark Licenses of such Grantor listed on Schedule I attached hereto;
B. all goodwill associated with such Trademarks and Trademark Licenses;
C. all Proceeds of any and all of the foregoing; and
D. all rights to xxx for past, present or future infringements thereof.
Notwithstanding anything to the contrary contained in clauses A, B, C and D above, the security interest created by this Trademark Security Agreement shall not extend to any Collateral excluded from the GCA.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Exhibit E to the
Guarantee and
Collateral Agreement
Β
SECTION 3. Guarantee and Collateral Agreement. The security interest granted pursuant to this Trademark Security Agreement is granted in conjunction with the security interest granted to the Collateral Agent pursuant to the GCA and the Grantors hereby acknowledge and affirm that the rights and remedies of the Collateral Agent with respect to the security interest in the Trademarks and Trademark Licenses made and granted hereby are more fully set forth in the GCA, the terms and provisions of which are incorporated by reference herein as if fully set forth herein. In the event that any provision of this Trademark Security Agreement is deemed to conflict with the GCA, the provisions of the GCA shall control unless the Collateral Agent shall otherwise determine.
SECTION 4. Termination. Upon the payment in full of the Secured Obligations and termination of the GCA, the Collateral Agent shall execute, acknowledge, and deliver to the Grantors an instrument in writing in recordable form releasing the collateral pledge, grant, assignment, lien and security interest in the Trademarks and Trademark Licenses under this Trademark Security Agreement.
SECTION 5. Counterparts. This Trademark Security Agreement may be executed in any number of counterparts, all of which shall constitute one and the same instrument, and any party hereto may execute this Trademark Security Agreement by signing and delivering one or more counterparts.
[signature page follows]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Exhibit E to the
Guarantee and
Collateral Agreement
Β
IN WITNESS WHEREOF, each Grantor has caused this Trademark Security Agreement to be executed and delivered by its duly authorized officer as of the date first set forth above.
Β
Very truly yours, | ||
[GRANTORS] | ||
By: | Β | Β |
Name: | Β | |
Title: | Β |
Β
Accepted and Agreed: | ||
[NAME OF COLLATERAL AGENT], as Collateral Agent | ||
By: | Β | Β |
Β | Name: | |
Β | Title: |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Exhibit E to the
Guarantee and
Collateral Agreement
Β
SCHEDULE I
to
TRADEMARK SECURITY AGREEMENT
TRADEMARK REGISTRATIONS, TRADEMARK APPLICATIONS
AND TRADEMARK LICENSES
Trademark Registrations:
Β
OWNER |
Β Β | REGISTRATION NUMBER |
Β Β | TRADEMARK |
Trademark Applications:
Β
Β | Β Β | APPLICATION | Β Β | Β |
OWNER |
Β Β | NUMBER | Β Β | TRADEMARK |
Trademark Licenses:
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT F
Capitalization Table
[See attached]
Β
- 207 -
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
Β | Β Β | OutstandingΒ CapitalΒ StockΒ ofΒ theΒ Company | ||
Β | Β Β | (on a fully diluted basis) | ||
Holder |
Β Β | ImmediatelyΒ Prior toΒ theΒ Closing |
Β | ImmediatelyΒ Following theΒ Closing |
Silver Lake Sumeru Fund, L.P. |
Β Β | [***] | Β | [***] |
Silver Lake Technology Investors Sumeru, L.P. |
Β Β | [***] | Β | [***] |
Iconiq Strategic Partners, L.P. |
Β Β | [***] | Β | [***] |
Iconiq Strategic Partners Co-Invest, L.P., BL Series |
Β Β | [***] | Β | [***] |
Xxxxxxxx Street Investment Partners, L.P. - 2013 DIF |
Β Β | [***] | Β | [***] |
Actuate Management, L.L.C. |
Β Β | [***] | Β | [***] |
Xxxxxxx Xxxxxx |
Β Β | [***] | Β | [***] |
Xxxxx Xxxxxx 2012 Irrevocable Gift Trust |
Β Β | [***] | Β | [***] |
Xxxxxxxx Xxxxxx 2012 Irrevocable Gift Trust |
Β Β | [***] | Β | [***] |
Xxxxx Xxxxxxxxxxx |
Β Β | [***] | Β | [***] |
Spanicciati Family 2013 Irrevocable Trust |
Β Β | [***] | Β | [***] |
The XxxxxxΒ & Xxxxx Xxxxxxxx Living Trust |
Β Β | [***] | Β | [***] |
Xxxxxxx Xxxxxxxx-Xxxxxx |
Β Β | [***] | Β | [***] |
Xxxx Xxxxx |
Β Β | [***] | Β | [***] |
Xxxxx Xxxxx |
Β Β | [***] | Β | [***] |
Xxxxxxx Xxxxxx |
Β Β | [***] | Β | [***] |
Xxxxxxx Xxxxxx |
Β Β | [***] | Β | [***] |
Xxxxxxx Xxxx |
Β Β | [***] | Β | [***] |
Xxxxxxxx XxXxxxx |
Β Β | [***] | Β | [***] |
Xxxxxx Xxxxx |
Β Β | [***] | Β | [***] |
Xxxxxx Xxxxxxxxx |
Β Β | [***] | Β | [***] |
Xxxxxxx Xxxxx |
Β Β | [***] | Β | [***] |
Special Value Continuation Partners, L.P. |
Β Β | βΒ Β | Β | [***] |
Xxxxxxxxxx Opportunities Fund VI, LLC |
Β Β | βΒ Β | Β | [***] |
Xxxxxxxxxx Senior Loan Fund II, LP |
Β Β | βΒ Β | Β | [***] |
Xxxxxxxxxx Senior Loan SPV III, LLC |
Β Β | βΒ Β | Β | [***] |
Xxxxxxxxxx Senior Loan Fund IV-B, LP |
Β Β | βΒ Β | Β | [***] |
Β Β | Β |
Β | Β | |
Total |
Β Β | [***] | Β | [***] |
Β Β | Β |
Β | Β |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT G
FORM OF SOLVENCY CERTIFICATE
of
SLS BREEZE INTERMEDIATE HOLDINGS, INC.
AND ITS SUBSIDIARIES
This Solvency Certificate is being executed and delivered on the date hereof pursuant to SectionΒ 4.01(g) of that certain Credit Agreement, dated as of SeptemberΒ Β Β Β , 2013 (the βCredit Agreementβ), among BLACKLINE SYSTEMS, INC., a California corporation, SLS BREEZE INTERMEDIATE HOLDINGS, INC., a Delaware corporation (βHoldingsβ), the lenders from time to time party thereto (the βLendersβ) and OBSIDIAN AGENCY SERVICES, INC., as the administrative agent (in such capacity, including any successor thereto, the βAdministrative Agentβ) and as collateral agent for the lenders.
The undersigned hereby certifies, solely in his capacity as Chief Financial Officer of Holdings, as follows:
As of the date hereof, immediately after giving effect to the consummation of the Transactions, including the making of the Loans under the Credit Agreement and the Revolving Loans under the Revolving Loan Agreement on the date hereof, and immediately after giving effect to the application of the proceeds of the Loans and the Revolving Loans used on the Closing Date:
Β
Β | a. | The fair value of the assets (on a going concern basis) of Holdings and its Subsidiaries on a consolidated basis, at a fair valuation, exceeds their debts and liabilities, subordinated or otherwise; |
Β
Β | b. | The present fair saleable value of the property (on a going concern basis) of Holdings and its Subsidiaries, on a consolidated basis, is greater than the amount that will be required to pay the probable liability of their debts and other liabilities, subordinated, contingent or otherwise, as such debts and other liabilities become absolute and matured; |
Β
Β | c. | Holdings and its Subsidiaries, on a consolidated basis, are able to pay their debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured; and |
Β
Β | d. | Holdings and its Subsidiaries, on a consolidated basis, do not have unreasonably small capital with which to conduct the business in which they are engaged as such business is now conducted and is proposed to be conducted following the Closing Date. |
For purposes of this Solvency Certificate, the amount of any contingent liability at any time shall be computed as the amount that, in light of all of the facts and circumstances existing at such time, would reasonably be expected to become an actual and matured liability. Capitalized terms used but not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement.
[Signature Page Follows]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
IN WITNESS WHEREOF, the undersigned has executed this Solvency Certificate in such undersignedβs capacity as the Chief Financial Officer of Holdings and its Subsidiaries, on behalf of Holdings and its Subsidiaries, and not individually, as of the date first stated above.
Β
SLS BREEZE INTERMEDIATE HOLDINGS, INC. | ||
By: |
Β | Β |
Name: |
Β | |
Title: |
Β |
[SIGNATURE PAGE TO SOLVENCY CERTIFICATE]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT H
SLS Breeze Holdings, Inc.
FORM OF WARRANT PURCHASE AGREEMENT
dated as of [β’]
by and among
SLS Breeze Holdings, Inc.
and
Each of the Investors
Listed on Exhibit A
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
TABLE OF CONTENTS
Β
Β | Β Β | Β | Page | Β Β | ||
ARTICLE I DEFINED TERMS | Β Β | Β | 1 | Β Β | ||
SectionΒ 1.1 |
Β | Definitions | Β Β | Β | 1 | Β Β |
ARTICLE II ACQUISITION TERMS | Β Β | Β | 4 | Β Β | ||
Section 2.1 |
Β | Purchase and Sale | Β Β | Β | 4 | Β Β |
ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY | Β Β | Β | 4 | Β Β | ||
SectionΒ 3.1 |
Β | Corporate Existence | Β Β | Β | 4 | Β Β |
Section 3.2 |
Β | Power and Authority | Β Β | Β | 4 | Β Β |
Section 3.3 |
Β | Capitalization; Voting Rights | Β Β | Β | 5 | Β Β |
Section 3.4 |
Β | Legal Bar | Β Β | Β | 5 | Β Β |
Section 3.5 |
Β | Government Approvals | Β Β | Β | 5 | Β Β |
Section 3.6 |
Β | Private Sale | Β Β | Β | 6 | Β Β |
Section 3.7 |
Β | Registration Rights | Β Β | Β | 6 | Β Β |
Section 3.8 |
Β | Representations Incorporated by Reference | Β Β | Β | 6 | Β Β |
ARTICLE IV COVENANTS OF THE COMPANY | Β Β | Β | 7 | Β Β | ||
Section 4.1 |
Β | Indemnification | Β Β | Β | 7 | Β Β |
Section 4.2 |
Β | Further Assurances | Β Β | Β | 7 | Β Β |
Section 4.3 |
Β | Covenants Incorporated by Reference | Β Β | Β | 7 | Β Β |
ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE INVESTORS | Β Β | Β | 8 | Β Β | ||
Section 5.1 |
Β | Power and Authority | Β Β | Β | 8 | Β Β |
Section 5.2 |
Β | Purchase for Investment | Β Β | Β | 8 | Β Β |
Section 5.3 |
Β | Financial Matters | Β Β | Β | 8 | Β Β |
ARTICLE VI THE CLOSING AND CLOSING CONDITIONS | Β Β | Β | 9 | Β Β | ||
Section 6.1 |
Β | The Closing | Β Β | Β | 9 | Β Β |
SectionΒ 6.2 |
Β | Deliveries | Β Β | Β | 9 | Β Β |
Β
i
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE VII MISCELLANEOUS |
Β Β | Β | 9 | Β Β | ||
SectionΒ 7.1 |
Β | Expenses | Β Β | Β | 9 | Β Β |
SectionΒ 7.2 |
Β | Severability | Β Β | Β | 10 | Β Β |
Section 7.3 |
Β | Notices | Β Β | Β | 10 | Β Β |
Section 7.4 |
Β | Amendment and Modification; Waiver | Β Β | Β | 10 | Β Β |
Section 7.5 |
Β | Survival of Agreement | Β Β | Β | 10 | Β Β |
Section 7.6 |
Β | Cumulative Remedies | Β Β | Β | 10 | Β Β |
Section 7.7 |
Β | Enforcement of Agreement | Β Β | Β | 11 | Β Β |
Section 7.8 |
Β | Entire Agreement | Β Β | Β | 11 | Β Β |
Section 7.9 |
Β | Governing Law | Β Β | Β | 11 | Β Β |
SectionΒ 7.10 |
Β | Submission to Jurisdiction; Consents to Service of Process | Β Β | Β | 11 | Β Β |
Section 7.11 |
Β | Waiver of Jury Trial | Β Β | Β | 11 | Β Β |
Section 7.12 |
Β | Counterparts | Β Β | Β | 12 | Β Β |
Section 7.13 |
Β | Titles and Subtitles | Β Β | Β | 12 | Β Β |
Section 7.14 |
Β | Successors and Assigns | Β Β | Β | 12 | Β Β |
Section 7.15 |
Β | No Strict Construction | Β Β | Β | 12 | Β Β |
Section 7.16 |
Β | Replacement of Warrant on Loss | Β Β | Β | 12 | Β Β |
Section 7.17 |
Β | Stockholders Agreement | Β Β | Β | 12 | Β Β |
EXHIBITS |
Β Β | |||||
Exhibit A |
Β | Investors | Β Β | |||
Exhibit B |
Β | Certificate of Incorporation | Β Β | |||
Exhibit C |
Β | Capitalization Table | Β Β | |||
Exhibit D |
Β | Form of Warrant | Β Β | |||
Exhibit E |
Β | Form of VCOC Letter | Β Β | |||
Exhibit F |
Β | Form of Stockholders Agreement | Β Β | |||
Exhibit G |
Β | Form of Registration Rights Agreement | Β Β | |||
Exhibit H |
Β | Form of Joinders | Β Β |
Β
ii
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
WARRANT PURCHASE AGREEMENT
THIS WARRANT PURCHASE AGREEMENT is made as of SeptemberΒ 25, 2013 (this βAgreementβ) by and among SLS Breeze Holdings, Inc., a Delaware corporation (the βCompanyβ), and each of the investors listed on Exhibit A hereto (together with their successor and assigns, the βInvestorsβ).
RECITALS
WHEREAS, the Company has authorized the sale and issuance to the Investors warrants to purchase an aggregate of 2.5Β million shares of Common Stock substantially in the form attached hereto as Exhibit D (the βWarrantsβ) to induce the Lenders to enter into the Credit Agreement and make the Loans;
NOW, THEREFORE, the parties hereto agree as follows:
ARTICLE I
DEFINED TERMS
SectionΒ 1.1 Definitions.
(a) The following terms, when used in this Agreement, have the following meanings, unless the context otherwise indicates:
βAffiliateβ means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with such Person.
βAgreementsβ means this Agreement, the Warrants, the Stockholders Agreement, the Registration Rights Agreement and all agreements and instruments contemplated hereby or thereby.
βApplicable Lawβ means any foreign, federal, state or local statute, law, rule or regulation or any judgment, decree, order, regulation or rule of any Governmental Authority.
βBoardβ means the Board of Directors of the Company.
βBylawsβ means the bylaws of the Company, as amended.
βCapital Stockβ means, with respect to any Person, all common stock, preferred stock and any other capital stock of such Person, and all shares, interests, participations and other ownership interest (however designated), of such Person, and all rights, warrants and options to purchase any of the foregoing, including each class of common stock and preferred stock of such Person if such Person is a corporation, each general and limited partnership interest of such Person if such Person is a partnership and each membership interest in a limited liability company.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βCertificate of Incorporationβ shall mean the Certificate of Incorporation of the Company substantially in the form attached hereto as Exhibit B.
βClosingβ means the consummation of the Companyβs issuance of the Warrants to the Investors and the consummation of the Investorsβ entry into the Credit Agreement and making the Loans.
βClosing Dateβ means the date on which the Closing occurs.
βCommissionβ means the United States Securities and Exchange Commission.
βCommon Stockβ means the common stock of the Company, par value $0.01 per share.
βCredit Agreementβ means the Credit Agreement, dated as of the date hereof, among Blackline Systems, Inc., SLS Breeze Intermediate Holdings, Inc., the lenders party thereto (the βLendersβ) and Obsidian Agency Services, Inc., as the administrative agent and collateral agent.
βGovernmental Authorityβ shall mean any Federal, state, local or foreign court or governmental agency, authority, instrumentality, regulatory body, board or commission.
βInvestorβ shall have the meaning set forth in the Recitals hereto.
βLoansβ shall have the meaning set forth in the Credit Agreement.
βLienβ means any security interest, mortgage, pledge, transfer restriction, defect, claim, Lien, limitation on voting rights, encumbrance, pre-emptive or similar right, equity or adverse interest of any nature.
βPermitsβ means all franchises, approvals, qualifications, authorizations, consents, Permits, licenses and other similar authority.
βPersonβ shall mean any natural person, corporation, business trust, joint venture, association, company, limited liability company, partnership, Governmental Authority or other entity.
βProceedingβ means any action, claim, suit or proceeding (including an investigation or partial proceeding, such as a deposition, or any appeal of any proceeding).
Β
2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βRegistration Rights Agreementβ means the Registration Rights Agreement, dated as of SeptemberΒ 3, 2013, by and among the Company and certain of its stockholders, and substantially in the form attached hereto as Exhibit G.
βRelated Personβ means, with respect to any Person (i)Β any Affiliate of such Person, (ii)Β any investment fund, investment account or investment Person whose investment manager, investment advisor or general partner, is such Person or any Affiliate of such Person or any member, partner, officer or employee of such Person or any Affiliate of such Person, (iii)Β any member or partner of any Person specified in clause (i)Β or (ii)Β above, and (iv)Β any officer or employee of any Person specified in clause (i), (ii)Β or (iii)Β above.
βSecurities Actβ means the Securities Act of 1933, or any similar federal statute, and the rules and regulations thereunder, all as the same shall be in effect at the time.
βStockholders Agreementβ means the Stockholders Agreement, dated as of SeptemberΒ 3, 2013, by and among the Company and certain of its stockholders, and substantially in the form attached hereto as Exhibit F.
βSubsidiaryβ means (a)Β a corporation more than 50% of the combined voting power of the outstanding voting stock of which is owned, directly or indirectly, by the Company, or by one or more Subsidiaries, or by the Company and one or more Subsidiaries, (b)Β a partnership of which the Company, or one or more other Subsidiaries, or the Company and one or more Subsidiaries, directly or indirectly, is the general partner and has the power to direct the policies, management and affairs or (c)Β any other Person (other than a corporation) in which the Company, or one or more Subsidiaries, or the Company and one or more Subsidiaries, directly or indirectly, has at least a majority ownership interest and power to direct the policies, management and affairs thereof.
βTaxesβ means any and all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.
βTransactionsβ means, the transactions contemplated by the Agreements, including the issuance, sale and delivery of the Warrants and the Warrant Shares.
βVCOC Letterβ means the letter, dated as of the date hereof, from the Company to each of the Investors, and substantially in the form attached hereto as Exhibit E.
βWarrant Sharesβ means shares of Common Stock issued or issuable upon exercise of the Warrants.
βWarrantsβ shall have the meaning set forth in the Recitals hereto.
Β
Β
3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(b) Unless the context otherwise requires: (i)Β βorβ is not exclusive, (ii)Β the words βincluding,β βincludesβ and similar words shall be deemed to be followed by βwithout limitationβ, (iii)Β unless the context otherwise requires, any reference to an βArticle,β βSectionβ or βclauseβ refers to an Article, Section or clause, as the case may be, of this Agreement, (iv)Β the words βherein,β βhereofβ and βhereunderβ and other words of similar import refer to this Agreement as a whole and not any particular Article, Section, clause or other subdivision, and (v)Β words used herein implying any gender shall apply to both genders.
ARTICLE II
ACQUISITION TERMS
SectionΒ 2.1 Purchase and Sale. Subject to the terms of this Agreement and as a condition to the Lenders obligation to make the Loans at the Closing, the Company shall issue to each Investor a Warrant to purchase the number of shares of Common Stock set forth opposite such Investorβs name in the appropriate column on Exhibit A.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company represents and warrants to the Investors that all of the statements contained in this Article III are true and complete at and as of the (i)Β date hereof and (ii)Β the Closing Date.
SectionΒ 3.1 Corporate Existence. The Company is a corporation duly incorporated, validly existing and in good standing under Delaware law and has all requisite power and authority to conduct its business and own its properties as now and proposed to be conducted and owned. The Company is qualified as a foreign corporation to do business in all jurisdictions in which the nature of its properties and business requires such qualification.
SectionΒ 3.2 Power and Authority.
(a) The Company has all requisite power and authority, and has taken all required corporate and other action necessary (including stockholder approval, if necessary) to permit it to own and hold properties, to carry on its current business, to execute and deliver each of the Agreements, to issue and sell the Warrants and to issue the Warrant Shares as herein provided, and otherwise to carry out the terms of each of the Agreements. Each of the Agreements has been duly executed and delivered by the Company and (assuming the due authorization, execution and delivery hereof and thereof by the other signatories thereto) and is a valid and binding obligation of the Company, enforceable against the Company in accordance
Β
4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
with its terms, except (i)Β as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditorsβ rights generally, (ii)Β as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (iii)Β to the extent the indemnification provisions contained herein and in the Registration Rights Agreement may be limited by applicable federal or state securities laws. No event has occurred and no condition exists that would constitute a violation of, or a default under, any of the Agreements.
(b) The Warrant Shares, when issued in compliance with the provisions of the Warrants, will have the rights, preferences, privileges and restrictions described in the Certificate of Incorporation; and will be free of any Liens other than restrictions on transfer under state and federal securities laws and as otherwise provided in the Agreements.
SectionΒ 3.3 Capitalization; Voting Rights.
(a) The capitalization table attached hereto as Exhibit C accurately reflects the outstanding Capital Stock of the Company (on a fully diluted basis) both immediately prior to and immediately following the Closing.
(b) All the outstanding shares of Capital Stock of the Company are duly authorized, validly issued, fully paid, nonassessable and have been issued in compliance with Applicable Law. The Warrants and Warrant Shares, upon issuance and payment therefor in accordance with the terms of this Agreement, will be duly authorized, validly issued, fully paid and nonassessable. The Warrant Shares have been duly and validly reserved for issuance on the exercise of the Warrants. None of the shares of the Common Stock are held in the Companyβs treasury. No Capital Stock of the Company is entitled to cumulative voting rights, preemptive rights, anti-dilution rights or so-called registration rights under the Securities Act, except as otherwise provided in this Agreement, the Stockholders Agreement, the Registration Rights Agreement, the Warrants or the Certificate of Incorporation or as set forth on Schedule 3.3.
SectionΒ 3.4 Legal Bar. The execution, delivery or performance of each of the Agreements will not (a)Β conflict with or result in a violation of the Certificate of Incorporation or Bylaws, (b)Β conflict with or result in a violation of any Applicable Law, (c)Β require any consent or authorization or filing with, or other act by or in respect of, any Governmental Authority, or (d)Β result in a breach of, constitute a default under or constitute an event creating rights of acceleration, termination or cancellation under any mortgage, lease, contract, franchise, instrument or other agreement to which the Company or any of its Subsidiaries is a party or by which any of them is bound.
SectionΒ 3.5 Government Approvals. No Permit from, nor any filing, declaration or registration with, any Governmental Authority or any other Person is required in connection with the execution, delivery or performance by the Company or any of its Subsidiaries of the Agreements or the consummation of the Transactions.
Β
5
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SectionΒ 3.6 Private Sale. The Company has not, either directly or through any agent, offered any securities to or solicited any offers to acquire any securities from, or otherwise approached, negotiated, or communicated in respect of any securities with, any Person in such a manner as to require that the offer or sale of the Warrants or Warrant Shares be registered pursuant to the provisions of SectionΒ 5 of the Securities Act and the rules and regulations of the Commission thereunder or the securities laws of any other jurisdiction. Neither the Company nor anyone acting on its behalf will take any action prior to the Closing that would cause any such registration to be required (including any offer, issuance or sale of any security of the Company under circumstances that might require the integration of such security with the Warrants or Warrant Shares under the Securities Act or the rules and regulations of the Commission thereunder) that might subject the offering, issuance or sale of the Warrants and Warrant Shares to the registration provisions of the Securities Act. Assuming the representations and warranties of the Investors contained in Article V are true and correct, the issuance of the Warrants and Warrant Shares is exempt from registration under the Securities Act. The Company has complied with all Applicable Laws in all issuances and purchases of its Capital Stock prior to the date hereof and has not violated any Applicable Law in making such issuances and purchases of its Capital Stock prior to the date hereof. Any notices required to be filed under Applicable Laws prior to or subsequent to the Closing shall be filed on a timely basis prior to the Closing or as so required. Neither the Company nor any Person authorized or employed by the Company as agent, broker, dealer or otherwise in connection with the offering or sale of the Warrant has offered the same or any such securities for sale to, or solicited any offers to buy the same from, or otherwise approached or negotiated with respect thereto with, any Person or Persons other than the Investors.
SectionΒ 3.7 Registration Rights. Following the Closing, the Company and its Subsidiaries will not have any obligations with respect to registration rights, including piggyback rights, to any Person, except as set forth in the Registration Rights Agreement or on Schedule 3.7.
SectionΒ 3.8 Representations Incorporated by Reference. The provisions of, and related definitions used in, Article III of the Credit Agreement are incorporated herein by reference in their entirety, but with the definitions used therein being construed in accordance with the remaining provisions of this Section. All references in the provisions incorporated herein by reference to Article III of the Credit Agreement to (a)Β the βLoan Partiesβ shall be deemed to be references to the Company and its Subsidiaries, (b)Β βHoldingsβ shall be deemed to be references to the Company, (c)Β the βTransactionsβ shall be deemed to be include the transactions contemplated hereunder, (d)Β βthe date hereofβ or βthe date of this Agreementβ shall be deemed to be references to the date of this Agreement, (e)Β βhereafterβ shall be deemed to be references to after the date of this Agreement and (f)Β βthis Agreementβ, βhereofβ or βhereunderβ shall be deemed to be references to this Agreement. All references herein to any Section of the Credit Agreement incorporated by reference herein shall be deemed to be a reference to such Section as so incorporated. The provisions of the Sections of the Credit Agreement incorporated by reference herein shall remain in effect as incorporated on the date hereof (or as amended in accordance with the terms of this Agreement) notwithstanding the termination of or any amendment to the Credit Agreement.
Β
6
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE IV
COVENANTS OF THE COMPANY
SectionΒ 4.1 Indemnification. The Company shall (i)Β indemnify, to the maximum extent permitted by law, each Investor, Related Person of each Investor, and the directors, officers, employees, agents and representatives of each of them, from and against all actual out-of-pocket expenses, claims, losses, damages and liabilities to the extent arising out of third-party claims or actions based upon (x)Β the status of any of them as a security holder in the Company or (y)Β an Investorβs exercise of its rights or performance of its obligations under any of the Agreements, or the consummation of any of the Transactions; and (ii)Β reimburse each such indemnified Person for all reasonable out-of-pocket legal and other expenses incurred in connection with (A)Β investigating, preparing or defending any such third-party claims or actions, and (B)Β any claim or action by such indemnified Person against the Company with respect to the Investorsβ rights and remedies under any of the Agreements in which such indemnified Person is the prevailing party.
SectionΒ 4.2 Further Assurances. The Company will, at its expense, promptly cure any defects in the creation and issuance of the Warrants and Warrant Shares, or in the execution and delivery of the Agreements.
SectionΒ 4.3 Covenants Incorporated by Reference. The provisions of, and related definitions used in, Sections 5.04 (Financial Statements, Reports, etc.) and 5.05 (Litigation and Other Notices) in the Credit Agreement are incorporated herein by reference in their entirety, but with the definitions used therein being construed in accordance with the remaining provisions of this Section. All references in the provisions incorporated herein by reference to Article V of the Credit Agreement to (a)Β the βLendersβ shall be deemed to be references to the Investors, (b)Β βHoldingsβ shall be deemed to be references to the Company, (c)Β the βBorrowerβ shall be deemed to be Blackline Systems, Inc., a California corporation and wholly-owned indirect subsidiary of the Company, (d)Β βthe date hereofβ or βthe date of this Agreementβ shall be deemed to be references to the date of this Agreement, (e)Β βhereafterβ shall be deemed to be references to after the date of this Agreement and (f)Β βthis Agreementβ, βhereofβ or βhereunderβ shall be deemed to be references to this Agreement. All references herein to any Section of the Credit Agreement incorporated by reference herein shall be deemed to be a reference to such Section as so incorporated. The provisions of the Sections of the Credit Agreement incorporated by reference herein shall remain in effect as incorporated on the date hereof (or as amended in accordance with the terms of this Agreement) notwithstanding the termination of or any amendment to the Credit Agreement.
Β
7
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF THE INVESTORS
Each of the Investors severally represents and warrants to the Company, at and as of the Closing that:
SectionΒ 5.1 Power and Authority. Such Investor has full power and authority and, if not an individual Investor, has taken all required corporate (or trust or partnership, as the case may be) and other action necessary to permit it to execute and deliver the Agreements, if applicable and all other documents or instruments required by the Agreements, and to carry out the terms of the Agreements and of all such other documents or instruments. Each of the Agreements has been duly executed and delivered by such Investor and (assuming the due authorization, execution and delivery hereof and thereof by the other signatories thereto) and is a valid and binding obligation of such Investor, enforceable against such Investor in accordance with its terms, except (i)Β as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditorsβ rights generally, or (ii)Β as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.
SectionΒ 5.2 Purchase for Investment. Such Investor is acquiring the Warrants and Warrant Shares for investment, for its own account and not with a view to distribution thereof in violation of federal securities laws of the United States, except for transfers permitted hereunder. Such Investor understands that the Warrants and Warrant Shares must be held indefinitely unless registered under the Securities Act or an exemption from such registration becomes available. Such Investor understands that the Warrants it is purchasing are characterized as βrestricted securitiesβ under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Act only in certain limited circumstances. Such Investor understands that no public market presently exists for the Warrants, and there can be no assurance that any such market will be created.
SectionΒ 5.3 Financial Matters. Such Investor represents and warrants to the Company that it understands that the acquisition of the Warrants involves substantial risk and that its financial condition and investments are such that it is in a financial position to hold the Warrants for an indefinite period of time and to bear the economic risk of, and withstand a complete loss of, such Warrants. In addition, by virtue of its expertise, the advice available to it and previous investment experience, such Investor has extensive knowledge and experience in financial and business matters, investments, securities and private placements and the capability to evaluate the merits and risks of the transactions contemplated by this Agreement. Such Investor represents that it is an βaccredited investorβ as that term is defined in Regulation D promulgated under the Securities Act.
Β
8
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
ARTICLE VI
THE CLOSING AND CLOSING CONDITIONS
SectionΒ 6.1 The Closing. The purchase and sale of the Warrants shall take place at the Closing to be held at the offices of Proskauer Rose, LLP, 0000 Xxxxxxx Xxxx Xxxx, Xxxxx 0000, Xxx Xxxxxxx, Xxxxxxxxxx 00000. The Closing shall occur on SeptemberΒ 25, 2013.
SectionΒ 6.2 Deliveries. At the Closing, (a)Β the Company will deliver to each Investor a Warrant to purchase the number of shares of Common Stock set forth opposite such Investorβs name in the appropriate column on Exhibit A, (b)Β each Investor will deliver to the Company executed counterpart signature pages to each of the Stockholders Agreement and the Registration Rights Agreement, in the forms attached as Exhibit H, (c)Β the Company shall have delivered to the Investors a counterpart of the VCOC Letter in the form attached hereto as Exhibit E that shall have been executed and delivered by a duly authorized officer of the Company and (d)Β there shall be made available to each of the Investors a certificate of the Secretary or an Assistant Secretary of the Company, dated the Closing Date and certifying: (1)Β that attached thereto is a true and complete copy of the Bylaws as in effect on the date of such certification; (2)Β that attached thereto is a true and complete copy of the Certificate of Incorporation as in effect on the date of such certification; and (3)Β that attached thereto is a true and complete copy of resolutions adopted by the Board authorizing the execution, delivery and performance of the Agreements, the issuance, sale, and delivery of the Warrants, and that all such resolutions are still in full force and effect and are all the resolutions adopted in connection with the transactions contemplated by this Agreement.
ARTICLE VII
MISCELLANEOUS
SectionΒ 7.1 Expenses.
(a) The Company shall pay all reasonable out-of-pocket costs and expenses incurred by the Investors and their counsel in connection with (i)Β any amendments, modifications or waivers of the provisions hereof (whether or not the transactions hereby contemplated shall be consummated) or (ii)Β any dispute or Proceeding in respect to the enforcement of the Investorsβ rights under any of the Agreements in which the Investors are the prevailing party.
(b) The provisions of this SectionΒ 7.1 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the invalidity or unenforceability of any term or provision of this Agreement, or any investigation made by or on behalf of the Investors. All amounts due under this SectionΒ 7.1 shall be payable on written demand therefor.
Β
9
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SectionΒ 7.2 Severability. In the event any one or more of the provisions contained in this Agreement be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
SectionΒ 7.3 Notices. Notices and other communications provided for herein shall be in writing and shall be delivered in the manner set forth in the Warrants.
All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt if delivered by hand or overnight courier service or sent by fax or on the date 5 Business Days after dispatch by certified or registered mail if mailed, in each case delivered, sent or mailed (properly addressed) to such party as provided in this SectionΒ 7.3 or in accordance with the latest unrevoked direction from such party given in accordance with this SectionΒ 7.3. As agreed to among the Company and the Investors from time to time, notices and other communications may also be delivered by e-mail to the e-mail address of a representative of the applicable Person provided from time to time by such Person.
SectionΒ 7.4 Amendment and Modification; Waiver. This Agreement may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any rights, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.
SectionΒ 7.5 Survival of Agreement. All covenants, agreements, representations and warranties made by the Company herein and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement shall be considered to have been relied upon by the Investors and shall survive the execution and delivery of this Agreement and the Closing, regardless of any investigation made by the Investors or on their behalf.
SectionΒ 7.6 Cumulative Remedies. The rights and remedies provided in this Agreement are cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or remedies available at law, in equity or otherwise.
Β
10
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SectionΒ 7.7 Enforcement of Agreement. Each party hereby acknowledges that the rights of each party to consummate the transactions contemplated hereby are special, unique and of extraordinary character and that, in the event that any party violates or fails or refuses to perform any covenant or agreement made by it herein, the non-breaching party will (i)Β be without an adequate remedy at law and (ii)Β suffer irreparable damage. In the event that any party violates or fails or refuses to perform any covenant or agreement made by such party herein, the non-breaching party or parties may, subject to the terms hereof and in addition to any remedy at law for damages or other relief to which such party may be entitled, institute and prosecute an action in any court of competent jurisdiction to enforce specific performance of such covenant or agreement or seek any other injunctive or equitable relief, without posting any bond or other undertaking.
SectionΒ 7.8 Entire Agreement. This Agreement, together with the exhibits hereto, constitutes the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter.
SectionΒ 7.9 Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of laws of any jurisdiction other than of the State of New York.
SectionΒ 7.10 Submission to Jurisdiction; Consents to Service of Process.
(a) Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby shall be instituted in the federal courts of the United States of America or the courts of the State of New York in each case located in New York City, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.
(b) Each party irrevocably consents to service of process in the manner provided for notices in SectionΒ 7.3. Nothing in this Agreement will affect the right of any party to serve process in any other manner permitted by law.
SectionΒ 7.11 Waiver of Jury Trial. Each party acknowledges and agrees that any controversy that may arise under this Agreement is likely to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Agreement or the transactions contemplated hereby.
Β
11
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
SectionΒ 7.12 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.
SectionΒ 7.13 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.
SectionΒ 7.14 Successors and Assigns. Whenever in this Agreement any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and assigns of such party; and all covenants, promises and agreements by or on behalf of the parties hereto that are contained in this Agreement shall bind and inure to the benefit of their respective successors and assigns. The Company shall not assign or delegate any of its rights or duties hereunder without the prior written consent of the Investors, and any attempted assignment without such consent shall be null and void.
SectionΒ 7.15 No Strict Construction. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.
SectionΒ 7.16 Replacement of Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of a Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of an Investor shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Investor, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated or destroyed; provided, that, in the case of mutilation, no indemnity shall be required if a Warrant in identifiable form is surrendered to the Company for cancellation.
SectionΒ 7.17 Stockholders Agreement. Notwithstanding anything therein to the contrary, each Investor shall be deemed to be an βEligible Stockholderβ for purposes of the Stockholders Agreement, and shall be entitled to, without limitation, all rights specifically provided to an βEligible Stockholderβ thereunder.
Β
12
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.
Β
SLS BREEZE HOLDINGS, INC. | ||
By: | Β | Β |
Β | Name: | |
Β | Title: | |
INVESTORS: | ||
SPECIAL VALUE CONTINUATION PARTNERS, LP | ||
By: | Β | Xxxxxxxxxx Capital Partners, LLC |
Its: | Β | Investment Manager |
By: | Β | Β |
Β | Name: | |
Β | Title: | |
XXXXXXXXXX OPPORTUNITIES FUND VI, LLC | ||
By: | Β | Xxxxxxxxxx Capital Partners, LLC |
Its: | Β | Investment Manager |
By: | Β | Β |
Β | Name: | |
Β | Title: | |
XXXXXXXXXX SENIOR LOAN FUND II, LP | ||
By: | Β | Xxxxxxxxxx Capital Partners, LLC |
Its: | Β | Investment Manager |
By: | Β | Β |
Β | Name: | |
Β | Title: |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
XXXXXXXXXX SENIOR LOAN SPV III, LLC | ||
By: | Β | Xxxxxxxxxx Capital Partners, LLC |
Its: | Β | Investment Manager |
By: | Β | Β |
Name: | Β | |
Title: | Β | |
XXXXXXXXXX SENIOR LOAN FUND IV-B, LP | ||
By: | Β | Xxxxxxxxxx Capital Partners, LLC |
Its: | Β | Investment Manager |
By: | Β | Β |
Name: | Β | |
Title: | Β |
Β
2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT A
INVESTORS
Β
Investor |
Β Β | Warrant Shares |
Special Value Continuation Partners, LP |
Β Β | [***] |
Xxxxxxxxxx Opportunities Fund VI, LLC |
Β Β | [***] |
Xxxxxxxxxx Senior Loan Fund II, LP |
Β Β | [***] |
Xxxxxxxxxx Senior Loan SPV III, LLC |
Β Β | [***] |
Xxxxxxxxxx Senior Loan Fund IV-B, LP |
Β Β | [***] |
Β Β | Β | |
Total |
Β Β | [***] |
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT B
CERTIFICATE OF INCORPORATION
See attached.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT C
CAPITALIZATION TABLE
See attached.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT D
FORM OF WARRANT
See attached.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT E
FORM OF VCOC LETTER
See attached.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT F
FORM OF STOCKHOLDERS AGREEMENT
See attached.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT G
FORM OF REGISTRATION RIGHTS AGREEMENT
See attached.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT H
FORM OF JOINDERS
See attached.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT I
Form of Warrant
[See attached]
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
WARRANT
SLS BREEZE HOLDINGS, INC.
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE βACTβ), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I)Β A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW. THIS WARRANT IS SUBJECT TO CERTAIN TRANSFER AND OTHER RESTRICTIONS SET FORTH HEREIN, AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT ARE SUBJECT TO CERTAIN TRANSFER AND OTHER RESTRICTIONS PURSUANT TO A STOCKHOLDERS AGREEMENT, DATED AS OF SEPTEMBER 3, 2013, AMONG THE ISSUER HEREOF (THE βCOMPANYβ) AND CERTAIN OF THE COMPANYβS STOCKHOLDERS (AS AMENDED AND MODIFIED FROM TIME TO TIME). THE COMPANY RESERVES THE RIGHT TO REFUSE THE TRANSFER OF THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT EXCEPT IN ACCORDANCE WITH THIS WARRANT AND SUCH AGREEMENT, A COPY OF WHICH SHALL BE FURNISHED WITHOUT CHARGE BY THE COMPANY TO THE HOLDER HEREOF UPON WRITTEN REQUEST.
Warrant Certificate No.: [β’]
Original Issue Date: [β’], 2013
FOR VALUE RECEIVED, SLS Breeze Holdings, Inc., a Delaware corporation (the βCompanyβ), hereby certifies that [Warrantholder], a [juisdiction and type of entity], or its registered assigns (the βHolderβ) is entitled to purchase from the Company [β’] duly authorized, validly issued, fully paid and nonassessable shares of Common Stock at a purchase price per share initially of $1.00 (subject to adjustment as provided herein, the βExercise Priceβ), all subject to the terms, conditions and adjustments set forth below in this Warrant.
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
This Warrant has been issued pursuant to the terms of the Warrant Purchase Agreement, dated as of [β’], 2013 (the βPurchase Agreementβ), between the Company and the investors listed on Exhibit A thereto.
1. Definitions. As used in this Warrant, the following terms have the respective meanings set forth below:
βAffiliateβ of any particular Person means any other Person controlling, controlled by or under common control with such particular Person, where βcontrolβ means the possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities, contract or otherwise.
βAggregate Exercise Priceβ means, on any Exercise Date, an amount equal to the product of (a)Β the number of Warrant Shares in respect of which this Warrant is then being exercised pursuant to SectionΒ 3 hereof, multiplied by (b)Β the Exercise Price in effect as of the Exercise Date.
βBoardβ means the board of directors of the Company.
βBusiness Dayβ means any day other than a Saturday, Sunday or day on which banks in New York, New York or Los Angeles, California are authorized or required by law to close.
βCommon Stockβ means the common stock, par value $0.01 per share, of the Company, and any capital stock into which such Common Stock shall have been converted, exchanged or reclassified following the date hereof.
βCommon Stock Deemed Outstandingβ means, at any time, the sum of (a)Β the number of shares of Common Stock actually outstanding at such time, plus (b)Β the number of shares of Common Stock issuable upon exercise, conversion or exchange of Convertible Securities actually outstanding at such time (treating as actually outstanding any Convertible Securities issuable upon exercise of Convertible Securities actually outstanding at such time), in each case, regardless of whether the Convertible Securities are actually exercisable, convertible or exchangeable at such time; provided, that Common Stock Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company or any of its subsidiaries.
βCompanyβ has the meaning set forth in the preamble.
βConvertible Securitiesβ means warrants, rights, options, evidence of indebtedness, shares of stock or other securities that are convertible into or exercisable or exchangeable for, with or without payment of additional consideration, shares of Common Stock or other Convertible Securities, either immediately or upon the arrival of a specified date or the happening of a specified event; provided, that options granted to directors, officers, employees, or consultants of the Company in connection with their service as directors of the Company, their employment by the Company or their retention as consultants by the Company, in each case authorized by the Board, shall not constitute Convertible Securities.
Β
2
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βExcluded Issuancesβ means any issuance or sale by the Company after the Original Issue Date of: (a)Β shares of Common Stock issued upon the exercise of this Warrant; or (b)Β shares of Common Stock issued directly or upon the exercise of options to directors, officers, employees, or consultants of the Company in each case (i)Β in connection with their service as directors of the Company, their employment by the Company or their retention as consultants by the Company, and (ii)Β authorized by the Board.
βExercise Dateβ means, for any given exercise of this Warrant, the date on which the conditions to such exercise set forth in SectionΒ 3 shall have been satisfied at or prior to 5:00 p.m., Los Angeles time.
βExercise Agreementβ means an Exercise Agreement in the form attached hereto as Exhibit A.
βExercise Periodβ means the period from the Original Issue Date through and including the earlier of (x)Β 5:00 p.m., Los Angeles time, on the tenth anniversary of Original Issue Date or, if such day is not a Business Day, on the next preceding Business Day or (y)Β the consummation of a Sale of the Company.
βExercise Priceβ has the meaning set forth in the preamble.
βFair Market Valueβ means, as of any date: (a)Β the volume weighted average of the closing sales prices of the Common Stock for such day on all domestic securities exchanges on which the Common Stock is then listed; (b)Β if there have been no sales of the Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices for the Common Stock on all such exchanges at the end of such day; (c)Β if on any such day the Common Stock is not listed on a domestic securities exchange, the closing sales price of the Common Stock as quoted on NASDAQ, the OTC Bulletin Board or similar quotation system or association for such day; or (d)Β if there have been no sales of the Common Stock on NASDAQ, the OTC Bulletin Board or similar quotation system or association on such day, the average of the highest bid and lowest asked prices for the Common Stock quoted on NASDAQ, the OTC Bulletin Board or similar quotation system or association at the end of such day; in each case, averaged over twenty (20)Β consecutive Business Days ending on the Business Day immediately prior to the day as of which βFair Market Valueβ is being determined; provided, that if the Common Stock is listed on any domestic securities exchange, the term βBusiness Dayβ as used in this sentence means Business Days on which such exchange is open for trading. If at any time the Common Stock is not listed on any domestic securities exchange or quoted on NASDAQ, the OTC Bulletin Board or similar quotation system or association, the βFair Market Valueβ of the Common Stock shall be the fair market value per share as determined jointly in good faith by the Board and the Holder; provided, however, that if the Board and the Holder are unable to reach agreement within a reasonable period of time, the Fair Market Value shall be determined in good
Β
3
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
faith by an independent investment banking or valuation firm selected jointly by the Board and the Holder or, if that selection cannot be made within ten days, by an independent investment banking or valuation firm selected by the American Arbitration Association in accordance with its rules.
βHolderβ has the meaning set forth in the preamble.
βOriginal Issue Dateβ means the date on which the Warrant was issued by the Company pursuant to the Purchase Agreement.
βNASDAQβ means The NASDAQ Stock Market LLC.
βOTC Bulletin Boardβ means the Financial Industry Regulatory Authority OTC Bulletin Board electronic inter-quotation system.
βPermitted Transfereeβ means, as to any Holder, such Holderβs Affiliates, which shall include any entity, parallel fund or alternative investment vehicle managed by such Holder or any of its Affiliates.
βPersonβ means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated organization or government or department or agency thereof.
βPurchase Agreementβ has the meaning set forth in the preamble.
βRegistration Rights Agreementβ means the Registration Rights Agreement, dated as of SeptemberΒ 3, 2013, by and among the Company and certain of its stockholders (as amended from time to time in accordance with its terms).
βReorganizationβ means any (i)Β capital reorganization of the Company, (ii)Β reclassification of the stock of the Company (other than a change in par value or from par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or combination of shares), (iii)Β consolidation or merger of the Company with or into another Person, (iv)Β sale of all or substantially all of the Companyβs assets to another Person or (v)Β other similar transaction (other than any such transaction covered by SectionΒ 4(d)), in each case which entitles the holders of Common Stock to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange for Common Stock; provided, however, that a Sale of the Company shall not constitute a Reorganization.
βSale of the Companyβ has the meaning set forth in the Stockholders Agreement, dated as of SeptemberΒ 3, 2013, by and among the Company and certain of its stockholders (as in effect on the date hereof).
βWarrantβ means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.
Β
4
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
βWarrant Sharesβ means the shares of Common Stock or other capital stock of the Company then purchasable upon exercise of this Warrant.
2. Term of Warrant. The Holder of this Warrant may exercise this Warrant for all or any part of the Warrant Shares on any day during the Exercise Period. Subject to SectionΒ 3(i) below, this Warrant shall expire and be of no further force and effect upon the expiration of the Exercise Period.
3. Exercise of Warrant.
(a) Exercise Procedure. During the Exercise Period, this Warrant may be exercised by the Holder for all or from time to time any part of the unexercised Warrant Shares, upon:
(i) surrender of this Warrant to the Company at its then principal executive offices (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction), together with a completed and executed Exercise Agreement; and
(ii) payment to the Company of the Aggregate Exercise Price in accordance with SectionΒ 3(b).
(b) Payment of the Aggregate Exercise Price. Payment of the Aggregate Exercise Price may be made, at the option of the Holder as expressed in the Exercise Agreement, by any of the following methods:
(i) delivery to the Company of a certified or official bank check payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company;
(ii) instructing the Company to withhold a number of Warrant Shares then issuable upon exercise of this Warrant with an aggregate Fair Market Value as of the Exercise Date equal to such Aggregate Exercise Price (or the applicable portion thereof);
(iii) surrendering to the Company securities of the Company having a value as of the Exercise Date equal to the Aggregate Exercise Price (or the applicable portion thereof), which value in the case of debt securities shall be the principal amount thereof plus accrued and unpaid interest, in the case of preferred stock shall be the liquidation value thereof plus accumulated and unpaid dividends and in the case of shares of Common Stock shall be the Fair Market Value thereof; or
(iv) any combination of the foregoing.
In the event of any withholding of Warrant Shares or surrender of other equity securities pursuant to clause (ii), (iii)Β or (iv)Β above where the number of shares whose value is equal to the Aggregate Exercise Price is not a whole number, the number of shares withheld by or surrendered to the Company shall be rounded up to the nearest whole share and the Company
Β
5
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
shall make a cash payment to the Holder (by delivery of a certified or official bank check or by wire transfer of immediately available funds) based on the incremental fraction of a share being so withheld by or surrendered to the Company in an amount equal to the product of (x)Β such incremental fraction of a share being so withheld or surrendered multiplied by (y)Β the value thereof as of the Exercise Date determined in accordance with clause (iii)Β above.
(c) Delivery of Stock Certificates. As promptly as practicable, and in any event within five Business Days after receipt by the Company of the Exercise Agreement, surrender of this Warrant and payment of the Aggregate Exercise Price (in accordance with SectionΒ 3(a) hereof), the Company shall execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder a certificate or certificates representing the Warrant Shares issuable upon such exercise, together with cash in lieu of any fraction of a share, as provided in SectionΒ 3(d) hereof. The stock certificate or certificates so delivered shall be in such denomination or denominations as the exercising Holder shall reasonably request in the Exercise Agreement and registered in the name of the Holder or such other Personβs name as shall be designated in the Exercise Agreement. This Warrant shall be deemed to have been exercised and such certificate or certificates of Warrant Shares shall be deemed to have been issued, and the Holder or any other Person so designated to be named therein shall be deemed to have become a holder of record of such Warrant Shares for all purposes, as of the Exercise Date.
(d) Fractional Shares. The Company shall not be required to issue a fractional share of Common Stock upon exercise of any Warrant. As to any fraction of a share that the Holder would otherwise be entitled to purchase upon such exercise, the Company shall pay to such Holder an amount in cash (by delivery of a certified or official bank check or by wire transfer of immediately available funds) equal to the product of (i)Β such fraction multiplied by (ii)Β the Fair Market Value of one share of Common Stock on the Exercise Date.
(e) Delivery of New Warrant. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised, at the time of delivery of the certificate or certificates representing the Warrant Shares being issued in accordance with SectionΒ 3(c) hereof, the Company shall deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired and unexercised Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.
(f) Expenses and Taxes. The Company shall pay all reasonable out-of-pocket expenses in connection with, and all issuance, stamp and similar taxes and other governmental charges that may be imposed with respect to, the issuance or delivery of Warrant Shares upon exercise of this Warrant; provided, that the Company shall not be required to pay any tax or governmental charge that may be imposed with respect to (i)Β the issuance or delivery of the Warrant Shares to any Person other than the Holder, or (ii)Β the sale or transfer of the Warrants or the Warrant Shares.
Β
6
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(g) Conditional Exercise. Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is required to be made in connection with a public offering, a Sale of the Company (pursuant to a merger, sale of stock, or otherwise), or any other event, such exercise may at the election of the Holder be conditioned upon the consummation of such transaction or event, in which case such exercise shall not be deemed to be effective until immediately prior to the consummation of such event.
(h) Reservation of Shares. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but unissued Common Stock or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of this Warrant, the maximum number of Warrant Shares issuable upon the exercise of this Warrant. The Company shall not increase the par value of any Warrant Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, and shall take all such actions as may be necessary or appropriate so that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant.
(i) Exercise Prior to Expiration. Notwithstanding any other provision of this Warrant and to the extent this Warrant is not previously exercised as to all Warrant Shares subject hereto, if the Fair Market Value of Warrant Shares is greater than the Exercise Price then in effect, this Warrant shall be deemed automatically exercised by the method set forth in SectionΒ 3(b)(ii) above immediately before its expiration. To the extent this Warrant or any portion thereof is deemed automatically exercised pursuant to this SectionΒ 3(i), the Company shall promptly notify the Holder of the number of Warrant Shares the Holder is to receive by reason of such automatic exercise.
(j) Tax Treatment. If the Holder elects (or is automatically deemed to elect pursuant to SectionΒ 3(i)) the method of exercise set forth in SectionΒ 3(b)(ii), the βexchangeβ of the Warrants is intended to qualify as a recapitalization within the meaning of SectionΒ 368(a)(1)(E) of the U.S. Internal Revenue Code of 1986, as amended, and the parties hereto shall report consistently therewith for all tax purposes.
4. Adjustment to Exercise Price and Number of Warrant Shares. The Exercise Price and the number of Warrant Shares issuable upon exercise of this Warrant shall be subject to adjustment from time to time as provided in this SectionΒ 4.
(a) Adjustment to Exercise Price Upon Issuance of Common Stock. Except in the case of an Excluded Issuance or an event described in either SectionΒ 4(d) or SectionΒ 4(e), if the Company shall, at any time or from time to time after the Original Issue Date, issue or sell (or in accordance with SectionΒ 4(c) is deemed to have issued or sold) any shares of Common Stock without consideration or for consideration per share less than the Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance or sale), then immediately upon such issuance or sale (or deemed issuance or sale), the Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance or sale) shall be reduced (and in no event increased) to an Exercise Price equal to the quotient obtained by dividing:
Β
7
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(i) the sum of (A)Β the product obtained by multiplying the Common Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) by the Exercise Price then in effect plus (B)Β the aggregate consideration, if any, received by the Company upon such issuance or sale (or deemed issuance or sale); by
(ii) the sum of (A)Β the Common Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) plus (B)Β the aggregate number of shares of Common Stock issued or sold (or deemed issued or sold) by the Company in such issuance or sale (or deemed issuance or sale).
(b) Adjustment to Number of Warrant Shares Upon Adjustment to Exercise Price. Upon each adjustment of the Exercise Price as provided in SectionΒ 4(a), the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment shall be increased to a number of Warrant Shares equal to the quotient obtained by dividing:
(i) the product of (A)Β the Exercise Price in effect immediately prior to such adjustment multiplied by (B)Β the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such adjustment; by
(ii) the Exercise Price resulting from such adjustment.
(c) Effect of Certain Events on Adjustment to Exercise Price.
(i) Issuance of Convertible Securities. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner grant or sell (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not immediately exercisable, and the price per share (determined as provided in this paragraph and in SectionΒ 4(c)(iii)) for which Common Stock is issuable upon the exercise, conversion or exchange thereof (or upon the exercise, conversion or exchange of Convertible Securities issuable upon the exercise, conversion or exchange thereof) is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Convertible Securities, then the total maximum number of shares of Common Stock issuable upon the exercise, conversion or exchange thereof (or upon the exercise, conversion or exchange of Convertible Securities issuable upon the exercise, conversion or exchange thereof) shall be deemed to have been issued as of the date of granting or sale thereof (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price under SectionΒ 4(a)), at a price per share equal to the quotient obtained by dividing:
(A) the sum (which sum shall constitute the applicable consideration received for purposes of SectionΒ 4(a)) of (x)Β the total amount, if any, actually received by the Company as consideration for the granting or sale of all such Convertible Securities, plus (y)Β the minimum aggregate amount of additional consideration payable to the Company upon the exercise, conversion or exchange thereof (or upon the exercise, conversion or exchange of Convertible Securities issuable upon the exercise, conversion or exchange thereof), by
Β
8
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(B) the total maximum number of shares of Common Stock issuable upon the exercise, conversion or exchange thereof (or upon the exercise, conversion or exchange of Convertible Securities issuable upon the exercise, conversion or exchange thereof).
(ii) Change in Terms of Convertible Securities. Upon any change in any of (A)Β the total amount received or receivable by the Company as consideration for the granting or sale of any Convertible Securities, (B)Β the minimum aggregate amount of additional consideration, if any, payable to the Company upon the exercise, conversion or exchange of any Convertible Securities (or upon the exercise, conversion or exchange of Convertible Securities issuable upon the exercise, conversion or exchange thereof), (C)Β the rate at which Convertible Securities hereof are convertible into or exchangeable for Common Stock, or (D)Β the maximum number of shares of Common Stock issuable in connection with any Convertible Securities, then (whether or not the original issuance or sale of such Convertible Securities resulted in an adjustment to the Exercise Price pursuant to this SectionΒ 4) (x)Β the Exercise Price in effect at the time of such change shall be adjusted or readjusted, as applicable, to the Exercise Price that would have been in effect at such time pursuant to the provisions of this SectionΒ 4 had such Convertible Securities still outstanding provided for such changed consideration, conversion rate or maximum number of shares, as the case may be, at the time initially granted, issued or sold, but only if as a result of such adjustment or readjustment the Exercise Price then in effect is reduced, and (y)Β the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment or readjustment shall be correspondingly adjusted or readjusted pursuant to the provisions of SectionΒ 4(b).
(iii) Calculation of Consideration Received. If the Company shall, at any time or from time to time after the Original Issue Date, issue or sell, or is deemed to have issued or sold, any shares of Common Stock or Convertible Securities: (A)Β for cash, the consideration received therefor shall be deemed to be the net amount received by the Company therefor; (B)Β for consideration other than cash, the amount of such consideration shall be the fair value of such consideration received by the Company, except where such consideration consists of marketable securities, in which case the amount of such consideration shall be the market price (as reflected on any securities exchange, quotation system or association or similar pricing system covering such security) for such securities as of the end of business on the date of receipt of such securities by the Company; (C)Β for no specifically allocated consideration in connection with an issuance or sale of other securities of the Company, together comprising one integrated transaction, the amount of the consideration therefor shall be deemed to be the fair value of such portion of the aggregate consideration received by the Company in such transaction as is attributable to such shares of Common Stock or Convertible Securities, as the case may be, issued in such transaction; or (D)Β to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving corporation, the amount of consideration
Β
9
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
therefor shall be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock or Convertible Securities, as the case may be, issued to such owners. The net amount of any cash consideration and the fair value of any consideration other than cash or marketable securities shall be determined in good faith jointly by the Board and the Holder; provided, however, that if the Board and the Holder are unable to reach agreement within a reasonable period of time, such fair value shall be determined in good faith by an independent investment banking or valuation firm selected jointly by the Board and the Holder or, if that selection cannot be made within ten days, by an independent investment banking or valuation firm selected by the American Arbitration Association in accordance with its rules.
(iv) Record Date. For purposes of any adjustment to the Exercise Price or the number of Warrant Shares in accordance with this SectionΒ 4, in case the Company shall take a record of the holders of its Common Stock for the purpose of entitling them (A)Β to receive a dividend or other distribution payable in Common Stock or Convertible Securities or (B)Β to subscribe for or purchase Common Stock or Convertible Securities, then such record date shall be deemed to be the date of the issue or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.
(v) Treasury Shares. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company or any of its wholly-owned subsidiaries, and the disposition of any such shares (other than the cancellation or retirement thereof or the transfer of such shares among the Company and its wholly-owned subsidiaries) shall be considered an issue or sale of Common Stock.
(d) Adjustment Upon Dividend, Subdivision or Combination of Common Stock. If the Company shall, at any time or from time to time after the Original Issue Date, (i)Β pay a dividend or make any other distribution upon the Common Stock or any other capital stock of the Company payable in shares of Common Stock or Convertible Securities, or (ii)Β subdivide (by any stock split, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, (x)Β the Exercise Price in effect immediately prior to any such dividend, distribution or subdivision shall be proportionately reduced and (y)Β the number of Warrant Shares issuable upon exercise of this Warrant shall be proportionately increased. If the Company at any time combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, (x)Β the Exercise Price in effect immediately prior to such combination shall be proportionately increased and (y)Β the number of Warrant Shares issuable upon exercise of this Warrant shall be proportionately decreased. Subject to SectionΒ 4(c)(iv), any adjustment under this SectionΒ 4(d) shall become effective at the close of business on the date the dividend, subdivision or combination becomes effective.
Β
10
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(e) Adjustment Upon Reorganization, Reclassification, Consolidation or Merger. In the event of any Reorganization, (A)Β each Warrant shall remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number of Warrant Shares then exercisable under this Warrant, be exercisable for the kind and number of shares of stock or other securities or assets of the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon such Reorganization if the Holder had exercised this Warrant in full immediately prior to the time of such Reorganization and acquired the applicable number of Warrant Shares then issuable hereunder as a result of such exercise (without taking into account any limitations or restrictions on the exercisability of this Warrant); and (B)Β appropriate adjustment (in form and substance satisfactory to the Holder) shall be made with respect to the Holderβs rights under this Warrant to insure that the provisions of this SectionΒ 4 shall thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock, securities or assets thereafter acquirable upon exercise of this Warrant (including, in the case of any consolidation, merger, sale or similar transaction in which the successor or purchasing Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share for the Common Stock reflected by the terms of such consolidation, merger, sale or similar transaction, and a corresponding immediate adjustment to the number of Warrant Shares acquirable upon exercise of this Warrant without regard to any limitations or restrictions on exercise, if the value so reflected is less than the Exercise Price in effect immediately prior to such consolidation, merger, sale or similar transaction). The provisions of this SectionΒ 4(e) shall similarly apply to successive Reorganizations. The Company shall not effect any Reorganization unless, prior to the consummation thereof, the successor Person (if other than the Company) resulting from such Reorganization shall assume, by written instrument substantially similar in form and substance to this Warrant and satisfactory to the Holder, the obligation to deliver to the Holder such shares of stock, securities or assets which, in accordance with the foregoing provisions, such Holder shall be entitled to receive upon exercise of this Warrant. Notwithstanding anything to the contrary contained herein, the Holder shall have the right to elect prior to the consummation of any Reorganization, to give effect to the exercise rights contained in SectionΒ 2 instead of giving effect to the provisions contained in this SectionΒ 4(e) with respect to this Warrant.
(f) Certain Events. If any event of the type contemplated by the provisions of this SectionΒ 4 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features) occurs, then the Board shall make an appropriate adjustment in the Exercise Price and the number of Warrant Shares issuable upon exercise of this Warrant so as to protect the rights of the Holder in a manner consistent with the provisions of this SectionΒ 4; provided, that no such adjustment pursuant to this SectionΒ 4(f) shall increase the Exercise Price or decrease the number of Warrant Shares issuable as otherwise determined pursuant to this SectionΒ 4.
(g) Certificate as to Adjustment.
(i) As promptly as reasonably practicable following any adjustment of the Exercise Price, but in any event not later than five Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail such adjustment and the facts upon which it is based and certifying the calculation thereof.
Β
11
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(ii) As promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not later than five Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer certifying the Exercise Price then in effect and the number of Warrant Shares or the amount, if any, of other shares of stock, securities or assets then issuable upon exercise of the Warrant.
(h) Notices. In the event:
(i) that the Company shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon exercise of the Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, to vote at a meeting (or by written consent), to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities, or to receive any other security; or
(ii) of any capital reorganization of the Company, any reclassification of the Common Stock of the Company, any consolidation or merger of the Company with or into another Person, or sale of all or substantially all of the Companyβs assets to another Person; or
(iii) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company;
then, and in each such case, the Company shall send or cause to be sent to the Holder at least ten days prior to the applicable record date or the applicable expected effective date, as the case may be, for the event, a written notice specifying, as the case may be, (A)Β the record date for such dividend, distribution, meeting or consent or other right or action, and a description of such dividend, distribution or other right or action to be taken at such meeting or by written consent, or (B)Β the effective date on which such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up is proposed to take place, and the date, if any is to be fixed, as of which the books of the Company shall close or a record shall be taken with respect to which the holders of record of Common Stock (or such other capital stock or securities at the time issuable upon exercise of the Warrant) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up, and the amount per share and character of such exchange applicable to the Warrant and the Warrant Shares.
5. Purchase Rights. In addition to any adjustments pursuant to SectionΒ 4 above, if at any time the Company grants, issues or sells any shares of Common Stock or Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of Common Stock as of immediately prior to such grant, issuance or sale (the βPurchase Rightsβ), then the Company shall provide the Holder the right to acquire, upon the terms applicable to
Β
12
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
such Purchase Rights, the aggregate Purchase Rights that the Holder would have acquired if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.
6. Transfer of Warrant. Subject to (x)Β the prior written consent of the Company (provided, that the Holder may transfer this Warrant without the prior consent of the Company to its Permitted Transferees) and (y)Β the transfer conditions referred to in the legend endorsed hereon, this Warrant and all rights hereunder are transferable, in whole or in part, by the Holder without charge to the Holder, upon surrender of this Warrant to the Company at its then principal executive offices together with (i)Β a properly completed and duly executed Assignment in the form attached hereto as Exhibit B, and (ii)Β duly executed counterpart signature pages to each of the Stockholders Agreement and the Registration Rights Agreement in the forms attached as Exhibit C. Upon such compliance, surrender and delivery, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly be cancelled.
7. Holder Not Deemed a Stockholder. Except as otherwise specifically provided herein, prior to the issuance to the Holder of the Warrant Shares upon the due exercise of this Warrant, the Holder shall not be entitled to vote or receive dividends or be deemed the holder of Warrant Shares for any purpose. Nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this SectionΒ 7, the Company shall provide the Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with the giving thereof to the stockholders.
8. Replacement on Loss; Division and Combination.
(a) Replacement of Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated or destroyed; provided, that, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.
Β
13
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(b) Division and Combination of Warrant. This Warrant may be divided or, following any such division of this Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its then principal executive offices, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the respective Holders or their agents or attorneys. The Company shall at its own expense execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance with such notice. Such new Warrant or Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable in the aggregate for an equivalent number of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such notice.
9. No Impairment. The Company shall not, by amendment of its certificate of incorporation or bylaws, or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed by it hereunder, but shall at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may reasonably be requested by the Holder in order to protect the exercise rights of the Holder against dilution or other impairment, consistent with the tenor and purpose of this Warrant.
10. Representations, Warranties and Covenants of the Company. The Company hereby represents, covenants and agrees:
(a) This Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized and validly issued.
(b) All Warrant Shares issuable pursuant to the terms hereof shall be, and the Company shall take all such actions as may be necessary or appropriate in order that such Warrant Shares are, upon issuance, validly issued, fully paid and non-assessable, issued without violation of any preemptive or similar rights, and free and clear of all taxes, liens and charges.
(c) The Company shall, at its own expense, (i)Β take all such actions as may be necessary or appropriate to ensure that (A)Β all Warrant Shares are issued without violation of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which Warrant Shares may be listed at the time of such exercise (except for official notice of issuance which shall be immediately delivered by the Company upon each such issuance), and (B)Β the Warrant Shares, immediately upon their issuance upon the exercise of the Warrants, will be listed on each securities exchange, if any, on which the Common Stock is then listed and (ii)Β obtain and keep effective any and all permits, consents and approvals of governmental agencies and authorities which may from time to time be required of the Company in order to satisfy its obligations hereunder.
Β
14
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(d) This Warrant is not inconsistent with the Companyβs certificate of incorporation or bylaws, does not contravene any law or governmental rule, regulation or order, does not and will not contravene any provision of, or constitute a default under, any agreement or other instrument to which the Company is a party or by which it is bound, and constitutes a legal, valid and binding agreement of the Company, enforceable in accordance with its terms. The Company shall not amend its certificate of incorporation, bylaws or other organizational documents in any way (whether by merger or otherwise) that would (i)Β adversely affect the Warrantholder or the holders of Warrant Shares in any manner different from such amendmentβs effect on the class of Common Stock taken as a whole, or (ii)Β result in a change in the Companyβs organizational form.
11. Warrant Register. The Company shall keep and properly maintain at its principal executive offices books for the registration of the Warrant and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on such register as the Holder thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except any assignment, division, combination or other transfer of the Warrant effected in accordance with the provisions of this Warrant.
12. Participation in Corporate Distributions. The Company shall not declare, make or pay any dividend or other distribution, whether in cash, securities (other than Common Stock or Convertible Securities) or other property, with respect to its Common Stock or any Convertible Securities unless (a)Β an adjustment to the Exercise Price and the number of Warrant Shares is made with respect thereto pursuant to SectionΒ 4 above or (b)Β the Company concurrently makes a distribution to the Holder consisting of (i)Β the amount of cash, securities and property distributed with respect to each outstanding share of Common Stock (in the case of Convertible Securities, determined on an as converted basis) multiplied by (ii)Β the number of shares of Common Stock then issuable upon exercise of this Warrant.
13. Miscellaneous.
(a) Notices. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given: (a)Β when delivered by hand (with written confirmation of receipt); (b)Β when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c)Β on the date sent by facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient; or (d)Β on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses indicated below (or at such other address for a party as shall be specified in a notice given in accordance with this SectionΒ 13(a)).
Β
If to the Company: | Β Β | SLS Breeze Holdings, Inc. |
Β Β | 00000 Xxxxxxx Xxxx., 00xx Xxxxx | |
Β Β | Xxxxxxxx Xxxxx, XX 00000 | |
Β Β | Attention: Controller | |
Β Β | Fax No.: (000) 000-0000 | |
Β Β | Email: accounting @xxxxxxxxx.xxx |
Β
15
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
with a copy (which shall not | Β Β | Silver Lake Sumeru Fund, L.P. |
constitute notice) to: | Β Β | 0000 Xxxx Xxxx Xxxx, Xxxxx 000 |
Β Β | Xxxxx Xxxx, XX 00000 | |
Β Β | Attention: Xxxxx Xxxxxxx | |
Β Β | Fax No.: (000) 000-0000 | |
Β Β | Email: Xxxxx.Xxxxxxx@XxxxxxXxxx.xxx | |
Β Β | and | |
Β Β | Xxxxxxxx & Xxxxx LLP | |
Β Β | 000 Xxxxxxxxxx Xxxxxx | |
Β Β | Xxx Xxxxxxxxx, XX 00000 | |
Β Β | Attention: Xxxxxxxxxxx Xxxxxxx | |
Β Β | Fax No.: (000) 000-0000 | |
Β Β | Email: xxxxxxxxxxx.xxxxxxx@xxxxxxxx.xxx | |
If to the Holder: | Β Β | c/x Xxxxxxxxxx Capital Partners, LLC |
Β Β | 0000 00xx Xxxxxx, Xxxxx 0000 | |
Β Β | Xxxxx Xxxxxx, XX 00000 | |
Β Β | Attention: Xxxxx Xxxxx | |
Β Β | Fax No.: (000) 000-0000 | |
Β Β | Email: xxxxx.xxxxx@xxxxxxxxxxxxxxxxx.xxx | |
with a copy (which shall not | Β Β | Proskauer Rose LLP |
constitute notice) to: | Β Β | 0000 Xxxxxxx Xxxx Xxxx, Xxxxx 0000 |
Β Β | Xxx Xxxxxxx, XX 00000 | |
Β Β | Attention: Xxxxxxx X. Xxxxxxxx | |
Β Β | Fax No.: (000) 000-0000 | |
Β Β | Email: xxxxxxxxx@xxxxxxxxx.xxx |
(b) Expenses. The Company shall pay all out-of-pocket costs and expenses, including reasonable attorneysβ fees and fees, costs and expenses of accountants, advisors and consultants, incurred by the Holder and its counsel in connection with (i)Β any amendments, modifications or waivers of the provisions hereof, or (ii)Β any dispute or proceeding in respect to the enforcement of the Holderβs rights under this Warrant or the Purchase Agreement in which the Holder is the prevailing party.
(c) Cumulative Remedies. Except to the extent expressly provided in SectionΒ 7 to the contrary, the rights and remedies provided in this Warrant are cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or remedies available at law, in equity or otherwise.
Β
16
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(d) Equitable Relief. Each of the Company and the Holder acknowledges that the rights of each party to consummate the transactions contemplated hereby are special, unique and of extraordinary character and that, in the event that any party violates or fails or refuses to perform any covenant or agreement made by it herein, the non-breaching party will (i)Β be without an adequate remedy at law and (ii)Β suffer irreparable damage. In the event that any party violates or fails or refuses to perform any covenant or agreement made by such party herein, the non-breaching party or parties may, subject to the terms hereof and in addition to any remedy at law for damages or other relief to which such party may be entitled, institute and prosecute an action in any court of competent jurisdiction to enforce specific performance of such covenant or agreement or seek any other injunctive or equitable relief, without posting any bond or other undertaking.
(e) Entire Agreement. This Warrant, together with the Purchase Agreement (including the exhibits thereto), constitutes the sole and entire agreement of the parties to this Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter.
(f) Successor and Assigns. Whenever in this Warrant any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and assigns of such party; and all covenants, promises and agreements by or on behalf of the parties hereto that are contained in this Warrant shall bind and inure to the benefit of their respective successors and assigns. Such successors or permitted assigns of the Holder shall be deemed to be a Holder for all purposes hereunder. The Company shall not assign or delegate any of its rights or duties hereunder without the prior written consent of the Holder, and any attempted assignment without such consent shall be null and void.
(g) Headings. The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.
(h) Amendment and Modification; Waiver. This Warrant may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by the Company or the Holder of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.
(i) Survival. The representations, warranties, covenants and conditions of the respective parties contained herein or made pursuant to this Warrant shall survive the execution and delivery of this Warrant.
Β
17
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
(j) Severability. In the event any one or more of the provisions contained in this Warrant be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
(k) Governing Law. This Warrant shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of New York.
(l) Submission to Jurisdiction. Any legal suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated hereby may be instituted in the federal courts of the United States of America or the courts of the State of New York in each case located in New York City, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by certified or registered mail to such partyβs address set forth herein shall be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. Each party irrevocably consents to service of process in the manner provided for notices in SectionΒ 13(a). Nothing herein will affect the right of any party to serve process in any other manner permitted by law.
(m) Waiver of Jury Trial. Each party acknowledges and agrees that any controversy that may arise under this Warrant is likely to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Warrant or the transactions contemplated hereby.
(n) Counterparts. This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.
(o) No Strict Construction. This Warrant shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.
[SIGNATURE PAGE FOLLOWS]
Β
18
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
IN WITNESS WHEREOF, the Company has duly executed this Warrant on the Original Issue Date.
Β
SLS BREEZE HOLDINGS, INC. | ||
By: | Β | Β |
Name: |
Β | |
Title: |
Β |
Accepted and agreed,
Β
[WARRANTHOLDER] | ||
By: | Β | Β |
Name: |
Β | |
Title: |
Β |
Β
19
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT A
EXERCISE AGREEMENT
To: Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β
Β
(1) | The undersigned Holder hereby elects to purchase Β Β Β Β Β Β Β Β Β Β Β Β shares of the Common Stock of SLS Breeze Holdings, Inc. (the βCompanyβ), pursuant to the terms of the Warrant dated [Β Β Β Β Β Β Β Β Β Β Β Β ], 2013 (the βWarrantβ) between the Company and the Holder, and [tenders herewith a certified or official bank check in the amount consistent with SectionΒ 3(b)(i) of the Warrant] [elects the method of exercise set forth in SectionΒ 3(b)(ii) of the Warrant][tenders herewith [β’] pursuant to SectionΒ 3(b)(iii) of the Warrant]. |
Β
(2) | Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such other name as is specified below. |
Β
Β Β | Β | |||
Β Β | (Name) | |||
Β | Β Β | Β | ||
Β Β | (Address) | |||
HOLDER: |
Β Β | Β Β | ||
Β Β | By: | Β Β | Β | |
Β Β | Title: | Β Β | Β | |
Β Β | Date: | Β Β | Β |
Β
20
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT B
ASSIGNMENT
(To transfer or assign the foregoing Warrant execute this form and supply required information. Do not use this form to purchase shares.)
FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby transferred and assigned to
Β
Β | Β |
Β Β | ||||
Β | (βThe Transfereeβ) | Β Β | ||||
Β | whoseΒ addressΒ is | Β Β | Β |
Β Β | ||
Β | Β |
Β Β | ||||
Β | Dated: Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β | Β Β | ||||
Β | HolderβsΒ Signature: | Β Β | Β |
Β Β | ||
Β | Holderβs Address: | Β Β | Β |
Β Β | ||
Β | Β |
Β Β |
The transfer made pursuant hereto is made without recourse to the Holder and without representation or warranty express or implied by the Holder, except that the Holder represents and warrants to the Transferee that it is the legal owner of the interest in the Warrant being assigned hereby.
Β
21
[***] = CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THIS OMITTED INFORMATION.
Β
EXHIBIT C
FORM OF JOINDERS
Β
22